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ABSTRACT 
 
Aim 
This study aimed to determine how CMs used by surgical patients are managed in the 
hospital system by doctors and pharmacists and what patient and practitioner 
influences affect this management.   
 
Research design and method 
Five systematic reviews were conducted to investigate the peer-reviewed literature for 
information about Australians use of CM; overseas and Australian doctors and CM; 
surgical patients use of CM and safety information about CMs in surgery as a basis to 
design and conduct three surveys. Surveys of hospital doctors, pharmacists and 
surgical patients were used to obtain measurement of people’s attitudes, perceptions, 
behaviours and usage of CMs. For healthcare practitioners, knowledge of 
complementary medicines (CMs), past training, current practice and interest in future 
practice of complementary therapies (CTs) and education was also investigated.   
 
Results 
Approximately 50% of surgical patients reported taking CMs in the 2 weeks prior to 
surgery and approximately 50% of these patients intended to continue use in hospital. 
The most commonly used CMs were: fish oil supplements, multivitamins, vitamin C 
and glucosamine supplements as well as some CMs considered to potentially increase 
bleeding risk or induce drug interactions. It was not uncommon for CMs to be used at 
the same time as prescription medicines.  
 
Most surgical patients in general self-prescribe their CMs or have them recommended 
by family and friends whereas medical practitioners were the main prescribers to 
cardiac surgery patients. Nearly 60% of patients using CMs in the 2 weeks prior to 
admission did not tell hospital staff about use. The main reason for non-disclosure 
was not being asked about use whereas fear of a negative response was rarely a 
concern. The most common sources of information surgery patients refer to were GPs, 
pharmacists and health food stores. Hospital doctors and pharmacists did not routinely 
refer to information sources about CMs safety.  
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The majority of doctors and pharmacists did not routinely ask patients about CMs, or 
record usage information. They had little training and knowledge of the evidence of 
commonly used CMs and lacked confidence in dealing with CMs-related issues. Their 
attitude to CMs is moderately negative and many are wary of safety, efficacy and 
cost-effectiveness issues. The majority of practitioners considered some CTs as 
potentially useful, particularly acupuncture, massage and meditation whereas the 
medicinal CTs and chiropractic were considered potentially harmful. Most 
practitioners were interested in future education about CMs and CTs and some would 
consider practising CTs. Personal usage of CTs was low although there was 
substantial interest in receiving future treatment. 
 
Conclusion 
Despite many strategically orientated initiatives developed in Australia to promote 
evidence based medicine (EBM) and quality use of medicines (QUM), it appears that 
CMs have been largely ignored and overlooked in the practice of Medicine and 
Pharmacy within the hospital system. Furthermore, it appears that in regards to CMs a 
‘don’t ask, don’t tell, don’t know’ culture exists within hospitals and that evidence 
based patient-centred care and concordance is not being achieved and potentially 
patient safety and wellbeing is being compromised. 
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Abbreviations and definitions 
 
 
In this paper the term ‘complementary medicine’ or CM will be used instead of 
‘complementary and alternative medicine’ or ‘CAM’ based on evidence that in 
practice it is generally used as an adjunct to conventional care and not as an 
alternative by patients. 
  
Complementary therapies (CTs) is an umbrella term which will be used here to 
refer to the 5 key categories of treatment considered CM by the above definition in 
Australia.  
• Mind-body practices e.g. meditation 
• Medicinal treatments e.g. herbal medicine 
• Manual treatments e.g. chiropractic, massage 
• Bioenergetic treatments e.g. acupuncture 
• Philosophical systems e.g. Ayurveda  
 
Complementary medicines (CMs) or complementary medicine product: is 
defined as herbal medicines, nutritional and food supplements and homeopathic 
remedies available over-the-counter (OTC) from pharmacies, supermarkets, health 
food stores, through mail order companies, the internet and from practitioner and 
medical clinics. 
 
Herbal medicines: refers to plant based medicines used for the prevention and 
treatment of disease. They may be presented in a variety of dose forms such as tablets 
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and capsules, liquids, powders or teas. In this report, common names of herbal 
medicines will generally be used. 
  
Nutritional supplements: refers to products containing essential nutrients (vitamins 
and/or minerals) or organic compounds essential for health and maintaining body 
functions e.g. a multivitamin tablet.  
 
Food supplements: refers to products which increase total dietary intake but are not 
conventional foods. These products may contain concentrated food extracts, for 
example soy, colostrum or whey protein, probiotics and sometimes contain additional 
vitamins, minerals, phytochemicals, amino acids, enzymes or herbs. 
 
Surgical patients: refers to people who have been admitted to hospital to undergo a 
surgical procedure. 
 
Higher education : refers to education of tertiary level and higher 
 
Higher income : refers to an annual income of $Au 100,000 or higher 
 
Prevalence of CMs use : The proportion of surveyed volunteers who used CM within 
the specified time period.  
 
Predictors of use : The characteristics of people using the specified medicines or 
therapies.  
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Abbreviations 
 
 
ADR – Adverse Drug Reaction 
ADRAC - Adverse Drug Reactions Advisory Committee 
AHA – Alternative Health Approach 
CHD – Coronary Heart Disease 
CMs – Complementary Medicines (refers to medicinal products only)  
CTs – Complementary Therapies (refers to medicinal and non-medicinal approaches) 
CVD – Cardiovascular Disease 
CYP – Cytochrome 
EBM – Evidence Based Medicine 
EBPC – Evidence Based Patient Care 
GMP – Good Manufacturing Practice  
GP – General Practitioner  
IM – Integrative Medicine 
LFTS – Liver Function Tests 
MI – Myocardial Infarction  
NHMRC – National Health and Medical Research Council 
OTC – Over The Counter 
PCC – Patient Centred Care 
P-gp – P glycoprotein  
QUM – Quality Use of Medicines  
TGA – Therapeutic Goods Administration 
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Overview of thesis 
 
 
 
This research is a study of surgical inpatient’s attitudes, perceptions, use and 
behaviours regarding CMs. It is also a study of hospital doctors and pharmacists’ 
attitudes, perceptions, practices and knowledge of CM, with a focus on medication 
safety. The findings of this research will have implications for public health, the 
hospital system, health education and clinical practice.  
 
A literature review of relevant information and research into CM, surgical patients, 
medical practitioners, pharmacists and safety is presented in Chapter One within four 
sections. This begins with Section A and a discussion of the introductory and 
background concepts relevant to this thesis. Section B presents information about the 
general population’s usage, attitudes, and perceptions about CM, with a systematic 
review of Australian studies. A second systematic review is presented of studies 
conducted overseas of medical practitioners and a third of Australian medical 
practitioners and their beliefs, referral patterns, knowledge, training and use of CM. 
Finally, a literature review of overseas and Australian studies of pharmacists and their 
beliefs, referral patterns, knowledge, training and use of CM is included. In section C, 
a systematic review of published studies regarding surgical patients use and attitudes 
to CM is included, with additional information about cardiac surgery patients. A 
review of the safety of OTC CMs will be presented in section D with a focus on drug 
interactions and safety issues of significance to surgery. This includes a systematic 
review of the published literature regarding CMs in surgery and presents a discussion 
of the limitation of the available information. 
 
Chapter two will describe the patient and practitioner surveys research design, 
methodology and ethical issues. Research results and statistical analysis will be 
presented in Chapter three. A discussion of the survey results will be presented in 
Chapter four as six sections. The first three sections will discuss results from the three 
practitioner surveys, the next two sections will discuss the two patient survey results 
and the final section will provide a general discussion which integrates information 
obtained from all studies and further discusses the emerging themes.  Chapter five 
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will present a summary of the research findings and conclusions. Recommendations 
to improve current practice and patient safety are also included in this chapter. 
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Chapter One 
 
Section A 
Introductory Concepts 
 
 
A.1.0  Introduction 
 
This section briefly illustrates some of the underlying concepts referred to in this 
thesis. It describes various definitions of complementary and alternative medicine and 
explores its evolution from the early 1990’s to current times. A discussion of evidence 
based medicine and its evolution to include a more patient centred focus is also 
explored with a focus on its relevance in CM. The section concludes with a discussion 
about the importance of investigating complementary medicines and their use in 
hospitals.  
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A.2.0  What is Complementary and Alternative Medicine 
(CAM)? 
 
Defining the term ‘complementary and alternative medicine’ is a difficult task as no 
one definition is accepted globally. In part, this is due to the multidimensionality of 
the concept. In some cases, CAM has been defined by what it is not, rather than what 
it is and definitions fail to acknowledge the relative nature of the concept. In most 
cases, the definition is also based on comparisons with orthodox medicine. It is 
interesting to observe the rapid shift in terminology which has occurred over the last 
decade in response to the changes in attitudes and perceptions about CAM. 
Commonly cited definitions of CAM are provided in Table 1. 
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Definition Year of 
publication 
Reference to 
interventions 
Reference to 
healthcare 
systems 
Reference to 
culture 
Reference to 
time  
‘ interventions neither taught widely in 
medical schools nor generally available 
in US hospitals” 
(1) 
1993 Yes No Yes No  
‘Complementary and alternative 
medicine (CAM) is a broad domain of 
healing resources that encompasses all 
health systems, modalities, and 
practices and their accompanying 
theories and beliefs, other than those 
intrinsic to the politically dominant 
health system of a particular society or 
culture in a given historical period. CAM 
includes all such practices and ideas 
self-defined by their users as preventing 
or treating illness or promoting health 
and well-being’. 
(2) 
1997 Yes Yes Yes Yes 
‘a broad set of health care practises 
that are not readily integrated into the 
dominant health care model, because 
they pose challenges to diverse and 
societal beliefs and practices (cultural, 
scientific, medical and educational)’ 
(3) 
 
1998 Yes  Yes  Yes  No  
‘ a group of therapeutic and diagnostic 
disciplines that exist largely outside the 
institutions where conventional 
healthcare is taught and provided’ (4) 
 
1999 Yes Yes Yes No 
‘Complementary and alternative 
medicine (CAM) is a broad domain of 
healing resources that encompasses all 
health systems, modalities, and 
practices and their accompanying 
1999 Yes Yes Yes Yes 
Table 1. Commonly cited definitions of Complementary and Alternative Medicine 
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theories and beliefs, other than those 
intrinsic to the politically dominant 
health system of a particular society or 
culture in a given historical period. CAM 
includes all such practices and ideas 
self-defined by their users as preventing 
or treating illness or promoting health 
and well-being. Boundaries within CAM 
and between the CAM domain and that 
of the dominant system are not always 
sharp or fixed.’ 
(4) 
 
'diagnosis, treatment and/or prevention 
which complements mainstream 
medicine by contributing to a common 
whole, satisfying a demand not met by 
orthodoxy, or diversifying the 
conceptual framework of medicine' (5) 
2000 Yes Yes Yes No  
 
Eisenberg et al offered their definition of ‘alternative medical therapies’ in 1993 as 
part of a survey they conducted of the general population (6). It is a functional 
definition that limits CAM to interventions only and makes no reference to the 
various paradigms it encompasses. This definition can now be considered obsolete in 
Europe and some countries such as the United States and Canada where many 
medical schools have begun to teach students CAM modalities and some hospitals 
offer CAM therapies.  
 
The 1990’s were a period of accelerated growth and interest in the use of CAM 
therapies. They were characterised by more tolerance and willingness to co-operate by 
the medical establishment, largely as a result of growing patient demand for and 
substantial expenditure on CAM. As surveys indicated that CAM was being used 
alongside conventional medicine instead of as a true alternative, the term ‘alternative 
medicine’ started to appear too limited. By 1997, the Office of Alternative Medicine 
in the United States was renamed the National Center for Complementary and 
Alternative Medicine (NCCAM) which underscored this shift in emphasis (7).  
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During this period, the National Institute of Health offered a much broader definition 
of CAM which acknowledged that CAM refers to more than treatment interventions 
but also includes various philosophical paradigms. It also acknowledged that the term 
CAM is relative to the setting of its use. As such, a treatment considered as CAM 
when practised within a specific time and culture may not be considered a CAM 
treatment when practised elsewhere or at a different time. Whilst being a much more 
comprehensive definition, it still does not provide a clear method of differentiating 
CAM practices from mainstream healthcare as it relies on the subjectivity of the 
individual. The definition currently used by the Cochrane Collaboration is essentially 
the same as the one developed by the NIH however it goes further by acknowledging 
the flexibility of what defines CAM.  
 
In the British Medical Journal, Zollman and Vickers defined CAM in a similar way to 
Eisenberg et al however they also included diagnostic methods which are different to 
mainstream methods thereby acknowledging that CAM also refer to health systems, 
not just treatments (4).  
 
The later definition developed by Ernst et al from the U.K. introduces the concept of 
CAM as being an adjunct to mainstream medicine as distinct from it being an 
alternative approach. This introduces the concept of ‘integrative medicine’ whereby 
both CAM and mainstream medicine are used together and is indicative of the 
changing usage patterns and attitudes to CAM.  
 
As seen by these different definitions, the boundary between CAM and mainstream 
medicine is a fluid one and has been shifting over time as a result of societies move 
towards medical pluralism. There are numerous examples of where the line between 
CAM and conventional is already blurred such as: 
 
• Acupuncture for pain control 
• Stress management for anxiety 
• Dietary manipulation for coronary heart disease 
• Massage as practised in rehabilitation medicine 
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A.2.1  Integrative medicine (IM) 
 
The term ‘integrative (or, sometimes, integrated) medicine’ describes a relatively 
recent development in CM. The NCCAM has defined integrative medicine as: health 
care that “combines mainstream medical therapies and CAM therapies for which there 
is some high-quality scientific evidence of safety and effectiveness.”(8). The 
integration of CM with conventional healthcare may provide an opportunity to 
enhance health and healing by emphasizing the importance of the patient-practitioner 
relationship, healthy diet and lifestyle approaches, psychological wellbeing and 
disease prevention strategies.  
 
Three levels of integration have been defined by the WHO to describe the extent of 
CM integration into pre-existing health care systems (9). These are: tolerant, inclusive 
and integrative situations. A tolerant situation is said to occur when the dominant 
conventional healthcare system is autocratic and CM may be practiced in parallel but 
is not officially recognised. An inclusive situation arises when CM is recognised but 
not fully integrated into delivery of healthcare. An integrative situation is when CM is 
officially recognised and incorporated into all aspects of health care, such as national 
medicines policies, utilisation in hospitals and reimbursed under insurance schemes, 
e.g. in China.  
 
It has further been suggested that integration occurs on two levels : the individual 
patient and at a broader policy level (10). Surveys have consistently shown that 
Australians use CM, often as an adjunct to conventional care suggesting that 
integration is already happening at an individual patient level (11-
13;13;14;14;15;15;16). At a broader level, the Royal Australian College of General 
Practitioners (RACGP) and the Australian Medical Association (AMA) have released 
position statements about CM in the last few years which promote the adoption of 
‘complementary medicine with high levels of scientific evidence and demonstrating 
safety and efficacy’ (17). The RACGP position statement goes onto state that such 
medicine should be ‘used as part of any high quality medical practice’(18).  It also 
stated ‘evidence based aspects of complementary medicine are part of the repertoire 
of patient care in mainstream medical practice’.  In contrast, the Pharmaceutical 
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Society of Australia’s position statement about CM has remained unchanged since 
1997 and makes no mention of promoting the integration of evidence based CMs into 
practice (19). It does state that ‘the provision of complementary medicines is at the 
discretion of individual pharmacists who must exercise their professional judgement. 
However, pharmacists involved in the supply of such products have the same 
obligation to provide information and advice, consistent with consumer needs, as they 
do with registered prescription and proprietary medicines’. 
 
Several theories have been put forward to explain the rise of integrative medicine. 
Parusnikova suggests that integration is motivated by a cognitive interest in CAM due 
to research suggesting particular therapies have merits and possibly by a need to 
control the CAM movement through a strategy based on incorporation and 
subordination and also to utilize its money-making potential (20). Some CAM 
practitioners are concerned that CAM might be “co-opted” by conventional medicine 
through the integrative process (21) whereas others view integrative medicine as a 
component of the patient-centered care movement. 
 
In spite of the debate regarding the definition of CAM, this thesis will use the term 
complementary medicine or CM. CM encompasses various therapies, healing systems 
and medicinal treatments. This thesis will use the term complementary medicines 
(CMs) to refer to the ingested medicines only: herbal medicines, nutritional and food 
supplements and homeopathic remedies.  These are medicinal products which are 
generally bought over-the-counter (OTC) in retail stores, over the internet and from 
health care clinics. Further details about definitions used in this thesis are presented 
in the glossary and abbreviations section.  
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A.3.0 Key principles in the practice of medicine and pharmacy 
 
A.3.1  Evidence based medicine (EBM) 
 
Evidence Based Medicine (EBM) is a tool widely used to evaluate health care 
information and act as a means to select and incorporate health care research into the 
practice of patient care. It is based on universally appealing ethical and clinical ideals 
in that it helps patients and doctors to make better informed choices. One well 
accepted definition is: 
 
‘Evidence based medicine is the conscientious, explicit, and judicious use of current 
best evidence in making decisions about the care of individual patients’            (22) 
  
The philosophical underpinnings of the EBM movement are more than a century old 
however the term was coined and its explicit incorporation into medical education and 
clinical practice has become widespread only in the past two decades. During this 
time, it appears that EBM has become widely accepted as the cornerstone of good 
clinical practice. 
 
In 1979 and again in 1983, a document published by the US Congressional Office of 
Technology Assessment claimed that ‘ it has been estimated that only 10-20% of all 
procedures currently used in medical practice have been shown to be efficacious by 
controlled trial’ (23). In other words, 80-90% of medical practice was not supported 
by scientific research evidence. This claim was based on a 1963 paper which had 
assessed the prescribing habits of 19 family doctors in a northern British town over a 
2 week period (24). Little about these surveys was actually relevant to the general 
practice of medicine and is even less relevant today however, it did create much 
debate and lead to further enquiry.  
 
The concept of EBM originated in Canada by a team of clinical epidemiologists over 
the next decade. In the 1970’s and 80’s, David Sackett and Walter Spitzer at 
McMasters University in Canada took up the challenge of determining and clarifying 
the theme of ‘effectiveness’ in medicine. Spitzer chaired a Task Force which 
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reviewed the primary evidence for preventative interventions in primary care and 
graded the evidence which was used to show that a treatment did more good than 
harm. Sackett organized a series of seminars on Health Care evaluation to highlight 
the usefulness of referring to randomised clinical studies when making decisions.  
 
Sackett and colleagues also promoted the idea that epidemiological principles should 
be used to incorporate the latest evidence produced by these reviews into the core of 
physician training and medical practice. Although this group first expanded on the 
concept in a textbook published in 1985 entitled “ Clinical Epidemiology” it was not 
until the early 1990’s that the phrase ‘evidence based medicine’ was being widely 
used and the new paradigm took root (25).   
 
In 1992, Sackett and colleagues referred to the crucial importance of clinical skills 
and the roles of both patients' needs and non-randomised evidence in an early paper 
on evidence based medicine (26).  They also stated that many aspects of clinical 
medicine cannot, or will not, ever be adequately tested however information derived 
from clinical experience and intuition can be misleading and clinicians are urged to be 
cautious when interpreting such information. Despite this, randomised controlled 
trials and systematic reviews have assumed pre-eminence as the gold standards and 
placed at the top of the hierarchy of evidence in EBM in the belief that they are least 
likely to provide 'misleading' information about the effect of an intervention (27).  
 
Increasingly, the limitations of this approach are being recognised and addressed in 
the literature. These encompass both philosophical and practical problems associated 
with its use resulting in a slow evolving process which is transforming EBM from its 
original form (28-31).  
 
Dracup and Bryan-Brown suggest three main deficiencies of EBM (28). First, the 
evidence on which decisions are based is developed from clinical trials with highly 
homogeneous samples, under controlled conditions and therefore not always 
generalisable to the individual patient and their particular circumstance. Second, 
evidence-based medicine is disease-oriented or based on protocols and not designed 
to answer the question, "What is the best treatment or procedure for this patient at this 
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particular time?" Lastly, evidence is unavailable for many of the questions that arise 
during the course of clinical practice.  
 
Buetow and Kenealy suggest that there six dimensions on which medicine is based : 
scientific evidence, theoretic evidence, practical evidence, expert evidence, judicial 
evidence and ethics-based evidence (30). When medicine focuses solely on scientific 
evidence, as is largely the case with EBM, it loses the ability to inform and defend 
judgements and decisions using additional insights from outside science. Buetow et al 
further make the observation that compared with earlier formulations of EBM, newer 
versions have started to emerge which acknowledge that research evidence alone is an 
inadequate guide to action and clinical expertise is the 'central', integrative force in 
clinical decision making (32). One of the key steps required to allow EBM to progress 
further is the redefinition of what constitutes evidence. 
 
A.3.1.1  EBM and CM 
 
CM practitioners and conventional medical practitioners share the similar goal of 
providing optimal health care to their patients. EBM is of relevance to all healthcare 
information, including information about CM. It is also of relevance to all healthcare 
interventions, regardless of their origins, including CM treatments.  
 
Already numerous randomised controlled studies (RCTs), systematic reviews and 
meta-analyses have been published in the peer-reviewed literature. One review 
identified a total of 20,209 articles published about CM during the period 1997-2002, 
representing 0.7% of the total number of MEDLINE - listed articles (33). Thirty 
percent were published in journals with an impact factor over 1.000 and 6.9% over 
5.000. Overall, 12.9% of published articles were randomised controlled studies and 
clinical trials and 0.5% were meta-analyses. According to a 2004 review, over 5800 
CM randomised controlled trials have been identified and made available through the 
central Cochrane Library (34), making CM one of the better represented specialties on 
the database.  
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Whilst this is encouraging, one of the most important issues regarding EBM and CM 
relates to the definition of evidence. EBM continues to give precedence to 
information derived from RCTs, as evidenced by the hierarchy of evidence supplied 
by the National Health and Medical Research Council (NHMRC), however this 
methodology is not always adequate or possible when investigating CM.   
 
One problem of special relevance in CM is that RCTs do not necessarily reflect ‘real 
world’ practice. Some CM therapies such as naturopathy, homeopathy or Traditional 
Chinese Medicine rely on individual diagnosis and individualised treatments and can 
comprise of multiple ingredient medicines and/or diet and lifestyle advice. The 
randomised controlled trial format relies on standardised treatments and although 
inclusion and exclusion criteria are used, they make little allowance for individual 
factors such as biological and social differences. As such, RCTs which isolate a  
multi-modality practice to one or two standardised treatments will fail to represent the 
practice as it is truly conducted.  
 
Other aspects of CM practice which are difficult to assess by RCT are those for which 
it is difficult to develop an adequate placebo, such as massage. Additionally, validated 
measures do not exist for assessing some outcomes, such as changes in Qi. There are 
also studies which are unlikely to be performed due to ethical considerations such as 
safety studies in pregnancy and lactation. As such, other methodologies are required 
which are considered valid by the research community and given appropriate 
recognition in the EBM hierarchy of evidence.   
 
Unlike the contemporary practice of Western medicine, some CM practices have been 
conducted for many generations giving rise to a wealth of information often called 
‘traditional evidence’. This information source is based on the tenets of good clinical 
practice – careful observation and knowledge of the patient, the treatment and the 
response. This method of data collection constitutes a different form of evidence 
which has the advantage of real world applicability although it may lack subjectivity. 
Whilst traditional information is still widely used to guide clinical practice, 
particularly in the absence of other forms of evidence, it is not recognised as a valid 
form of evidence according to the NHMRC.  
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One last observation that requires discussion is the relative lack of funding 
opportunities for the conduct of clinical trials in CM, in comparison to pharmaceutical 
research. Unlike the investigation of pharmaceutical drugs, CM therapies and 
medicines are rarely patentable and therefore provide manufacturers and suppliers 
with little incentive to fund expensive clinical studies. The short-fall can be made up 
by other potential funding sources such as government funding or philanthropic 
donations however these are highly competitive and rarely earmarked for CM 
research (35). Until adequate funding becomes consistently available, there will 
remain a relative shortage of world-class RCTs in CM in comparison to 
pharmaceutical research. 
 
A.3.1.2  EBM implementation in Australia 
 
A 2005 study of 244 Australian physicians found that they clearly endorse the 
principles of EBM, have a good understanding of EBM technical terms and would 
endorse evidence-based health policy however studies show that patterns of care in 
relation to particular clinical conditions vary considerably from evidence-based 'best 
practice'(36). In order to change this situation, several strategically orientated 
initiatives have been developed to promote EBM in Australia. These include the 
Australasian Cochrane Collaboration, handbooks and projects either developed or 
funded by the NHMRC, and new centres such as the National Institute of Clinical 
Studies, Effective Healthcare Australia, the Australian Centre for Evidence Based 
Clinical Practice and the Australian Safety and Efficacy Register of New 
Interventional Procedures – Surgical (ASERNIP-S)(36).  
 
Quality improvement (QI) has also received much attention and national leadership is 
being provided by numerous bodies such as the Australian Council for Safety and 
Quality in Health Care (now usually called the Safety and Quality Council). Another 
major Australian initiative was the development of The National Strategy for the 
Quality Use of Medicine (QUM) as part of the National Medicines Policy in 1999. 
The goal of the QUM strategy is to optimize the use of medicines to improve health 
outcomes. The safe and appropriate use of CMs falls within its scope however there is 
little information available about how this is achieved.  
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A.3.1.3  The challenge of implementing EBM in clinical practice 
 
New research is being continually generated and published in an effort to improve 
clinical practice and our understanding of health and disease, disease diagnosis and 
treatment. Ideally, as new research becomes available, it will be evaluated, 
disseminated and ultimately influence clinical practice. However, major difficulties 
arise in introducing these innovations into routine practice and one of the most 
consistent findings in the international literature is the gap between evidence and 
practice (37).  
 
In practice, there are many barriers which slow down or even prevent this process 
from occurring (38): 
1. Lack of access to the evidence 
2. Organisational barriers 
3. Ineffectual continuing education programs 
4. Low patient adherence to treatments 
 
Lack of time and opportunity to become familiar with the relevant new evidence is 
another factor offered by Grol and Grimshaw as it has been estimated that general 
internists would need to read 20 articles a day all year round to maintain present 
knowledge (37). The availability of systematic reviews and guidelines reduces the 
need for doctors and pharmacists to read original studies however it is still difficult to 
keep up with such syntheses.  
 
A study of U.K. general practitioners found that the process of applying clinical 
evidence was influenced by the personal and professional experiences of the 
practitioner, their relationship with the patient and patient experiences (39). A study 
of 400 Australian nurses which investigated their beliefs about barriers to evidence 
implementation identified lack of support from others to use the research and the 
anticipated outcomes of using research as additional factors (40): Norman further 
suggests that not understanding the evidence, not believing the evidence and  not 
knowing how to use it are also barriers (41).  
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Australian GPs are pleased about the move towards using EBM however had 
concerns about the motives behind evidence based guidelines and whether they were 
based on effectiveness or cost-effectiveness or a political agenda (42). As a result, 
reluctance to use EBM may be motivated by uncertainty about the genuineness of the 
authors. Furthermore, some GPs considered previous experience of greater 
importance in clinical practice than external research evidence, a similar finding to 
Freeman and Sweeney (39).  
 
Although EBM encourages the use of primary research studies and systematic 
reviews to inform clinical decisions, several surveys have suggested that most medical 
practitioners still rely heavily on the opinion of colleagues or consultants when 
making these decisions (43-45). Mayer and Piterman identified that if GPs found 
evidence conflicted with their own prior beliefs, they would talk with colleagues 
about the evidence for psychological support and affirmation (46). 
 
A review of the literature reveals that barriers to the adoption of evidence into clinical 
practice are continuously being investigated in healthcare however CM specifically 
has not been investigated leaving much unknown about the barriers preventing the 
integration of ‘proven’ CM interventions into hospital practice.  
 
A.3.2 Shared decision making and patient focussed models 
 
Shared decision making is the term used to describe the process of two way 
information giving (medical and personal) between the clinician and the patient 
concerning all the options available, with a final decision being made jointly between 
both clinician and patient. It replaces the paternalistic approach and empowers the 
patient to become an active and equal partner in their own health care.  
 
A.3.2.1  Patient centred care (PCC) 
 
Patient-centred care (PCC) is a phrase originally coined by Balint in 1969 to express 
the belief that each patient “has to be understood as a unique human being”(47). A 
broad definition of PCC employed today is “care that is closely congruent with and 
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responsive to patients’ wants, needs, and preferences”(48). Three elements are 
considered important in PCC : communication, partnerships and a focus on health 
promotion and healthy lifestyles which goes beyond focussing on a specific condition 
(49). Systematic reviews show that patient-centred care results in increased adherence 
to management protocols, reduced morbidity and improved quality of life for patients 
(50). As a result, patient-centeredness has been promoted extensively in the literature 
and is now considered by many to be the standard for quality interpersonal care and 
both good clinical and moral practice (51). 
 
In order for PCC to be effective, the patient must want to be actively involved in their 
own care. A review of quantitative studies demonstrated that demographic factors 
affecting patients’ preferences for taking a more active role in decision making are: 
younger and better educated patients, and women (52). Interestingly these are the 
same characteristics shared by typical users of CM (14;53).  
 
A.3.2.2  Evidence based patient choice (EBPC) 
 
The theory of ‘evidence based patient choice’ (EBPC) brings together two important 
modern movements in western health care, namely evidence-based medicine (EBM), 
and patient-centred care (PCC). The integration of EBM and PCC means providing 
patients with evidence based information in a way that facilitates their ability to make 
choices about their health care (54). It also means practitioners must consider their 
understanding of the patient and their values when defining the clinical question used 
as a starting point in EBM, thereby producing information that is relevant to the 
patient (55).  
 
A.3.2.3  Concordance 
 
The model of concordance was introduced by the Royal Pharmaceutical Society in 
1997 as a more patient centred approach between medication prescribers (including 
pharmacists) and patients than had existed previously. The terms "non-compliance" or 
"non-adherence" had been widely used prior to this time and could be seen to suggest 
an unequal, paternalistic relationship.  
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Concordance aims to achieve the best possible use of medicines and is reached 
between medication prescriber and patient through negotiation until a therapeutic 
alliance is achieved (56). It requires the healthcare practitioner to recognise the 
primacy of the patient’s decision in taking medicines. Patients are encouraged to ask 
questions and express concerns about the medication prescribed to them and 
communicate their preferences for treatments and decision making. The prescriber 
provides evidence based information together with their relevant clinical experiences. 
The negotiation necessitates compromise on both sides until a mutually acceptable 
decision is reached. In situations where the patient defers a decision, the prescriber 
then makes it for the patient, whilst taking into account the individual factors present. 
 
Australian pharmacists are supportive of the principles of concordance and believe 
that establishing a “therapeutic alliance” is a high priority in the consultation between 
pharmacists and their patients (57). Furthermore, they believe that pharmacists should 
respect patients’ beliefs and coping strategies, provide opportunities for patients to 
communicate their thoughts and be involved in negotiating about their treatment. 
  
Overall, there are four common elements present in the shared decision making 
models : partnership, communication (including negotiation), information giving, and 
agreement. In all models, the health care professional (whether medical practitioner or 
pharmacist) and the patient are viewed as equals in terms of information transfer and 
decision making.  
 
In order for these models to be effective and successful, both parties must be 
motivated to develop a therapeutic alliance, have adequate communication skills, be 
able to access, understand and assess the evidence and be able to compromise to reach 
a mutually acceptable goal. If either party is unable or unwilling to engage in these 
steps then an equal partnership has failed to be achieved.  
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Chapter One 
 
Section B 
CTs and the general community, 
medical practitioners and 
pharmacists  
 
 
B.1.0  Introduction 
 
This chapter is a literature review of relevant information and research about CM. It 
explores what is currently known about the use of CMs and CTs by the general 
population starting with overseas trends and then focussing on the Australian public. 
Information is next presented about medical practitioners and pharmacists and their 
beliefs and attitudes, referral patterns, personal usage, practice and knowledge of CM. 
This is included because the public demand for CM means these health professionals 
are coming into contact with CM users or patients enquiring about use and it is their 
task to provide healthcare advice. Overseas trends are reported for both groups 
followed by a focus on Australian studies.  
 
This chapter also presents three systematic reviews of the international peer-reviewed 
literature. The first systematic review evaluates information available about the 
Australian public and their use of CM. The second systematic review evaluates 
information regarding overseas medical practitioners and CM and the third evaluates 
information about Australian medical practitioners and CM. In addition, reviews of 
overseas and Australian pharmacists and their attitudes, perceptions, training, 
knowledge and use of CM are also presented  
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The decision to undertake multiple systematic reviews of the literature was made as 
this is a valuable process which reduces bias and enables limitations and gaps in the 
current knowledge base to be more easily identified.  
 
B.2.0  Overseas trends in the use of CM  
 
Unfortunately, the lack of consensus regarding a definition as to what is or what is not 
to be included in the category of CM has unquestionably complicated efforts to 
document, in a consistent fashion, the prevalence and patterns of CM use. Results are 
often confounded by a lack of distinction between CM products, CM practitioners and 
CM therapies (which may or may not require a CM practitioner). A lack of 
consistency between surveys as to how many therapies should be included and which 
type of therapies further complicates the issue. In some instances, respondents have 
not been provided with a definition of CM thereby relying on their own subjective 
definition (58). This can lead to misinterpretation and inaccuracies such as when the 
use of a pharmaceutical medicinal agent is interpreted as a CM product by 
respondents.  
 
Despite this, it is apparent that the use of CM is widespread in Australia, the United 
States, United Kingdom, Canada and Europe (4;11;13-15;59-65). Global statistics 
have established that at least half the individuals living in the industrial world are 
using CM with a trend towards the use of ingestive therapies such as nutrient 
supplementation and herbal medicine, and manual therapies such as massage and 
chiropractic (66). 
 
In the United States, Eisenberg et al identified that 47.3% of all Americans had visited 
a CM practitioner with an estimated 427 million consultations to CM practitioners in 
1990 increasing to 629 million in 1997(60). More recently, a national analysis of CM 
use in the United States based on 31,044 interviews identified 62% of the surveyed 
population as having used some form of CM therapy in the previous 12 months 
(67;68). This figure includes those people who used ‘prayer for one’s own health’. 
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When prayer is excluded from the analysis, CM usage within the last 12 months is 
reduced to 36%. Barnes et al report that the ten most commonly used CM therapies 
during the previous 12 months were: use of prayer specifically for one's own health 
(43.0%), prayer by others for one's own health (24.4%), natural products (18.9%), 
deep breathing exercises (11.6%), participation in prayer group for one's own health 
(9.6%), meditation (7.6%), chiropractic care (7.5%), yoga (5.1%), massage (5.0%), 
and diet-based therapies (3.5%). 
 A large survey of 17626 Canadian residents aged over 15 years estimated that 15% 
had used some form of CM therapy in the previous 12 months with use most 
prevalent amongst women, people aged 45-64 years and those with higher income 
(69). It also identified chiropractic as the most popular CM therapy. 
 In Europe, it has been estimated that between 20-50% of the population are using CM 
therapies, a figure which differs between countries and is influenced by whether CM 
therapies are located in the national health systems or not, methodological variations 
in data collection and the definitions employed to describe ‘alternative’ therapies (70). 
In France, homeopathy is one of the most popular CM therapies and was used by 16% 
of the population in 1982, 29% in 1987 and 36% in 1992(71). In Germany, herbal 
medicines and homeopathy are used by 95% of doctors because they are taught as part 
of conventional medical training and therefore widely used. 
The use of CM is also prevalent in the United Kingdom. In 1993, a survey of use of 
CM found that 33% of the population had used some form of CM therapy and that 
10% had consulted a CM practitioner in the previous year (72). In 2001, a population-
based survey of  English adults (n=5010) identified over 28% as using CM during the 
previous year, and nearly half having used CM at some stage in their lives (73). A 
study of residents from North East Scotland, compared usage habits and attitudes to 
CM from 1993 (n=341) to 1999 (n=432) (74). Over this period, use of CM increased 
from 29% to 41%, with a statistically significant increase in the use of aromatherapy, 
acupuncture and reflexology. Surveys of patients with chronic and difficult to manage 
diseases (e.g. cancer, HIV infection, multiple sclerosis, psoriasis, and rheumatological 
conditions) suggest usage is higher amongst these populations. Osteopathy, 
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chiropractic, homoeopathy, acupuncture, and herbalism are among the most popular 
CM therapies in the United Kingdom.  
 
The 2002/03 New Zealand Health Survey (n = 12 000) indicated that approximately 
24% of adults had visited a CM practitioner over the 12-month study period (75). 
Massage therapists, chiropractors, osteopaths, homeopaths or naturopaths were the 
most commonly consulted CM practitioners.  
 
B.2.1 Description of people who use CM 
 
Several general variables have been identified as having a relationship to 
complementary medicine supplement use. These are  race or ethnicity, age, education, 
income, and lifestyle variables such as drinking, smoking, and exercising (76). The 
use of CM amongst specific patient populations has also been investigated with a 
higher level of use observed amongst people with chronic conditions.  
 
A study with a sample of over 30,000 American women found 33.5% used CM with 
use increasing with increasing age, peaking at 45–54 years old (77).  
 
There is evidence that people with more health conditions and poorer health are also 
more likely to use CM therapies and CMs (78-83).  For instance, a survey of cancer 
patients conducted in 14 European countries (n=956) revealed that CM is popular 
amongst this group with 35.9% using some form of CM (range between countries 
14.8% to 73.1%) (84). Herbal medicine was the most commonly used CM therapy 
and its use tripled from the time before diagnosis to the time after diagnosis with 
cancer. Other examples include patients with glaucoma (81), Parkinson’s disease (78), 
headache syndromes (82), chronic heart failure (83) and rheumatological conditions 
(80).  
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B.2.2 Reasons for the popularity of CM 
 
A wide variety of reasons for the use of CM and its prevailing popularity have been 
reported in the literature. Some of these have been described as positive motivations 
such as the pursuit for wellness (85), an interest in health promotion and disease 
prevention (1;60;86), a preference for holistic and ‘natural’ approaches to health 
care(86), the perceived safety and effectiveness of CM and that it is generally pleasant 
and non-invasive(87).  Numerous studies have shown that CM is typically used as an 
adjunct to conventional medical care (11-13;60;86;88;89). According to Eisenberg et 
al, 79% of respondents who used CM and visited conventional doctors perceived the 
combination to be superior than when either was used alone(90).   
A U.S. based national survey by Astin reported that a holistic philosophy of life and 
interest in alternative lifestyles, a life changing experience which altered their world 
view and interest in self care as major factors predisposing people to use CM (86). 
Other studies have produced similar findings (91-94).  
 
There are also negative motivations which may explain its use such as dissatisfaction 
with conventional medical care. Although some evidence supports this view (95-97) 
other studies have failed to identify disenchantment as a major reason for CM use 
(86;90;91). When dissatisfaction with conventional medicine was identified, this 
related to dissatisfaction with the quality of medical care (96), failure for conventional 
treatments to provide adequate outcomes (98;99), concerns about safety and toxicity 
of conventional treatments (100;101), increased relative cost of conventional care 
(95), and perceived barriers to obtaining conventional care (96). Post-modern values 
such as rejection of authority and ‘the establishment’ have also been attributed to the 
increased popularity of CM (102).  
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B.2.3 What resources are being used by the general population 
for CM information? 
 
In today’s age, healthcare practitioners are no longer the main providers of healthcare 
information and advice. The public can access and be exposed to health information 
in a variety of ways such as the lay and medical media, family and friends, work 
colleagues, shop staff, marketing material from manufacturers, books and the Internet. 
Considering that many people self-select their CMs and do not discuss use with a 
healthcare professional (CM or conventional), it appears that many find these sources 
of information or referral sufficient on which to make a decision.  
 
Despite their important tole in healthcare, relatively little information is available 
about the public’s use of medical practitioners and pharmacists as sources of CM 
information and what they think of the information provided. Studies investigating the 
reasons why patients using CM do not disclose use to their medical physician provide 
some insight into this issue.  
 
Eisenberg et al identified that only 39.8% of CM users disclosed their use to 
physicians in 1990, and in 1997 this figure was 38.5% suggesting disclosure had 
remained poor (60). Similar findings have been reported in numerous other studies 
with one review of 12 studies involving patients attending medical clinics identifying 
non-disclosure rates of 23–72% (103). Of the 12 studies analysed, cancer patients 
were assessed in four studies, patients with other conditions were assessed in three, 
three studies involved general clinic patients and one study was a general population 
study. The wide variations in findings can be attributed to different study designs, 
patient populations, and definitions and types of CM.  
 
In all 12 studies, the same three themes were consistently reported by patients as 
reasons for lack of disclosure (104). Most commonly, these were: concern about 
eliciting a negative response from the physician followed by the patient's perception 
that the medical practitioner did not need to know about CM use because they are 
ignorant of CM and unable to contribute useful information and lack of physician 
enquiry about use. 
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B.3.0 Trends in the use of CM in Australia 
 
The first major study reported in the peer-reviewed literature about the use of CMs by 
Australians was conducted by MacLennan et al in 1993 (63). The survey identified 
that 48.5% of adult South Australians had used at least one non-medically prescribed 
CM product (excluding calcium, iron and prescribed vitamins) in the previous 12 
months. People using CMs were more likely to be peri-menopausal females, better 
educated, have a higher alcohol intake, be of normal weight and more likely to be 
employed than non-users. The study has been replicated twice since then showing that 
CMs and CTs remain popular amongst the general population and there use is 
generally increasing (13;14).  
 
A systematic review is presented of Australian population studies in order to provide 
further details about current usage.   
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B.3.1  Systematic review of CTs use by the Australian general 
population 
 
B.3.1.1 Aim:  
The main aim was to determine the prevalence and patterns of CM use by the general 
population in Australia. Secondary aims were to investigate whether people using 
CMs and/or CTs report use to physicians, their reasons for use, and perceptions about 
CMs and/or CTs and sources of advice regarding CM.  
 
B.3.1.2 Methods:  
A search was performed using the following databases for all years available through 
until October, 2006: Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), MEDLINE, ScienceDirect, Proquest. Search terms used included, but 
were not limited to:  
•  ‘complementary medicine’ AND ‘Australia’ 
• ‘alternative medicine’ AND ‘Australia’ 
• ‘holistic medicine AND ‘Australia’ 
• ‘integrative medicine’ AND ‘Australia’ 
• ‘CAM’ AND ‘Australia’ 
• ‘CM’ AND ‘Australia’ 
• ‘herbal medicine’ AND ‘Australia’ 
• ‘natural therapies’ AND ‘Australia’ 
• ‘naturopathy’ AND ‘Australia’ 
A search was also conducted whereby the word ‘medicine’ was replaced by the word 
‘therapy’ and then ‘therapies’.  
 
Articles identified in this manner were searched to ascertain relevance to this 
systematic review. The reference lists of articles considered suitable for inclusion 
were also searched to identify additional relevant studies which have not been 
identified by the previous search strategy. Articles were considered eligible if they 
were population based surveys, presented in English, published in the peer-reviewed 
literature and described research conducted with the general population living in 
Australia. Studies were also considered eligible if presented at a prominent Australian 
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conference. A full-length copy of the study by Kermode et al was unable to be located 
and was not included in this review.  
  
B.3.1.3 Results: 
 
B.3.1.3.1 Description of studies 
 
Thirteen articles met the inclusion criteria which described data obtained from eleven 
different studies. One article described data obtained nationally from patients 
attending chiropractic clinics (105), three  described data from surveys conducted 
with residents of South Australia (13;14;63), three described surveys of people with 
cancer (12;58;106) and one described a survey of people with HIV (107). Two articles 
used the same data obtained from the Australian Longitudinal Study on Women's 
Health (11;12) and two other articles used the same data obtained from a national 
population based survey of older Australians aged over 65 years (108;109). One 
conference presentation met inclusion criteria in which results from a national 
population based survey conducted by telephone were presented (15). Seven articles 
reported response rates which were above 60%. A summary of results from relevant 
articles is presented in Table 1.  
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 Year of 
publication  
First author Number of 
respondents and 
special features of 
population examined 
Mode  of 
data 
collection 
Response 
rate (as 
presented by 
the papers 
authors) 
Estimated prevalence of 
CMs and CTs use  
Specific CMs used by 
studied population (if 
reported) 
Other findings 
1996 MacLennan et 
al(63) 
N=3004 persons aged 
15 or older living in 
South Australia  
 
Data 
collected by 
personal 
interviews in 
1993 
73% 48.5% had used at least one 
non-medically prescribed CM 
product (excluding calcium, 
iron and prescribed vitamins) 
in the previous 12 months 
37.6% vitamins 
9.9% herbal medicines 
9.2% minerals 
7.8% evening primrose 
supplements 
4.4% homeopathic 
remedies 
3.5% aromatherapy oils 
3.0% ginseng 
1.8% Chinese medicines 
1.3% PMTese 
0.1% Esten 
3.6% others 
CM users were more likely 
to be perimenopausal 
females, better educated, 
have a higher alcohol intake, 
be of normal weight and 
more likely to be employed 
than non-users.  
20.3% of respondents had 
visited at least one 
alternative practitioner, most 
commonly chiropractors 
(15%). The users of 
alternative practitioners were 
more likely to be younger, 
live in the country and be 
overweight. Women were 
more likely to consult 
naturopaths, iridiologists, 
and reflexologists than men.  
1998 Kermode et al 
(110) 
N= 645 residents of the 
North Coast of New 
South Wales 
Telephone 
survey 
unknown up to 50% visited a 
complementary health 
practitioner each year 
unknown  
2000 De Viseer et al 
(107) 
n= 925 men and women 
living with HIV/AIDS in 
Australia 
Cross-
sectional 
survey of 
convenience 
Not reported  56% of respondents used 
alternative therapies 
 
46% nutritional 
supplements 
24% massage 
Attitudes toward both 
allopathic and alternative 
therapies were positive.  
Table 1. Australian surveys estimating prevalence of CM usage 
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(91% male;9%female) 
sample –data 
collection 
conducted in 
1997 
 21% herbal medicines 
20% meditation 
10% acupuncture 
7% traditional Chinese 
medicine 
3% exercise 
2% yoga 
1% reiki 
 
The choice of allopathic 
and/or alternative therapies 
was related to disease 
progression.  
Choice of therapy was also 
related to attitudes toward 
allopathic and alternative 
therapies.  
Many users of alternative 
therapies believe that such 
therapies can alleviate the 
side effects of antiretroviral 
drugs. 
2002 MacLennan et 
al 
(13)  
N=3027 persons aged 
15 years or older living 
in South Australia  
Data 
collected by 
personal 
interviews in 
2000 
70.4% 52.1% had used at least one 
non-medically prescribed 
alternative medicine (excluding 
calcium, iron, and prescribed 
vitamins) in the previous 12 
months  
 
23.3% of respondents had 
visited at least one CM 
practitioner with increasing use 
of acupuncturists, 
reflexologists, 
aromatherapists, and herbal 
therapists. 
36.4% used vitamins 
15.3% aromatherapy oils 
13.4% herbal medicines 
10.6% minerals 
8.0% evening primrose oil 
4.9% other 
4.3% homeopathic 
remedies 
3.2% Chinese medicines 
1.6% menopause 
products 
 
People using CMs more 
likely to be female, better 
educated, have a higher 
income, and be employed. 
Since 1993, females using 
significantly more herbal 
medicines, ginseng, Chinese 
medicines, aromatherapy 
oils. Many self-prescribed. 
Among users, 57.2% did not 
tell their doctor. Most 
thought alternative 
medicines were safe but 
thought they were, or should 
be, subject to the same 
standards as prescribed 
medicines. Among 
respondents, 92.9% wished 
product information to be of 
standard and content similar 
to those supplied with 
pharmaceuticals.  
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Year of 
publication 
Author/s Number of 
respondents and 
special features of 
population examined 
Mode  of 
data 
collection 
Response 
rate (as 
presented by 
the papers 
authors) 
Estimated prevalence of 
CMs and CTs use  
Specific CMs used by 
studied population (if 
reported) 
Other findings 
2003 Adams et al 
(11) 
N=41,817 
Research conducted as 
part of the Australian 
Longitudinal Study on 
Women's Health  
Survey  98% 28% women aged 45-50 years 
had consulted a CM 
practitioner in the previous 12 
months 
19% of women aged 18-23 
years 
15% of women aged 70-
75years 
Not reported CM users  are more likely to 
live in non-urban areas, 
report poorer health, have 
more symptoms and illness 
than non-users and are 
higher users of health care 
services than non users 
2003 Sibbritt et al 
(58) 
N= 9375 Australian 
women aged 73-78. 
with cancer 
 
 
Data 
collected 
from survey 
conducted in 
1999  
Not reported For all cancers combined, 
14.5% of women with cancer 
consulted a CM practitioner. 
This percentage varied 
depending on the type of 
cancer: skin (15.0%), breast 
(11.5), bowel (8.8%), and other 
(16.5%). 
Not reported  
2003 Jamison JR 
(105) 
N= 758 Convenience 
sampling of patients 
attending 21 
chiropractic clinics in 5 
states and the ACT 
Data were 
collected 
using a 
questionnaire  
Not reported 40% took vitamins Not reported Chiropractors were only 
occasionally informed about 
the medication practices of 
their patients. 
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Year of 
publication 
Author/s Number of 
respondents and 
special features of 
population examined 
Mode  of 
data 
collection 
Response 
rate (as 
presented by 
the papers 
authors) 
Estimated prevalence of 
CMs and CTs use  
Specific CMs used by 
studied population (if 
reported) 
Other findings 
2004 Brownie and 
Rolfe (108) 
 
N= 1263 randomly 
selected older 
Australians (> 65 years) 
randomly selected from 
the 2000 Australian 
Electoral Commission 
roll. 
All states and territories 
were proportionally 
represented in the 
sample. 
 
Self 
administered 
postal survey  
62% 43% reported using some form 
of supplement at the time of 
the survey (n=548);  52% of 
females and 35% of males. 
26% Vitamin C 
17% multivitamin/mineral 
17% fish oils 
16% vitamin E 
13% calcium (+/- vitamin 
D) 
11% garlic 
9% vitamin B (single or 
mixed) 
7% single vitamin 
6% zinc 
5% ginkgo biloba 
 
Supplement users were 
more likely to report arthritis, 
osteoporosis, experience 
more symptoms consume 
more medication than non-
supplement users.  
In contrast, there was a 
reduced likelihood of taking 
a supplement for those with 
hypertension, by those using 
blood pressure medication 
and heart tablets. 
2005 Adams et al 
(12) 
N= 11,202 women aged 
50-55years 
* Research was 
conducted as part of the 
Australian Longitudinal 
Study on Women's 
Health 
Data 
collected 
from survey 
conducted in 
2001 
99.5% For all cancers combined, 
15.7% of women with cancer 
consulted a 
naturopath/herbalist, while 
10.9% of women without 
cancer consulted a 
naturopath/herbalist.  
Not reported Mid-aged women with 
cancer were found to be 
more likely to consult a 
naturopath/herbalist than 
mid-aged women without 
cancer. 
Naturopathy/herbalism 
consultations appear to be 
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The percentage of 
naturopath/herbalist 
consultations varied depending 
on the type of cancer presents 
: breast cancer (17.4%), bowel 
cancer (22.2%) and other 
cancer (14.8%) are higher than 
for women with cervical cancer 
(6.3%). 
utilized alongside 
conventional health 
services. 
2005 Girgis et al 
(106) 
N= 1492 cancer 
patients attending nine 
major public cancer 
treatment centers in 
New South Wales, 
Australia 
Survey 65% 
 
For all cancers, 17.1% of 
patients were using at least 
one CT  
 
Herbal treatments and 
naturopathy are the most 
popular (constituting over 30% 
of all CM use recorded). 
Not reported The two main demographic 
characteristics of CM users 
were gender and age, where 
females were more likely to 
use CM than males and that 
CM use declined as age 
increased. Time since 
diagnosis was identified as 
the only significant clinical 
predictor of CM use, where 
CM use increased with time 
until 5 years since diagnosis.  
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Year of 
publication 
Author/s Number of 
respondents and 
special features of 
population examined 
Mode  of 
data 
collection 
Response 
rate (as 
presented by 
the papers 
authors) 
Estimated prevalence of 
CMs and CTs use  
Specific CMs used by 
studied population (if 
reported) 
Other findings 
2006 Brownie (109)  N= 1263 randomly 
selected older 
Australians (> 65 years) 
randomly selected from 
the 2000 Australian 
Electoral Commission 
roll. 
All states and territories 
were proportionally 
represented in the 
sample. 
 
Self 
administered 
postal survey 
62% 43% reported using some form 
of supplement at the time of 
the survey (n=548);  52% of 
females and 35% of males. 
Supplements used by 
<5% were: 
St Johns wort, valerian, St 
Mary’s thistle, Echinacea, 
Brahmi, Saw palmetto, 
Ginseng 
Supplement use was 
significantly associated with 
gender (female) and chronic 
musculoskeletal ailments 
such as arthritis, 
osteoporosis and 
generalised back or neck 
problems. The most 
common potential drug-
supplement interaction was 
between calcium 
supplements and 
antihypertensives. 
2006 MacLennan et 
al 
(14)  
N=3015  South 
Australian respondents 
over the age of 15 years  
Data 
collected by 
personal 
interviews in 
2004 
71.7%  52.2% had used at least one 
non-medically prescribed 
alternative medicine (excluding 
calcium, iron, and prescribed 
vitamins) in the previous 12 
months  
 
CM therapists had been visited 
by 26.5% of the population. In 
those with children, 29.9% 
administered CMs to them and 
17.5% of the children had 
visited CM therapists. 
39.2% vitamins 
20.6% herbal medicines 
13.6% minerals 
11.2% aromatherapy oils 
3.8% soy products 
2.3% traditional Chinese 
medicines 
2.2% homeopathics 
6.1% other 
Greatest use for women 25-
34 yrs, higher income and 
education. CMs used mostly 
to maintain health. CM users 
had lower quality-of-life 
scores than non-users. 
Among CM users, 49.7% 
used conventional 
medicines on same day and 
53.2% did not report use of 
CMs to doctor. About 50% 
assumed CMs 
independently tested by 
government agency; of 
these, 74.8% believed they 
were tested for quality & 
safety, 21.8% for claims, 
17.9% for efficacy. 
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Year of 
publication 
Author/s Number of 
respondents and 
special features of 
population examined 
Mode  of 
data 
collection 
Response 
rate (as 
presented by 
the papers 
authors) 
Estimated prevalence of 
CMs and CTs use  
Specific CMs used by 
studied population (if 
reported) 
Other findings 
2006 Xue et al (15) N=1067 national 
population-based study 
Computer 
assisted 
telephone 
survey 
Not reported Nationally, 68.9% used at least 
one CT and/or visited a CM 
practitioner in the previous 12 
months 
 
44.2% nationally had 
consulted a CM practitioner in 
the previous 12 months 
 
 
CTs used by >10% of the 
sample were: 
Clinical nutrition (45.8%) 
Massage (27.2% 
Meditation (17.2%) 
Western herbalism 
(16.3%) 
Aromatherapy (16.1%) 
Chiropractic (16.1%) 
Yoga (12.0%) 
 
Use of CTs was higher in 
females, people with higher 
education, higher income, 
who ranked their health as 
fair –poor, were aged 18-34 
years and employed.  
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B.3.1.3.2. Methodological concerns 
 
As is the case with studies conducted overseas, it is difficult to make accurate 
comparisons between studies because there is a lack of consistency between 
definitions being used to describe CMs and CTs. For example, MacLennan et al 
described the prevalence of CMs use and excluded medically prescribed products 
whereas Jamieson included all CMs, regardless of the prescriber(13;14;63;105). 
Sibbritt et al asked participants about their use of ‘alternative health practitioners’ 
without defining what this meant thereby leaving the interpretation open to the 
individual whereas Adams asked specifically about herbal medicine practitioners and 
naturopaths and excluded the use of herbal therapy and naturopathic products and 
remedies purchased over the counter, self-administered, and provided by conventional 
practitioners (12;58). Additionally, investigators asked about use of CMs or CTs over 
varying time frames. For example, Xue et al asked about use of CMs and CTs over 
the previous 12 months whereas Brownie and Rolfe asked participant about their use 
at the specific time of the survey (15;108) thereby making it difficult to make relevant 
comparisons. 
 
B.3.1.3.3. Usage trends 
 
Overall, the data collected indicates that the use of CMs and CTs is prevalent amongst 
the general population, of all ages, regardless of gender and also used by people with 
various health conditions such as cancer and  HIV-AIDs (11-15;58;105-109). 
 
Studies of the general population indicate usage is between 40% (105) and 52% (14) 
for CMs. Consistently, surveys report that women are more likely to use CM therapies 
and treatments than men (13;14;63;106;109) and people who use CMs have higher 
income and higher education (13;14;63). There is also some evidence that people 
living in non-urban areas (11;63), with poorer health (11) or lower quality of life 
scores (14) are more likely to use CMs or see a CM practitioner. 
 
Vitamins are the most popular type of CMs used (13;14;63;107;108) however the use 
of herbal medicine has been increasing steadily. In particular, women’s use of herbal 
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medicines significantly increased from 16.6% in 2000 to 24.9% in 2004 (P<0.01) 
according to surveys conducted in South Australia (14).  
 
The percentage of people visiting a CM practitioner has also been steadily increasing 
in recent years. MacLennan et al report that in 1993, use was estimated as 20.3% of 
the population (63), rising to 23.3% in 2000 (13) and further increasing to 26.5% in 
2004 (14). These studies appear to have under-estimated use nationally as results from 
a national population study reported that 44.1% had consulted a CM practitioner in 
the previous 12 months (15). 
 
Xue et al reported on a combined result for the use CMs and CTs indicating that  
68.9% of Australians had used at least one CT and/or visited a CM practitioner in the 
previous 12 months (15). Use was highest in New South Wales where it was 
estimated that 72.1% of the population had used CTs and/or visited a CM practitioner, 
and lowest in South Australia where the estimate was 60.8%.  
 
Data from the Australian Longitudinal Study on Women's Health indicate that 19% of 
women aged 18-23 years had consulted with a CM practitioner in the previous 12 
months, 28% women aged 45-50 years and 15% of women aged 70-75years (11) 
however usage is lower for women with cancer and ranges from 14.5% (58) to 15.7% 
(12). More specifically, Adams et al reported that middle aged women with cancer 
were more likely to visit a naturopath or herbalist than women of the same age 
without cancer (12). Girgis et al identified that the time since diagnosis was the only 
significant clinical predictor of CM therapy use by people with cancer, where CM use 
increased with time until 5 years since diagnosis (106). In regards to people with HIV-
AIDs, de Visser et al identified that the choice of conventional and/or complementary 
therapies was related to disease progression (107). 
 
It is difficult to compare usage figures between older Australians with the general 
population because the survey by Brownie and Rolfe asked participants about their 
use of CMs at the time of the study whereas the larger general population studies by 
Xue et al and MacLennan et al asked about use in the previous 12 months (13-
15;108). It is however possible to conclude that use of CMs is lower amongst older 
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males than older females. Overall, older Australians using CMs are more likely to 
have musculoskeletal conditions, osteoporosis, report more symptoms and use more 
medicines than people who do not use CMs (108). 
 
B.3.1.3.4 What is actually being used? 
 
A variety of nutritional and food supplements and herbal medicines are being used by 
Australians however it is difficult to determine exactly what these substances are 
because most studies group CMs into broad categories such as clinical nutrition, 
herbal medicines, vitamins or minerals. As a result, information about the use of 
specific ingredients is limited.  
 
The most detail is provided by Brownie and Rolfe which name actual CMs being 
taken by their sample population, which comprised of older Australians (108). 
According to this study, the most commonly used CMs were (starting with most 
popular): vitamin C, multivitamins, fish oil supplements, vitamin E, calcium 
supplements, garlic, vitamin B, single vitamins (not specified), zinc and ginkgo 
biloba. 
 
Xue et al report on the use of specific CTs in their recent national population based 
survey (15). The five most commonly used CTs used by the sample were (starting 
with most popular): clinical nutrition, massage, meditation, western herbalism and 
aromatherapy. MacLennan’s surveys of South Australians report that in 2000, vitamin 
therapy, aromatherapy, herbal medicine, mineral therapy and homeopathy were the 5 
most commonly used CTs. In 2002 this changed slightly and was : vitamin therapy, 
herbal medicine, mineral therapy, aromatherapy and traditional Chinese medicine.  
 
A workforce survey of the practice of Western herbalism and naturopathy in Australia 
confirmed that these practices make up a sizeable component of the Australian 
healthcare sector (111). It was estimated that approximately 1.9 million consultations 
are conducted annually generating an annual turnover of approximately $AUD 85 
million for consultations only. The report also identified that most people are not 
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referred to naturopaths or herbalists by other health care professionals but are referred 
by word of mouth.  
 
B.3.1.3.5 Patient disclosure to physicians 
 
Although six studies have indicated that people use CM as and adjunct to 
conventional medicine (11-14;107;108), only two studies reported whether medical 
physicians are told about this use. Both indicate that people using CMs do not 
routinely tell physicians about use (13;14). No studies have reported on any 
investigation into the reasons for non-disclosure. According to Jamison, chiropractors 
are not always aware of their patient’s use of medication (105) suggesting the problem 
of non-disclosure may not be confined to medical practitioners. 
 
B.3.1.3.6 Sources of advice and information 
 
One study reported that the main sources of advice people receive about CMs are: self 
(28%), family/friends (26%), medical doctor (21.2%), media (15.1%), health food 
store (14%), CM practitioner (13.4%), chemist (9.7%) (13). It is not clear whether 
these are also considered sources of information about CMs and CTs.  
 
B.3.1.3.7 Reasons for use 
 
Two studies reported people’s reasons for using CM. The earlier study found people 
reported using CM in general : to prevent disease (34.6%), to cure sickness (17.8%), 
both reasons (31.3%) or they didn’t know (16.3%) (13). More recently, a study 
reported that the majority of people using CMs did so to maintain general health 
(70%) (14).  
 
B.3.1.3.8 Perceptions about CM 
 
Overall, most people (65%) are aware that CMs can be potentially unsafe according to 
one study (13). Perceptions about how CMs are regulated are varied. One study 
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reported that most people thought CMs were, or should be, subject to the same 
standards as prescribed medicines and a later study reported that some people 
assumed CMs were independently tested by a government agency for quality and 
safety, the claims made and for efficacy (13;14). 
 
Many people with HIV-AIDs using CTs believed they can alleviate the side effects of 
antiretroviral drugs (107). Additionally, a positive attitude to both allopathic and CM 
therapies were reported for this population. 
 
B.3.1.3.9 Limitations of the review 
 
The main limitation of this review relates to the heterogeneity of the included studies 
which reduced the ability of the review to compare results and summarise key trends. 
Whilst every effort was made to locate relevant studies, it is possible that others exist 
which were not identified using the search strategy.  
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B.4.0  Medical practitioners and CM  
 
The widespread public use of CM means that medical practitioners are likely to be 
coming into increasingly frequent contact with CM users or patients enquiring about 
use. As a reflection of this, an increasing number of studies have been conducted to 
investigate physicians attitudes, perceptions, usage, training, referral and knowledge 
of CM. 
  
B.4.1 Overseas and Australian trends for medical physicians 
 
A 1995 meta-analysis of 12 studies found that in general, physicians viewed 
complementary medicine as moderately effective, with younger physicians more 
optimistic about these therapies than their older counterparts(112). Zollman and 
Vickers reported that medical doctors also regarded CM as scientifically unproven 
and are concerned about ensuring the best choice of treatment for their patients (113). 
Common concerns include risk of delayed diagnosis, cessation of effective treatments, 
adverse effects and drug interactions, conflicting advice and treatments. Astin et al 
analysed data from 19 surveys conducted between 1982 and 1995 of mainstream 
medical practitioners and identified similar and additional concerns amongst 
physicians who oppose its use : concerns that CM practitioners do not have sufficient 
knowledge to diagnose disease, CM lacks evidence of efficacy and CM may be 
harmful either directly by inducing adverse events or indirectly by delaying use of 
other treatments (114).  
 
There has been relatively little investigation of medical practitioners in Australia and 
their perceptions, attitudes, use and referral to CTs.  
 
A systematic review of the literature regarding overseas medical physicians is 
presented in B.4.2 and a systematic review of the literature regarding Australian 
medical practitioners is presented in B.4.3.  
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B.4.2 Systematic review of overseas medical practitioners and 
CM 
 
B.4.2.1 Aim:  
The primary aim was to review the literature on medical practitioner’s attitudes, 
beliefs, and knowledge of CMs. Secondary aims were to review the literature on 
medical practitioner’s personal usage of CM, confidence in dealing with CM-related 
issues, frequency of asking patients about CMs use, information seeking behaviour 
and sources of information used for CMs queries, referral patterns to CM and interest 
in CM training.  
 
B.4.2.2. Methods:  
A search was performed using the following databases for all years available through 
until October, 2006: Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), MEDLINE, ScienceDirect, Proquest. Search terms used included, but 
were not limited to:  
•  ‘Complementary medicine’ and ‘physician’ 
• ‘Alternative medicine’ and ‘physician’ 
• ‘Holistic medicine’ and ‘physician’ 
• ‘Natural medicine’ and ‘physician’ 
• ‘Herbal medicine’ and ‘physician’ 
• ‘Unconventional medicine’ and ‘physician’ 
• ‘Natural therapies’ and ‘physician’ 
• ‘Naturopathy’ and ‘physician’ 
 
Additional searches were conducted whereby the word ‘physician’ was replaced by 
the word ‘doctor’ and the word ‘medicine’ was replaced with the word ‘therapies’ and 
then ‘therapy’.  
 
Articles identified in this manner were searched to ascertain relevance to this 
systematic review. The reference lists of articles considered suitable for inclusion 
were also searched to identify additional relevant studies which have not been 
identified by the previous search strategy. Articles were considered eligible if they 
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were published in English, available in the peer-reviewed literature and presented 
research conducted with the medical practitioners residing outside Australia. Articles 
published prior to 2000 were excluded because the survey data were deemed too old 
to be of relevance to current practice.  
 
B.4.2.3 Results: 
 
B.4.2.3.1 Description of studies 
 
Eighteen studies were identified and deemed relevant to this systematic review 
(16;115-130). Fourteen studies involved GPs, one oncologists, one medical physicians 
(excluding GPs), one academics at a teaching hospital, one gastroenterologists and 
five contained a mixed sample which included participants who were not medical 
practitioners. Eight studies were conducted in the United States, six in the U.K. and 
one in each of the following countries: Canada, Germany, Israel, Norway and Italy. 
Seven studies had a response rate above 60% and three failed to report a response 
rate. A summary of the key findings relevant to this review are presented in Table 3.  
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents  
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Chen et al 
(131) 
2000 U.S. N=44 family 
practice 
physicians 
from the 
Cincinnati, 
Ohio 
36.4% Not reported Beyond simply 
referring patients to 
alternative 
practitioners, there 
were 7 (15.9%) 
physicians who 
practiced certain 
types of alternative 
treatments, which 
included massage, 
herbal medicine, 
acupuncture, 
reflexology, 
chiropractic, 
homeopathy, 
hypnosis, and 
Qigong. 
 
The overall 
referral rate to 
alternative 
practitioners 
during the past 
year of this study 
was 61.4%  
The treatments 
having the 
highest referral 
rates were 
chiropractic 
(50.0%), 
massage 
(36.4%), and 
acupuncture 
(29.5%). 
 
 
 
 Less than 50% of 
the physicians who 
made suggestions 
and/or referrals did 
so based on 
patients' symptoms 
or when they 
believed the 
patients would 
benefit from the 
treatments; most 
physicians made 
suggestions and/or 
referrals when they 
had no other 
choice, such as 
when they saw no 
improvement 
under conventional 
treatments. 
Perry and 
Dowrick 
(132) 
2000 U.K. N=131 General 
practitioners 
52% Acupuncture, 
osteopathy and 
chiropractic were 
the most highly 
regarded by 
respondents in 
terms of 
effectiveness. 
18% regularly used 
some form of CT in 
their practice, mainly 
homeopathy and 
acupuncture 
During the 
previous week 
56.5% of 
respondents had 
been involved in 
complementary 
medical activity 
with their 
Knowledge and 
training desires 
were highest for 
homeopathy and 
acupuncture. 
 
A minority were 
confident 
discussing CTs 
with patients 
 
They were most 
Table 3. Studies published from 2000 about physician’s attitudes, beliefs, training, knowledge, 
referral patterns and practice of CM. 
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Homeopathy and 
hypnotherapy 
received a mixed 
reaction, while 
medical 
herbalism, 
aromatherapy 
and reflexology 
were viewed 
more sceptically. 
Respondents 
were generally 
uncertain about 
the theoretical 
validity of these 
therapies: 50% 
though 
acupuncture had 
a valid basis, 
compared with 
only 23% for 
homeopathy and 
8% for 
reflexology. 
patients: 13% 
had treated 
directly, 31% had 
referred to and 
38% had 
endorsed one or 
more 
complementary 
therapies. 
21% had received 
training in 1 or 
more CTs, mainly 
homeopathy, 
acupuncture and 
hypnotherapy 
 
49% would like 
training in CTs, 
mainly 
acupuncture, 
homeopathy and 
hypnotherapy 
confident 
discussing 
acupuncture and 
homeopathy 
Corbin 
and 
Shapiro 
(16) 
2000 U.S. N=302 Physicians 
in the 
Denver, 
Colorado 
area 
43%  24% had personally 
used CM. 
48% had 
recommended 
CM to a patient; 
Physician 
recommendation 
of CM was most 
strongly 
associated with 
physician self-
use  
 
84% thought they 
needed to learn 
more about CM to 
adequately address 
patient concerns. 
76% of physicians 
reported having 
patients using CM; 
59% had been 
asked about 
specific CM 
treatments; few 
physicians felt 
comfortable 
discussing CM 
with  patients  
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Lewith et 
al  (117) 
2001 U.K. n = 
2,875 
All Members 
and Fellows 
of the Royal 
College of 
Physicians 
(GPs 
excluded 
from data 
analysis) 
23% Attitudes to CM 
were generally 
positive, 
particularly 
among those in 
palliative care, 
rehabilitation, 
nuclear 
medicine, and 
genito-urinary 
medicine 
32% of respondents 
practised CM 
themselves 
Acupuncture, 
aromatherapy and 
manipulative 
medicine (osteopathy 
and chiropractic) 
were the most 
commonly practised 
CM therapies 
 
CM is used by 
physicians more 
frequently in private 
as compared to NHS 
practice. 
41% referred 
patients to CM 
Of those who 
referred patients, 
78% referred 
between 0-3 
patients per 
month 
 
Acupuncture, 
aromatherapy 
and manipulative 
medicine 
(osteopathy and 
chiropractic) are 
the most 
commonly 
referred to 
therapies. 
 87% of those using 
CM themselves, or 
as part of their 
clinical team's 
commitment, had 
not had any CM 
training. 
Thomas et 
al (133) 
2001 U.K. N= 964  General 
practitioners 
78.6%  39.5% of GP 
partnerships provided 
access to some form 
of CM therapy for 
their NHS patients. 
24.6% of 
partnerships had 
made NHS 
referrals for CM 
therapies 
 Acupuncture and 
homoeopathy were 
the most 
commonly 
available therapies 
at GP clinics 
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Silverstein 
and 
Spiegel 
(125) 
2001 U.S.  N=165 Students 
ands faculty 
of the State 
University of 
New York, 
Health 
Science 
Center at 
Brooklyn 
 
85%   Age and training 
were negatively 
correlated in a 
statistically 
significant 
manner with the 
likelihood of a 
physician 
prescribing CMs  
Although many 
physicians asked 
their patients about 
their use of 
alternative 
remedies, most do 
not check the 
remedies in a 
reference text. 
Age and training 
were negatively 
correlated in a 
statistically 
significant manner 
with asking patients 
specifically about 
CMs and  checking 
the side effects and 
drug interactions of 
in a reference text. 
 
Rooney et 
al (124) 
2001 U.S.  Survey of all 
medical and 
associate 
staff. 
 
 
79% Little support for 
aromatherapy, 
magnetic field 
therapy, 
naturopathic 
medicine, or 
ethnic healing 
methods. 
55% reported using 1 
or more of 18 
therapies for 
themselves. Over 
25% of providers 
used nutritional 
supplements, herbal 
medicines, or 
hydrotherapy with a 
patient. 
Over 50% had 
referred a patient 
for biofeedback 
or chiropractic 
Biofeedback, 
chiropractic most 
commonly 
referred to CTs 
Associate staff, 
female staff, 
 >50% would like to 
offer acupuncture, 
biofeedback, 
chiropractic care, 
hydrotherapy, 
nutritional 
supplements, or 
massage to 
patients in the 
future 
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primary care 
providers, and 
those who had 
personally used 
CM therapies 
were more likely 
to have referred, 
or wish to offer 
more therapies in 
the future 
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Rosenbau
m et al 
(134) 
2002 U.S. N=213 Academic 
physicians at 
a large 
teaching 
hospital  
44% Biofeedback 
(15%), 
meditation (15%) 
considered most 
useful CTs; least 
useful were 
homeopathy 
(55%), healing 
touch (41%), 
herbal medicine 
(33%), 
chiropractic 
(28%), Ayurvedic 
(20%); Overall 
10% thought 
none were 
useful. 
Those with most 
knowledge most 
likely to consider 
CM useful and 
recommend it 
Those who 
personally used 
CM most likely to 
consider it useful 
and estimated 
higher patient 
use than others. 
 
33% had personally 
used CM  
Most popular 13% 
massage, 10% 
meditation, 7% herbal 
medicine, 6% 
chiropractic, 4% 
acupuncture, 4% 
biofeedback 
Those with most 
knowledge were 
most likely to to 
recommend it 
 
77% had 
recommended at 
least 1 of the CM 
therapies listed 
 
Most commonly 
57% biofeedback  
41% massage 
40% meditation 
36% chiropractic 
* biofeedback, 
massage and 
meditation were 
available at the 
institute 
Those who had 
personally used 
CM were most 
likely to have more 
knowledge of CM 
 
18% thought they 
knew ‘quite a a bit’ 
about biofeedback 
14% for meditation, 
13% hypnosis 12% 
massage 10% for 
homeopathy 10% 
herbal medicine    
9% for acupuncture  
 
46% thought CM 
education should 
be required on the 
medical curriculum 
and 82% thought it 
should be elective 
 
40% thought <10% 
of patients used 
CM and 60% 
thought <20% of 
patients used CM 
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Kaczorow
ski et al 
(135) 
2002 Canada 837 
questio
nnaires 
were 
distribut
ed and 
417 
complet
ed 
questio
nnaires 
(49.8%) 
were 
returne
d. The 
samplin
g frame 
of 
eligible 
particip
ants 
consiste
d of 229 
family 
physicia
ns and 
608 
speciali
sts 
All family 
physicians 
and 
specialists 
with a 
practice 
address in 
Hamilton, 
Ontario, 
Canada. 
Overall 
respons
e rate 
50.2% 
For the 
individu
al 
groups, 
a 
respons
e rate of 
50.2% 
(115/22
9) for 
family 
physicia
ns and 
49.7% 
(302/60
8) for 
speciali
sts 
Concerns 
identified : lack of 
regulation 
(69.6%), 
credentials of 
CM providers 
(60%), 
knowledge level 
of consumers 
about therapies 
(52.3%), 
knowledge level 
of physicians 
about therapies 
(46.5%), lack of 
formal 
communication 
between CM 
providers and 
physicians 
(45.8%). 
GPs were 
significantly more 
concerned about 
general use of 
therapies for 
maintaining 
health, lack of 
regulation , 
credentials of 
complementary 
therapists, 
knowledge level 
 The chief reason 
for consulting or 
referring patients 
to CM providers 
was “Patient 
request,” and this 
ranged from 
6.1% for 
homeopathy to 
29.4% for 
acupuncture. 
Very few 
selected from the 
other options 
such as :  belief 
in holistic 
treatment, 
knowing CM 
providers, no 
response to 
conventional 
therapy, no harm 
could result from 
therapy, or 
personal 
experience with 
services. 
Main reasons for 
not 
consulting/referri
ng patients to 
CM providers 
were: insufficient 
Both family 
physicians and 
specialists 
indicated that their 
primary learning 
needs were to 
increase 
knowledge of: (1) 
scientific principles 
underlying 
complementary 
therapies (ranging 
from 21.2% for 
homeopathy to 
34.9% for 
megavitamins); (2) 
evidence related to 
efficacy (ranging 
from 33.3% for 
homeopathy to 
53.3% for herbal 
medicine); and (3) 
potential 
interactions 
between 
conventional and 
complementary 
medicine (ranging 
from 14.5% for 
chiropractic to 
46.0% for herbal 
medicine). Desired 
educational formats 
for receiving 
information on 
Half of 
respondents 
(50.3%) reported 
that they “Very 
often” (15.1%) to 
“Often” (35.2%) 
ask their patients 
about the use of 
complementary 
therapies and 
specialists were 
significantly more 
likely to do so than 
general 
practitioners.  
The vast majority 
of physicians 
reported that 
complementary 
providers “Almost 
never” (29.0%) or 
“Never” (56.5%) 
consult with them 
about their 
patients.  
Specialists were 
significantly more 
likely to report that 
complementary 
providers 
consulted with 
them less 
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of consumer 
about 
complementary 
therapies and 
knowledge level 
of physicians 
about 
complementary 
therapies than 
specialists 
knowledge of 
complementary 
services (ranging 
from 9.4% for 
chiropractic to 
31.1% 
naturopathy), no 
therapeutic value 
(ranging from 
7.0% for 
acupuncture to 
23.9% for 
naturopathy), 
belief therapy 
may be harmful 
(ranging from 
1.7% for 
acupuncture to 
22.7% for 
homeopathy) and 
cost of therapy to 
patients (ranging 
from 11.1% for 
acupuncture to 
27.2% for 
naturopathy). 
 
 
 
 
 
 
complementary 
therapies varied 
considerably with 
continuing medical 
education (34.7%) 
and workshops 
(23.6%) as the 
most popular. 
 
frequently than 
their general 
practitioner 
colleagues. 
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Schmidt et 
al (136) 
2002 U.K. and 
Germany 
N= 97 
in U.K. 
N=99 in 
German
y 
General 
practitioners 
in U.K. and 
Germany 
68% Overall GPs 
attitude toward 
CM was more 
positive for f 
German GPs  
compared to  
British GPs, 
although  not 
statistically 
significant. 
 
70% of British 
GPs thought it is 
safe to prescribe 
CM to patients, 
22% thought that 
it was not safe 
and the rest did 
not mention 
safety. 
76% of the 
German GP 
sample said it is 
safe to prescribe 
CAM and 19% 
thought it was 
not safe. 
The top three 
illnesses GPs 
thought CM 
A significantly higher 
number of German 
GPs reported having 
practised as a CM 
practitioner before 
(n=30) and having 
personally used CM 
themselves (n=31) 
compared to British 
GPs. This was 
specifically the case 
for acupuncture. 8% 
of British respondents 
claimed to practise or 
have practised 
chiropractic 
treatment, 5% 
acupuncture 
treatment, 5% 
homeopathic 
treatment and 3% 
osteopathy.  
19% of German GPs 
claimed to work or 
have worked as an 
acupuncturist, 11% 
as a chiropractor, 6% 
as a homeopath and 
3% as an osteopath.  
 
6% of the British GPs 
British GPs 
reported higher 
levels of referrals 
to CM 
practitioners than 
German GPs. 
The most popular 
CTs that UK GPs 
referred their 
patients to were 
chiropractic 
treatment (79%), 
acupuncture 
(67%) and 
osteopathy 
(66%). German 
GPs referred 
their patients 
mainly to 
acupuncture 
treatment (82%), 
chiropractic 
treatment (73%) 
and herbal 
medicine (28%) 
Significantly 
more British GPs 
referred patients 
to Alexander 
technique, 
aromatherapy, 
homeopathy and 
osteopathy. 
Significantly 
more German 
 Most GPs, 
irrespective of 
country, were 
concerned about 
the lack of 
scientific evidence 
about CM. British 
GPs were also 
highly concerned 
about lack of 
knowledge about 
its indications and 
the lack of 
availability on the 
NHS. German GPs 
expressed that 
many practitioners 
are prejudiced 
against CAM and 
that generally 
there is less 
patient feedback 
on alternative 
methods 
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would be useful 
for include 
stress, headache 
and depression 
However, 
considerably less 
British GPs 
would prescribe 
CM for 
headaches and 
more British GPs 
would prescribe 
CM for stroke, 
HIV/AIDS and 
ME (post-viral 
fatigue 
syndrome) 
compared to 
German GPs.  
 
 
 
 
 
 
 
 
 
had personally used 
chiropractic treatment 
before, 2% 
acupuncture and 2% 
homeopathy.  
11% of German GPs 
had personally used 
acupuncture before, 
7% chiropractic and 
5% homeopathy 
GPs referred 
their patients to 
herbal medicine 
and naturopathy.  
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Nass et al 
(137) 
2002 U.S. Questio
nnaires 
mailed 
to 1000 
randoml
y 
selecte
d  
gastroentero
logists 
Not 
reported 
 Respondents that had 
received continuing 
medical education on 
CM therapies were 
more likely to use CM 
therapies themselves 
(39.8% vs 23.4%), 
recommend CM 
therapies to their 
patients (50.5% vs 
27.0%) 
 The majority of 
respondents 
obtained 
information about 
CM from medical 
journals (75.7%), 
the media (57%), 
continuing medical 
education (48.1%), 
the internet 
(22.4%), or other 
sources (15.9%).  
Very few 
respondents 
reported that they 
had received 
lectures on CM 
during medical 
school (5.1%), 
residency (3.7%) or 
fellowship training 
(3.7%). 
 
Those that had 
received 
continuing medical 
education on CM 
therapies were 
more likely to 
always ask 
patients about CM 
therapy use 
(27.5% vs 12.7%). 
Reasons for 
discontinuing CAM 
use were side effects 
(40.0%); expense 
(24.4%); or 
ineffectiveness 
(15.0%).  
Most common side 
effects associated 
with CM were 
abnormal LFTs, 
diarrhea, nausea. 
Most common 
benefits reported 
were relief of pain, 
general improvement 
of symptoms (e.g. 
nausea, diarrhoea) 
and well being, and 
an improvement in 
liver enzymes using 
milk thistle. 
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Kemper et 
al (138) 
2003 U.S. N= 537 
include
d 111 
physicia
ns, 30 
advanc
ed 
practice 
nurses, 
46 
pharma
cists, 
and 350 
dietician
s 
* a 
highly 
self-
selecte
d 
sample  
 Not 
reported 
79% thought 
herbs and dietary 
supplements 
may have some 
benefit 
34% stated ‘I’m 
sceptical’ 9% 
thought most 
benefits are due 
to placebo 
27% ‘I’m 
concerned that 
patients may be 
harmed by them’ 
74%’my 
colleagues are 
poorly trained to 
answer 
questions about 
them’ 
 
77% used herbs and 
natural supplements 
personally (not 
including 
multivitamins) 
 
CMs used were: 
59% multivitamins 
48% calcium 
36% vitamin E 
30% vitamin C 
19% vitamin B 
complex or individual 
B vitamin 
17% echinacea 
12% chamomile 
12% soy 
11% magnesium 
 
 66% reported 
receiving training 
about herbs and 
dietary 
supplements in the 
previous year 
The average score 
on the knowledge 
test was 10/20 
overall 
Most respondents 
knew the most 
common clinical 
uses for echinacea 
and St Johns wort 
Key deficits were in 
knowledge of 
adverse effects 
4/10 average 
confidence score 
overall 
1.4/5 average 
communication 
score 
 
Key deficits were 
in  confidence in 
reporting adverse 
effects, 
communicating 
with patients about 
herbs and natural 
supplements and 
recording this 
information inI 
hospital records 
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Giveon et 
al (121) 
2003 Israel N=150 
complet
ed the 
survey 
Conveni
ence 
sample 
Primary care 
physicians 
attending a 
weekly 
routine 
continuing 
medical 
education 
program at 
the 
Department 
of Family 
Medicine, 
Tel Aviv 
University. 
91% 51% of 
physicians 
claimed that 
herbal remedies 
have no or only 
mild side effects, 
and 63% claimed 
that they have no 
or only mild 
interactions with 
conventional 
drugs. Seventy-
three percent of 
physicians took 
no or little 
interest in 
complementary 
medicine, and 
75% in herbal 
medicine. 
 31% practiced some 
kind of 
complementary 
medicine. 
25% did not refer 
patients for 
complementary 
medicine and 
69% did so 
occasionally 
25% had some 
training in 
complementary 
medicine 
68% estimated up 
to 15% of their 
patients use CM; 
53% that up to 
15% of their 
patients use herbal 
remedies; 50% 
that 10% of their 
patients report use 
of herbal 
remedies; and 
52% that 10% of 
their patients 
consult them about 
herbal drug use. 
58% of physicians 
always or often 
asked their 
patients about CM 
use, and 60% 
usually asked their 
patients about 
herbal use. 
GPs with no 
knowledge of 
herbs asked 
significantly less 
often than those 
with substantial 
knowledge.  
GPs who were 
satisfied when 
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their patients 
discussed CM with 
them tended to 
inquire about its 
use significantly 
more often than 
those who were 
indifferent or felt 
bad (angry, 
worried, sad).  
Those who never 
referred patients 
for CTs on their 
own initiative 
queried patients 
significantly less 
often about use 
than GPs who 
often referred  
Physicians with a 
low estimate of 
patient use of CM 
had a significantly 
lower tendency to 
ask about its use 
and a significantly 
lower estimate of 
the percentage of 
patients who 
disclose use of 
CM. 
No relationship 
between 
percentage of 
physicians who 
questioned 
patients about use 
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of CM or 
personally 
practiced CM,  
physician age, 
gender, place of 
graduation, 
number of years in 
practice, or 
qualifications in 
CM . 
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Thomas et 
al 
(127) 
2003 U.K.      the proportion of 
practices making 
NHS referrals 
remained 
unchanged since 
the 2001 survey 
 one in two 
practices in 
England now offer 
their patients some 
access to CM 
Van 
haselen et 
al 
(128) 
2004 U.K. Respon
ses 
were 
obtaine
d from 
149 
GPs 
and 24 
nurses 
and 32 
other 
primary 
care 
team 
member
s. 
Primary 
health care 
workers in 
Northwest 
London. 
General 
Practitioners 
(GPs) were 
targeted in a 
postal 
survey, other 
members of 
the primary 
care team, 
such as 
district and 
practice 
nurses, were 
targeted via 
colleagues. 
40% Only 6% against 
any integration of 
CM into 
mainstream 
primary care; 
70% thought 
integration of CM 
could lead to 
cost savings , 
especially in pain 
conditions; 55% 
thought cost 
increases could 
occur, especially 
in poorly defined 
conditions (55%). 
Prevalent 
attitude that CTs 
should be 
provided by 
health care 
professionals, 
such as doctors, 
who are trained 
in CM 
 83% of 
respondents had 
previously 
referred (or 
influenced 
referral) for CM 
treatments 
Acupuncture 
and 
homoeopathy 
were the 
therapies for  
which patients 
were most 
frequently 
referred, followed 
by manual 
therapies 
There was a 
significant interest 
in more 
training/information 
on CM (66%) 
The main reasons 
for CM referral 
were : patients 
request (68%), 
conventional 
treatments failed 
(58%) and 
evidence (36%)  
56% would 
consider 
participating in 
studies 
investigating CM. 
Greatest interest in 
acupuncture  
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Milden 
and 
Stokols 
(118) 
2004 U.S. N=51 California 
physicians 
26% 
Physicians who 
had been in 
practice the 
longest (and 
were therefore 
presumably 
older) expressed 
the most 
opposition to 
CM. 
Both their lack of 
CM training, as 
well as the length 
of time they had 
been influenced 
by the 
institutional 
norms that 
historically have 
resisted CM, 
may explain their 
opposition.  
Gender was 
neither 
significantly 
correlated with 
nor predictive of 
positive CM 
beliefs, attitudes, 
or behaviours. 
 
Physicians' use or 
recommendations of 
CM in their practices 
are limited by 
concerns about 
medical professional 
norms, yet are 
positively associated 
with their use of 
computer technology 
for self-education and 
communication with 
peers.  
 61% do not feel 
sufficiently 
knowledgeable 
about CM safety or 
efficacy, and 81% 
would like to 
receive more 
education on CM 
modalities. 
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Risberg et 
al 
(139) 
2004 Norway N=828 Norwegian 
oncologists, 
nurses, 
clerks and 
therapeutic 
radiographer
s 
Total 
respons
e rate 
was 
61%. 
The 
followin
g 
respons
e rates 
were 
attained
: 
108/156 
oncologi
sts 
(69%); 
242/414 
nurses 
(58%); 
103/164 
therape
utic 
radiogra
phers 
(63%) 
and 
49/94 
clerks 
(52%). 
In 
seven 
cases, 
Females showed 
a significantly 
more positive 
view towards 
‘CM than males 
(33% versus 
14%) 
 
No significant 
differences 
according to age 
group. By 
contrast, 
approximately 
one-third of 
nurses, 32% of 
therapeutic 
radiographers 
and 55% of 
clerks reported 
more positive 
views  
 
In regards to CM 
more 
participants, 
including 
physicians, 
expressed 
positive attitudes, 
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the 
occupati
on was 
not 
given. 
with few 
describing 
themselves as 
negative. 
 
Again, females 
were more 
positive than 
males (79% 
versus 
53%,).Physicians 
were less 
positive than 
nurses, clerks 
and therapeutic 
radiographers  
 
However, more 
physicians had a 
positive attitude 
and fewer were 
negative to 
complementary 
treatments (13%) 
than to 
alternative 
treatments 
(81%). 
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Author/s Year of 
publicatio
n 
Country 
where 
survey 
conducted 
Sample 
size 
Description 
of 
respondents 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – personal 
use and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
Cocconi et 
al (116) 
2006 Italy N= 
1734  
 
Physicians 
belonging to 
the province 
of Parma 
66% 53% thought 
unconventional 
medicine (UM) 
had some 
efficacy 
 
92% did not practice 
unconventional 
medicine (UM). 
Of the 143 physicians 
who declared that 
they practice any type 
of UM on their 
patients, only 8% 
practice UM alone; 
the remaining 92% 
provide UM together 
with conventional 
medicine. 
Fifty percent of the 
physicians practicing 
UM on their patients 
stated that they 
prescribed UM 
medications. 
Homeopathy was the 
most widely practiced 
discipline (44%), 
followed by 
acupuncture (34%), 
herbal therapy (29%) 
and manipulative 
treatments (20%). Of 
the different 
manipulative 
treatments mentioned 
 A large majority of 
the UM 
practitioners (77%) 
had been trained to 
practice UM by 
means of formal 
educational 
courses; the other 
23% said that they 
were self-educated. 
76% reported that 
patients wanted 
unconventional 
therapies  
 
Some 41% of 
physicians 
practising UM 
declared that they 
subscribe to one or 
more UM journals 
and 36% that they 
belonged to at 
least one UM 
society. 
Eighty-two percent 
treated conditions 
of the 
musculoskeletal 
system, 32% 
psychological or 
somatic disorders, 
28% headaches 
and 18% allergic 
conditions or 
digestive 
disorders. A 
smaller proportion 
treated female 
endocrine or 
genital disorders, 
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in the questionnaire, 
most physicians 
declared that they 
practiced applied 
kinesiology and a 
minority chiropractic 
or osteopathy. Less 
than 20% but more 
than 10% of the UM 
practitioners reported 
practicing 
homotoxicology, 
posturology and 
traditional Chinese 
medicine. 
lung disease or 
disorders of the 
oral cavity 
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B.4.2.3.2 Methodological concerns 
 
Similar methodological concerns arose during the conduct of this systematic review as 
experienced in the previous systematic review of the Australian general population 
use of CMs.  
 
Studies exploring physicians and CM are frequently compromised by poor response 
rates. Eight studies in the review had a response rate of less than 60%, or did not 
report a response rate thereby reducing the generalisability of their results. Low 
response rates can also mean these surveys are skewed towards respondents who have 
strong opinions, either positive or negative, about CM. Five studies pooled data from 
different populations besides medical practitioners thereby making it difficult to 
determine the relevance of the findings. To account for this, their findings were not 
included in the following discussion unless a separate result was reported for medical 
practitioners or otherwise indicated. In some instances, reporting was unclear about 
whether ‘use’ of CM refers to personal use for physicians own health or the practise 
of CM for patients health which would lead to an inaccurate conclusion. As is the case 
so often with studies investigating CM, there is a lack of consistency between 
definitions being used to describe CM. Additionally, some studies failed to make the 
distinction between referral to CM treatments (which may or may not have required a 
CM practitioner) or specific type of CM practitioner and time frames for referral 
differed. The methods used to assess attitudes to CM were highly variable and not 
always clearly reported, further complicating their interpretation and comparison.  
 
B.4.2.3.3 Personal use of CM 
 
Physician’s personal use of CM affects their likelihood of patient referral, attitudes 
and perceptions of CM and correspondingly, the advice given to patients (140).   
 
The data generally indicate that in the United States, 24% of GPs have used CM (16),  
up to 39.8%  of gastroenterologists (141) and 33% of academic physicians at a 
teaching hospital (142). The CTs most commonly used were: massage, meditation, 
herbal medicine, chiropractic, acupuncture and biofeedback. One study identified that 
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if physicians had received training about CM, they were more likely to personally use 
it (141). A similar result was obtained by Rosenbaum et al who found that personal 
use of CM was associated with greater self-reported knowledge of CM and a higher 
estimate of patient use (143).  
 
One study of GPs in the U.K. identified personal use of CM. Results indicate that 6% 
of GPs personally used chiropractic, 2% acupuncture, 2% homeopathy (144). A study 
of German GPs found usage was higher amongst this group than U.K. based GPs and 
11% of German GPs had personally used acupuncture, 7% chiropractic and 5% 
homeopathy (145).  
 
A comparison between medical practitioners based in the U.S. compared with those in 
the E.U. shows that homeopathy is less frequently used by U.S. physicians whereas 
acupuncture and chiropractic is used in both regions.  
 
B.4.2.3.4 Practice of CM 
 
In regards to the practice of CTs, 15.9% of U.S. GPs reported practising at least one 
CT, most commonly massage, herbal medicine, acupuncture, reflexology, 
chiropractic, homeopathy, hypnosis and QiGong (in order from highest to lowest) 
(131). Although these results provide some useful information, they should be 
interpreted cautiously as they come from a small sample. Perry et al reported that 18% 
of GPs in the UK practice a CT, mostly homeopathy and acupuncture (146) whereas 
32% of a sample of physicians (excluding GPs) reported practising a CT, mostly 
acupuncture, aromatherapy and manipulative therapies (117). In the U.K. CM is 
practiced by physicians more frequently in private as compared to NHS practice 
(117). A greater percentage of GPs in Israel practice a CT than in the U.K. or U.S., 
with Giveon et al estimating this as 31% (121). More German GPs practice CTs than 
U.K. GPs, with 19% reporting having worked using acupuncture, 11% with 
chiropractic, 6% with homeopathy, 3% with osteopathy (147). Few Italian GPs 
practised a CT, and of those that did, homeopathy, acupuncture and herbal medicine 
were most popular (116).  
 
Chapter ONE Section B – Use of CTs by the general population, physicians and pharmacists 
95 
B.4.2.3.5 Referral patterns 
 
In the United Kingdom, 41% of physicians (excluding GPs) referred patients to CTs, 
most commonly acupuncture, aromatherapy and manipulative therapies with therapies 
referred to being similar to those being practiced by the sample (117). According to 
Rosenbaum et al, 77% of academic physicians at a U.S. teaching institute reported 
having referred patients to CTs, most commonly biofeedback, massage, meditation 
and chiropractic and physicians with greater self-reported knowledge of CM were 
more likely to refer patients to CM (148). It must be noted that the institute where the 
study was conducted offered these services which is likely to have influenced the 
results. Two studies of GPs in the U.S. reported that referral to CTs ranges from 48%-
61% (16;131). Corbin et al reported that referral was most strongly associated with 
personal use of CM (16). A survey of gastroenterologists in the U.S. identified that 
having received continuing medical education about CM increased the likelihood of 
patient referral (141). 
  
British GPs reported higher levels of referrals to CM practitioners than German GPs 
(149). The most popular CM therapies that U.K. GPs referred their patients to were 
chiropractic treatment (79%), acupuncture (67%) and osteopathy (66%) (150). 
German GPs referred their patients mainly to acupuncture treatment (82%), 
chiropractic treatment (73%) and herbal medicine (28%) (151). A comparison 
between the two groups revealed that significantly more British GPs referred patients 
to Alexander technique, aromatherapy, homeopathy and osteopathy than German 
GPs. Significantly more German GPs referred their patients to herbal medicine and 
naturopathy(152).  
 
Of all the surveys reviewed, two identified reasons for referral to CM. These included:  
patient request (128;135) evidence supporting use (128), if other treatments had failed 
(128;131).  
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B.4.2.3.6 Training, knowledge and information sources 
 
Overall, most GPs in the U.S. reported wanting more education about CM. This 
ranged from 81% (118) to 84% (16). Milden and Stokols reported that 61% of GPs 
did not feel sufficiently knowledgeable about CM efficacy and safety (118). Nearly 
half (46%) of  academic physicians at a U.S. institute thought CM education should 
be on the medical curriculum and 82% thought it should be offered as an elective 
subject (153). In the U.K. 87% of physicians (excluding GPs) using CM themselves, 
or as part of their clinical team's commitment, had not had any CM training (117). In 
regards to U.K. GPs, 21% had received training with one or more CT, mostly 
homeopathy, acupuncture and hypnotherapy (154) and 40% would like to receive 
training in the same three modalities (155).  
 
Limited information is available about the resources used by medical practitioners for 
information about CM. One study of U.S. gastroenterologists reported that 76% 
obtained information about CM from medical journals, 57% the media, 48.1% 
continuing medical education ,22.4%  the internet , or other sources (15.9%)(141). 
 
B.4.2.3.7 Asking patients about CM 
 
The data available demonstrate that physicians do not routinely ask patients about use 
of CM. Approximately half the respondents in the Canadian- and Israeli- based 
studies reported asking their patients about CM use (121;135). Kaczorowski reported 
that Canadian medical specialists were significantly more likely to ask patients than 
GPs (135). Giveon et al explored this behaviour in greater depth and found that 
several variables were associated with the frequency of asking patients about CM use 
(121).. These were: physician’s knowledge about CM, estimation of patient use and 
attitudes to CM. The physicians least likely to ask patients reported no knowledge 
about CM, a low estimate of patient CM or a negative or indifferent attitude to CM. 
No information was specifically reported about physicians in the U.K. or U.S. in this 
regard.  
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B.4.2.3.8 Confidence 
 
The confidence of U.S. or Canadian based physicians in dealing with CM-related 
issues was not reported in any study located. One study of U.K. GPs investigated this 
issue and reported that a minority were confident discussing CM with patients (156). 
The CTs they were most confident discussing were: acupuncture and homeopathy. 
 
B.4.2.3.9 Attitudes and beliefs 
 
Varying levels of interest and acceptance of CM by physicians has been demonstrated 
in the reviewed studies with results generally indicating a growing curiosity about 
specific CTs. According to Schmidt et al, the overall attitude of U.K. and German 
GPs toward CM was positive with a slightly more positive attitude expressed by the 
German GPs (157). Similarly, U.K. physicians (excluding GPs) expressed a generally 
positive attitude to CM, particularly among those in palliative care, rehabilitation, 
nuclear medicine, and genito-urinary medicine (117).  
 
In regards to specific CTs, acupuncture, osteopathy and chiropractic were the most 
highly regarded by U.K. GPs in terms of effectiveness whereas homeopathy and 
hypnotherapy received a mixed reaction and medical herbalism, aromatherapy and 
reflexology were viewed more sceptically (158).  
 
Little support for aromatherapy, magnetic field therapy, naturopathic medicine, or 
ethnic healing methods was reported for a sample of medical staff and associate 
workers in the U.S.(124). U.S. academic physicians thought biofeedback and 
meditation were the most useful CTs whereas homeopathy, healing touch, herbal 
medicine, chiropractic, Ayurvedic medicine was considered the least useful (120). 
Overall 10% of this sample thought none of the CM therapies were useful. Having 
greater knowledge of CM or personal use was associated with a more favourable 
attitude about the usefulness of CM (120).  
 
Physicians also have several concerns about CM. British and German GPs are 
concerned about the lack of scientific evidence about CM. British GPs were also 
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highly concerned about lack of knowledge about its indications and the lack of 
availability on the N.H.S. (159). German GPs were also concerned that many 
practitioners are prejudiced against CM (160). In another survey, UK GPs expressed 
uncertainty about the theoretical validity of CTs with 50% considering acupuncture 
had a valid basis, compared with only 23% for homeopathy and 8% for reflexology 
(161). 
  
Canadian physicians had numerous concerns about CM which included (starting with 
the most prevalent):  lack of regulation, credentials of CM providers, the knowledge 
level of consumers about CTs, the knowledge level of physicians about CTs and lack 
of formal communication between CM and medical practitioners (135). GPs were 
significantly more concerned about general use of therapies for maintaining health, 
lack of regulation, credentials of complementary therapists, knowledge level of 
consumer about complementary therapies and knowledge level of physicians about 
complementary therapies than specialists (135).  
 
In regards to their perceptions about the safety of CTs, 70% of British GPs thought it 
is safe to prescribe CM to patients, 22% thought that it was not safe which was similar 
to German GPs of which 76% said it is safe to prescribe CM and 19% thought it was 
not safe (162). Fifty one percent of primary care physicians in Israel claimed that 
herbal medicines had no or only mild side effects, and 63% claimed that they had no 
or only mild interactions with conventional drugs (121). 
 
4.2.3.3.10 Limitations of this review 
 
Similar to the previous systematic review, the main limitation of this review relates to 
the heterogeneity of the included studies which reduced the ability of the review to 
compare results and summarise key trends. Whilst every effort was made to locate 
relevant studies, it is possible that others exist which were not identified using the 
search strategy. 
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B.4.3. Systematic review of Australian medical practitioners 
and CM 
 
B.4.3.1 Aim:  
The primary aim was to review the literature on Australian medical practitioner’s 
attitudes, beliefs, and knowledge of CMs. Secondary aims were to review the 
literature on medical practitioner’s personal usage of CM, confidence in dealing with 
CM-related issues, frequency of asking patients about CMs use, information seeking 
behaviour and sources of information used for CMs queries, referral patterns to CM 
and interest in CM training.  
 
B.4.3.2 Methods:  
A search was performed using the following databases for all years available through 
until October, 2006: Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), MEDLINE, ScienceDirect, Proquest. Search terms used included, but 
were not limited to:  
• ‘Australia’ and ‘complementary medicine’ and ‘physician’ 
• ‘Australia’ and ‘alternative medicine’ and ‘physician’ 
• ‘Australia’ and ‘holistic medicine’ and ‘physician’ 
• ‘Australia’ and ‘natural medicine’ and ‘physician’ 
• ‘Australia’ and ‘unconventional medicine’ and ‘physician’ 
• ‘Australia’ and ‘natural therapies’ and ‘physician’ 
• ‘Australia’ and ‘naturopathy’ and ‘physician’ 
 
Additional searches were conducted whereby the word ‘physician’ was replaced by 
the word ‘doctor’ and the word ‘medicine’ was replaced with the word ‘therapies’ and 
then ‘therapy’.  
 
Articles identified in this manner were searched to ascertain relevance to this 
systematic review. The reference lists of articles considered suitable for inclusion 
were also searched to identify additional relevant studies which have not been 
identified by the previous search strategy. Articles were considered eligible if they 
were published in English, available in the peer-reviewed literature and presented 
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research conducted with the medical practitioners residing within Australia. Articles 
published prior to 2000 were excluded because the survey data were deemed too old 
to be of relevance to current practice.  
 
B.4.3.3 Results: 
 
B.4.3.3.1 Description of studies 
 
Four studies were located of which three studies had a response rate above 60% (163-
165). Three studies were conducted with general practitioners (163;165;166), one 
with radiation oncologists and medical oncologists (167) and one was a national study 
of general practitioners (166). No studies of other hospital doctors were located. A 
summary of key findings from the studies reviewed is presented in Table 4.  
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Author/s Year of 
publicati
on 
Sample 
size 
Description of 
respondents 
and setting 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – 
personal use 
and practise of  
Referral 
patterns to 
CM 
Training, 
knowledge and 
information 
Other relevant 
information 
Pirotta et 
al  
(165) 
2000 N=488 GPs in Victoria 64%  Nearly half had 
considered using 
CM 
93% had 
referred at 
least once in 
the previous 
year  
 
Acupuncture 
and hypnosis 
were most 
popular 
At least 80% of 
GPs reported 
that they knew 
something of 
acupuncture, 
hypnosis, 
meditation and 
chiropractic; 
about half knew 
something of 
herbal medicine, 
naturopathy and 
vitamin and 
mineral therapy; 
while 60%-70% 
had only heard 
of osteopathy, 
homoeopathy, 
spiritual healing, 
reflexology and 
aromatherapy. 
 
Most 
respondents 
(93%) agreed 
that there 
should be some 
education on 
complementary 
therapies in core 
medical 
undergraduate 
GPs  
underestimate 
their patients' use 
of complementary 
therapies. 
Table 4. Australian medical practitioners and CM 
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curricula. 
 
GPs have 
trained in 
various 
therapies--
meditation 
(34%), 
acupuncture 
(23%), vitamin 
and mineral 
therapy (23%), 
hypnosis (20%), 
herbal medicine 
(12%),  
chiropractic 
(8%), 
naturopathy 
(6%), 
homoeopathy 
(5%), spiritual 
healing (5%), 
osteopathy 
(4%), aroma-
therapy (4%), 
and reflexology 
(2%) 
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Author/s Year of 
publicati
on 
Sample 
size 
Description of 
respondents 
and setting 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – 
personal use 
and practise of  
Referral 
patterns to 
CM 
Training, 
knowledge and 
information 
Other relevant 
information 
Easthope 
et al (163) 
2000 N=290 GPs in Tasmania 62%   66% had 
referred 
patients to 
complementar
y therapies in 
the last year 
and 55% to 
non-medically 
trained CM 
practitioners  
Acupuncture, 
hypnotherapy 
and 
Feldenkreis 
were most 
popular  
 
  
Newell 
and 
Sanson-
Fisher 
(168) 
2000 N= 161  Oncologists in 
Australia: 
60 radiation 
oncologists, 64 
medical 
oncologists and 
37 who could not 
be classified 
61%  CTs most likely 
to be considered 
helpful : 
meditation, 
acupuncture and 
hypnotherapy.  
 
Oncologists 
tended to 
consider the 
psychosocial 
  Oncologists 
reported 
knowing most 
about 
acupuncture, 
antioxidant 
therapy and 
meditation and 
least about 
cellular therapy, 
magnetotherapy 
and psychic 
surgery 
Perceptions of 
patients' use of 
most therapies 
varied widely, 
with herbal 
therapies, 
antioxidant 
therapy and 
meditation 
considered the 
most 
commonly 
used 
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therapies helpful 
for patients 
being treated 
both palliatively 
and curatively.  
Acupuncture 
considered 
helpful, 
especially for 
palliative 
patients.  
 
Many therapies 
considered more 
likely to help 
palliative 
patients and, 
conversely, 
more harmful for 
curative 
patients. 
 
Less familiar, 
more physical or 
invasive 
therapies 
dominated those 
considered likely 
to be harmful.   
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Author/s Year of 
publicati
on 
Sample 
size 
Description of 
respondents 
and setting 
Respon
se rate 
Beliefs and 
attitudes to CM 
Use of CM – 
personal use 
and practise of  
Referral 
patterns to 
CM 
Training, 
knowledge and 
information 
Other relevant 
information 
Cohen et 
al 
 (169) 
2005 N=636 GPs in Australia 33.2% >66% thought 
the following CM 
therapies were 
effective and 
>80% thought 
they were safe: 
acupuncture, 
massage, 
meditation, 
yoga, hypnosis 
 
Therapies 
considered to 
have low 
effectiveness 
and low harm 
potential were: 
Spiritual healing, 
aromatherapy, 
reflexology 
40% had 
personally used 
nutritional, herbal 
or other 
supplements in 
the previous 4 
weeks 
 
The most 
common ones 
used were (from 
highest) : 
Multivitamins, 
vitamins C, B, E, 
glucosamine, fish 
oils, zinc, folic 
acid, iron, 
antioxidants, 
selenium, garlic, 
evening primrose 
oil 
GPs most 
frequently 
referred to 
massage, 
meditation 
yoga and 
acupuncture 
GP’s who were 
self-taught or 
had attended 
introductory 
workshops : 
23% meditation, 
18% 
vitamins/mineral 
therapy, 12% 
yoga, 11% 
herbal medicine, 
11% 
acupuncture 
 
12% had a 
diploma or 
certificate in 
acupuncture 
>20% 
expressed 
interest in 
attending an 
introductory 
workshop on 
meditation, 
massage, 
hypnosis, yoga, 
herbal medicine 
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B.4.3.3.2 Methodological concerns 
 
Whilst three out of four studies had a response rate above 60%, the largest study of 
had a response rate of 33%, thereby reducing the generalisability of the results. The 
low response rate can also mean the results are skewed towards respondents who have 
strong opinions, either positive or negative, about CM.   
 
B.4.3.3.3 Attitudes and beliefs 
 
Two studies evaluated physician’s attitudes and beliefs about CTs. Cohen et al 
reported that greater than 66% of GPs thought the following CTs were effective and 
over 80% thought they were safe: acupuncture, massage, meditation, yoga, hypnosis. 
The CTs considered to have low effectiveness and low harm potential were: spiritual 
healing, aromatherapy, reflexology (166).  
 
A survey of oncologists demonstrated they considered meditation, acupuncture and 
hypnotherapy as helpful whereas CTs considered harmful were coffee enemas, 
psychic surgery, Iscador therapy and diet therapies (170). When asked about these 
perceptions in regards to palliative or curative use, oncologists tended to consider the 
psychosocial therapies helpful for patients being treated both palliatively and 
curatively and acupuncture was also considered helpful, especially for palliative 
patients. Many therapies were considered more likely to help palliative patients and, 
conversely, more harmful for curative patients. The less familiar, more physical or 
invasive therapies dominated those considered likely to be harmful.  
 
B.4.3.3.4 Personal use of CTs 
 
Only one study evaluated physicians personal use of CTs and demonstrated that 40% 
of GPs  had personally used nutritional, herbal or other supplements in the 4 weeks 
prior to the survey and the common CMs used were (from highest) :multivitamins, 
vitamins C, B, E, glucosamine, fish oils, zinc, folic acid, iron, antioxidants, selenium, 
garlic, evening primrose oil (166). Previously, a survey indicated that nearly half of 
GPs surveyed had considered using CM (165). 
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B.4.3.3.5 Referral patterns 
 
Pirotta et al reported that 93% of GPs had referred patients at least once in the 
previous year to CTs with acupuncture and hypnosis being the most popular referrals 
(165). The same year, another study demonstrated that GP referral to CTs in the 
previous year was far less, only 66% and 55% had referred patients to non-medically 
trained CM practitioners. Acupuncture, hypnotherapy and Feldenkreis were the most 
popular referral choices (163). Five years later, the most frequent GP referrals to CTs 
were reported as massage, meditation, yoga and acupuncture (166). 
 
B.4.3.3.6 Training, knowledge and information sources 
 
GPs have trained in various CTs, specifically: meditation (34%), acupuncture (23%), 
vitamin and mineral therapy (23%), hypnosis (20%), herbal medicine (12%), 
chiropractic (8%), naturopathy (6%), homoeopathy (5%), spiritual healing (5%), 
osteopathy (4%), aroma-therapy (4%), and reflexology (2%)(165).A later survey 
found that 12% of GPs had a formal diploma or certificate in acupuncture and more 
that 20% expressed interest in attending an introductory workshop on meditation, 
massage, hypnosis, yoga, herbal medicine (166). 
 
At least 80% of GPs reported that they knew something of acupuncture, hypnosis, 
meditation and chiropractic; about half knew something of herbal medicine, 
naturopathy and vitamin and mineral therapy; while 60% -70% had only heard of 
osteopathy, homoeopathy, spiritual healing, reflexology and aromatherapy (165). 
Similarly, oncologists reported knowing most about acupuncture and meditation. 
They also reported knowing the least about cellular therapy, magnetotherapy and 
psychic surgery (164). None of these studies evaluated participant’s actual knowledge 
about CTs.  
 
Most GPs (93%) agreed that there should be some education on complementary 
therapies in core medical undergraduate curricula (165). No studies were located that 
investigated physicians information seeking behaviours, resources used for 
information about CM or actual knowledge about commonly used CMs.  
Chapter ONE Section B – Use of CTs by the general population, physicians and pharmacists 
108 
B.4.3.3.7 Asking patients about use of CM 
 
No studies were located which investigated the methods or frequency of 
communication with patients about CM or the reasons for non-communication.  
 
B.4.3.3.8 Limitations 
 
The main limitation of this review relates to the heterogeneity of the included studies 
which reduced the ability of the review to compare results and summarise key trends. 
Whilst every effort was made to locate relevant studies, it is possible that others exist 
which were not identified using the search strategy. It is also apparent that most 
investigation has been conducted with GPs thereby limiting the generalisability of 
these results to hospital doctors.  
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B.5.0  Pharmacists and CM 
 
The three major functions of the pharmacist are: identifying potential and actual drug 
related problems, resolving actual drug-related problems and preventing potential 
drug-related problems (171). This requires knowledge of the available evidence 
regarding the drug, knowledge of the patient and their disease and communication 
with the patient and other health care professionals. 
 
Within the hospital setting, clinical pharmacists interact with patients on daily ward 
rounds, conduct medication reviews and counselling sessions, liaise with medical 
teams to advise on appropriate use of medicine and provide drug information for 
nurses, doctors and other pharmacists. Drug information pharmacists investigate and 
advise on the more difficult drug related queries and are available to provide 
information to patients and all hospital health care staff. Dispensing pharmacists must 
also be aware of and advise on the safe and appropriate use of medicines.  
 
With the widespread interest and use of CM, pharmacists are likely to be coming into 
contact with people interested in using or already using CMs. As a reflection of this, 
recent surveys have indicated that most pharmacists consider it important to have 
knowledge about CM or herbal medicine and be able to provide information to 
patients (172;173).  
 
B.5.1 Review of the literature  
 
In order to identify what information has been published in the international peer-
reviewed literature about pharmacist’s attitudes, beliefs, personal usage, personal 
practice, referral patterns, training or knowledge of CM, a search was undertaken of 
the databases Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
MEDLINE, ScienceDirect and Proquest. Articles were considered for this review if 
studies were conducted with either community or hospital pharmacists and available 
in English.  Relevant articles were identified by searching the databases for all years 
available through to October, 2006. Table 5 lists relevant studies of overseas and 
Australia-based pharmacists.  
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Year of 
publica
tion 
First 
author 
Country 
where 
survey 
conducte
d 
Sample 
size  
Description 
of 
respondents 
and setting 
Respons
e rate 
Beliefs and attitudes 
to CM 
Use of CM – 
personal use 
and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
1990 Nelson 
MV et al 
(174;175
) 
U.S and 
U.K. 
U.S. 
n=197 
U.K. 
n=434 
Random 
sample of 
hospital and 
community 
pharmacists 
U.S. 
19.7% 
 
U.K. 
63.0% 
Acupuncture was 
the Alternative 
Health Approach 
(AHA) felt to be 
most useful by the 
majority of 
pharmacists, both in 
the U.S. (83.8%) 
and in Britain 
(91.0%). The most 
utilized AHAs were 
osteopathy (21.8%) 
and chiropractic 
(19.3%) by U.S. 
pharmacists and 
homeopathy 
(10.1%) and herbal 
medicine (6.0%) by 
British pharmacists.  
 Osteopathy 
(38.6%) and 
chiropractic 
(33.5%) most 
often referrals by 
U.S. 
pharmacists, 
whereas 
homeopathy 
(14.7%) and 
osteopathy 
(14.5%)  most 
often referrals by 
British 
pharmacists.  
The 5 most 
common reasons 
for 
recommending 
vitamins and 
minerals included 
alcoholism, 
anaemia, 
arthritis, 
athletically 
active, children, 
colds, dieting, 
fatigue, feeling 
nervous, 
headaches, old 
age, pain, 
pregnancy, 
prophylaxis, skin 
problems, stress 
More than 50% of 
U.S. and British 
pharmacists had 
'never heard of' or 
'only heard of' about 
half of the 21 AHAs 
assessed. 
Differences exist in 
the perceived 
knowledge, 
perception of 
usefulness, 
referrals, and 
utilization of AHAs 
between U.S. and 
British pharmacists 
Table 5. Summary of results from pharmacist’s studies  
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or other.  
About 40% of the 
U.S.A. 
community 
pharmacists 
recommended 
multivitamins 
more than five 
times a week 
compared to 
28.6% of U.K. 
community 
pharmacists. 
Anaemia 
(48.6%), dieting 
(44.8%), 
alcoholism 
(42.3%), 
pregnancy 
(40.0%), and 
fatigue (36.8%) 
were the five 
most common 
reasons for 
pharmacists to 
recommend 
vitamins and 
minerals. 
A large number 
of pharmacists 
placed the non-
specific 
symptoms of 
fatigue and 
stress in the five 
most common 
reasons.  
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Year of 
publica
tion 
First 
author 
Country 
where 
survey 
conducte
d 
Sample 
size  
Description 
of 
respondents 
and setting 
Respons
e rate 
Beliefs and attitudes 
to CM 
Use of CM – 
personal use 
and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
1999 Bouldin 
et al 
(176) 
U.S. N=512 
 
Community 
pharmacists 
- 
geographica
lly stratified 
random 
sample of 
community 
pharmacies 
in the 
United 
States 
26.3% Pharmacists 
generally did not 
believe herbal 
products are well 
standardized, or are 
well accepted by the 
Food and Drug 
Administration or the 
National Association 
of Boards of 
Pharmacy. 
 
Pharmacists' 
attitudes toward 
herbals do not 
reflect much 
confidence in these 
products.  
Some caution may 
be the result of 
informational bias, 
as pharmacists do 
not possess 
sufficient information 
on herbals.  
 
 
 
  96% of respondents 
indicated that they did 
not feel that they had 
enough information 
regarding potential 
interactions involving 
herbal products 
Approximately 73% 
of pharmacists 
responding indicated 
that their pharmacy 
carried 
commercially-
prepared herbal 
products 
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Year of 
publica
tion 
First 
author 
Country 
where 
survey 
conducte
d 
Sample 
size  
Description 
of 
respondents 
and setting 
Respons
e rate 
Beliefs and attitudes 
to CM 
Use of CM – 
personal use 
and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
1999 Rickert 
et al 
(177) 
U.S. N=18 
(n=6 
hospital, 5 
managed 
care, 5 
independe
nt, 2 chain 
pharmacie
s) 
Metropolitan 
St Louis 
area 
60% Opinion as to the 
value of herbal 
medicine : 
Very valuable(n=4), 
somewhat 
valuable(4), don’t 
work/sceptical(3), 
none(2), very 
marketable(2), need 
FDA regulation and 
standardisation(2) 
 
  Sources of 
information: 
Journals (n=5,  
books(4), continuing 
education(2), 
internet(2), 
Micromedex(2), 
media(1), 
manufacturers(1), 
grandmother(1) 
22%(4)  
 
2000 Chang 
et al 
(178) 
U.S  N=164 
(68.0% 
practiced 
in a 
community 
pharmacy;
4.1% 
hospitals; 
5.2% 
academia) 
 76% Whether site sold 
herbal medicines or 
not had no impact 
on attitudinal items.  
  Those with prior 
education or access 
to herbal information 
at work more likely to 
agree that providing 
herbal information 
was a pharmacists 
professional 
responsibility.  
45.1% had previous 
continuing education 
on herbal medicines; 
the average score on 
the herbal knowledge 
test was 6.3 
(maximum score of 
15).  
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Year of 
publica
tion 
First 
author 
Country 
where 
survey 
conducte
d 
Sample 
size  
Description 
of 
respondents 
and setting 
Respons
e rate 
Beliefs and attitudes 
to CM 
Use of CM – 
personal use 
and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
2001 Howard 
et al 
(179) 
U.S. N=70  Not 
reported  
 A majority 
(52.9%) 
reported taking 
dietary 
supplements 
including 
echinacea, 
zinc, and 
chromium 
picolinate. 
Fewer than half 
of pharmacists 
stated they have 
recommended a 
dietary 
supplement to a 
patient. 
Pharmacists stated 
the top information 
sources were: 
published clinical 
trials, allopathic health 
care providers, 
alternative medicine 
practitioners, and 
word of mouth. The 
Internet was an 
important source for 
recommendations 
although not for 
personal use. More 
than 90% rates the 
ability to view 
reference citations 
and computerized 
alerts on drug-dietary 
supplement 
interactions "very 
important" or 
"important". Interest 
was high in accessing 
computerized 
monographs. 
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Year of 
publica
tion 
First 
author 
Country 
where 
survey 
conducte
d 
Sample 
size  
Description 
of 
respondents 
and setting 
Respons
e rate 
Beliefs and attitudes 
to CM 
Use of CM – 
personal use 
and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
2003 Dolder 
et al 
(180) 
U.S. 
postal 
survey 
N=434 
(n=186 
community 
pharmacist
s, n=144 
hospital 
pharmacist
s, n=87 
‘other’ job 
titles) 
Pharmacists 
registered in 
California 
22% 63% reported 
patients regularly 
asked them about 
CMs 
37% 
personally 
used CMs 
regularly 
Most 
commonly: 
coenzyme 
Q10, 
echinacea, 
garlic, ginkgo, 
ginseng. 
Glucosamine, 
chondroitin, 
saw palmetto, 
vitamins C and 
E, zinc 
Most frequently 
recommended 
CMs : echinacea, 
ginkgo, 
glucosamine, 
chondroitin, 
melatonin, saw 
palmetto, soy, St 
John’s wort, 
valerian, vitamin 
E, zinc 
52% regularly 
asked patients 
about CMs 
Pharmacists who 
received training 
significantly more 
likely to ask 
patients about 
CMs and record 
use; those who 
personally used 
CMs significantly 
more likely to ask 
patients, 24% 
routinely 
maintained a 
record of patients 
CMs use; % 
recording use did 
not differ for self-
use; recording 
use more likely 
79% had received 
training, attended 
educational seminars, 
or examined literature 
chiefly focussed on 
CMs 
Primary source of 
information was: 53% 
professional 
publications, 23% 
educational programs, 
15% lay press 
84% desired 
additional training or 
information in CMs 
* definition of 
alternative 
medications was 
‘any product, 
including herbal 
medicines, vitamins, 
minerals and natural 
products that may 
be purchased at a 
health food store, 
pharmacy, 
supermarket or 
alternative health 
store/magazine for 
the purpose of self-
treatment’. This did 
not include 
multivitamins, 
calcium, iron and 
vitamin D which are 
typically prescribed 
by medical 
practitioners. 
Chapter ONE Section B – Use of CTs by the general population, physicians and pharmacists 
116 
with inpatient 
pharmacists than 
outpatients  
2003 Clauson 
et al 
(181) 
U.S. N=534 Pharmacists 
licensed 
and 
maintained 
a residence 
in Missouri 
18.2%    2.4% reported being 
able to "always 
answer natural 
product questions" 
and 1.7% were "very 
satisfied" with their 
level of natural 
product knowledge. 
Most felt they were 
"sometimes able to 
answer natural 
product questions" 
(61.6%) and that they 
were "somewhat 
satisfied" with their 
level of natural 
product knowledge 
(44.3%).The majority 
(79.8%) made efforts 
to learn about natural 
products 1 to 6 times 
per year. 
5.8% of responding 
pharmacists stated 
that they "never" 
made an effort to 
learn more about CMs 
.Written continuing 
education (CE) was 
the most popular 
ways to improve 
knowledge about CM 
as rated by 70.2%. 
 
Over half (56.9%) 
of all Missouri 
Pharmacist 
Survey (MPS) 
respondents 
indicated that 
they received 
questions about 
natural products 
on a weekly 
basis, with the 
vast majority 
(82.4%) reporting 
that they 
received 
questions at least 
monthly. 
The topic areas 
that pharmacists 
ranked as "very 
important" were 
"interactions" 
(84.5%), "side 
effects/adverse 
events" (80.0%), 
"patient 
counseling" 
(71.2%), 
"therapeutic 
uses" (68.2%), 
and "dosing" 
(59.2%). 
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Year of 
publica
tion 
First 
author 
Country 
where 
survey 
conducte
d 
Sample 
size  
Description 
of 
respondents 
and setting 
Respons
e rate 
Beliefs and attitudes 
to CM 
Use of CM – 
personal use 
and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
2003 Welna et 
al (182) 
U.S. N=533  52.4% Half the pharmacists 
(51%) believed that 
herbs and natural 
products (H/NPs) 
were safe, but only 
19% believed they 
were effective.  
The amount of 
government 
oversight of H/NPs 
was considered "not 
adequate" by 78% of 
pharmacists 
53% reported 
personal use 
of herbs and 
natural 
products 45% 
reported 
having 
recommended 
them to a 
family 
member.  
Pharmacists 
working in 
community/out
patient settings 
and 
pharmacists 
living in non-
urban areas 
were more 
likely to report 
use. 
 
 
 
 
 
Slightly more 
than half of the 
respondents 
(56%) reported 
suggesting to a 
patient that he or 
she try an H/NP.  
 
Trade 
journals/professional 
newsletters, 
continuing education 
coursework, reference 
texts, and reports of 
randomized clinical 
trials were considered 
very important 
sources of information 
about H/NPs. 
 However, almost all 
respondents (95%) 
felt available 
information on H/NPs 
was "not adequate" or 
only "somewhat 
adequate." 
Patients' 
requests, 
consumer 
demand, 
manufacturer's 
reputation, and 
manufacturer's 
ability to provide 
product quality 
data were key 
factors 
influencing 
respondents' 
decisions to 
purchase and 
stock H/NPs in 
the pharmacy. 
On average, 
pharmacists 
reported that 
patients ask them 
questions 
regarding H/NPs 
7 times per 40-
hour workweek; 
other health care 
practitioners ask 
an average of 1.3 
times/ wk. 
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Year of 
publica
tion 
First 
author 
Country 
where 
survey 
conducte
d 
Sample 
size 
Description 
of 
respondents 
and setting 
Respons
e rate 
Beliefs and attitudes 
to CM 
Use of CM – 
personal use 
and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
2003 Koh et 
al(183) 
Singapor
e 
N=420 
Survey  
(67% 
women; 
43% from 
Singapore, 
12% 
Malaysian, 
45% 
overseas; 
35.5% 
retail, 34% 
hospital; 
10% 
academic; 
4% sales; 
1% 
manufactu
ring; 6% 
research 
and 
developme
nt; 9% 
other) 
convenienc
e sample at 
conference, 
hospitals 
and 
community 
stores 
Not 
reported 
9.3% used CM 
because they 
thought ‘it was 
natural and safer’  
Main reason for not 
using CM: 
62% satisfied with 
conventional 
medicine; 47% lack 
of evidence of 
effectiveness; 8% 
more expensive 
than conventional 
medicine, 8% longer 
time to see effect, 
5% other reasons 
 
73% of those who 
used CM were 
moderately satisfied 
with it, 14% 
extremely satisfied, 
6% not satisfied 
 
 
84.3% had 
used CM at 
some stage s; 
66.2% in the 
past 12 
months 
Most 
commonly 
used CM: 
Herbal 
medicine, 
TCM, 
massage, 
aromatherapy, 
homeopathy 
Main reason 
for use: 
maintenance 
of health 
(51%), 
recommended 
by friends or 
family(48%), to 
treat health 
problem(48%), 
to relieve 
stress (31%) 
Main 
conditions 
treated with 
79% of CM users 
would also 
recommend it to 
family and 
friends 
Knowledge score: 
7.23+- 1.96. 
(maximum score 
assumed to be 15 but 
not clearly stated). 
 
81% stated their 
training did not equip 
them with necessary 
skills and knowledge 
to counsel patients 
about herbal 
medicines  
90.5% thought the 
professional 
curriculum should 
have more 
components about 
herbal medicine  
 
78% interested in 
future training on 
herbal medicine, 58% 
on TCM, 34.5% 
acupuncture, 27% 
homeopathy.  
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CM: Back 
problems, 
sprains or 
strains, 
headache, 
allergies, 
insomnia.  
70.5% using 
both CM and 
conventional 
medicine did 
not inform or 
consult a 
doctor and 
82% reported 
this was 
because they 
felt they did not 
need physician 
advice. 
 
 
 
 
 
 
 
 
 
Self-rated knowledge 
of herbal 
medicine:49% felt 
they did not know 
much about it, 40% 
felt they had moderate 
knowledge, 7% knew 
‘nothing at all’; 4.5% 
knew ‘a great deal’.  
 
Information sources: 
books/ 
magazines(64%), 
friends/family(36%), 
internet(31%), 
pharmacists(17%), 
sales people(14%), 
TV(10%), 
doctors(4%), other 
means e.g. 
journals/seminars/ 
university(20%. 
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Year of 
publica
tion 
First 
author 
Country 
where 
survey 
conducte
d 
Sample 
size  
Description 
of 
respondents 
and setting 
Respons
e rate 
Beliefs and attitudes 
to CM 
Use of CM – 
personal use 
and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
2005 Naidu et 
al (184) 
Australia N=484 
(75% 
community 
pharmacist
s, 13% 
hospital, 
12% other) 
Mainly 
community 
pharmacists 
32.3% Generally positive 
attitude to CM.  
77% thought CM is 
a useful adjunct to 
conventional 
medicine; 73% 
thought CM includes 
ideas from which 
conventional 
medicine could 
benefit.  
39% currently 
using CM; 38% 
had previously 
used CM; 23% 
have never 
used CM 
Of those who 
had used CM, 
74% used 
vitamins/herbs, 
6% massage, 
4% 
acupuncture, 
3% 
homeopathy, 
3% 
naturopathy, 
2% 
respectively for 
chiropractic, 
relaxation, 
TCM and 
yoga, 1% 
aromatherapy, 
1% Tai Chi.  
 
Those working 
in community 
pharmacy 
were 
significantly 
more likely to 
23% 
recommended 
CMS daily 
whereas 16% 
had never 
recommended 
any form of CM. 
Of those that do 
recommend 
CMs, 20% do so 
weekly, 5% 
monthly and 35% 
occasionally.  
65% that had not 
personally used 
CM 
recommended 
them 
occasionally. 
 
Most common 
reason for 
recommending 
CM: proven 
mechanism of 
action (33%), 
maintenance of 
good health 
(24%).  
 
Therapies that 
pharmacists had 
heard of and thought 
they knew enough to 
explain to patients 
about them: 
acupuncture, 
chiropractic, herbal 
medicine, massage, 
meditation, yoga.  
Type of CM that the 
most pharmacists 
thought they knew 
enough to treat 
patients with :herbal 
medicine(15%) 
 
61% reported having 
access to herbal 
medicine information 
at their site of work. 
91% thought it is 
necessary for 
pharmacists to have 
knowledge of both CM 
and conventional 
medicine in order to 
inform patients about 
their options.  
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have used CM. 
36% of 
hospital 
pharmacists 
had never 
used any form 
of CM 
compared to 
16% of 
community 
pharmacists 
who had not 
used CMs. 
Chief reasons for 
not 
recommending 
CM : lack of 
evidence(83%), 
satisfaction with 
conventional 
medicine(10%).  
 
Conditions they 
would consider 
recommending 
CM for: 
insomnia(75%), 
arthritis(72%), 
anxiety(56%), 
PMT(57%), back 
problems(51%), 
sprains and 
strains(40%), 
depression 
(39%), headache 
(38%), 
allergies(29%), 
dysmenorrhea 
(27%), 
hypertension 
(14%), 
cancer(11%).  
 
 
  
 
61% would consider 
continuing education 
about CM, 27% 
possibly consider and 
13% not consider.  
 
Most frequently used 
information sources 
were:books and 
magazines(25%), 
journals(29%), 
combination (22%), 
university and other 
training (8%), 
manufacturer 
provided information 
(8%), Internet (4%).  
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Year of 
publica
tion 
First 
author 
Country 
where 
survey 
conducte
d 
Sample 
size  
Description 
of 
respondents 
and setting 
Respons
e rate 
Beliefs and attitudes 
to CM 
Use of CM – 
personal use 
and practise of  
Referral patterns 
to CM 
Training, knowledge 
and information 
Other relevant 
information 
2005 Brown et 
al 
(185) 
US N=107 Community 
pharmacists 
– state of 
Texas 
27.0%   Among CM 
users, 
pharmacists 
most often 
encouraged CM 
use if medically 
appropriate. In 
pharmacies that 
stocked herbal or 
homeopathics, 
pharmacists 
significantly more 
likely to 
encourage use of 
CM when 
medically 
appropriate and 
recommend 
other CTs if 
appropriate. 
When no 
references 
available to 
research CM, 
pharmacists 
tended to neither 
encourage nor 
discourage CM 
use based on 
lack of scientific 
evidence of their 
effectiveness. 
Pharmacists were not 
comfortable with 
responding to CM 
inquiries but believed 
they needed adequate 
knowledge about CM. 
In general, 
pharmacists rarely 
asked patients about 
their CM use.  
 
Pharmacists' rate of 
inquiry about CM use 
increased significantly 
when this information 
could be documented 
in patient profiles and 
when pharmacists 
had additional training 
in CM.  
A majority (71.0%) 
of pharmacists had 
encountered 
patients who were 
using CM, which 
was defined broadly 
in the survey to 
include herbal 
products, vitamins 
and minerals, 
homeopathic 
products, massage, 
meditation, and 
other types of CM.  
 
Pharmacists 
documented CM use 
by patients in 11.0% 
of cases and 
reported monitoring 
for drug-related 
problems in 38.4% 
of users. 
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B.5.1.1 Results : 
 
B.5.1.1.1. Description of studies 
 
It is apparent that the majority of studies have been conducted in the United States 
(178;186-193), with one from Canada (194), one from Singapore (195) and one from 
Australia (196). All studies focus on community pharmacists and three included 
hospital pharmacists within their sample (197-199). For studies where response rates 
were reported, only one had a response rate above 60% (178) thereby limiting the 
generalisability of the results. Some studies focused on herbal medicines, while others 
asked about complementary therapies. For the case of this review, all studies 
incorporated some information about CMs in their survey.  
 
B.5.1.1.2 Pharmacists beliefs and attitudes  
 
There was little consistency in respect to pharmacist’s attitudes and beliefs about 
CMs. In the U.S. there is a perceived lack of regulation about the quality of herbal 
medicines and a perceived lack of efficacy of CMs as reported by Welna et al and 
Bouldin et al (200;201).  In 1999, Bouldin et al reported that pharmacists' attitudes 
toward herbals did not, on the whole, reflect much confidence in these products as 
currently supplied (202). It was suggested that some of this caution may be the result 
of an informational bias, in which pharmacists do not possess sufficient information 
on herbals, consequently resulting in limited understanding of these products and a 
low level of comfort with their use. Four years later, Welna et al produced similar 
results with only 19% of pharmacists believing herbal and natural supplements were 
effective and 51% believing herbs and natural products (H/NPs) were safe (203).  
 
To date, only one Australian study has explored pharmacist’s beliefs and attitudes 
about CM and results remain to be confirmed in future studies. The survey of chiefly 
community pharmacists reported that pharmacists had a generally positive attitude to 
CM. Nearly three-quarters (74%) thought herbal medicine was useful, 77% thought 
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CM is a useful adjunct to conventional medicine; 73% thought CM included ideas 
from which conventional medicine could benefit (204).  
 
A comparison of these results would suggest that Australian pharmacists have a more 
positive attitude to CM than overseas pharmacists however the attitudes of Australian 
pharmacists prior to 2004 were not known and may have been similar in the late 
1990s when Bouldin et al and Rickert et al conducted their studies (192;205). It must 
also be noted that the regulatory environment of CMs in Australia and the United 
States is different and may account for some attitudinal differences.  
 
B.5.1.1.3 Personal use of CTs 
 
It is difficult to determine the percentage of pharmacists who use CMs or CTs as some 
studies do not tend to differentiate between the two in their surveys or results are not 
clearly reported. Despite these limitations, it appears that 37-53% of U.S. pharmacist 
use CMs, 39% of Australian pharmacists use CTs (74% are vtamins/herbs)  and most 
(84%) pharmacists from Singapore and Malaysia use CTs. One survey suggested that 
pharmacists working in community/outpatient settings and pharmacists living in non-
urban areas were more likely to report use of CMs than others (206).  In Australia, 
vitamins/herbs were the most popular form of CM used with relatively little use of 
massage, acupuncture, homeopathy, naturopathy, chiropractic, relaxation, TCM, yoga, 
aromatherapy or Tai Chi. Those working in community pharmacy were significantly 
more likely to have used CM than hospital pharmacists.  
 
B.5.1.1.4  Referral patterns to CTs 
 
In 1990, osteopathy (38.6%) and chiropractic (33.5%) were the most commonly 
referred to CTs by U.S. pharmacists, whereas homeopathy (14.7%) and osteopathy 
(14.5%) were the most common CT referrals by British pharmacists (207;208). About 
40% of the U.S community pharmacists recommended multivitamins more than five 
times a week compared to 28.6% of U.K. community pharmacists. Anaemia (48.6%), 
dieting (44.8%), alcoholism (42.3%), pregnancy (40.0%), and fatigue (36.8%) were 
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the five most common reasons for pharmacists to recommend vitamins and minerals. 
The non-specific symptoms of fatigue and stress were also common reasons for CT 
referral.  
 
The number of U.S. pharmacists referring patients to use CMs increased over the next 
decade and by 2003, 56% of U.S. pharmacists reported suggesting to a patient they try 
a herb and natural supplement (209). It also appears that pharmacists working within 
pharmacies which stock herbal or homeopathic products were significantly more 
likely to encourage the use of CM when medically appropriate and to recommend 
other CM therapies appropriate for patients' conditions (210). In 2005, an Australian 
study of chiefly community pharmacists found 23% recommended CMs daily 
whereas 16% had never recommended any form of CM. The most common reasons 
pharmacists recommended CM were if they perceived it had a proven mechanism of 
action and for the maintenance of good health. Overwhelmingly, the main reason 
pharmacists did not recommend CMs was if they perceived it lacked supportive 
evidence. Similarly, a U.S, study identified that pharmacists would not encourage or 
discourage use of CM when no references were available to research CM (211).  A 
study of pharmacists mainly from Singapore and Malaysia found 79% of CM users 
would also recommend it to family and friends (212). Currently, there is limited 
information about hospital pharmacist’s referral patterns in the international literature 
and which specific CTs are actively encouraged or discouraged when patients express 
an interest in their use. 
 
B.5.1.1.5 Knowledge and information sources 
 
Considering their major role as medication advisors, it was thought that the issue of 
pharmacist’s knowledge and use of information sources was important to explore. 
Two studies have evaluated pharmacists’ actual knowledge about CMs with all 
studies conducted overseas and indicating that knowledge test scores were low 
(178;213). A 2000 study provides the most robust information and identified that 
average score on a herbal knowledge test was 6.3 (maximum score of 15) (178). 
Pharmacists with previous continuing education scored significantly higher than those 
without prior continuing education and pharmacists knew mostly about the uses of 
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herbal medications. No significant differences were seen between those who sold or 
did not sell herbal medicines, or community versus non-community settings. It should 
be noted that Chang et al incorporated the ‘I don’t know’ responses into the number of 
incorrect answers which may have decreased the knowledge scores. A similar test was 
undertaken with a convenience sample by Koh et al in Singapore who identified 
participants had an  average score of 7.23 on a  knowledge test (maximum score of 15 
assumed but not clearly stated)  (214).  
 
Overseas pharmacists generally appear to be aware of their knowledge deficit and do 
not perceive they have sufficient knowledge about CM. They are also aware of not 
being able to answer CM-related queries on a regular basis and few are satisfied with 
their level of knowledge or are comfortable answering CM enquiries (181;213;215).   
 
In contrast, Australian pharmacists perceived their level of knowledge about 
acupuncture, chiropractic, herbal medicine, massage, meditation, yoga to be sufficient 
to explain these therapies to patients if necessary however only 15% thought they had 
sufficient knowledge to be able to treat patients with herbal medicine (216). To date, 
no published studies are available which have focussed on Australian pharmacist’s 
actual knowledge about the safety and efficacy of commonly used CMs and limited 
information is available about hospital pharmacists in general.  
 
Pharmacists use a variety of information sources for CM information, most  
commonly journals, professional publications, books and magazines (188;192;217-
220). One survey also identified CM practitioners and service providers as an 
information source (221). The adequacy of information available is questionable 
according to Welna et al where 95% of respondents felt available information on 
herbs and natural products was "not adequate" or only "somewhat adequate." 
 
B.5.1.1.6 Pharmacists and CM training  
 
Although it is difficult to interpret the studies which have investigated pharmacists 
previous level of training about CM, it is apparent that many pharmacists are 
interested in future training with figures ranging from 61% (222) -84% (188). 
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Continuing education appears to be the most common method of receiving training in 
CM (178;181). Over 80% of Australian pharmacists supported CM training at 
undergraduate and post-graduate levels (223). Koh et al identified that 90.5% of 
pharmacists thought the professional curriculum should include more components 
about herbal medicine (224). The relevance of this finding to Australian pharmacists 
is unknown as the sample mainly consisted of pharmacists based in Asia.  
 
B.5.1.1.7 Patient communication about CM 
 
Communication between health care professionals and patients is an essential part of 
providing safe and effective health care. Whilst there has been substantial 
investigation into the communication behaviours and barriers of medical physicians 
and their patients regarding CM, relatively little is known about pharmacists. The 
information currently available is derived from two studies and suggests that 
pharmacists do not routinely ask patients about use of CMs however a pharmacists' 
rate of inquiry increases significantly if they have had received training about CMs or 
when the information could be documented in patient profiles (225;226). Pharmacists 
who personally used CMs were also more likely to ask patients about their use (227) 
however patient use is not routinely documented by pharmacists (228).  
 
B.5.1.1.8 Limitations of the available literature 
 
Despite the fact that 12 studies have explored pharmacists relationship with CTs from 
various perspectives, only one reported a response rate above 60% thereby limiting 
the generalisability of the results. In addition, all studies focussed on community 
pharmacists thereby providing limited information about hospital pharmacists and 
issues which are more distinctly relevant to their practice. Only one Australian study 
of pharmacists was identified which had a low response rate (32%) and involved 
chiefly community pharmacists, also reducing the generalisabity of its findings. The 
definitions used to describe CMs varied between surveys with one survey specifically 
excluding multivitamins, calcium, iron or vitamin D from the definition, thereby 
leading to an under-estimation of use (188). Although three studies had reported 
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pharmacist’s knowledge of CM was poor, non-validated surveys were used and 
methodologies were not fully reported making it difficult to interpret the results.   
 
B.6.0  Summary 
 
Overall, there were several methodological concerns consistently identified by the 
systematic reviews presented in Section B.   
 
Importantly, numerous studies failed to adequately report on the methodologies used 
to collect data making it difficult to interpret the quality of the study, the reported 
results, and their generalisability. For instance, numerous studies failed to report on 
response rates. Where response rates were reported, this was highly variable and in 
many cases well below 60%. In some studies, a convenience sample was used in the 
data collection, further detracting from the generalisability of results. In some studies, 
non-validated surveys were used whereas in others, insufficient information was 
presented to determine whether questionnaires had been validated. This makes it 
difficult to determine whether the questionnaires used in the study produced results 
which accurately reflected the behaviours, perceptions and knowledge of study 
participants. When these factors are considered together, it is clear that the strength of 
the conclusions drawn by the many studies with inadequately reported methodologies 
is diminished and there are considerable defects in the literature. 
 
The methods used to collect data about the publics use of CMs and doctors and 
pharmacists attitudes, knowledge and use of complementary medicine included face 
to face interviews, self-administered surveys and computer assisted telephone surveys. 
When results from studies which gathered information about the same research 
question using different methodologies were available, these could be cross-
referenced to see common themes that emerged. This was undertaken where possible 
and provided the basis for the findings presented in the systematic reviews.  
  
Despite these limitations, it is apparent that the use of CTs is widespread in Australia, 
the United States, United Kingdom, Canada and Europe. The factors consistently 
associated with use are: gender, ethnicity, age, education and income. Complementary 
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medicine is used as an adjunct to conventional care due to a range of positive and 
negative motivations such as health promotion, pursuit of wellness, dissatisfaction 
with conventional care or failure of conventional treatments to provide adequate 
outcomes. Importantly, patients do not routinely disclose use of CMs to medical 
practitioners. 
 
In Australia, vitamins are the most commonly used CMs whereas the use of herbal 
medicines is increasing, especially amongst women. There is limited information 
about the specific medicines being used or the prescribers of such medicines. The 
percentage of people visiting CM practitioners is also increasing. There is limited 
information about the information sources used by the public to learn about CM, their 
attitudes to CM or reasons for non-disclosure about use to medical physicians.  
 
Overseas studies indicate that most physicians want more education about CM. There 
is limited information available about their perceived or actual knowledge of CM, 
information seeking behaviours or resources referred to for CM enquiries. It is 
difficult to assess the personal use and practice of CM by physicians due to variations 
in definitions used however it appears that approximately one-third of physicians have 
personally used CM, approximately 1 in 3 Israeli physicians practice CM, less than 1 
in 3 physicians practice CM in the United States or U.K. and it is rare for Italian 
physicians to practice CM. Some physicians refer patients to CM however the patterns 
of referral are difficult to estimate based on current information. Physicians do not 
generally ask patients about their use of CMs and the attitudes and beliefs of 
physicians to CM is highly variable and once again, difficult to assess. Of note, few 
studies have been conducted with hospital doctors and no studies have been 
conducted with anaesthetists or surgeons regarding CM.  
 
In Australia, most investigation has been conducted with GPs and very little is known 
about hospital doctors. At least 40% of GPs have personally used CM and at least 
two-thirds refer patients to CTs. Acupuncture, massage, meditation and yoga are 
considered the most efficacious CTs and most GPs think they know something of 
acupuncture, hypnosis, meditation and chiropractic. No studies were located which 
assessed physician’s perceived or actual knowledge of CM, information seeking 
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behaviours or resources used for CM enquiries. No studies have investigated whether 
physicians ask patients about CM use, reasons for non-communication or responses to 
patients if use is revealed.  Importantly, information about hospital doctors is limited 
to one study of radiation oncologists and medical oncologists and there is no 
information about other hospital doctors, including anaesthetists and surgeons.  
 
Studies of pharmacists in the international literature indicate that most research has 
focussed on community pharmacists and none have focussed on hospital pharmacists. 
For studies where response rates were reported, only one had a response rate above 
60% and only one study has been conducted with Australian pharmacists. Overall, it 
appears there is little consistency in respect to pharmacist’s attitudes and beliefs about 
CTs and there more U.S. pharmacists use CMs than Australian pharmacists. Only two 
studies have evaluated pharmacists’ actual knowledge about CMs, both conducted 
overseas and demonstrating knowledge is limited. Overseas pharmacists are aware of 
their knowledge deficit however Australian pharmacists perceive they have sufficient 
knowledge to explain several CTs to customers. Currently, no published studies are 
available which have focussed on Australian pharmacist’s actual knowledge about the 
safety and efficacy of commonly used CMs and limited information is available about 
hospital pharmacists in general. 
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Chapter One 
 
Section C 
CMs and adult surgical patients  
 
 
C.1.0 Introduction 
 
This section presents a systematic literature review of adult surgical patients and CM 
that explores the prevalence of CM use, reasons for use, disclosure to hospital staff, 
beliefs and perceptions about CM, information sources used and interest in hospitals 
offering access CM services. It will start with a systematic review of relevant overseas 
studies and then focus on what is known about Australian surgical patients. This 
review will also encompass cardiac surgery patients as a special sub-group of interest.  
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C.2.0 International trends 
 
The use of CMs by the general population living in Western countries is well 
established however less is known about their use by adult surgical patients. A 
systematic review of the peer-reviewed international literature was undertaken to 
determine what information is currently known about this population and CMs.  
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C.2.1 Systematic review of surgical patients and CM use 
 
 
C.2.1.1 Aim: 
The primary aim was to determine the incidence of pre-operative CMs and CTs use 
by adult surgical patients. Secondary aims were to investigate the frequency of 
surgical patient’s use of CMs that may induce adverse events during the intra-
operative and perioperative periods, patients disclosure to hospital staff, reasons for 
use, beliefs and perceptions about CMs, sources of advice and recommendation 
regarding CM and interest in hospitals offering CM services.  
 
C.2.1.2 Methodology: 
A search was performed using the following databases for all years available through 
until October, 2006: Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), MEDLINE, ScienceDirect, Proquest. Search terms used included, but 
were not limited to:  
• ‘Complementary medicine’ and hospital 
• ‘Herbal medicine’ and ‘hospital’ 
• ‘Alternative medicine’ and ‘hospital 
• ‘Integrative medicine’ and ‘hospital’ 
• “ Complementary and Alternative medicine’ and ‘hospital’ 
• ‘Naturopathy’ and ‘hospital’ 
• ‘Natural therapies’ and ‘hospital’ 
 
A search was also conducted whereby the word ‘medicine’ was replaced by the word 
‘therapy’ and then ‘therapies’. The above terms were re-used again but ‘hospital’ was 
replaced with ‘surgery’, ‘surgeon’, ‘anaesthesia’ and ‘anesthesiology’. 
 
Articles identified in this manner were searched to ascertain relevance to this 
systematic review. The reference lists of articles considered suitable for inclusion 
were also searched to identify additional relevant studies which have not been 
identified by the previous search strategy. Articles were considered eligible if they 
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were population based surveys, presented in English, published in the peer-reviewed 
literature and described research conducted with the surgical population. 
 
C.2.1.3 Results: 
 
C.2.1.3.1 Description of studies 
 
Fourteen studies were considered eligible for this review. Eleven studies were 
conducted in the United States (229-239), one study in Denmark (240), one in the 
United Kingdom (241) and one in Australia (242). All studies were conducted prior to 
surgery except for Glintborg et al which was conducted after patients were discharged 
and involved a mixed sample of surgical and medical patients (243). Four studies 
focussed on CM therapies (236-239) and where response rates were reported, only 
one study had a response rate below 60% (231). One study was conducted in Australia 
and one study focussed on cardiac surgery patients (239;242). A summary of key 
findings from relevant articles is presented in Table 1. Relevant information from the 
Australian study and cardiac surgery study will be discussed in greater detail after this 
review. 
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Date of 
publication 
Author/s Setting  Sample 
size 
Respon
se rate 
Usage findings Specific CMs and 
CTs used 
Description of CM 
users 
Disclosure  Other relevant 
information 
2000 Tsen et al (235) 
 
U.S. 
Patients 
presenting for 
evaluation in 
the 
preoperative 
clinic 
N=3106  81% Herbal medicines: 
22% 
Vitamin supplements: 
51% 
The five most 
commonly used herbal 
medicines were (from 
highest to lowest) : 
Echinacea(7.3% of all 
patients), ginkgo 
biloba(4.0%), St 
John’s wort (3.3%), 
garlic(3.2%) and 
ginseng(3.2%0   
 
Females more 
frequently used herbal 
medicines (23.6%) 
compared to males 
(19.2%).  
Significant variation 
amongst age groups 
with use of herbal 
medicines greatest in 
age group 50-70 years 
 
Not reported Reasons for 
use: health 
care provider 
recommendatio
n (21%), 
recommendatio
n of friend or 
family member 
(36%), TV or 
magazine 
advertisement 
(12%), decided 
‘on their own’ 
(36%) 
 
2000 Kaye et al 
(230) 
  
 
U.S. 
Patients 
presenting at 
pre-
anaesthetic 
evaluation 
prior to 
outpatient 
surgery 
N= 755  
 
68% 32% were self-
administering one or 
more herb-related 
product 
64% were actively 
taking one or more 
dietary supplement at 
the time of the survey.  
 
 
  
Of CM users : 
Multivitamins (90%), 
garlic (43%), ginkgo 
biloba (32%), St 
John’s wort (30%), ma 
huang (18%), 
Echinacea (12%). 
Aloe vera (10%), 
cascara (8%), licorice 
(3%) 
Not reported Nearly 70% 
of patients 
taking one or 
more herb-
related 
product did 
not report 
use when 
asked during 
routine 
anaesthetic 
assessment 
 
 
 
Table 1. Summary of key findings from studies about CM by surgical patients 
 
 136 
Date of 
publication 
Author/s Setting  Sample 
size 
Respon
se rate 
Usage findings Specific CMs and 
CTs used 
Description of CM 
users 
Disclosure  Other relevant 
information 
2000 Norred et al 
(232) 
 
U.S.  
Patients 
undergoing 
elective 
surgery 
N=500  N/A 51% had used herbs, 
vitamins, dietary 
supplements, or 
homeopathic 
medicines within the 2 
weeks prior to surgery 
Use of CM products 
that could potentially 
inhibit coagulation :  
27% 
Affect blood pressure: 
12% 
Cause sedation: 9% 
Have ‘cardiac’ effects: 
5% 
Alter electrolytes:4% 
 
24% used substances 
from 2 or more 
categories of CMs 
(herbs, vitamins, 
dietary supplements, 
or homeopathic 
medicines)  
24% took 50 different 
herbs, 41% took 9 
types of vitamins, 44% 
took 31 types of 
dietary supplements, 
and 1% of patients 
took the homeopathic 
arnica 
 Not reported  
 
 
 
 
 
 
 
 
 
 
 
 
2000 Liu et al 
(244) 
Cardiac 
surgery 
patients 
attending an 
urban, 
academic 
medical centre 
N=263 70% 75% had used CM in 
the previous 12 
months. 
When prayer and 
vitamins are excluded, 
usage is 44% 
53.6% had used 
vitamins in the 
previous 12 months, 
36.1% prayer, 17.1% 
nutritional therapy, 
11.4% massage, 
11.4% meditation, 
 For vitamins : college 
education or higher 
and older age.  
17% 
discussed 
CM with 
physicians or 
surgeons : of 
those that 
didn’t, 36% 
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in New York 11,4% chiropractic, 
9.9% herbal 
medicines, 4.2% 
acupuncture. 
No information about 
specific CMs used 
reported 
 
would like to 
discuss 
whereas 48% 
did not.  
2001 Leung et al (231) 
 
Elective 
surgery 
patients at 5 
U.S. teaching 
hospitals 
N=2560  
 
60% 39.2% used CMs; 
herbal medicine most 
popular type (67.6% of 
all CMs used), then 
vitamins supplements 
(15.1%) and minerals 
(7.3%) 
Usage ranged 
between sites from 
22% - 44% 
53% ceased use prior 
to surgery. 
Specifically, of these 
36.8% ceased used 
within 2 days before 
surgery, 28.% within 
2-7 days, 12.4% within 
8-14 days, 22.5% 
more than 14 days 
prior to surgery 
Herbs used : (from 
highest usage to 
lowest) 
echinacea(12.7% of 
total sample), ginkgo 
biloba(8.6%), 
garlic(7.9%), 
ginseng(7.4%), St 
John’s wort(4.3%), 
valerian(2.5%), Saw 
palmetto(2.3%), kava 
kava(1.3%), 
yohimbe(0.2%) 
 
Users of CMs were 
more likely to be 
female, aged 35-49 
years, have higher 
income levels, 
Caucasian, higher 
education, problems 
with sleep, joints, 
back, allergies, 
addiction, history of 
general surgery; 
decreased likelihood is 
diabetic, or using anti-
thrombotic medicines 
 
44.4% did not 
consult with 
primary 
physician, 
56.4% did not 
inform 
anaesthetist 
prior to 
surgery 
 
 
73.7% of 
patients using 
CMs reported 
feeling benefits 
such as 
increased 
energy levels, 
decreased 
disease 
symptoms, 
disease 
prevention, 
mood elevation 
 
Reasons for 
use: improve 
general health 
(54.9%), 
prevent 
disease 
(33.3%) 
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Date of 
publication 
Author/s Setting  Sample 
size 
Respon
se rate 
Usage findings Specific CMs and 
CTs used 
Description of CM 
users 
Disclosure  Other relevant 
information 
2002 Wang et al 
(237) 
 
U.S. Patients 
undergoing 
outpatient 
procedures 
only 
N=857  85.7% 32% had used CM 
therapies Massage (15.2%), herbal medicine 
(9.7%), relaxation 
therapy (8.3%), 
acupuncture (6.6%) 
 Not reported A significant 
proportion of 
patients (42%) 
indicated their 
willingness to 
use 
acupuncture as 
a treatment 
modality for 
anxiety during 
the 
preoperative 
period; those 
with previous 
experience of 
CM had a 
significant 
greater interest 
compared to 
individuals who 
had no 
experience 
(66.3% vs. 
29.9%) 
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Date of 
publication 
Author/s Setting  Sample 
size 
Respon
se rate 
Usage findings Specific CMs and 
CTs used 
Description of CM 
users 
Disclosure  Other relevant 
information 
2002 Norred 
(233) 
 
U.S.  
Elective 
surgical 
outpatients 
randomly 
surveyed with 
anonymous 
self-report 
questionnaires 
during day-
surgery 
admission 
N=6852  
 
91% 67% used CM within 
the previous 2 weeks 
Herbal medicines: 
27% 
Dietary supplements: 
39% 
Vitamin supplements: 
54%  
Homeopathic 
medicines: 1% 
Use of CM products 
that could potentially 
interact with 
anaesthetics and 
inhibit coagulation : 
34% of participants. 
These were 
significantly more 
likely to be older than 
40 years, Caucasian, 
college educated. 
 
 
 
 
 
 
Herbs: garlic (9.5%), 
herbal teas (8.1%), 
cranberry (5.2%), 
ginkgo biloba (4.6%), 
ginseng (4.2%), 
echinacea (4.1%) and 
ephedra products 
(3.2%) 
Dietary supplements: 
calcium (21.5%), iron 
(7.0%), glucosamine 
(6.9%), zinc (5.5%), 
magnesium (4.7%), 
potassium (4.3%) and 
chondroitin (4.0%) 
Vitamin supplements: 
multivitamins (37.5%), 
vitamin E (23.3%), 
vitamin C (21.4%) 
CMs users were 
significantly more 
likely to be female, 
older than 40 years of 
age, Caucasian, 
college-educated, 
admitted for 
neurosurgery than 
other procedures 
compared with CM 
non-users.  
Not reported  
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Date of 
publication 
Author/s Setting  Sample 
size 
Respon
se rate 
Usage findings Specific CMs and 
CTs used 
Description of CM 
users 
Disclosure  Other relevant 
information 
2002 Skinner and 
Rangasami 
(241) 
Patients 
attending for 
anaesthesia in 
a British district 
general 
hospital 
 
 
N=2723  81% One or more herbal 
medicines was taken 
by  4.8% of the 
sample at the time of 
the survey or in the 
previous 2 weeks 
Herbal medicines 
used (from highest to 
lowest): garlic(1.6% of 
all patients), ginseng 
(1.25%), ginkgo biloba 
(1.1%), St John’s wort 
(0.99%), echinacea 
(0.7%) 
Females patients 
significantly more 
likely to be using 
herbal medicines than 
males  
Not reported  
2002 Norred 
(234) 
 
U.S. N=496   
 
99% 73.4% used CMs in 
the 2 weeks prior to 
surgery 
Use of CM products 
that could potentially 
inhibit coagulation :  
40% 
Affect blood pressure: 
32% 
Cause sedation: 17% 
Have ‘cardiac’ effects: 
20% 
Alter electrolytes:9% 
Herbs recognized to 
interact with 
pharmaceuticals were 
consumed by 23% of 
patients 
37% used herbal 
medicines in the 2 
weeks prior to 
surgery; 59% used 
vitamin supplements; 
45% used dietary 
supplements; 1% 
used homeopathic 
remedies  
 
 Not reported  
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2003 
 
Wang et al 
(238) 
  
 
 
U.S. 
Patients 
undergoing 
inpatient 
procedures  
 
N = 1235  
 
72% 
 
57.4% had used in the 
past or were still using 
at least 1 type of CM 
therapy  
* When prayer and 
chelation was 
removed, usage was 
49.1% 
 
Past and present use : 
Self-prayer (29%), 
chiropractic (23%), 
massage/reflexology 
(15%), relaxation 
therapies (14%), 
herbal medicines 
(13%), megavitamins 
(9%) and acupuncture 
(7%) 
Current use : 25.1% 
using at least one 
form of CM (excluding 
prayer) 
 
 
 
Up to 20% of 
all 
respondents 
did not 
disclose use 
to 
perioperative 
physicians 
unless 
specifically 
asked. 
Inpatients 
were more 
likely to 
disclose use 
than 
outpatients.  
 
 
Reasons for 
use : ‘few or no 
side effects’ 
(35.3%), 
‘recommended 
by friend or 
medical doctor’ 
(18.9%), ‘keeps 
me healthy’ 
(13.4%), ‘works 
better or just as 
well as 
conventional 
medicine’ 
(11.4%), 
‘problem not 
serious enough 
to be seen by a 
medical doctor’ 
(7%), or ‘other’ 
(14%). 
76% of all 
respondents 
were willing to 
use CM as part 
of their 
anaesthesia 
care. Most 
interest was 
expressed for 
acupuncture, 
hypnosis and 
herbal 
medicine.  
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Date of 
publication 
Author/s Setting  Sample 
size 
Respon
se rate 
Usage findings Specific CMs and 
CTs used 
Description of CM 
users 
Disclosure  Other relevant 
information 
2004 Grauer et al(242) Two public hospitals in 
Australia 
N=1102 92% 14.3% used herbal 
medicine in previous 6 
weeks 
20.4% used vitamin 
supplements 
Herbs used (starting 
with highest use) : 
Garlic, evening 
primrose, ginkgo 
biloba, St John’s wort 
and echinacea 
 
Vitamins used 
(starting with highest 
use) : multivitamins, 
vitamins B,C,E and D 
 
 
Herbal and vitamin 
supplements users 
were younger than 
non-users 
 
27.8% of 
herbal users 
informed 
hospital 
doctors about 
use 
 
2004 Adusumilli et al (229) 
 
U.S.  
Patients 
undergoing 
elective 
surgery 
N=2186  65% 57% had used herbal 
medicine during their 
lives; 38% in past 2 
years; 16% continued 
in the month of 
surgery 
CMs usage by surgical 
subpopulations: 
Cardiac surgery : 29%  
Plastic surgery:35% 
General surgery:37%  
Urology: 45% 
Neurosurgery:41% 
Gynecology: 52% 
Herbs used in 
previous 2 years: 
echinacea (48%), aloe 
vera 30%, ginseng 
28%, garlic 27%, 
ginkgo biloba 22% 
 
CTs that were also 
used: chiropractics 
(18% of total sample), 
acupuncture (14.5%), 
hypnosis (10.8%), 
homeopathy (8.6%), 
spiritual healing 
(7.4%) 
 
Use of herbal 
medicines higher in 
patients undergoing 
gynecological and 
urological procedures 
than vascular 
procedures.  
Significantly higher 
proportion of patients 
without a primary care 
physician (48%) 
reported using herbal 
medicines compared 
to those with one 
(38%).  
Patients with heart, 
lung, gastrointestinal, 
neurologic or urinary 
Of the 
patients 
taking herbal 
medicines, 
7% 
volunteered 
information 
about use to 
staff.  
20% were 
asked about 
use by the 
primary care 
physician; 
17% by the 
operating 
surgeon, 4% 
by the , 
Information 
sources for 
people using 
herbal 
medicines: 
friends (36%), 
family (27%), 
magazines 
(11%), 
audiovisual 
media (8%), 
newspapers 
(6%), internet 
or healthfood 
shop (12%) 
Reasons for 
use: personal 
autonomy on 
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symptoms were 
significantly less likely 
to use herbal medicine 
than patients without 
these symptoms  
Patients with a better 
perception of their 
health status more 
likely to use herbs 
than those with a poor 
or average self-rating 
of health  
Herb use lowest in 
people with a history 
of diabetes mellitus, 
hypertension, high 
cholesterol.  
anaesthetist 
and 10% by 
another 
health-care 
worker. 
The most 
common 
reasons for 
non-
disclosure 
was thinking 
CMs are not 
‘real 
medicine’ 
 
health (26%), 
dissatisfaction 
with 
conventional 
care (17%), 
availability 
(14%), spiritual 
or religious 
beliefs (5%) 
2005 Glintborg et al 
(245) 
Copenhagen 
hospital – 
surgical and 
medical 
patients 
recently 
discharged 
N=200  
(n=83 
surgical) 
Not 
reported 
63% used CMs on a 
regular basis 
Most common CMs 
used daily or on 
demand: multivitamins 
(41%), fish oils (14%), 
calcium (10%)  
Not reported Only 21% of 
hospital files 
had correctly 
recorded 
patients use 
of CMs 
Patients 
generally 
unaware of the 
possibility of 
adverse effects 
with CMs 
Patients taking 
CMs without 
consulting their 
physician 
70% of the CM 
products were 
taken by 
people who 
had self-
prescribed  
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Date of 
publication 
Author/s Setting  Sample 
size 
Respon
se rate 
Usage findings Specific CMs and 
CTs used 
Description of CM 
users 
Disclosure  Other relevant 
information 
2006  Velanovich et al  
(236) 
U.S. 
Patients seen 
in a single 
surgeon's 
practice 
N=151 
 
100% 40% of patients used 
some type of CM. 17% 
used body/structure 
interventions 
(chiropractic, massage 
therapy, and 
acupuncture), 31% 
used herbal 
medications, and 3% 
used mind/spirit 
interventions (yoga, 
hypnosis). Eight (12%) 
patients used more 
than one type of CM. 
Of patients using CMs 
, 21% used ginseng, 
17% homeopathy, 
15% glucosamine and 
chondroitin, 13% 
ginkgo biloba, 9% 
black cohosh, 4% saw 
palmetto, 4% flaxseed 
oil, 4% bee pollen, 4% 
echinacea, 2% 
carnitor, 2% ephedra, 
2% grapeseed extract, 
2% astragalus, 2% St 
John’s wort,2% 
evening primrose oil, 
2% megadose 
vitamins 
47% of Caucasians 
used CM, compared to 
29% of African-
Americans. 44% of 
females used CM, 
compared to 34% of 
males (p = NS). 49% 
of patients ≤ 60 years 
old used CM, 
compared to 32% of 
patients > 60 years old 
48% of patients with a 
cancer diagnosis used 
CM, compared to 31% 
of patients with a 
benign diagnosis . 
Not reported No actual 
postoperative 
adverse event 
occurred  with 
use of CM. 
Suggestion that 
sample size too 
small to detect 
a true 
difference or 
not enough is 
known about 
the occurrence 
rates of these 
events 
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C.2.1.3.1 Methodological concerns 
 
As is the case with many investigations in the field of CM, it is difficult to make 
accurate comparisons between studies because there is a lack of consistency between 
definitions used to describe CM. For example, Kaye et al used the term ‘nutraceutical’ 
without providing a clear definition, Norred excluded the use of CMs prescribed by 
medical practitioners and Wang (2003) provided a list of 19 CTs including some 
which are questionably called CM such as self-help strategies. Investigators asked 
about use of CMs or CTs over varying time frames and usage figures were reported in 
a variety of ways making a comparison difficult. As previously discussed, the surveys 
investigating patients potentially unsafe behaviours were based on an inaccurate and 
limited review and is unlikely to truly estimate patients use of potentially unsafe CMs. 
Non-English speakers were poorly represented in these studies and recall bias is likely 
to be a problem when patients are asked to remember their use of either CMs or CTs 
in the previous 12 months and may result in either an over-estimation or under-
estimation of use (239). 
 
C.2.1.3.2 Surgical patients using CMs and CTs 
 
Three general factors have been associated with the use of CMs amongst surgical 
patients: being female (231;233;242), Caucasian (231;233;239;242) and highly 
educated (231;233;239;242). These same factors have been associated with use of 
CMs in general population surveys (1;14). The age group most likely to be using CMs 
appears to be between 35 years to 60 years (231;233;236).   
 
CTs which are popular amongst surgical patients are: chiropractic, massage, herbal 
medicine, megavitamin therapy and relaxation techniques. Studies which have 
focussed on the use of all ingested medicinal agents such as herbal medicines, 
vitamins, dietary supplements, or homeopathic medicines, report prevalence of use 
ranging between 16% (229) and 73% (233) however it is difficult to interpret survey 
results because patients were asked about use over different time frames.  For 
example, the prevalence of CMs use ranged from 51% (232) to 73% (234) when only 
studies that asked patients specifically about their use in the 2 weeks prior to surgery 
were considered.  Adusumilli reported on patient use over three different time frames 
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and stated that 57% of patients had used herbal medicine at some time during their 
lives, 38% in the previous 2 years and 16% in the month  prior to surgery (229) 
whereas Kaye et al reported only on current use (230), Skinner et al on current use 
including use during the previous 2 weeks (241), Wang (2003) on current use or past 
use without defining a time frame and Grauer et al about use in the past 6 weeks 
(242). 
 
As these studies highlight, asking patients about past use or use on the day of the 
survey will provide different results. It is suspected that studies asking about current 
use and immediate past use (such as the last 2 weeks) will provide the most accurate 
information as patients will have good recall of their habits in comparison to asking 
about behaviours conducted several months or years earlier. Considering the 
American Society of Anesthesiologists (ASA) advises that patients should discontinue 
use all herbal medicines two weeks prior to surgery, the time estimated for the 
compounds to be fully metabolized (246), determining current use and use during this 
period would be of most relevance when considering the potential implications for 
patient safety. 
 
Some studies reported separate usage figures for herbal medicines and this ranged 
from 5% (241) in the United Kingdom to 37% (234) in the United States. In Australia, 
one study identified herbal use at 14.3% (242). The herbal medicines that surgical 
patients have consistently reported using are: ginkgo biloba, garlic, ginseng, St John’s 
wort, echinacea and ephedra products (in the United States only) (229-
231;233;235;241;242). In regards to nutritional supplements, multivitamins were 
reported as the most commonly used (230;233;242). 
  
C.2.1.3.3 Use of CMs which have the potential to induce adverse events  
 
Whilst information can be extrapolated from general usage studies, three studies have 
been specifically conducted to determine the percentage of people taking CMs which 
could potentially increase the risk of haemorrhage, either due to interactions or direct 
pharmacological activity (232-234). The largest study of over 6000 participants 
conducted at 16 sites reported that 34% of patients were taking such products in the 2 
weeks prior to surgery (233). All studies referred to information published in a review 
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article co-written by the chief researcher as the basis for defining which CMs should 
be considered potentially unsafe (247).  
 
The review by Norred and Brinker includes some CMs listed as potentially harmful 
based on theoretical concerns which are unlikely to be borne out in practice and some 
CMs are incorrectly included. For example, medicinal herbs with high concentrations 
of the prodrug coumarin were considered potentially dangerous (Apium graveolens, 
Matricaria recucita, Aesculus hippocastanum, Tanacetum parthenium) and the 
authors stated they could have additive effects with pharmacological anticoagulants if 
converted to 4-hydroxycoumarin. However, only certain moulds and fungus convert 
coumarin to a 4—hydroxycoumarin and the extent of conversion of coumarin to 
anticoagulant derivatives by humans is insignificant (248)(further discussion about 
CM safety in surgery is presented in Section D). As a result, the inclusion of these 
substances will lead to an over-estimation of patient’s potentially unsafe practices. 
Alternately, the Norred studies may under-estimate the true percentage of patients at 
risk as they solely focus on bleeding tendencies and fail to consider other mechanisms 
such as sympathomimetic effects and interactions with anaesthetic drugs and drugs 
used during the perioperative period. 
  
C.2.1.3.4 Disclosure to hospital staff 
 
Patient disclosure was poor in the five studies in which it was evaluated (229-
231;238;239;242). Four studies investigated disclosure to various hospital doctors and 
one study referred to ‘health care staff’ without defining this term further (229). No 
studies specifically reported on disclosure to hospital nurses or pharmacists. 
According to Kaye et al, nearly 70% of patients taking one or more CM product at the 
time of the survey did not report this information when asked during routine 
anaesthetic assessment (230).  Adusumilli found that of the patients taking herbal 
medicines, only 7% volunteered this information to health-care staff in the 
preoperative period (229). In addition, they report that 20% of patients using CMs 
were asked about use by primary care physician, 17% by the operating surgeon, 4% 
by the anaesthetist and 10% by another health-care worker. Leung et al reported that 
56% of patients did not disclose use of CM to an anaesthetist prior to surgery (231) 
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and Wang et al reported that 20% of patients did not tell physicians about CM use 
unless directly asked (238). Liu et al reported that 83% of cardiac surgery patients had 
not discussed use of CMs and CTs with their physician or surgeon and 48% of non-
disclosers did not want to discuss use. In Australia, Grauer et al identified only 28% 
of surgical patients using herbal medicines as having informed hospital doctors about 
use (242).  
 
Only one study investigated possible reasons for surgical patients non-disclosure in 
greater depth and reported that patients did not consider CMs as ‘real medicine’ and 
therefore did not think it relevant to inform health professionals about their use (229). 
Skinner et al, reported there was no documentation of use on the anaesthetic forms of 
patients using them (241) and suggested that either the anaesthetist or patient did not 
consider them to be of sufficient importance. 
 
Studies with the general population report many other reasons for patient non-
disclosure which are yet to be evaluated in this population. In addition, Skinner et al 
identified a lack of documentation regarding patient’s use of CMs, the reasons for this 
omission remain unclear and have not been investigated (241). 
 
C.2.1.3.5 Reasons for use 
 
Patients reported numerous and varied reasons for their use of CMs such as : because 
it had been recommended by a friend or family member, healthcare professional or 
they had self-selected, because patients had a sense of personal autonomy about their 
health, were dissatisfied with conventional health care, because CM was perceived as 
relatively safe, had few or no side effects, works just as well or better than 
conventional medicine, due to a TV advertisement, improvement of general health 
and disease prevention of disease, chronic medical problems, because the problem 
was considered not serious enough to consult a medical doctors  (229;235;238). The 
most common reasons for use of herbs or vitamins supplements was in the treatment 
of chronic medical conditions according to the Australian study (242).  
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C.2.1.3.6 Sources of advice and recommendation  
 
CMs were self-prescribed by 36% (235) - 70% (249) of surgical patients. Tsen further 
reported that 36% of people used CMs because of recommendations by family and 
friends(235) and Wang et al reported that 18.9% of patients using CMs did so because 
they were recommended by a ‘friend or medical doctor’ without differentiating 
between the two groups (238). Both Tsen et al and Grauer et al reported that a 
healthcare provider had recommended CMs without defining this term further 
(235;242). None of the studies clearly reported whether pharmacists, medical 
specialists, general practitioners or CM practitioners were also sources of 
recommendation. 
 
Limited information is available about the sources of information used by the surgical 
population regarding CM. Only one study specifically investigated this issue and 
identified patients sources of information were : friends (36%), family (27%), 
magazines (11%), audiovisual media (8%), newspapers (6%), internet or healthfood 
shop (12%) (229). Of note, medical practitioners, pharmacists and other health care 
professionals were not included.  
 
C.2.1.3.7 Beliefs and perceptions about CMs and CTs 
 
Only Liu et al evaluated patients perceptions of the effectiveness of the CTs being 
used however this referred to CM as a whole and not individual therapies (239).  
Studies failed to directly evaluate patients beliefs and perceptions about use of CMs. 
Assuming their reasons for use is a reflection of their beliefs, it appears that some 
patients perceive CMs as safe and effective however little else is known and no 
information is available about Australian patients in this regard.  
 
C.2.1.3.8 Interest in hospital CM service provision 
 
Two studies asked patients about their willingness to use CM as part of perioperative 
medical care. One study reported that 76% of all respondents were willing to use CM 
as part of their anaesthesia care with most interest in acupuncture, hypnosis and herbal 
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medicine (238). In an earlier study of outpatients, 42% were willing to use 
acupuncture as a treatment modality for anxiety (237). Once again, no information is 
available about Australian patients in this regard. 
  
C.2.1.4 Limitations of this review 
 
As with the three other systematic reviews presented as part of this dissertation, the 
main limitation of this review relates to the heterogeneity of the included studies 
which reduced the ability to compare results and summarise key trends. Whilst every 
effort was made to locate relevant studies, it is possible that others exist which were 
not identified using the search strategy.  
 
C.2.2 Australian hospitals 
 
It is now well established that the general population uses CMs however published 
studies about the prevalence and patterns of CM use by hospital patients are limited. 
Three studies have been published in the peer-reviewed literature of people presenting 
at Emergency Departments (250-252), one study with inpatients (253), one study with 
patients being treated in a psychiatric unit (254)  and one of surgical patients (242).  
 
C.2.2.1 Emergency departments 
 
A study conducted at Royal North Shore Hospital in Sydney revealed up to 52% of 
people presenting to the Emergency Department over a three-month period (n=325) 
used CM within the previous 12 months, 41.2% within the previous 3 months, 34.2% 
within the previous month and 30.5% in the previous week (252). The most 
commonly used CM products were tea tree oil preparations (13.3% of products), 
garlic capsules (10.6%), evening primrose oil (7.5%), aloe vera (4.3%), chamomile 
(10.2%) and ginseng (3.4%). 
 
Most preparations were self-selected (41%) or recommended by a friend or family 
member (35.5%) although recommendations were also received from naturopaths 
(9%) and qualified medical practitioners (5%). Most respondents had at least once 
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consulted a CM practitioner (63.1%) with more women consulting naturopaths, 
iridologists, reflexologists and aromatherapists than men. Disclosure was poor as only 
20.7% of CM users had told their primary medical practitioner about CM use. 
Reasons given for non-disclosure were a perceived lack of responsiveness by the 
doctor to CM, a belief that it was irrelevant to the doctor, or fear that disclosing use 
could jeopardise their continued use of CM. 
 
A smaller follow-up study conducted at the same hospital and published 7 years later 
found 70.3% of patients (n= 94) had used at least one CM treatment in the last 12 
months with nutritional supplements most frequently used (74.0%) followed by herbal 
medicines (26.3%), essential oils (14.2%) and traditional Chinese medicines (7.5%) 
(251). Most CM users (62%) were using conventional medicines at the same time. 
Within the month before admission, 56.4% reported using at least one CM treatment 
and of these 44% had taken CM within the 2-3 days prior to admission.  
 
More recently, a cross-sectional survey of patients seen in the emergency department 
at the Royal Melbourne Hospital, Melbourne identified 68.1% as having used CM in 
the previous year (255), 50.2% within the previous week and 12.4% on the previous 
day (256). Patients who had used CMs in the previous year were significantly 
younger, better educated and more likely to female than patients who had not (257).  
Of the patients that had taken CMs during the previous year, 57% were also taking a 
prescription medicine at the same time. Documented drug-CM interactions were 
identified for 9 patients (3.3%) with warfarin and St Johns wort the most commonly 
involved medicines. Of these 9 patients, 3 had advised their physicians of CM use, 
two had advised their CM practitioner and 2 had told no one. Theoretical interactions 
were identified in 51 patients (18.6% of CM users). Disclosure to physicians about 
CM use in general was poor as 71.6% had failed to inform their physician about use. 
  
 
C.2.2.2 Other patients 
 
A study conducted at St Vincent’s Hospital Sydney found that 36% of the 511 
inpatients surveyed took complementary medicines whilst in hospital, 74% of which 
were self prescribed and 51% not being recorded on the patients medication chart 
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(253). Of those patients taking complementary medicines, 18% were considered 
substances that had the potential for adverse effects or interactions. 
 
CM usage has been investigated amongst patients being treated in an Australian 
psychiatry unit (258). Structured interviews were conducted with 52 patients of which 
48 were men with a mean age of 56.7 years. During the preceding 6 months, 51.9% of 
people had used CM. The most common products taken were vitamins and minerals 
(n = 18) and herbal medicines (n = 14). Use of CM products was not related to 
demographic or medical factors, but was significantly less frequent among patients 
seeing their local physician >1 time per month. Only 17 of the respondents using CMs 
(63.0%) informed their physician about these therapies. People using CM daily 
ranked their satisfaction level with these products significantly higher than with 
conventional therapies and their attitude toward CMs was positive overall, and was 
slightly more favorable among users than nonusers. 
 
C.2.2.3 Surgical patients 
 
The use of CMs by Australian surgical patients remains under researched. Currently, 
only one Australian study has been published in the peer-reviewed literature (242). 
This study evaluated preoperative use of CMs and rates of patient disclosure to 
hospital doctors and provided only limited information about these behaviours. As 
such, there remains no information about patient’s attitudes and beliefs about CM, 
reasons for non-disclosure or interest in hospitals offering CM services.  
 
The study was conducted at two public hospitals in Victoria (Box Hill and St 
Vincent’s Hospitals) and collected data from 1102 patients attending pre-admission 
clinics over an 8 month period. The voluntary survey was anonymous and self-
administered in English, thereby excluding non-English speakers. The sample 
population had an average age of 54 years and was predominantly female (61%). 
Participants were asked about use of CMs within the previous 6 weeks and 14.3% 
reported having used herbal medicines and 20.4% used vitamin supplements.  
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The most popular herbal medicines used by this sample were garlic (13.6% of all 
herbal medicines used), evening primrose (8.1%), ginkgo biloba (6.1%), St John’s 
wort (5.7%), echinacea (3.9%), valerian (3.5%), horseradish (3.5%), ginseng (3.5%), 
cranberry (2.6%), aloe (2.6%). It is worth noting that nearly 35% of all herbal 
medicines used were unspecified. The most popular vitamin supplements used were 
multivitamins (27.8% of all vitamins used), vitamin B (22.5%), vitamin C (21.5%), 
vitamin E (9.3%), vitamin D (3.9%), vitamin A (2.3%), vitamin K (0.3%) and 12.4% 
were unspecified.  
 
Of those patients that had used CMs, 27.8% had disclosed this use to hospital doctors 
or staff and 41.8% had informed their general practitioner. Disclosure to other 
healthcare professionals was not investigated nor was reasons for non-disclosure. 
CMs were often self selected (63.2%) and 26.6% had taken them on the advice of a 
healthcare practitioner however this term was not further defined.  
 
According to these results, prevalence of CMs use by Australian surgical patients was 
lower than typically reported by U.S. based studies. This is surprising when one 
considers over 50% of the Australian population use CMs compared to less than 20% 
in the U.S.(14;68). The researchers suggested this was partly explained by the more 
stringent regulation of herbal medicines in Australia and that most Australian health 
insurers do not reimburse the cost of CM products whereas numerous health insurance 
companies in the United States do this. This last point can be disputed as another 
source claims that most insurance companies in the United States do not cover herbal 
products or therapies (259). Another reason for the difference in results may relate to 
differences in sample characteristics however the Australian study did not report 
demographic data beyond age and gender so comparisons are not possible. 
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C.2.2.4 Cardiac surgery patients 
 
Cardiac surgery patients were chosen as a sub-set of special interest because there is a 
paucity of information in the international literature about this population in regards to 
CMs despite CVD being highly prevalent in the Western World.   
Cardiovascular disease affects over 3.2 million Australians with an expectation that 
this figure will substantially increase over the coming decades due to the growing 
number of older Australians (260).  People with CVD use more health services than 
the average Australian including use of specialist care, pharmacotherapy, surgery and 
rehabilitation. When combined with advancing age, severity of disease and other co-
morbidities, these patients are also exposed to increasing risk of adverse events and 
interactions.  
 
Reviews on the role of CM in the management of CVD suggest that some treatments 
offer potential benefits such as in hyperlipidemia, hypertension and congestive heart 
failure (261;262) with evidence to support the use of supplements such as fish oils 
(263) and the herbal medicine Hawthorn (264). 
 
Although potential benefits are possible with CMs, there are also potential risks. Of 
relevance to the patient with cardiovascular disease, some CMs such as St John’s 
wort, have the potential to interact with drugs such as warfarin, antiplatelet therapy, 
antihypertensives and digoxin (265). Adverse events can also be induced through 
direct effects on cardiac function or haemostasis. These safety concerns are of 
particular importance to patients with acute or severe disease, undergoing surgery, of 
advanced age or taking multiple medications. As an additional complicating factor, 
most Australians self-select CMs rather than receive professional advice and many 
fail to discuss use with medical practitioners (13). 
 
A review of the peer-reviewed international literature indicates only three studies 
have evaluated use of CTs by cardiology inpatients and only one study has 
specifically focused on cardiac surgery patients and their use of CTs, leaving many 
questions unanswered (266-270).  
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Liu et al collected data from 263 patients undergoing preoperative or postoperative 
cardiothoracic surgical evaluations at an urban, academic medical centre in New York 
(271). Most respondents were male in this sample (70%) and overall, 75% were 
reported as having used CTs within the previous 12 months. It is important to note 
that the definition used to describe CTs included prayer and vitamin supplements and 
when these two approaches were excluded, usage was determined as 44%. More 
specifically, 53.6% used vitamin supplements, 17.1% nutritional therapy, 11.4% 
massage, 11.4% chiropractic, 11.4% meditation and 9.9% herbal medicines. The 
study found older people with college education or higher tended to use vitamins 
more than others. Similar to other studies of surgical patients in general, most patients 
had not discussed CM use with their physicians or surgeons. Of the 83% who had not 
discussed CM, 48% did not want to discuss the topic, 36% reported they would like to 
discuss it and 16% did not respond. Liu et al did not report which specific CMs were 
being used by cardiac surgery patients, who had prescribed them, reasons for use or 
whether patients had an interest in hospitals providing CM services (272).   
 
Currently, the prevalence of CMs use by Australian cardiac surgery patients has not 
been investigated or published in the peer-reviewed literature.  
 
C.2.3. Summary 
 
Studies conducted overseas indicate that surgical patients use CMs prior to surgery 
and do not routinely disclose their use to hospital doctors. Their disclosure to other 
health care professionals is unknown and little investigation has been conducted to 
determine reasons for this behaviour. There is limited information available about 
surgical patient’s beliefs and perceptions about CMs and CTs, interest in hospitals 
offering CM services, information sources used and the prescribers to this population. 
Currently, information about Australian surgical patients is derived from only one 
study which provides limited information about usage and disclosure and no 
information about patients beliefs and perceptions about CM, reasons for non-
disclosure, information sources used or interest in hospitals offering CM services. 
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Cardiac surgery patients are an under-researched group regarding CTs and only one 
study has been published in the literature suggesting they also use CMs and do not 
generally discuss use with physicians or surgeons.   
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Chapter One 
 
Section D 
CMs safety with a focus on issues 
relevant to surgical patients  
 
 
 
D.1.0  Introduction  
 
This chapter is a literature review of relevant information and research about the 
safety of CMs, with a focus on safety issues of relevance to the surgical patient. It will 
present a brief discussion about medication safety and explore the limitations of case 
reports and spontaneous reporting systems as methods of collecting data about the 
safety of CMs. This will include discussion about communication failures, 
practitioner and patient awareness of safety issues and limitations of several 
information sources. A systematic review is presented which explores the 
international literature for published reviews about the safety of CMs in the 
perioperative period and the limitations of the available evidence will further be 
discussed. The algorithm METOPIA is discussed at the end of this section.  
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D.1.1  What is safety? 
 
Safety is a complex issue determined by considering the combination of ‘likelihood’ 
and ‘consequence’. These two variables will differ for each medicine and individual 
patient in their particular circumstance. The likelihood of an adverse reaction can be 
graded from rare to common and the consequence from clinically insignificant to fatal 
with many possibilities lying somewhere between these extremes (See Figure 1).  
 
In regards to medication safety, avoidance of an adverse drug reaction (ADR) is 
paramount. Several factors have been associated with an increased likelihood of 
developing an ADR such as advanced age and polypharmacy however most ADRs 
occur in people who are prescribed treatment within the limits of accepted clinical 
practice (273).   
 
 
 
Figure 1. Interaction between the two variables of ‘likelihood’ and ‘severity’ of 
consequence in regards to medication safety. 
Near 
impossible 
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D.2.0  Adverse reactions and CMs 
 
The amount of literature published about the safety of pharmaceutical medicines is 
overwhelming.  It has been estimated that 35% of the primary published literature 
about medicine-related adverse events appears as formal studies or randomised 
controlled trials and 30% in anecdotal reports (274).  In regards to herbal medicines, 
there is a relative lack of clinical trials so reliable information from other sources is 
important such as well-documented case reports and spontaneous reporting schemes 
(275;276). For researchers, a cluster of case reports describing similar adverse drug 
reactions can provide grounds for hypothesis-testing experiments and they can be 
used to generate signals of possible safety concerns for clinicians. These methods of 
data collection rely on collecting sufficient information about individual events to 
allow causes to be identified and trends to be tracked.  To enable the development of 
strategies which can reduce the risk of adverse drug reactions, data collection must 
also extend to other areas such as identification of system problems that contribute to 
medication related occurrences, evaluation of strategies to improve medication safety, 
comparison of incidence data locally and nationally and evaluation of health care 
professionals awareness of the potential problems (277).   
 
Whilst well documented case reports and spontaneous reporting systems are well 
established methods for investigating safety concerns with pharmaceutical medicines, 
they have several important limitations.  Notably, case reports tend to be incomplete, 
uncontrolled and retrospective (278;279) and there is much under-reporting of adverse 
drug reactions (280). In countries where CMs are not registered as medicines, 
spontaneous reporting schemes for adverse reactions are likely to be less effective as 
the degree of exposure (product sales, percent contamination) is difficult to know with 
certainty (278;281) and determining the prevalence of adverse reactions, almost 
impossible.  
 
In a review of 1520 published case reports, Kelly identified many which ignore much 
of the Bradford Hill’s criteria and proposed that professional journals consider stricter 
requirements for publishing adverse drug event reports with the inclusion of an 
objective assessment of causality as a minimum standard (279). Karch agrees and 
suggests that an objective causality assessment, such as the Naranjo algorithm (282), 
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will allow the reader to impose some structure on the evaluation of individual case 
reports (278). Whilst the grading score provides no additional data, it does make clear 
the merits and faults of the report. The problem of case reports providing inadequate 
data also applies to CMs. For example, a systematic review of the literature and 
evaluation of reports of herb-drug interactions identified 108 cases of suspected 
interactions of which 68.5% were classified as 'unable to be evaluated,' and only 13% 
as 'well-documented' (283).  
 
The question of whether the observed effect is a reaction to intrinsic or extrinsic 
factors must also be considered, particularly if the CM product in question was not 
manufactured under a code of GMP (284). Use of poor quality products with 
problems of adulteration, substitution or incorrect starting materials are not normally 
concerns with pharmaceutical medicines but are concerns with herbal medicines 
(276). To evaluate a case report involving a herbal medicine, confirmation of 
botanical identity is essential and detailed information about the herb used, part of 
plant use, type of extraction and formulation is important.  
 
The widespread problem of under-reporting of adverse drug reactions is a major 
limitation of spontaneous reporting system. Research about under-reporting of serious 
ADRs in the United States and Canada indicates that formal reporting rates may be as 
low as 1.5% of total ADRs leaving many adverse reactions unidentified by this 
channel (280). It is likely that reporting rates of less severe ADRs are even lower 
leaving many mild to moderate side-effects undetected and a hidden source of patient 
morbidity. Under-reporting of adverse reactions is also accepted as a significant issue 
with CMs (276). 
 
D.2.1 Multiple communication failures? 
 
Australian surveys consistently report that patients self-select their CMs and do not 
routinely inform their medical practitioners about use (13;14). One study conducted 
with surgical patients in Victoria identified that most do not inform hospital doctors 
about their use of herbal medicines, suggesting the problem of non-disclosure may 
also be present within the hospital setting (242). Unless practitioners ask patients 
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about use, adverse reactions induced by CMs may be overlooked, mistakenly 
attributed to other causes or diagnosed as a new disease symptom and therefore 
remain undetected and unreported. Importantly, known or suspected adverse reactions 
cannot be anticipated and avoided if patient use is not identified.  
Currently there are no published Australian studies which have identified whether 
medical practitioners ask patients about CMs, what barriers prevent them from 
initiating such a discussion, whether they are aware of safety issues associated with 
commonly used CMs or whether patient use is documented. These factors are 
important to investigate so that targeted strategies can be developed to encourage 
more open communication about CMs which will not only promote patient-centred 
care but also enable better detection and prevention of adverse events.  
Pharmacists also play a role in lodging case reports of suspected adverse reactions to 
ADRAC and publishing case reports in the literature. Two studies conducted overseas 
with predominantly community pharmacists indicate that pharmacists do not routinely 
ask patients about use of CMs (285;286) thereby limiting their ability to identify and 
prevent adverse reactions induced by CMs unless patients volunteer the relevant 
information unsolicited. No studies have been identified in the peer-reviewed 
literature of Australian pharmacists which have explored whether they ask patients 
about CMs whilst taking a medication history, what barriers prevent them from 
initiating such a discussion, whether they are aware of safety issues associated with 
commonly used CMs or whether patient use is documented.  
 
An Australian study of Western herbalists and naturopaths identified that they too 
observe adverse reactions to CMs. This study found that only one third indicated they 
report adverse events and 27% were aware of the Australian adverse drug reaction 
reporting procedures. Reports were generally made to manufacturers and/or 
professional associations with less reporting to the Australian Drug Advisory 
Committee or the Therapeutic Goods Administration. The study further states that 
44% of practitioners felt their primary educational courses have not adequately 
prepared them for inter-professional communications (287).  
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Patients also play an important role in identifying adverse reactions and promoting 
patient safety. According to a study from the U.K., consumers are less likely to inform 
their healthcare professionals of adverse effects to herbal medicines (288) making 
their detection even more difficult. Studies have been conducted, mainly in the U.S., 
which evaluated patient’s patterns of non-disclosure (289) however these tend to 
focus on medical practitioners and often fail to consider whether patients inform 
pharmacists or other healthcare professionals about CMs. Currently there are no 
published Australian studies which have investigated patients reasons for non-
disclosure to healthcare professionals.  
 
Within hospitals, patients come into contact with many different healthcare 
professionals and the opportunities for communication failures are multiplied. Causes 
of communication failure may occur at the individual, team and organisational levels 
and could require more complex solutions than those necessary in community 
practises. Currently, there is a paucity of published literature about the 
communication failures present within hospitals in regards to CMs. Patient disclosure 
studies are generally conducted within community settings, and studies of medical 
practitioners and pharmacist’s communication behaviours regarding CMs also tend to 
involve community practises.  
 
It is important to identify communication failures between patients and healthcare 
professionals and between healthcare professionals themselves as communication 
failures account for the overwhelming majority of unanticipated adverse events in 
patients (290). Communication failures also hinder the detection of adverse events 
and event reporting and thereby impede efforts to develop strategies which will 
improve patient safety in the future.  
 
D.2.2 Awareness of safety issues associated with CMs 
 
When open communication about CMs is successful, it seems prudent for healthcare 
practitioners to be aware of general safety issues that can arise and have some 
familiarization with what may be expected so that adverse events can be anticipated 
and avoided.  
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According to Cohen at al, Australian GPs perceive CMs as potentially harmful (166) 
and  Pirrota et al report that approximately half of Australian GPs thought they knew 
something of herbal medicine, naturopathy and vitamin and mineral therapy (165), 
however there is no information about GPs actual knowledge of the safety issues 
associated with CMs. There is a paucity of information about hospital doctors and 
their perceptions of the potential safety of CMs and knowledge of actual safety issues 
in the international literature. The only Australian study of hospital doctors involved 
oncologists and demonstrated they considered diet therapies as harmful  (291) 
however there is no published information about other groups or actual knowledge of 
safety issues for any group.   
 
A study of pharmacists in the U.S. demonstrated that 49% thought herbs and natural 
products were not safe (292) and two other studies have identified that pharmacists’ 
actual knowledge about CMs is low (178;213). Information about Australian 
pharmacists is scant and the only study conducted and published to date reported they 
perceive their level of knowledge about herbal medicine to be sufficient to explain 
this therapy to patients (293). To date, no published studies are available which have 
focussed on Australian pharmacist’s actual knowledge about the safety of commonly 
used CMs and limited information is available about hospital pharmacists in general 
in the international literature.  
 
D.2.3 Information sources  
 
Biased and misleading media reporting can misinform both healthcare practitioners 
and their patients about medication safety. Moynihan et al identified that media 
coverage about new drugs often exaggerates their benefits and downplays the 
associated risks (294). Incomplete or inaccurate press releases generated by medical 
journals and provided to reporters further complicate the issue and are now considered 
more common than once thought (295). CMs are not immune to these same influences 
and misinformation about their safety and efficacy abounds.  
One example is provided by the incomplete press release which describes results from 
an article entitled ‘Adverse reactions associated with Echinacea—the Australian 
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experience’ by Mullins and Heddle (296). The press release described five allergic 
reactions to different echinacea preparations and further stated that 51 adverse 
reaction reports involving echinacea had been reported to ADRAC (297).  It failed to 
include the important fact that these reports were collected over a 21 year period, a 
detail included in the full-length article. This case also provides an example of peer-
review failure as this important detail was not included in the article abstract.  
 
There is evidence that CMs are widely assumed to be a safe, non-pharmaceutical 
option that can be used to prevent, treat and manage disease by the Australia public 
(13). MacLennan et al indicate that many people self-prescribe CMs without 
professional advice, no doubt on the assumption they are safe, however little has been 
published about the information sources they use (13) and currently, no Australian 
studies have been published which investigate hospital patients perceptions of the 
safety of CMs and what sources of information they use.  
 
It has been reported in the literature that pharmacists refer to journals, professional 
publications, books and magazines for information about CM (188;192;298-301). 
Although there is limited information about the resources used by doctors, it can be 
assumed they also use peer-reviewed journals as an information source. As 
demonstrated by the Vioxx™ debacle at the New England Journal of Medicine, the 
peer-review procedure is vulnerable in a number of areas, including publication of 
information describing medication safety and adverse drug reactions (278). This is not 
limited to information about pharmaceutical medicine but also applies to information 
about the safety of CMs which is inconsistent, sometimes contradictory and incorrect.   
 
D.3 Surgical patients and CMs 
 
The systematic review presented in Chapter One section C found that numerous 
surveys have demonstrated that surgical patients use CMs however there is little 
published information about the reasons for communication failure in hospitals 
regarding CMs. Furthermore, there is little published information about the 
perceptions of practitioners and patients about the safety of CMs and the information 
sources they use to find information about CMs and CTs.  
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The use of CMs in the perioperative period has implications for the anaesthetist, 
surgeon, physician and patient. With the use of CMs by surgical patients and their 
lack of disclosure about use, adverse reactions and drug interactions can result and 
remain undetected and unmanaged leading to unanticipated perioperative anaesthetic 
or surgical complications (302-304).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 166 
D.4 Systematic review of the literature regarding CMs safety 
in the perioperative period. 
 
D.4.1 Aim:  
The primary aim was to review the international literature for what is considered to be 
the main safety issues associated with CMs use in the perioperative period and which 
CMs were commonly cited as posing a potential problem. The secondary aim was to 
identify limitations of the current literature.  
 
D.4.2 Methods:  
A search was performed between May and November 2006 using the following 
databases for all years available : MEDLINE, ScienceDirect, Clinicians Health 
Channel – Fulltext and Proquest. Search terms used included, but were not limited to:  
 
The following search terms were used:  
• ‘Complementary medicine’ and hospital 
• ‘Herbal medicine’ and ‘hospital’ 
• ‘Alternative medicine’ and ‘hospital 
• ‘Integrative medicine’ and ‘hospital’ 
• ‘Complementary therapies’ and ‘hospital’ 
• ‘Herbal therapies’ and ‘hospital’ 
• ‘Alternative therapies’ and ‘hospital’ 
• ‘Integrative therapies’ and ‘hospital’ 
• ‘Naturopathy’ and ‘hospital’ 
• ‘Natural therapy’ and ‘hospital’ 
• ‘CAM’ and ‘hospital’ 
• All the above terms with ‘surgery’ instead of ‘hospital’ 
• All the above terms with ‘surgical’ instead of ‘surgery’ 
• All the above terms with ‘surgeon’ instead of ‘surgical’ 
• All of the above terms with ‘anaesthesia’ instead of ‘surgical’  
• All of the above terms with ‘perioperative’ instead of ‘anaesthesia’ 
The bibliographies of articles relevant to CMs safety in surgery were scanned for 
additional review articles which may be appropriate for inclusion and the libraries of 
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the supervisor and researcher were searched for additional articles. Articles were 
considered eligible if they were published in English, available in the peer-reviewed 
literature, presented a review of the evidence and consisted of a fully referenced 
literature review.  
 
D.4.3 Results:  
 
D.4.3.1 Description of articles 
 
The search identified 12 review articles  (302-313) There is a dominance of herbal 
medicines in the articles and relatively little information included about other CMs. 
Three reviews were published in anaesthesia journals (304;306;307), three in 
complementary medicine or integrative medicine journals (308;313;314), three in 
surgery journals (309;311;312), one in a nursing journal (303), one in a medicine 
journal (310) and no review articles were found in any pharmacy journal. A summary 
of results from relevant review articles is presented in Table 1.  
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Year of 
publication 
Author/s Main concerns relating to use of 
CMs 
CMs noted as 
putting surgical 
patients at risk 
Strengths of review Limitations of review  Other observations 
2000 Leak (307) Potential to elevate blood 
pressure or untoward 
cardiovascular effects, enhance 
potential for bleeding, potentiate 
or prolong anaesthetic agents, 
hepatotoxicity, hormonal effects, 
electrolyte disturbances 
Ephedra 
Panax ginseng 
Licorice  
Ginkgo  
Garlic 
Feverfew 
Ginger 
Valerian 
Kava kava 
Echinacea 
Saw palmetto 
Goldenseal  
Numerous mechanisms 
considered in the review 
No methodology provided 
to describe review 
process.  The relevance of 
some information to 
surgical patients is unclear 
e.g. concerns over Saw 
palmetto because a 
secondary information 
source stated it may 
cause additive effects with 
hormonal therapies such 
as oestrogen  
 
 
2000 Petry (315) Potential to prolong bleeding time Garlic 
Vitamin E 
Discusses benefits of 
selected CMs and CM 
therapies for the surgical 
patients together with some 
safety information 
No methodology provided 
to describe review 
process.   
 
 
 
Table 1. Review articles in the international literature which provide information about the safety of CMs for surgical patients 
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2001 Norred and 
Brinker 
(308) 
Potential to prolong bleeding time Botanical coumarins 
Numerous herbs 
and dietary 
supplements that  
are known or 
suspected to inhibit 
platelet aggregation 
 
Comprehensive review 
Usually mentions origins of 
evidence e.g. case reports, 
and highly referenced 
No methodology provided 
to describe review 
process.   
Provides an incomplete 
picture of the potential 
safety issues associated 
with the use of CMs in the 
perioperative period.  
Of 129 references, 32 
refer to secondary 
information sources 
about CMs safety 
2001 Dorman 
(306) 
Pharmacological effects mainly 
sympathomimetic, sedative and 
potential to prolong bleeding time 
Ephedra 
Panax ginseng 
Licorice 
Valerian 
Kava kava 
St John’s wort 
Garlic 
Ginkgo 
Ginger 
Feverfew  
 
 
Editorial highlights possibility 
of safety issues 
No methodology provided 
to describe review 
process.  All information 
derived from German 
Commission E 
monographs 
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Year of 
publication 
Author/s Main concerns relating to use of 
CMs 
CMs noted as 
putting surgical 
patients at risk 
Strengths of review Limitations of review  Other observations 
2001 Flanagan 
(303) 
Purity and  contamination issues 
Self-medication  
Ephedra 
Feverfew 
Garlic 
Ginger 
Ginkgo 
Ginseng 
Goldenseal 
Licorice 
Senna 
St John’s wort 
Valerian  
 
 
 
 
 
Advises readers to establish  
a local protocol  
No methodology provided 
to describe review 
process.   
Not one primary study 
or case report was cited 
out of 32 references 
Table 1. Review articles in the international literature which provide information about the safety of CMs for surgical patients 
 171 
Year of 
publication 
Author/s Main concerns relating to use of 
CMs 
CMs noted as 
putting surgical 
patients at risk 
Strengths of review Limitations of review  Other observations 
2001 Sabar et al 
(310) 
General adverse effects possible 
with the use of popular CMs 
Echinacea 
Garlic 
Ginger 
Ginkgo biloba 
St John’s wort 
Ginseng 
Kava kava 
Feverfew 
Ephedra 
 
 
 
 
 
 
 
Includes brief history of herbal 
medicine and its contribution 
to modern day  medical 
practice 
No methodology provided 
to describe review 
process.   
Origins of the evidence 
cited is often not 
mentioned  in the text and 
no distinction is made 
between theoretical 
concerns and documented 
risks potentially  
overstating the risks  
Of 110 references,  72 
refer to primary studies, 
case reports or meta-
analyses 
 172 
Year of 
publication 
Author/s Main concerns relating to use of 
CMs 
CMs noted as 
putting surgical 
patients at risk 
Strengths of review Limitations of review  Other observations 
2001 Pribitkin and 
Boger (309) 
Increased risk of bleeding during 
surgical procedures:  
Feverfew 
Garlic 
Ginger 
Ginkgo 
Asian ginseng 
   
2001 Cassileth 
and 
Barrazzuol 
(305) 
Purity and contamination of CMs 
General safety, side effects and 
interactions with other drugs 
Arnica 
Bromelain 
*Chaparral 
Coenzyme Q10 
*Comfrey 
Danshen 
Dong Quai 
Echinacea 
*Ephedra 
Feverfew 
Garlic 
Comprehensive list of herbal 
medicines reviewed  
No methodology provided 
to describe review 
process.    
Some information is 
extrapolated from rare 
case reports or  in vitro 
studies  and much is 
based on theoretical 
reasoning without alerting 
reader to these limitations 
potentially overstating the 
risks 
Many claims not 
referenced  
 
 
Several herbs listed are 
not available OTC in 
Australia 
Of 51 references, 31 
are citations of 
secondary information 
sources about CMs 
safety and only 15 are 
primary information 
sources such as clinical 
trials or case reports 
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Ginger 
Ginkgo 
Ginseng  
Hawthorn 
Horse chestnut 
Jin bu huan 
Juniper 
Licorice 
*Lobelia 
*Mistletoe 
Pau D’Arco 
Pennyroyal 
Poke root 
Sassafras 
Shark cartilage 
St John’s wort 
Tryptophan 
*Yohimbe 
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Year of 
publication 
Author/s Main concerns relating to use of 
CMs 
CMs noted as 
putting surgical 
patients at risk 
Strengths of review Limitations of review  Other observations 
2002 Hodges and 
Kam (304) 
 Echinacea 
Garlic 
Ginkgo 
Ginseng 
St John’s wort 
Valerian 
Ephedra 
Kava kava 
Grapefruit 
Ginger  
Included methodology used to 
conduct literature review. 
Both benefits and risks are 
discussed 
Differentiates between 
theoretical risk, anecdotes 
and  documented cases and 
formal studies  
  
2003  Tessier and 
Bash (311) 
General safety, side effects and 
interactions with other drugs 
Ephedra 
Ginger 
Garlic 
Ginkgo  
Ginseng (Korean 
and American) 
Comprehensive  No methodology provided 
to describe review 
process.    
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Ginger 
Dong quai 
St John’s wort 
Goldenseal 
Licorice 
Saw palmetto 
Echinacea 
Valerian 
Chaparral 
Guar gum 
Kava kava 
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Year of 
publication 
Author/s Main concerns relating to use of 
CMs 
CMs noted as 
putting surgical 
patients at risk 
Strengths of review Limitations of review  Other observations 
2005  deAzevedo 
Pribitkin 
(302) 
Purity and contamination of herbal 
products 
The various pharmacological 
actions of herbs such as 
cardiovascular hypoglycemic, 
sedative, oestrogenic, 
photosensitization 
Interactions due to St John’s wort 
and interactions with digoxin  
Coumarin containing 
herbs 
Salicylate containing 
herbs 
Numerous other 
herbs claimed to 
inhibit platelet 
function 
Numerous mechanisms 
considered  
No methodology provided 
to describe review 
process.    
Some information is 
incorrect and based on 
faulty assumptions e.g. 
coumarin and salicylate 
containing herbs 
automatically increasing 
risk of bleeding 
Of 107 references, 29 
refer to secondary 
sources  
2006 Heller et al 
(312) 
Interactions with other drugs 
Increased risk of bleeding during 
surgical procedures 
Unwanted pharmacological effects  
Chondroitin 
Glucosamine 
Ephedra 
Echinacea 
Ginkgo biloba 
Goldenseal 
Milk thistle 
Ginseng 
Kava kava 
Saw palmetto 
Comprehensive  No methodology provided 
to describe review 
process.    
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St Johns wort 
Ginger 
Eicosapentaenoic 
acid 
Vitamin E 
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D.4.3.1 Methodological concerns 
 
Most review articles did not report on the methodology used to search the literature 
and some reviews cited numerous secondary sources of information without making it 
apparent that little information was based on evaluation of the original research. Many 
reported adverse effects and interactions reflected theoretical reasoning in the absence 
of clinical data and some were based on case reports and in vitro tests. Few articles 
discussed the limitations of such information sources and the problems inherent with 
making clinically relevant theoretical predictions from in vitro studies.  
 
D.4.3.2 CMs commonly reported as posing a safety risk  
 
The CMs which were commonly reported as posing a potential risk to surgical 
patients are: ephedra, echinacea, feverfew, garlic, ginger, ginkgo biloba, ginseng, 
goldenseal, kava kava, licorice, St John’s wort and valerian. CMs which were less 
commonly reported as presenting a potential risk were: saw palmetto, dong quai and 
chapparal, aristolochia, arnica, bromelain, coenzyme Q10, comfrey, dan shen, 
grapefruit, guar gum, hawthorn, horse chestnut, juniper, lobelia, mistletoe, pau d’arco, 
pennyroyal, poke root, sassafras, senna, shark cartilage, tryptophan, yohimbine. The 
CMs which were consistently reported as specifically increasing the risk of bleeding 
were: feverfew, garlic, ginger and ginkgo biloba and several articles included 
coumarin containing herbs.  
 
D.4.3.3. Authors main concerns relating to CMs  
 
The main concerns expressed by authors can be grouped into three broad categories. 
Firstly authors were concerned about the potential for CMs to exert unwanted 
pharmacological actions such as anti-platelet and anticoagulant activities, 
cardiovascular effects, hormonal and sedative effects. Drug interactions were another 
category although few authors identified the specific interactions of concern. Finally, 
the possible contamination of CMs was stated as a potential problem.  
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D.4.3.4 Lack of formal clinical studies  
 
The frequent reliance on evidence other than clinical studies highlights the lack of 
research conducted in the area of CMs safety and is largely responsible for the 
inconsistent information presented in the published reviews. From a clinical 
perspective, evaluating the likelihood and consequence of a predicted adverse reaction 
and herb-drug interaction is of primary importance however this is difficult to 
determine from the available evidence. 
 
To illustrate the problems clinicians face when wanting to find consistent and reliable 
information about the safety of CMs, Table 2 has been compiled which lists the main 
concerns that authors of five review articles raise about five CMs often reported as 
presenting a potential risk for surgical patients (302;304;306;307;310).  
 
 180 
 
As Table 2 illustrates, there are inconsistencies in the information presented in peer-
reviewed journals regarding the safety of herbal medicines in surgery. Furthermore, 
some information included is of questionable relevance to the perioperative period 
and a review of the literature suggests that inaccuracies are also present. It is likely 
that the scarcity of clinical data has resulted in misinterpretation and overstatement of 
the risks.  
  
The reporting about garlic was most consistent and all 5 review articles stated that it 
may increase the risk of bleeding. Four out of 5 reviews stated ginger posed a 
bleeding risk and one added a concern about reducing blood pressure that was not 
reported in the other articles.  
 
CMs reported as being known or suspected to pose a risk to surgical patients and main concerns 
of authors 
Echinacea Feverfew Garlic Ginger Ginkgo 
Concerns about 
hepatotoxicity 
effects most often 
reported and 
sometimes 
interactions with 
immunesuppressa
nts 
(304;310) 
 
May  theoretically 
reduce 
effectiveness of 
corticosteroid 
drugs (307) 
 
Mention of 
allergies to daisy 
family (304) 
Inhibition of 
platelet function 
leading to 
increased risk of 
bleeding 
(302;306;307) 
 
 
Concern over 
adverse effects 
such as apthous 
ulcers, 
gastrointestinal 
irritation and 
withdrawal 
effects(310) 
Inhibition of 
platelet function 
leading to 
increased risk of 
bleeding 
(302;304;306;307;
310) 
 
 
 
 
 
 
 
Inhibition of 
platelet function 
leading to 
increased risk of 
bleeding 
(302;306;307;310) 
 
 
Less commonly, 
concern over 
reducing blood 
pressure(302) 
 
 
 
Increased risk of 
bleeding, most 
articles  refer to 
case reports as 
evidence 
(302;304;316) 
 
Some suggest 
effect more likely 
when used with 
antithrombotic 
agents  
(306;307) 
 
One report also 
states ginkgo toxin 
n leaf and seed 
thought to be 
neurotoxic (310) 
 
Table 2.  Key themes emerging from the review articles about 5 CMs  
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Three articles stated that feverfew inhibits platelet function and poses a bleeding risk 
although a review of the literature reveals that the evidence is not definitive. Several 
in vitro studies have demonstrated inhibition of platelet aggregation for feverfew 
(317;318) however, no significant effects were seen in a clinical study casting doubt 
on the relevance of the test tube findings (319).  
 
The reporting about ginkgo biloba was interesting as three articles stated it could 
increase bleeding; referring to case reports and sometimes in vitro tests as supportive 
evidence and two other articles stated the risk was associated with the combined use 
of ginkgo and antithrombotic agents. All failed to mention three placebo-controlled 
studies which have not detected a significant effect for ginkgo biloba on platelet 
function or coagulation (320-322) One was an escalating dose study which found that 
120 mg, 240 mg or 480 mg given daily for 14 days did not alter platelet function or 
coagulation (320). It is important to note that four of the five review articles were 
published prior to 2003 and the three clinical studies were reported in 2003, 2004 and 
2005. This highlights the problems of extrapolating from case reports and test tube 
results and the importance of keeping up to date with the most recent clinical 
evidence.  
 
Sabah et al (310) reported that echinacea was potentially hepatotoxic and the claim is 
referred back to a review by Miller published in 1998 (323) and not original research. 
In contrast, the review by Hodges and Kam published one year later states that 
although echinacea preparations contain pyrrolizidine alkaloids, hepatotoxicity is 
unlikely because they are structurally different to the pyrrolizidine alkaloids known to 
be hepatotoxic (304). This example highlights the inconsistencies present in the 
literature.  
 
The problems of inconsistent and contradictory information about the safety of CMs 
are not limited to these reviews but also occur with electronic databases such as 
AltDexMed in the Micromedex database and others.  
 
As demonstrated in the Chapter 1, section B, the systematic reviews of medical 
practitioners and pharmacists indicate that little is known about the resources used by 
hospital doctors and pharmacists for information about CMs and CTs. Although all 
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public hospitals in Victoria have access to AltDexMed in the Micromedex database, it 
is not known whether this resource is used.  
 
D.5.0  Herb - drug interactions 
 
D.5.1 Approaches used to evaluate herb interactions 
 
Most studies conducted to investigate herb-drug interactions have used in vitro testing 
of herbal constituents in microsomal systems, supersomes, cytosols, expressed 
enzymes or cell culture systems such as transfected cell lines, primary cultures of 
human hepatocytes and tumour derived cells (324). There has also been some 
investigation in vivo in normal animals, transgenic and humanised animals and 
increasingly, there has been some investigation conducted in humans. Whilst these 
studies are useful, they are not without limitations. Table 3 presents a summary of the 
limitations relevant to different types of research. Most interactions studies conducted 
to date have focussed on herbal constituents and their effects on cytochrome (CYP) 
enzymes and increasingly P-glycoprotein (P-gp) with few studies investigating effects 
on drug transport or phase II metabolism.  
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Study type Advantages Limitations 
 
In vitro • Provides information about 
mechanisms 
• Relatively simple to conduct 
compared with clinical studies 
• Relatively cheap to conduct 
compared with clinical studies 
• Relatively quick to conduct 
 
• May use doses higher than can be 
achieved in clinical practice 
• Does not account for poor bioavailability 
of the test compound  
• May use one isolated constituent 
whereas herbal extracts contain 
multiple constituents 
• Does not account for human genetic 
polymorphism 
In vivo using 
animal models 
• Can address some of the issues 
relating to bioavailability 
• Can produce quicker results than 
clinical studies 
• Can provide information when 
clinical studies are not able to be 
conducted 
 
• Species variations make results 
different to interpret 
• Selection of appropriate dosage can be 
difficult and often very large doses used 
• Does not account for human genetic 
polymorphism 
Clinical studies  • Provide the most relevant 
information and are the most 
definitive 
• Most studies conducted in healthy male 
subjects however most relevant results 
are obtained when conducted with the 
same population who will be using the 
product 
• Inter-product variability in constituent 
ratios means tested product may not 
accurately represent effects of other 
products 
• Cannot differentiate between gut and 
liver effects (e.g. cytochromes) 
• Does not provide information about 
mechanisms 
• Costly to produce 
• Time consuming 
• May never be done due to ethical 
reasons (e.g. safety studies in 
pregnancy) 
 
 
 
 
Table 3. Advantages and limitations of herb-drug interaction studies  
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D.5.2. An overview of the main interaction mechanisms 
 
When one considers the great variation in physical properties and pharmacological 
effects of the numerous substances used as medicines, together with the variable 
nature of herbal medicines and food supplements, it is apparent that a virtually endless 
number of interactions are possible. Interaction mechanisms can be broadly 
categorised as pharmacodynamic or pharmacokinetic interactions (Figure 1). 
Regardless of the interaction mechanism at work, there remain three possible 
outcomes: increased therapeutic or adverse effects, decreased therapeutic or adverse 
effects or a unique response that does not occur when either agent is used alone (325).  
 
 
 185 
 
Pharmacodynamic  Pharmacokinetic 
Herb – drug 
interactions 
Absorption 
e,g, P-gp, 
chelation 
 
Distribution 
Excretion 
e.g. urinary 
pH 
Cardio- 
vascular 
e.g. 
hypertensiv
e 
Haemoto- 
logical 
e.g. 
antiplatelet 
Metabolic 
e.g. 
hypoglyc 
emic 
Immune 
Others  
Neuro – 
endocrine 
e.g. 
sedatives 
Metabolism 
e.g. CYP 
enzymes 
Figure 1. Main classes of interactions  
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D.5.3 Problems in extrapolating data 
 
A review of the peer-reviewed literature reveals that there is a lack of clinical data and 
research regarding interactions between herbs and drugs and it is apparent that much 
remains untested. Despite this, several OTC herbal medicines have demonstrated 
pharmacodynamic and pharmacokinetic interactions with drugs in clinical studies. 
One major concern is those herbal medicines which interact with transporters such as 
P-gp or cytochromes such as CYP3A4 which are responsible for the transport or 
metabolism respectively of many drugs commonly used in clinical practice.  
 
 
In some instances results obtained in vitro or with animal models about interactions 
do not accurately predict clinically significant effects in humans. This makes 
predicting the clinical significance of a possible interaction problematic and a reliance 
on evidence other than clinical data is bound to lead to inaccuracies. The herbs ginkgo 
biloba and saw palmetto will be used here as examples to illustrate this point.   
 
In vitro and/or tests with animal models have shown both cytochrome induction and 
inhibition for ginkgo biloba (326-341). In contrast, four clinical studies have failed to 
identify a clinical significant effect on a variety of cytochromes. In one clinical study, 
Gurley et al demonstrated that ginkgo biloba had no significant effect on CYP1A2, 
CYP2D6 or CYP3A4 activity (342). Markowitz et al also conducted a human study 
and found no significant effects on CYP2D6 or CYP3A4 activity (343). Two further 
clinical studies found no significant effect for ginkgo biloba on CYP2C9 activity 
(344;345).  
 
Saw palmetto showed potent inhibition of CYP3A4, CYP2D6, andCYP2C9 in vitro 
(346) however no significant effect was observed on CYP2D6 or CYP3A4 activity 
according to a clinical study by Markowitz et al  (347). Gurley et al also found no 
significant effect for saw palmetto on CYP1A2, CYP2D6, CYP2E1 or CYP3A4 
activity in healthy subjects (348). 
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To add to the complexity of the problem, in some instances researchers have 
conducted testing with individual herbal components or different forms of a herb 
finding different effects on CYPs. For example Fukao et al demonstrated using animal 
models that diallyl sulphide (100 micromol/kg) slightly but significantly increased 
cytochrome CYP2E1 activity (1.6-fold vs. control), whereas diallyl disulfide and 
diallyl trisulfide did not affect CYP2E1 activity or the hepatic total CYP level or 
CYP1A1/2 activity (349). The significance of these results in clinical practice is 
difficult to determine as the overall effect on CYP activity will depend on the 
concentrations of these various constituents present in a garlic product. The example 
also highlights the general difficulty in extrapolating results for one herbal extract to 
another as there may be a significant chemical variation between batches of the same 
herbal product and between different products of the same herb produced by various 
manufacturers.  
 
D.5.4 M.E.T.O.P.I.A. algorithm 
 
Predicting whether a clinically significant drug interaction will occur is a complex 
process as many individual factors come into play. Firstly, understanding the basic 
mechanisms of action of each medicine is essential as is keeping in mind the level of 
evidence supporting the interaction. Additionally, the types of medicines involved, 
administration route, dosage and time frames of use must be considered. The severity 
of the interaction is also influenced by factors such as genetics, environmental 
influences, diet, underlying disease and age. Finally, the importance an interaction is 
given is related to some extent by the setting in which it occurs. 
 
It has been suggested that the M.E.T.O.P.I.A. algorithm provides a framework for 
making rational decisions about the possibility of a herb-drug interaction 
(325;325;350).  
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The acronym M.E.T.O.P.I.A. refers to : 
 
Medication and mechanisms 
• Understanding the medicines involved is essential. For example, when drugs 
with a narrow therapeutic index are being used, extra care is required.  
• An understanding of the pharmacokinetic parameters and pharmacodynamic 
effects of the medicines involved is fundamental to predicting the likelihood 
of a proposed interaction occurring. In the case of herbal medicines, this 
information be not be available and much will be speculative.  
 
Evidence available 
• A review of the literature is required to determine what evidence is available 
and its strengths and limitations. As illustrated, in vitro studies are poor 
indicators of the clinical significance of an anticipated interaction however it 
may be the only evidence available. 
 
Timing and dose — introducing which, when and for how long? 
• For physicochemical interactions in particular, the scheduled administration 
times of the medicines is important to consider.  
• This step also includes considering the chronicity of use of the medicinal 
agents as interaction mechanisms may only develop over several days or 
weeks (such as CYP induction) or may occur rapidly. 
 
Outcomes possible 
• The time of onset and severity of the possible clinical consequence may be 
predicted from the available evidence however in the case of herbal medicines 
where much remains untested, this is likely to be speculative.  
 
Practitioner considerations 
• Evaluation of whether the practitioner is able and willing to monitor and 
manage a potential interaction, should it become clinically significant. This 
can be dependant on the practitioner and patients setting, For example, in a 
hospital setting, an interaction is may be considered important if it requires 
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something to be done to relieve patient symptoms or will have a significant 
impact on critical therapy. Practitioners and nursing staff are in an ideal 
position to detect and manage interactions should this be necessary. In a 
community setting, general practitioners, pharmacists, CM practitioners are 
better placed and adequate patient self-monitoring becomes more important. 
 
Individual considerations 
• Consideration of individual patient risk factors which may be present and 
increase the likelihood of an adverse reaction 
• The patient’s individual treatment preferences  
• The patient’s ability to self-monitor a potential interaction and seek 
professional advice if they are concerned  
 
Action required 
Having considered the previous steps to predict the ‘likelihood’ and ‘consequence’   
of an interaction, five actions are possible.  
• Avoid the new medicinal agent — the relatively high likelihood and/or 
severity of the consequence make it an unacceptable risk so an alternative 
treatment should be considered  
• Avoid unless adequate medical monitoring is possible — the relatively high 
likelihood and/or severity of the consequence may be acceptable if 
professional help is available to manage the outcome and supervise treatment. 
• Caution —the likelihood of an adverse effects is relatively lower and/or a 
more minor consequence is possible than the previous level making it an 
acceptable risk if patients are made aware of the possibility and seek 
professional advice if concerned. 
• Observe — there is a relatively low likelihood and/or negligible clinical 
consequence of a predicted interaction making it an acceptable risk     
• Prescribe — there is a relatively high likelihood of a beneficial consequence 
making the interaction clinically useful.  
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The evidence on herbal medicines safety is incomplete, complex, and confusing. 
Similar to pharmaceutical medicines, they are associated with both risks and benefits. 
As more people take herbal medicines, the pressure increases on healthcare 
professionals such as doctors and pharmacists to be well informed about the subject, 
and on researchers to fill the many and somewhat embarrassing gaps in our current 
knowledge (351). As Ernst points out, failing to do (and fund) this work would 
constitute the true risk associated with herbal medicines (351). 
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Chapter Two 
 
Patient and practitioner surveys: 
aims, research design, 
methodology and ethical 
considerations  
 
 
2.0 Introduction  
 
This chapter describes the aims and objectives of the patient and practitioner surveys, 
the research design and methodology used to perform surveys of surgical patients and 
practitioners in regards to their attitudes, perceptions and behaviours regarding CMs 
and CTs. The various locations, samples, sampling procedures and recruitment details 
are outlined. It also encompasses inclusion and exclusion criteria. Finally, this chapter 
details the methods of data collection and analysis, and ethical considerations that 
may impact on the study. 
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2.1 Aims and objectives of practitioner and patient surveys 
 
The main aim of the surveys is to determine how CMs used by surgical patients are 
managed in the hospital system by doctors and pharmacists and what patient and 
practitioner influences affect this management.   
 
The main objectives of the hospital doctors and pharmacist surveys were:  
 
• To establish whether a patient’s use of CMs is addressed in the work practices 
of hospital doctors and pharmacists 
• To examine the personal beliefs and attitudes of hospital doctors and 
pharmacists regarding CMs 
• To establish whether hospital doctors and pharmacists are familiar with the 
evidence supporting the use of CMs and the safety issues associated with the 
use of CMs 
• To identify learning needs and concerns regarding the use of CMs and CTs. 
 
The secondary objectives of these surveys were: 
 
• To examine the perceptions of hospital doctors and pharmacists to other CTs 
• To determine hospital doctors and pharmacists personal use of CMs and CTs 
and interest in future use 
• To explore the extent of integration of CTs into professional practice by 
hospital doctors and pharmacists and interest in future practise 
• To identify other CM-related issues that may be of relevance to medical and 
pharmacy practice and education  
 
The main objectives of the surgical patients’ surveys were: 
 
• To explore the prevalence and patterns of CMs use by surgical patients prior 
to surgery 
• To investigate whether CMs which are potentially harmful in the perioperative 
period are being used by surgical patients 
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• To explore whether surgical patients using CMs prior to surgery receive 
professional advice about use  
• To examine the personal beliefs and attitudes of surgical patients to CMs 
• To establish whether surgical patients would consider using diet, lifestyle and 
CTs if offered by hospitals  
 
The secondary objectives were: 
• To determine which information sources are used by surgical patients for 
information about CMs and CTs 
• To identify other CM-related issues that may be of relevance to surgical 
patients  
 
Patient and practitioner surveys were compared with the aim to: 
• identify communication barriers preventing patients and practitioners from 
discussing CMs - from both the patient and practitioner perspectives  
• explore differences in attitudes to CMs. between patients and practitioners 
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2.2 Research design 
 
The surveys performed attempted to describe the current situation in Victorian 
hospitals and provide baseline information from which future studies can be 
developed and compared.  
 
Questionnaires were considered to be an appropriate tool to collect data in the hospital 
because they allowed participants time to consider their responses and facilitated the 
exchange of potentially sensitive information which may not have been offered as 
readily using focus groups. It was also felt that information provided anonymously 
would encourage open disclosure without participant’s fear of being judged 
negatively. This was an important factor as surveys undertaken in the community had 
indicated that patients taking complementary medicines can be fearful of telling their 
general practitioner about use and it was not known whether the same reluctance to 
admit use to a health care researcher would be encountered in the hospital setting.   
 
There are several limitations of the survey method such as its lack of suitability for 
people who are illiterate, unable to comprehend the survey questions or who can not 
read or write English. These were not major factors in the health professional’s 
studies but were relevant in the patient’s studies. The impersonal nature of the study 
may have affected the response rates as people felt less compelled to participate than 
if asked directly by the researcher; however the surveys were disseminated by hand 
directly to potentially eligible participants, which was likely to help increase response 
rates. The range of responses from the questionnaires provided mainly categorical 
data and some descriptive, qualitative data. 
 
The surveys were conducted in three phases (see Figure 1).  
2.1.1. Phase 1 
 
In Phase 1, a survey was conducted with cardiac surgery inpatients at one hospital site 
before the larger survey in phase 2 in order to identify whether the methods of data 
collection used were effective and the survey tool would require modification to yield 
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further constructive data not adequately collected by the original survey.  Cardiac 
surgery patients were chosen as a sub-set of special interest to the researcher because 
there is a paucity of information in the international literature about this population in 
regards to CMs, some CMs have proven benefits in CVD (such as fish oils) (352), 
some are known or suspected to interact with drugs commonly used in CVD (353) 
and CVD is highly prevalent in the Western world.  
The study site, Cabrini Hospital Malvern, was chosen because it has two dedicated 
cardiac surgery wards, the attending cardiovascular surgeons expressed interest and 
support for the study and the Directors of Nursing and Surgery offered to provide 
trained staff for data collection, thereby maximising data collection efficiency.   
 
2.1.2. Phase 2 
 
In Phase 2, a survey was conducted of all eligible surgical patients admitted to two 
tertiary hospitals. This second survey was undertaken to maximise generalisability in 
the sample being surveyed by providing greater diversity in socioeconomic 
background. Cabrini and Frankston Hospitals were selected as potential survey sites 
after interviews with the Directors of Surgery indicated their hospitals would provide 
patients of different socioeconomic backgrounds. Selection of the two hospital sites 
was ultimately decided when the Director of Clinical Practice Improvement at 
Frankston Hospital and the Director of Nursing at Cabrini Hospital offered to provide 
trained staff to undertake data collection on the wards thereby maximising data 
collection efficiency. 
2.1.3. Phase 3 
 
Three separate surveys were conducted in Phase 3.  
 
The largest survey was conducted at Frankston Hospital and involved the complete 
medical and pharmacy staff. This provided information about the hospital staff 
responsible for taking medication histories, prescribing medication, and providing 
patients with drug information and counselling. Frankston Hospital was chosen as the 
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survey site for Phase 3 because of the interest shown by Directors of the Medical, 
Surgical and Clinical Improvement Departments. It was anticipated that this interest 
would provide a good response rate to the survey.  The data collected enabled 
comparisons to be made between sub-groups of health care professionals working 
within the same setting and comparisons with the other two practitioner surveys. By 
grouping data collected from the medical practitioners at this site, meaningful 
comparisons could also be made with surveys of GPs in the community.  
 
Two additional surveys were conducted to increase the reliability and generalisability 
of the results obtained. This involved increasing the number of study sites used for 
data collection thereby increasing the sample size and potentially, the diversity of 
participants. It was decided to focus on anaesthetists and pharmacists after a review of 
the published literature (see Chapter 1, section B) revealed that no surveys are 
available which have focussing on these sub-groups and their attitudes, perceptions, 
behaviours and knowledge of CM.  
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Study 
Literature 
review including 
5 systematic 
reviews 
Surgical patient 
surveys 
 
Phases 1 and 2 
Cardiac surgery 
patients Phase 1 
Surgical patients   
Phase 2 
Hospital doctors and 
pharmacist surveys 
 
Phase 3 
All hospital 
doctors and 
pharmacists 
at 1 site 
Anaesthetists 
at 3 sites 
Hospital 
pharmacists 
at 4 sites  
Figure 1. Outline of the research study 
 198 
2.3 Methodology used in conducting the surveys 
2.3.1 Settings 
 
Four Victorian hospitals were selected as sites for data collection: Cabrini Hospital 
(Malvern), Frankston, Austin and Alfred Hospitals.  
2.2.2.1. Frankston Hospital, Frankston 
 
Frankston Hospital is part of Peninsula Health and is a 300-bed public, teaching 
hospital and the major provider of acute secondary and tertiary hospital services on 
the Mornington Peninsula in Victoria. It services both metropolitan and semi-rural 
areas and provides general and specialty medical and surgical services.  
2.2.1.2.   Cabrini Hospital, Malvern 
 
Cabrini Hospital is a 460-bed private hospital in Melbourne with two cardiac wards.  
Although the hospital administrator and CEO does not collect demographic data about 
the hospital’s patients they are of the belief that patients attending this hospital will 
generally have higher education and higher income than those attending Frankston 
Hospital and the majority are English speakers.    
2.2.1.3.   Austin Hospital, Heidelberg 
 
Austin Hospital is one of three sites that form Austin Health. Austin Health has more 
than 840 beds and treats approximately 65,000 inpatients and 130,000 outpatients a 
year. The Austin Hospital is a major teaching public hospital located in Melbourne’s 
north eastern suburb of Heidelberg.  
2.2.1.4.   Alfred Hospital, Prahran 
 
The Alfred Hospital is one of three sites that form Bayside Health. It treats more than 
one quarter of a million patients annually. It provides the most comprehensive range 
of specialist medical and surgical services in Victoria and is located in Prahran which 
is in Melbourne’s inner south east.  
 199 
2.2.2. Populations studied 
 
Phase 1 and 2 of the surveys project involved surgical patients only.  
 
• Phase 1 : all eligible cardiac surgery patients admitted to Cabrini Hospital 
• Phase 2 : all eligible surgical patients admitted to Cabrini and Frankston Hospitals 
 
Phase 3 involved three different population samples working within the hospital 
setting. 
• A combined sample of surgeons, anaesthetists, medical physicians and 
pharmacists  
• Anaesthetists 
• Hospital pharmacists  
 
2.2.2.1. Inclusion and exclusion criteria for surgical patients 
 
Adult patients over 18 years of age and who were admitted to the surgical wards but 
had not yet undergone surgery, agreed to participate and were able to fill out the 
questionnaire unassisted, were included in the survey. Patients undergoing emergency 
surgical procedures were excluded from the survey.  
 
In Phase 1, patients who met the general inclusion criteria and who were admitted by 
cardiothoracic surgeons to the two cardiac wards at Cabrini Hospital over the period 
for data collection were included. These wards were 1 North and 1 South.  
 
In Phase 2, patients who met the general inclusion criteria and who were admitted to 
all surgical wards at Cabrini and Frankston Hospitals over the period for data 
collection were included. Wards where data collection had previously been 
undertaken were not included a second time. The inclusion/exclusion criteria aimed to 
maximise generalisability in the sample being surveyed by providing as much 
diversity as possible in age, gender and socioeconomic background.  
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2.2.2.2. Inclusion and exclusion criteria for hospital staff 
 
Both part-time and full-time hospital pharmacists, surgeons, physicians and 
anaesthetists were included in the survey, including registrars and pre-registrants. 
There was no age restriction. The inclusion/exclusion criteria aimed to maximise 
generalisability in the sample being surveyed by providing as much diversity as 
possible in age, experience and sub-specialties.  
 
Registrars were included because in the Australian medical system, after graduation, 
doctors generally practice within the hospital system before graduating to practice 
within the community. Therefore this period of training has an influence on 
community practise also. The number of years undertaken within the hospital system 
varies considerably depending on the doctor’s vocation. Following the initial one to 
two years, doctors may enter a training program in which they become known as a 
registrar. Upon successful completion of the program, the doctor is known as a 
consultant (e.g. medical physician, surgeon or anaesthetist) and becomes recognised 
as the Senior Medical Staff within the hospital system.  
 
Clinical pharmacists interact with patients on daily ward rounds, conduct medication 
reviews and counselling sessions, liaise with medical teams to advise on appropriate 
use of medicine and provide drug information for nurses, doctors and other 
pharmacists. As such, they were considered important inclusions in the survey. 
Graduate pharmacists have recently completed a pharmacy degree and have to work 
for twelve months before registration exams. Known as pre-registrants, these 
pharmacists provide a perspective from a younger generation and were also included. 
Drug information pharmacists investigate and advise on the more difficult drug 
related problems and are likely to have greater knowledge of CMs so were also 
included in the survey.  
2.2.3. Data collection 
 
Data collection proceedings were slightly different for surgical patients at Cabrini and 
Frankston Hospitals and described in 2.2.3.1. Data collection for doctors and 
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pharmacists was supervised by the Director of each relevant department and described 
in subsequent sections 2.2.3.2; 2.2.3.3; 2.2.3.4.  
 
2.2.3.1. Surgical patients surveys 
 
Phase 1 survey of cardiac surgery patients was conducted at Cabrini Hospital Malvern 
between September and December 2004. Trained nursing staff undertook data 
collection on the designated wards during their daytime shifts after patient admission 
by cardiothoracic surgeons. Each ward was provided with a written sheet outlining the 
aims of the study and inclusion and exclusion criteria for patients and trained charge 
nurses helped to supervise staff in data collection. Nursing staff was involved in 
screening patients for eligibility and offered the survey in blank envelopes to patients 
in their rooms. It was later collected by nursing staff at the end of each shift and 
placed into a designated box in the charge nurses office for safe storage. The 
researcher visited the hospital wards regularly to answer queries from nurses and 
collect completed surveys from the wards.  
 
Phase 2 survey of surgical patients was conducted at two sites: Cabrini Hospital, 
Malvern and Frankston Hospital, Frankston between July and November 2005. The 
same method of data collection was undertaken at Cabrini Hospital as had been 
previously used in the cardiac surgery patient survey.  At Frankston Hospital, a 
trained research assistant undertook data collection on the surgical wards during the 
daytime shift. Returned surveys were stored in the research assistant’s office until the 
study period ended. Regular email and telephone communication was maintained 
between the researcher and research assistant during this time. The Director of 
Clinical Practice Improvement supervised the research assistant on site.  
 
2.2.3.2. Anaesthetists survey 
 
Data collection was undertaken between March and May 2005 at three tertiary public 
hospitals (the Austin, Alfred and Frankston Hospitals) in Melbourne after approval 
was obtained from the Directors of Anaesthesia and Human Research Ethics 
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Committees at RMIT University and all hospital sites. Cabrini Hospital was not 
included as a study site because it has no department of anaesthesia.  
 
The anonymous, self-administered questionnaire was distributed by the department 
administration staff to all anaesthetists listed on department registers as working at the 
site at the time of the study. Anaesthetist’s not directly involved in patient care were 
asked to omit questions about patient communication. Over the following three 
months, non-responders were reminded at least twice to complete the survey. No 
inducements to participate were provided. Completed surveys were returned to the 
department and stored in their administration offices. The researcher maintained 
regular email and telephone contact with the data collection supervisor and sites were 
visited each month to collect completed surveys.  
 
2.2.3.3. Pharmacists survey 
 
The survey was conducted at four tertiary hospitals (the Austin, Alfred, Frankston and 
Cabrini Hospitals) in Melbourne between August 2004 and May 2005, after approval 
was obtained from the Directors of all Pharmacy departments and Human Research 
Ethics Committees at RMIT and all sites. The anonymous, self-administered 
questionnaire was distributed by Directors and/or a specified staff member to all 
pharmacists listed on department registers as working at the site at the time of the 
study. Pharmacists not directly involved in patient care were asked to omit questions 
about patient communication. Each site was given three months to complete the 
survey and over this period, non-responders were reminded at least twice. No 
inducements to participate were provided. Completed surveys were returned to the 
department and stored in their administration offices. The researcher maintained 
regular email and telephone contact with the data collection supervisor and sites were 
visited each month to collect completed surveys.  
 
2.2.3.4. Combined health professionals survey  
 
The survey was conducted between December 2004 and April 2005 at Frankston 
Hospital after approval was obtained from the Directors of Surgery, Medicine, 
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Anaesthesia and Clinical Practice Improvement and the Human Research Ethics 
Committees at RMIT University and Peninsula Health.  
  
The anonymous, self-administered questionnaire was distributed to all hospital 
doctors and pharmacists listed on department registers as working at the site at the 
time of the study and who had not yet completed the survey from previous studies. 
The Director of Clinical Practice Improvement co-ordinated data collection with each 
department. Doctors and pharmacists not directly involved in patient care were asked 
to omit questions about patient communication. Non-responders were reminded at 
least twice to complete the survey during the study period. No inducements to 
participate were provided. Completed surveys were returned to the Department of 
Clinical Practice Improvement and stored in administration offices. The researcher 
maintained regular email and telephone contact with the data collection supervisor 
and the site was visited each month to collect completed surveys.  
 
2.2.4. Survey tools  
 
The main instruments for data gathering were the self-administered and structured 
questionnaires (see Appendix  A,B,C).  
 
Three different questionnaires were used. The survey used in Phase 1 for cardiac 
surgery patients was slightly modified for use in Phase 2. The survey used for the 
three health professional’s studies remained unchanged for the duration of the project.   
 
All questionnaires were developed after systematic review of published studies (see 
Chapter 1 sections B, C, D) relating to the field of CMs. A consideration of this data 
helped enhance reliability and validity of the study. However, new items were 
required to capture additional information relevant to the projects aims. This became 
clear after conducting systemic reviews and face to face interviews about the 
proposed study design with the Directors of Pharmacy, Surgery, Anaesthesia and 
Clinical Practice Improvement. Many of the potential new items for the instrument 
were generated from these interviews. 
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Once drafts of the initial patient and practitioner questionnaires were developed, 
another series of in depth, face to face interviews with the Directors of Pharmacy, 
Surgery, Anaesthesia and Clinical Practice Improvement were conducted. 
Modifications to the questionnaire were made based on their feedback. Input was also 
sought from an experienced statistician, marketing consultant and the Director of 
Nursing at Cabrini Hospital who made recommendations and amendments to the 
initial questionnaire drafts. All Directors gave permission for the researcher to 
proceed with the survey and it was ascertained that ethics approval would be required 
from the hospitals before the surveys could be conducted. 
 
Following this, both questionnaires were then pre-tested with a small group of 
hospital staff and lay persons who provided extensive feedback. A preliminary pilot 
test of the patient surveys was then conducted with three health care consumers (who 
were not included in the survey sample) who vetted any inappropriate, sensitive or 
ambiguous questions. A preliminary pilot test of the health professionals survey by an 
experienced anaesthetist, physician, surgeon, pharmacist and marketing consultant 
(who were not included in the survey sample) vetted any inappropriate, sensitive or 
ambiguous questions. They also evaluated the content of the questionnaire to help 
assess consistency and accuracy. The surveys were then re-drafted with a few minor 
changes made to the questionnaires before proceeding with the study. 
 
Whilst these steps ensured the survey questions had face validity, a further formal 
validation process would have been valuable. Nevertheless, achieving high response 
rates provide confidence in the findings.   
 
2.2.4.1. Cardiac surgery patient survey 
 
Surveys identified in the literature search were used as a basis for the design and 
development of the patient surveys. The final questionnaire consisted of 25 questions 
with a range of multiple choice and multiple response questions and regular 
opportunities for respondents to provide additional comments in free text. Both closed 
and open ended questions were also used to collect more accurate data. Surveys did 
not collect participant names or addresses to encourage objective responses to 
potentially sensitive questions. Patient information about the study and consent details 
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were clearly stated on the first page.  Also on the first page was a definition of the 
phrase ‘complementary medicines’. This was defined as herbal medicines, vitamin 
and mineral supplements and food supplements which can be bought in a 
supermarket, pharmacy, health-food store, on the internet, from a mail order company 
or from a practitioner. It was stated that this did not refer to therapies such as 
massage, acupuncture or chiropractic. The survey had five general sections and asked 
about the following: characteristics of respondents, behaviours, perceptions and 
attitudes regarding CMs and interest in CTs.  
 
Seven questions provided data about respondent’s age, gender, education, country of 
birth, smoking status, income and confirmation that they were a surgical patient. Two 
further questions asked respondents about their use of prescription medicines and 
CMs in the 2 weeks prior to admission. Patients reporting no use of CMs were 
instructed to omit further questions pertaining to use and continue with the final 
questions regarding perceptions of CM safety, information sources and interest in 
CTs. If patients answered affirmatively to CMs use, they completed all questions in 
the remainder of the questionnaire. This included the name and number of CMs taken, 
reasons for use, intention to continue use in hospital and whether hospital doctors, 
staff or their general practitioner had been informed about use. Respondents were 
asked whether CMs were self-prescribed or prescribed by a health practitioner, their 
monthly spend on CMs, sources of information used regarding CMs and reasons for 
non-disclosure whilst in hospital (where relevant). The final question asked all 
respondents whether they would consider using a range of diet, lifestyle or CM 
therapies if offered by hospitals and to nominate which ones were of interest from a 
list of 16 therapies. An opportunity was provided for respondents to suggest other 
therapies not included in the list. The question did not state whether these would be 
offered as inpatient or outpatient services our how the services would be funded. 
 
2.2.4.2 General surgery patient survey 
 
Due to feedback from nurses and analysis of patient responses from the cardiac 
surgery survey, the initial survey was modified in order to provide more in depth 
information about patient attitudes and use of CMs and promote a higher response 
rate (See Appendix B). .In summary, these changes were: the deletion of 2 questions 
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considered irrelevant, changed positioning of several questions to encourage better 
response rates, integrating 2 questions into one with a new question/answer format for 
easier patient use and the addition of 2 new questions to gather more information 
about patient attitudes.  
 
A letter was sent to the HREC at Cabrini to notify them of the changes and seek 
approval for use of the new survey. Appendix G provides further details of the 
modifications made to the cardiac surgery patient survey.  
 
2.2.4.3 Health professionals survey 
 
Four studies were used as a basis for the design and development of the practitioner 
surveys (121;165;166;354). The final version consisted of 23 questions which 
included multiple choice and multiple response questions and regular opportunities 
for respondents to provide additional comments in free text (See Appendix C). Both 
closed and open ended questions were also used to collect more accurate data. 
Surveys did not collect participant names or addresses to encourage objective 
responses to potentially sensitive questions. Information about the study and consent 
details were clearly stated on the first page.   
 
On the first page, the phrase ‘complementary medicines’ was defined as: ”herbal 
medicines, vitamin and mineral supplements and food supplements which can be 
bought in a supermarket, pharmacy, health-food store, on the internet, from a mail 
order company or from a practitioner”. It was stated that this did not refer to therapies 
such as massage, acupuncture or chiropractic unless specified. Only respondents 
directly involved in patient care were asked to respond to all questions whereas those 
not directly involved in patients were asked to omit questions regarding patient 
communication. The survey had six general sections and asked about the following: 
characteristics of respondents, behaviours, perceptions, attitudes, confidence and 
knowledge of CMs.  
 
Seven questions provided data about respondent’s age, gender, years in practice, 
position in the hospital, if directly involved in patient care, average number of patients 
seen each week and previous training received about CM.  Seven questions asked 
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respondents about their behaviours. Four of the seven questions specifically asked 
about patient and staff communication and included: frequency of enquiry about 
patients use of CMs, reasons for not asking patients about use, advice given to CM-
users and methods of communication about CMs use with other staff. These were 
included to identify current practice and some of the barriers which exist to prevent 
patient communication about CMs. Two of the seven questions collected data about 
respondents information seeking habits and information sources used for CM-related 
queries. One further question asked about their personal use of CMs and CTs and 
asked about use in the previous 12 months and interest in future use. Three questions 
asked about their perceptions of patients use of CMs prior to and after admission and 
the potential usefulness and harmfulness of 15 CTs available in Australia, as 
identified by Pirrotta et al (165). Attitudes to CMs were assessed using a 5-point 
Likert scale (strongly agree = 1, unsure = 3, strongly disagree = 5) which was 
applied to 5 attitudinal statements in a multi-part question. A maximum score of 25 
was possible indicating a highly negative attitude and a minimum score of 5 
indicating a positive attitude. One question asked respondents how they would 
generally respond if a patient asked whether they should use, or consult a practitioner 
of a specific CT. Four possible responses were provided and applied to 15 CTs: not 
confident to discuss the advantage or disadvantages with patients, actively encourage, 
actively discourage, or neither encourage or discourage. This question was included in 
order to get a deeper understanding of respondent’s attitudes to CTs and their 
confidence when dealing with CM-related issues. One further question was included 
regarding confidence, asking respondents about their confidence in detecting possible 
safety issues arising from patient use of CMs. Three studies were used as a basis for 
the knowledge section of the questionnaire (178;192;355). Multiple response 
questions were used to assess respondent’s knowledge of the efficacy and/or safety of 
11 OTC CMs. These were: chamomile, coenzyme Q 10, echinacea, ginger, garlic, 
ginkgo, glucosamine, fish oils, St John’s wort, valerian, vitamin E. The eleven CMs 
were chosen after a review of the literature and discussion with staff at a major 
Australian CMs manufacturing company indicating they are widely used by the 
general community (356) and/or have the potential to induce adverse events of 
relevance to the surgical patient. Respondents were asked to match the listed 
properties to the listed CMs and were advised they could provide multiple responses 
if appropriate or tick a box indicating they were unsure of the answer. The ‘unsure’ 
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box was included to minimize the chance of respondents guessing. These properties 
were : ‘has potential to increase bleeding, exert sedative activity, interact with 
warfarin, digoxin, selective serotonin re-uptake inhibitor (SSRI) drugs and/or 
cyclosporine, proven efficacy’.  Definitions of the terms used in this section were not 
provided. On May 20, 2005 AltMedDex database from Micromedex was used to 
obtain answers to the knowledge section (357). It is a comprehensive electronic 
resource on drugs and CMs available at all public hospital sites participating in the 
study. According to this source, participants needed to mark 21 individual boxes to 
attain a score of 100%.  
2.2.5 Statistics 
 
The data was analysed using descriptive statistics via frequency distributions and 
cross-tabulations. In addition, sub-group analyses were performed to detect any 
interesting patterns in the responses among the various populations/patients.  
 
Data was analysed using the software program SPSS 13.0 (Statistical Package for the 
Social Sciences) using descriptive statistics along with Chi-square tests to analyse 
categorical variables and ANOVA and paired t-test and Pearson r correlations to 
analyse continuous variables. P values of less than 0.05 were considered significant.  
 
2.2.6 Ethics  
 
 The study required consultation with the Directors of Surgery, Medicine, Anaesthesia 
and Pharmacy in each participating hospital to ensure permission and support. At 
Cabrini Hospital, consultation with the Director of Nursing was also conducted.  
Applications were made to the HRECs of RMIT, Frankston, Austin, Alfred and 
Cabrini Hospitals and approval was granted from all sites (see Appendix F). 
 
 In order to ensure the questions were non-judgemental, pre-testing was undertaken. 
Recruitment for the survey was at the discretion of the Directors of each department 
and was voluntary. The names and addresses of individuals were not recorded in the 
survey, coding of the questionnaire did not link participants to their responses and 
participants were not and will not be identified in published data. Completed surveys 
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and all data was stored in a secure location in the researchers home office and only the 
researcher and supervisor have access to the data encrypted onto storage hardware.  
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Chapter Three 
 
Results from patient and practitioner 
surveys  
  
3.0 Introduction 
 
This chapter presents results from the five studies conducted as part of this research 
project. It has been divided into five separate sections for ease of use and will present 
the results of each study individually. 
 
Section 3.1 presents results from the anaesthetists study followed by Section 3.2 
which presents results from the pharmacists study and finally Section 3.3 which 
presents results from the combined doctor/pharmacist study at Frankston Hospital. 
Results from the CS patient study and surgical patient study will be presented in 
Sections 3.4 and 3.5 respectively.  
 
The complete raw data for all the survey results are presented in Appendix E. 
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3.1 Anaesthetists survey 
 
Ninety seven completed questionnaires were received (61% response rate).  
3.1.1 Sample characteristics 
 
Respondent’s average age was 39.8 years (SD 8.6), 88% were male and 96% saw up 
to 50 patients each week. All were directly involved in patient care. The response 
group was made up of 67.5 % senior anaesthetists, 26.2% registrars and 6.2% trainees 
whereas the non-response group was made up of 63.0% senior anaesthetists, 26.0% 
registrars and 10.8% trainees. 
3.1.2 Communication with patients and other staff 
 
Table 1 presents data about the frequency with which anaesthetists asked patients 
about use of CMs. There was no significant difference between respondents aged less 
than 40 years compared to those over 40 years with regards to this enquiry 
(F(1,93)=1.99, p=.162). Two people commented that use of CMs is generally written 
on the pre-admission form. Anaesthetists reported multiple reasons for not routinely 
asking patients about CMs including forgetting to ask (53.5%), assuming the patient 
would tell them (34%), ‘I don’t have sufficient knowledge about it’ (34%), not 
thinking the information was relevant (22%), it’s too time consuming (13%) and not 
having the opportunity to ask (2%).  
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Table 1. Frequency of patient enquiry, confidence in personal knowledge and use of 
resources. 
 
Data are presented as n(%) 
 
The advice given to patients taking CMs is presented in Table 2.  One respondent 
commented that they advised patients to stop taking “the ones beginning with ‘g’ 
because they cause bleeding”, another commented “any with anticoagulant action”, 
and a third “any they cannot name the ingredients of”. Two people commented that it 
was too late for them to advise patients about CM use because “I usually see them on 
the day of surgery”.  
 
 
 
 
 
 
 
 
 
 
How often do you 
ask patients about 
use of CMs ? 
How often do you 
feel confident that 
you have sufficient 
knowledge to 
identify when CMs 
could adversely 
affect patient care? 
How often do you 
check for side 
effects and drug 
interactions if CMs 
are being use? 
 
Always or often 
8(10) 12(15) 9(11) 
  
Sometimes 
13(16) 35(45) 20(26) 
  
Occasionally 
17(21) 15(19) 13(17) 
  
Rarely or never 
43(53) 16(21) 36(46) 
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Table 2. Advice given to patients identified as using CM products 
 
What advice do you generally give to patients 
taking CMs?  
n(%) 
Cease taking all CMs 18(20) 
Cease taking specific CMs 41(45) 
I don't feel confident to advise on CMs use 28(31) 
Consult another health care practitioner about CMs 9(10) 
Keep taking all CMs 3(30) 
 
Data are presented as n(%) 
 
Multiple answers were received to the question “ If you do ask patients about use, 
what do you do with this information?” 78% recorded this information in the patient’s 
history, 6% on the patients medication chart, 28% verbally informed the relevant 
surgeon or physician, 1.5% told another health care professional (e.g. pharmacist) and 
16% did not record the information anywhere.   
 
When asked to estimate the percentage of patients taking CMs in the 2 weeks prior to 
admission, 76% thought usage was less than 40%. Post-admission, it was perceived 
by 93% that patient usage had reduced to less than 25%. 
 
3.1.3 Confidence in dealing with CM-related issues 
 
When patient’s use of CMs was identified, 15% of respondents always or often felt 
confident that they had sufficient knowledge to identify when use could adversely 
affect patient care. More data is presented in Table 1. Those who were more 
confident about CM related issues were significantly more likely to ask patients about 
possible use of CMs (r=-.429, p<.001).  
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3.1.4 Use of information resources 
 
 
 
Most respondents (89%) did not routinely check for side effects and drug interactions 
if patient use was identified (Table 1).  Resources used for information about CMs 
and CTs were peer-reviewed medical journals (used by 58%), databases such as 
Medline (49%), the internet (41%), colleagues (37%), seminars (35%), reference texts 
such as MIMs (31%) and 12% referred to pharmacists. Respondents who check for 
side effects are significantly more likely to attain greater knowledge scores than those 
that reported doing this rarely or never (r=-.275, p=.007). 
 
3.1.5 Attitudes to CMs and CTs 
 
The mean attitude score was 18.87 (SD2.22) indicating a moderately negative attitude 
to CMs (5 considered positive and 25 negative).  Responses to attitudinal statements 
about CMs are presented in Table 3. Notably, there was widespread agreement with 
the statements “CMs need more hospital based research” and “Regulations for CM 
practitioners need to be tightened”.  Figures 1 and 2 presents respondent’s 
perceptions of the potential usefulness and harmfulness of CTs.  Most respondents 
perceived chiropractic as potentially harmful followed by Chinese herbal medicine 
and herbal medicine. Nearly all respondents thought acupuncture was potentially 
useful with many also reporting hypnosis, massage, meditation and yoga as 
potentially useful. Figure 3 presents perceptions of usefulness and harmfulness on the 
same graph, for ease of comparison with the other practitioner studies. Figure 4 
presents respondents general advice given to patients enquiring about CTs. 
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Data presented as n(% of the total number of respondents for that statement) 
Responses  
Attitudinal statements 
 
SA 
 
A 
 
NAD 
 
D 
 
SD 
CMs are appropriate for use in the 
hospital setting  
2(2) 13(13) 41(42) 34(35) 9(9) 
CMs are generally a waste of time 
and money  
13 (13) 41(40) 23(24) 18(19) 2(2) 
CMs are potentially dangerous and 
need to be monitored  
12(12) 65(67) 16(16) 3(3) 1(1) 
CMs offer a false sense of hope and 
exploit vulnerable individuals  
11(11) 40(41) 25(26) 
 
17(17) 4(4) 
CMs offer patients cost effective 
treatment options  
1(1) 9(9) 23(24) 51(53) 13(13) 
CMs need more hospital based 
research  
42(43) 46(47) 6(6) 2(2) 1(1) 
CMs are something that most of my 
colleagues would consider  
0(0) 8(8) 28(29) 51(53) 9(9) 
Regulations for CM practitioners 
need to be tightened  
36(37) 48(49) 11(11) 1(1) 1(1) 
SA= strongly agree; A=agree; NAD=neither agree or disagree; D=disagree; SD=strongly disagree 
Table 3. Responses to attitudinal statements  
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Figure 1. Anaesthetists perceptions of the potential harmfulness of CTs 
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Perceptions of usefulness of CTs
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Figure 2. Anaesthetists perceptions of the potential usefulness of CTs 
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Figure 3. Anaesthetists perceptions of the potential usefulness and harmfulness of CTs, presented together 
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General responses to patients interest in using CTs
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Figure 4. Anaesthetists response to patients enquiry about CTs. 
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3.1.6 Personal use and practise of CTs 
  
Vitamin and mineral supplements had been taken by 10% of anaesthetists within the 
previous 12 months and 4% had taken herbal medicines. The most commonly used 
CMs were fish oils supplements, multivitamins, glucosamine, vitamin C and garlic. In 
regards to CTs, non-medicinal therapies were most popular chiefly massage (21%). 
When asked which CT they would like to receive in future, 66% were interested in 
massage, 61% acupuncture, 61% meditation, 60% yoga, 37% hypnosis and 33% 
vitamin/mineral therapy whereas 20% or fewer were interested in other CTs. Very 
few respondents were already practising a CT however there was interest in practising 
some CTs in the future, notably acupuncture (Figure 5).  
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Figure 5. CTs anaesthetists have practised and would consider practising 
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3.1.7 Training and knowledge 
 
No formal training about CM had been received by 49% of the sample. Post-graduate 
lectures had been attended by 27%, under-graduate lectures by 9%, specific seminars 
by 8% whereas 27% had undertaken self-directed learning. A total of 69% were 
interested in further training about CMs and CTs.  
 
Anaesthetists achieved a mean score of 20.08 (SD 15.95) out of a possible 100 in the 
knowledge section. When knowledge scores were compared between the three sites, 
no significant differences were found (F(2,96)=.578, p=.563) demonstrating the 
remarkable consistency of the results. No significant difference in knowledge scores 
was found between respondents aged less than 40 years compared to those older than 
40 years (t(93)=1.64).  
 
Participants who reported greater confidence in their ability to identify potential 
safety issues relating to CMs tended to achieve higher knowledge scores ( r=-.429, 
p<.001) and those with higher knowledge scores tended to ask patients about their 
potential CMs use more frequently ( r=-.303, p=.003) and were more likely to check 
for side effects and drug interactions when patient use was identified (r=-.275, 
p=.007). Seventy four respondents attempted the question about which CMs may 
increase bleeding (see Table 4). According to AltMedDex from Micromedex 
database, the correct answers were : garlic, ginkgo biloba, ginger and fish oils. Further 
details of results from the knowledge section are presented in Appendix E.  
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Table 4. Responses to question about which CMs may increase bleeding. 
 
 
 CMs listed  Respondents who 
marked this response 
n(%) 
Garlic 59(79.7) 
Ginkgo biloba 53(71.6) 
Ginger 42(56.8) 
Fish oils 6(8.1) 
Vitamin E 4(5.4) 
Chamomile 4(5.4) 
Echinacea 5(6.8) 
Valerian 3(4.1) 
Glucosamine 2(2.7) 
Coenzyme Q10 2(2.7) 
St Johns wort 14(18.9) 
CMs which may 
increase the risk of 
bleeding ? 
Total 74(100.0) 
Data presented as n (% of the total number of respondents to that question) 
 
 
In regards to their opinion about the importance of CM education to be included in the 
medical undergraduate curriculum, 29.2% thought it was very important, 61.5% 
thought it was somewhat important and 9.4% thought it was not important.  
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3.2 Hospital Pharmacists survey 
 
Surveys were distributed to 140 pharmacists with 107 returning completed 
questionnaires (response rate 76%).  
 
3.2.1 Sample characteristics 
 
The majority of respondents were women (78%) and pharmacists directly involved in 
patient care (82%). Respondents mean age was 34.9 years (SD 12.3), mean number of 
years in practice was 12.4 years (SD 11.9) and mean number of patients seen each 
week was 72 (SD 97). The study sample shares age and gender characteristics with 
the National Pharmacy labour force (358).  
 
3.2.2 Pharmacists communication with patients and staff 
 
Table 1 presents data on the frequency with which pharmacists ask patients about use 
of CMs, their confidence in identifying potentially unsafe outcomes relating to CM 
use and the frequency of using resources to check for potential safety issues.  There 
was a significant difference in the frequency of asking patients about CM use between 
age groups with younger pharmacists (under 25 years of age) significantly more likely 
to enquire than older pharmacists (35 years and older) (t(39.10)=4.08, p<0.001). 
There was no significant relationship between knowledge scores and frequency of 
enquiry(r=-.087, p=.417) or how often respondents checked for side effects and drug 
interactions and frequency of enquiry (r=-.144, p=.187). 
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Table 1. Frequency of patient enquiry, pharmacist’s confidence and use of resources 
 
 
Data presented as n(% of the total number of respondents for that question) 
 
The main reasons pharmacists reported for not asking patients about CMs were 
forgetting to ask (58%), assuming patients will tell without being asked (27%), not 
having the opportunity (23%), not having sufficient knowledge (22%), not thinking it 
relevant (22%) or because it was ‘too time consuming’ (17%). If patient use of CMs 
was identified, 53% of pharmacists generally advised patients to cease taking specific 
CMs, 35% recommended they consult another healthcare practitioner for advice about 
them, 24% didn’t feel confident to advise patients about use, 9% advised to keep 
taking all CMs (9%), 7% advised to cease all CMs. Thirteen respondents added 
comments in free text expressing concerns about interactions and three others stated 
that hospital protocol advises them to tell patients to stop using all CMs.   
 
 
 
How often do you 
ask patients about 
use of CMs ? 
How often do you 
feel confident that 
you have sufficient 
knowledge to 
identify when CMs 
could adversely 
affect patient care? 
How often do you 
check for side 
effects and drug 
interactions if CMs 
are being use? 
Always  26(29) 3(3) 21(24) 
Often ( more than 60% of 
the time)  
23(26) 20(23) 18(21) 
 Sometimes 14(16) 34(39) 28(33) 
 Occasionally 11(12) 22(25) 14(16) 
 Rarely (less than 5% of the 
time) 
9(10) 7(8) 5(6) 
Never  6(7) 1(1) 0(0) 
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Of those who asked patients about CMs, 59% stated they recorded usage information 
in the patient history, 28% recorded the information in the patients medication chart 
and 3% did not record the information. Some (29%) verbally informed the relevant 
surgeon, anaesthetist or physician and 28% verbally informed other healthcare 
professionals such as a dietician or other pharmacist. The advice given to patients 
using CMs is presented in Table 2.  
 
Table 2. Advice given to patients identified as using CMs. 
What advice do you generally give to patients 
taking CMs?  
n(%) 
Cease taking all CMs 6(7) 
Cease taking specific CMs 43(53) 
I don't feel confident to advise on CMs use 19(24) 
Consult another health care practitioner about CMs 28(35) 
Keep taking all CMs 7(9) 
Data are presented as n(%) where the % is the  percentage of the total number of 
respondents 
 
Most (77%) respondents thought that less than 40% of patients used CMs in the 2 
weeks prior to admission and nearly all (92%) respondents thought patients usage 
reduced to less than 25% whilst in hospital.  
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3.2.3 Pharmacists attitudes towards CMs 
 
Responses to attitudinal statements about CMs are presented in Table 3 and indicate 
pharmacists are concerned about safety, efficacy, regulatory and cost issues associated 
with CMs. The mean attitude score was 18.6 (SD2.18) which can be considered 
moderately negative (a score of 5 was considered positive and 25 considered 
negative). Notably, 87% of respondents agreed with the statement that CMs are 
potentially dangerous and need to be monitored, 88% agreed that CMs required more 
hospital based research and 92% agreed that CM practitioners required tighter  
regulation.  
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Table 3. Responses to attitudinal statements.  
 
Data presented as n(% of the total number of respondents for that statement) 
 
 
3.2.4 Training, information sources and knowledge  
 
Some pharmacists (62%) had received training about CMs and CTs and 83% were 
interested in receiving further training. Undergraduate lectures were the main source 
of education (45%) followed by self-directed learning (24%), specific 
lectures/seminars (16%) and/or post-graduate lectures (10%) whereas 2% had 
undertaken formal study of a certificate, diploma or degree in CM. All respondents 
reported referring to resources for information about CMs and CTs. The most popular 
sources of information were databases such as Medline (67%), reference texts (65%), 
Responses  
Attitudinal statements 
 
SA 
 
A 
 
NAD 
 
D 
 
SD 
CMs are appropriate for use in the 
hospital setting  
4 (4) 22(21) 38(37) 35(34) 5(5) 
CMs are generally a waste of time and 
money  
3(3) 32(31) 30(29) 38(36) 2(2) 
CMs are potentially dangerous and need 
to be monitored  
22(21) 71(66) 11(10) 3(3) 0(0) 
CMs offer a false sense of hope and 
exploit vulnerable individuals  
8(8) 35(33) 41(39) 21(20) 0(0) 
CMs offer patients cost effective 
treatment options  
1(1) 13(13) 28(27) 51(49) 11(11) 
CMs need more hospital based research  45(43) 48(45) 10(9) 1(1) 2(2) 
CMs are something that most of my 
colleagues would consider  
2(2) 15(14) 45(43) 36(35) 6(6) 
Regulations for CM practitioners need to 
be tightened  
42(40) 55(52) 8(8) 1(1) 0(0) 
SA= strongly agree; A=agree; NAD=neither agree or disagree; D=disagree; SD=strongly disagree 
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the World Wide Web (59%), colleagues (39%), peer-reviewed journals (38%), 
company literature (32%), seminars/conferences/lectures (30%), CM practitioners 
(15%), family and friends (10%).  
 
The knowledge section of the survey was attempted by 95% of respondents (n=102) 
who had a mean score was 39.9 (SD 19.9) out of a possible 100. Those that reported 
feeling confident more frequently in their knowledge of CMs safety were significantly 
more likely to attain greater knowledge scores (r=-.429, p<.001). There was no 
significant relationship between knowledge scores and age (r=-.09, p=.393), how 
often respondents asked patients about CMs (r=-.087, p=.417) or how often 
respondents checked for side effects and drug interactions (r=-.144, p=.187).  
3.2.5 Patterns of personal use and perceptions about CTs  
 
The CTs most commonly used by respondents in the previous 12 months were 
vitamin and mineral therapy (27%) and massage (26%) and to a lesser extent, Chinese 
medicine (10%), yoga (10%), herbal medicine (9%) and spiritual healing (9%). Over 
50% of respondents would consider receiving treatment with a range of CTs in the 
future. In order of popularity, these were: massage (64%), meditation (60%), 
vitamin/mineral therapy (51%), acupuncture (51%), yoga (50%), aromatherapy 
(40%), herbal medicine (39%), chiropractic (37%), Chinese herbal medicine (32%), 
osteopathy (28%), naturopathy (20%) and reflexology (20%).  Few pharmacists have 
personal experience practicing any CT, however there is interest in practicing 
vitamin/mineral therapy by nearly 35%, herbal medicine by over 25% and massage by 
approximately 20% (Figure 1).   
 
Figure 2 presents pharmacist’s perceptions of the potential usefulness and 
harmfulness of 15 CTs. Notably, acupuncture, massage, vitamin/mineral therapy, 
yoga, meditation, chiropractic, Chinese herbal medicine, herbal medicine  were 
considered useful by at least 70% of respondents and homeopathy was considered 
least useful by the majority of respondents. Despite most respondents perceiving 
herbal medicine, Chinese herbal medicine and chiropractic as potentially useful, they 
were also considered potentially harmful whereas meditation, reflexology and 
spiritual healing were not widely considered potentially harmful. If a patient were to 
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ask whether they should use CTs or consult a CM practitioner, more pharmacists 
encourage the use of massage and the least encourage the use of hypnosis, 
homeopathy, naturopathy and spiritual healing whereas homeopathy is the most 
discouraged CT (Figure 3).  
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Figure 1. CTs pharmacists have practised and would consider practising in the future 
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Perceptions of usefulness and harmfulness of CTs
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Figure 2. Pharmacist’s perceptions of the potential usefulness and harmfulness of 15 CTs  
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Pharmacists response to patients enquiring about CTs
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Figure 3. Pharmacists responses when patients enquire about CTs.  
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3.3 Combined Health Professionals survey – Frankston 
Hospital 
 
A total of 158 Frankston hospital staff met the inclusion criteria with 127 participating 
(response 80.4%).  
 
3.3.1 Sample characteristics 
 
There were significantly more males than females (t(126)=33.51, p<.001) in the 
sample. The majority of medical staff was made up of males (89.7%) in contrast with 
the pharmacy group who were predominantly female (75.0%). The mean age of 
respondents was 44.59 years (SD10.20) however there was a significant difference in 
age (t(123)=42.78, p<.001). Pharmacists were the youngest group with a mean age of 
39.00 yrs (SD16.76) and surgeons the oldest at 48.53 years (SD10.21). Within each 
group, the pharmacy group had the widest age variation, most likely due to the 
inclusion of a small group of pharmacy pre-registrants. There was also a significant 
difference in the number of years respondents had been in practice (t(121)=16.69, 
p<.001) and a significant difference in the average number of patients seen each week 
(t(115)=15.97, p<.001). For the complete sample, the mean number of years in 
practice was 18.98 years (SD12.56) with medical physicians having spent the most 
years in practice at 20.72 years (SD12.18) compared with pharmacists at 17.56 years 
(SD16.6). The mean number of patient seen each week was 53.33 (SD35.96) with 
surgeons seeing the most patients (mean 63.28 SD 31.89) and pharmacists the least 
(mean 45.60 SD23.97). Further sample characteristics are presented in Figure 1. 
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3.3.2 Communication and advice given to patients 
 
As seen in Table 1, only 10% of respondents reported always asking patients about 
use of CMs. When individual groups were compared, no significant difference was 
found between them in regards to how often they asked patients about CMs 
(F(3,116)=2.34, p=.077). No significant difference was also found between medical 
staff and hospital pharmacists in the frequency of asking patients about use 
(F(1,118)=1.97, p=.163). There was a significant difference between age groups in 
how often patients were asked about their CM use (F(5,111)=2.68, p=.025).  
Respondents less than 40 years of age were more likely to ask patients about CMs 
than older respondents.  
 
 
 
 
 
 
 
Figure 1. Respondent’s role in the hospital 
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Table 1. Frequency of asking patients about CMs 
Data presented as n(% of the total number of respondents for that question) 
 
The most common reasons reported for not asking patients about use of CMs were 
that they forget to ask 43.9%,  don’t think it is relevant 37.8%,  and/or don’t have 
sufficient knowledge anout it to ask 33.7% (Table 2). Comparison between the 
groups reveals that for all groups except the surgeons, forgetting to ask was the most 
common reason given. For the surgeons, 54.2% stated they didn’t have sufficient 
knowledge and/or didn’t think it was relevant (45.8%). If respondents did ask patients 
about CM use, most (80.0%) recorded the information in the patient history or 
inpatient chart (Table 3).  
 
 
Position 
Do you ask 
patients about 
use of CMs ? 
  
  
Anaesthetist 
(incl. 
registrars) 
Physician/ 
Specialist Surgeon 
All medical 
staff 
Hospital 
pharmacist 
(incl. pre-
registrants 
and 
students) Total 
 
Always 
 
1(5.6) 6(10.9) 3(9.4) 10(9.5) 2(13.3) 12(10.0) 
  
Often (more than 
60% of the time) 2(11.1) 5(9.1) 1(3.1) 8(7.6) 1(6.7) 9(7.5) 
  
Sometimes  
(30%-59%) 0(0.0) 16(29.1) 3(9.4) 19(18.1) 5(33.3) 24(20.0) 
  
Occasionally 
 (5%-29%) 5(27.8) 11(20.0) 11(34.4) 27(25.7) 4(26.7) 31(25.8) 
  
Rarely  
(less than 5%) 7(38.9) 12(21.8) 10(31.3) 29(27.6) 3(20.0) 32(26.7) 
  
Never 3(16.7) 5(9.1) 4(12.5) 12(11.4) 0(0.0) 12(10.00 
  
Total 18(100.0) 55(100.0) 32(100.0) 105(100.0) 15(100.0) 120(100.0) 
 237 
 
 
Data presented as n(% of the total number of respondents for that question) 
Position 
Reasons for 
not asking 
patients about 
CMs  
 
Anaesthetist 
(incl. 
registrars) 
Physician/ 
Specialist Surgeon 
All medical 
staff 
Hospital 
pharmacist 
(incl. pre-
registrants 
and 
students) Total 
 
I assume 
patients will tell 
me 
4(25.0) 12(25.0) 5(20.8) 21(23.9) 4(40.0) 25(25.5) 
  
I forget to ask 
 8(50.0) 23(47.9) 6(25.0) 37(42.0) 6(60.0) 43(43.9) 
  
I don't have 
sufficient 
knowledge 
about it 
5(31.3) 12(25.0) 13(54.2) 30(34.1) 3(30.00 33(33.7) 
  
I don't have the 
opportunity to 
ask 
 
0(0.0) 
 
2(4.2) 
 
1(4.2) 
 
3(3.4) 
 
3(30.0) 
 
6(6.1) 
  
I don't think it is 
relevant 4(25.0) 19(39.6) 11(45.8) 34(38.6) 3(30.0) 37(37.8) 
  
It is too time 
consuming 3(18.8) 5(10.4) 3(12.5) 11(12.5) 1(10.0) 12(12.2) 
  
Total 
 16(100.0) 48(100.0) 24(100.0) 88(100.0) 10(100.0) 98(100.0) 
Table 2. Reasons reported by respondents for not asking patients about CMs 
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Table 3. Methods used to communicate information about patients use of CMs 
Data presented as n(% of the total number of respondents for that question) 
 
 
Respondents were asked about the advice they generally give to patients taking CMs.  
As seen in figure 2, few respondents tell patients to continue taking all their CMs and 
few advise patients to cease all CMs. When responses are compared between the 
groups, overall 35.3% of all medical staff don’t feel confident giving patients advice 
about CMs. This was most obvious amongst surgeons where 54.8% felt unconfident 
about giving advise. An explicit recommendation (to stop taking specific CMs) was 
given by most hospital pharmacists whereas only a third of medical staff gave similar 
advice. The difference in giving specific advice to patients and position held in the 
hospital was statistically significant (χ2 (1) = 6.34, p=.012). The medical staff that did 
Position 
What respondents do 
with information 
about patients use of 
CMs  
 
Anaesthetist 
(incl. 
registrars) 
 
Hospital 
pharmacist 
(incl. trainees 
and students) 
 
Physician/ 
Specialist 
 
Surgeon 
 
Total 
 
Record use in the 
patient history 
 
12(80.0) 6(54.5) 41(83.7) 21(84.0) 80(80.0) 
Record use on 
inpatient medication 
chart 
 
2(13.3) 5(45.5) 2(4.1) 1(4.0) 10(10.0) 
Verbally inform other 
health professionals 
about CMs use (e.g. 
pharmacist, dietician) 
0(0.0) 3(27.3) 3(6.1) 0(0.0) 6(6.0) 
Verbally inform 
relevant surgeon, 
anaesthetist, physician 
about CMs use 
3(20.0) 0(0.0) 2(4.1) 1(4.0) 6(6.0) 
I don't record this 
information 
 
1(6.7) 0(0.0) 6(12.2) 5(20.0) 12(12.0) 
 
Total 
 
15(100.0) 
 
11(100.0) 
 
49(100.0) 
 
25(100.0) 
 
100(100.0) 
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feel confident enough to give advice would suggest referral to another health care 
practitioner. This suggestion was most prevalent amongst anaesthetists (50.0%).  
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Figure 2. Advice generally given to patients using CMs.  
 
3.3.3 Confidence in dealing with CMs-related issues 
 
As seen in Figure 2, over a quarter of respondents did not feel confident giving 
patients advice about CMs. In addiiton, many hospital doctors and pharmacists lacked 
confidence that they had sufficient knowledge to identify when CMs could adversely 
affect patient care (see Figure 3). Analysis of individual groups found that surgeons 
were the only significantly different group when it came to confidence levels 
(t(114)=3.66, p<.001). A planned contrast revealed that anaesthetists were 
significantly more confident than surgeons (t(127)=2.47, p=.015) and physicians were 
also significantly more confident than surgeons (t(127)=2.79, p=.006).  However as a 
% respondents  
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group, planned contrasts revealed that medical staff were significantly less confident 
than hospital pharmacists (F(1,116) = 4.14, p=.044). 
 
Frequency of feeling confident
always
2%
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17%
sometimes
31%
occasionally
31% rarely14%
never 
5%
 
 
 
 
3.3.4 Training, knowledge and information--seeking behaviour 
 
When presented with a patient using CMs, only 17.5% responded they always or 
often checked for side effects or drug interactions and 36.7% rarely or never checked. 
Figure 4 presents responses by individual professional groups.  
 
A significant difference was found between position in the hospital and how 
frequently they checked for safety information using a one-way analysis of variance 
(ANOVA) (F(3,111)=8.10, p<.001). On average, surgeons tended to check the least 
and this was significantly different to physicians (t(111)=3.81, p<.001) and hospital 
pharmacists (t(111)=4.48, p<.001). A One-way analysis of variance (ANOVA) 
Figure 3. Frequency respondents feel confident they have sufficient knowledge to 
identify when CMs could adversely affect patient care 
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revealed that hospital pharmacists checked for side effects and drug interactions 
significantly more than combined medical staff (F(1,113)=8.78, p<.004).  
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Most medical and pharmacy staff had not received formal, under-graduate or post-
graduate training about CM (Table 4). Anaesthetist’s knowledge about CM was 
derived from postgraduate lectures (33.3%) and self-directed study (22.2%). 
Physician’s knowledge about CM chiefly came from self-directed study (20.0%). 
Only two surgeons reported receiving education about CM in post graduate lectures 
and only one surgeon reported attending seminars, receiving undergraduate training or 
undertaking self-directed learning. Self directed learning and undergraduate lectures 
were the main sources of training undertaken by pharmacists regarding CM. Interest 
in future training about CM was expressed by most pharmacists (77.8%) and 
anaesthetists (77.8%) with 51.8% of medical physicians and 45.5% of surgeons 
reporting interest in future training. Figure 5 presents data about respondent’s 
perception of the importance of undergraduate medical training about CM. 
 
Figure 4. Frequency respondents checked for safety information if patient using 
CMs  
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Table 4. Training received by respondents regarding CM
Position 
Anaesthetist 
(incl. 
registrars) 
Physician/ 
Specialist Surgeon 
All medical 
staff 
Hospital 
pharmacist 
(incl. pre-
registrants 
and 
students) Total 
What CM training have you 
had in the past 
  
  N % N % N % N % N % N % 
Formal study 
(certificate/diploma/degree) 0 .0% 0 .0% 0 .0% 0 .0% 1 5.0% 1 .8% 
  
Specific lectures/seminars 
1 5.6% 3 5.5% 1 3.0% 5 4.7% 3 15.0% 8 6.3% 
  
No formal training 
11 61.1% 40 72.7% 30 90.9% 81 76.4% 8 40.0% 89 70.6% 
  
Postgraduate lectures 
6 33.3% 6 10.9% 2 6.1% 14 13.2% 3 15.0% 17 13.5% 
  
Self directed study 
4 22.2% 11 20.0% 1 3.0% 16 15.1% 7 35.0% 23 18.3% 
  
Undergraduate lectures 
3 16.7% 3 5.5% 1 3.0% 7 6.6% 7 35.0% 14 11.1% 
  
Total 
18 100.0% 55 100.0% 33 100.0% 106 100.0% 20 100.0% 126 100.0% 
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Figure 5. Respondent’s perception of the importance of CM training in under-graduate 
medical education. 
 
Hospital doctors and pharmacists requiring CM information referred to different 
resources. Hospital doctors referred to peer-reviewed medical journals (51.3%), 
databases such as MEDLINE (42.5%) and reference texts (40.0%) as their top three 
sources of information whereas hospital pharmacists preferred to use reference texts 
(70%), World Wide Web (60%), seminars and conferences (45.0%). Information 
about resources used by the complete sample is presented in Figure 6 and information 
about use by different groups is presented in Table 5.  
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Figure 6. Information sources used by respondents for CMs and CTs 
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Table 5. Resources used for CM information as reported by different groups 
Position 
Anaesthetist (incl. 
registrars) 
Physician/ 
Specialist Surgeon All medical staff 
Hospital pharmacist 
(incl. pre-registrants 
and students) Total 
Where do you source CMs and CTs 
information ? 
  
  N % N % N % N % N % N % 
 Peer-reviewed medical journals 
10 62.5% 25 53.2% 6 35.3% 41 51.3% 6 30.0% 47 47.0% 
  Reference texts such as MIMs 
7 43.8% 18 38.3% 7 41.2% 32 40.0% 14 70.0% 46 46.0% 
  Databases such as 
Pubmed/Medline 8 50.0% 22 46.8% 4 23.5% 34 42.5% 7 35.0% 41 41.0% 
  The Internet (World Wide Web) 
6 37.5% 19 40.4% 6 35.3% 31 38.8% 12 60.0% 43 43.0% 
  Community or hospital pharmacists 
5 31.3% 18 38.3% 2 11.8% 25 31.3% 4 20.0% 29 29.0% 
  Colleagues 
4 25.0% 14 29.8% 5 29.4% 23 28.8% 6 30.0% 29 29.0% 
  Seminars/conferences/lectures 
7 43.8% 8 17.0% 3 17.6% 18 22.5% 9 45.0% 27 27.0% 
  Medical media/non peer reviewed 
journals 3 18.8% 12 25.5% 2 11.8% 17 21.3% 3 15.0% 20 20.0% 
  Company literature 
1 6.3% 8 17.0% 4 23.5% 13 16.3% 5 25.0% 18 18.0% 
  Complementary medicine 
practitioners 2 12.5% 6 12.8% 0 .0% 8 10.0% 3 15.0% 11 11.0% 
  Friends and/or family 
0 .0% 5 10.6% 1 5.9% 6 7.5% 4 20.0% 10 10.0% 
  Health food shop staff 
0 .0% 2 4.3% 0 .0% 2 2.5% 0 .0% 2 2.0% 
  Total 16 100.0% 47 100.0% 17 100.0% 80 100.0% 20 100.0% 100 100.0% 
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The mean score obtained in the knowledge section was 17.79% (SD 18.78). A one-
way analysis of variance (ANOVA) found that hospital pharmacists attained a 
significantly higher knowledge score than medical staff (F(1,123)=35.06, p<.001). 
While hospital pharmacists achieved a mean score of 38.60%, medical staff achieved 
an average score of 14.06% (Table 6).  When comparing knowledge scores of the 
individual medical groups, a significant difference was found (F(2,115)=13.42, 
p<.001) with anaesthetists achieving the highest score. The lowest scoring group was 
the surgeons with an average of 5.09% correct. Anaesthetists and surgeons 
(t(18.66)=4.10, p=.001); and physicians and surgeons  (t(81.92)=4.31, p<.001) scored 
significantly different to each other.  
 
Table 6. Knowledge scores for the individual groups and as totals 
Percent correct based on 
Micromedex 
 Respondent group M % SD 
Anaesthetist (incl. registrars) 
24.37 18.66 
Physician/Specialist 
16.24 16.86 
Surgeon 
5.05 7.43 
Medical staff only as a total 
14.06 16.25 
Hospital pharmacist (incl. pre-
registrants and students) 38.60 18.71 
Total 
17.79 18.78 
 
Questions about the complementary medicines glucosamine, ginkgo biloba and St 
Johns wort attracted the most responses whereas questions about coenzyme Q10, 
echinacea and chamomile attracted the least. Detailed results from the knowledge 
section are presented in Appendix E.  
 
3.3.5 Doctors and pharmacists attitudes to CMs  
 
Responses to the attitudinal statement about CMs are presented in Table 7.  
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Table 7. Responses of the complete sample to attitudinal statement about CMs.  
 
Data presented as n(% of the total number of respondents for that statement) 
 
 
The mean attitude score was 18.86 (SD 2.24) indicating a moderately negative 
attitude to CMs (5 was considered positive and 25 negative) No significant 
differences were found in attitude scores between the four professional groups within 
the hospital (F(3,77)=.78, p=.509). There was also no significant difference in attitude 
scores between medical staff and hospital pharmacists (F(1,79)=.48, p=.49).  There 
was also no significant correlation of attitude scores with age (r=.15, p=.188), the 
average number of patients seen each week (r=..08, p=.484), or the number of years in 
practice (r=.12, p=.287). 
Responses  
Attitudinal statements 
 
SA 
 
A 
 
NAD 
 
D 
 
SD 
CMs are appropriate for use in the 
hospital setting  
1 (0.8) 18(14.9) 52(43.0) 36(29.8) 14(11.6) 
CMs are generally a waste of time and 
money  
10(8.2) 49(40.2) 41(33.6) 20(16.4) 2(1.6) 
CMs are potentially dangerous and need 
to be monitored  
17(13.8) 83(67.5) 16(13.0) 7(5.7) 0(0.0) 
CMs offer a false sense of hope and 
exploit vulnerable individuals  
15(12.2) 45(36.6) 41(33.3) 21(17.1) 1(0.8) 
CMs offer patients cost effective 
treatment options  
0(0.0) 9(7.3) 34(27.6) 66(53.7) 14(11.4) 
CMs need more hospital based research  47(38.5) 59(48.4) 13(10.7) 1(0.8) 2(1.6) 
CMs are something that most of my 
colleagues would consider  
0(0.0) 7(5.7) 36(29.3) 67(54.5) 13(10.6) 
Regulations for CM practitioners need to 
be tightened  
54(43.9) 59(48.0) 10(8.1) 0(0.0) 0(0.0) 
SA= strongly agree; A=agree; NAD=neither agree or disagree; D=disagree; SD=strongly disagree 
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3.3.6 Perceptions about usefulness and harmfulness of specific CTs and patients use 
of CMs 
 
Of the total sample, most (58%) thought 25% or fewer patients used CMs in the 2 
weeks prior to admission, 30.4% thought usage was between 26-50% and 11.6% 
thought this was greater than 50% during this period. Once patients were admitted to 
hospital, 89.8% of respondents thought CMs usage had reduced to 25% or less with 
8.3% thinking 26-50% of inpatients used CMs and 1.8% thought this was above 50%.  
 
Hospital doctors and pharmacists were also asked about their opinion of the potential 
usefulness and harmfulness of 15 CTs. Over 70% of respondent’s perceived 
acupuncture, massage, yoga and chiropractic as potentially useful whereas few people 
thought reflexology and homeopathy were potentially useful (figures 6 and 8). The 
medicinal therapies (herbal medicine, Chinese herbal medicine and vitamin/mineral 
therapy) and manipulative therapies were considered potentially harmful by the most 
respondents whereas relatively few people thought meditation was potentially harmful 
(figures 7 and 8). Perceptions of potential usefulness and harmfulness of CTs are 
presented together in Figure 8 where it is apparent that acupuncture, meditation, 
massage and yoga are considered potentially useful and low risk whereas chiropractic, 
although considered useful, is also considered potentially harmful by the majority of 
respondents.  
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Figure 6. Opinions of all participants responding to the question regarding the potential usefulness of CTs.  
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Perceptions of the harmfulness of CTs
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Figure 7. Opinions of all participants responding to the question regarding the potential harmfulness of CTs.  
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Perceptions of usefulness and harmfulness of CTs
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Figure 8. Perceptions of usefulness and harmfulness plotted together 
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3.3.7 Doctors and pharmacists past behaviours with CTs and 
interest in practising or receiving CT treatment in the 
future 
 
Respondents were asked about whether they had received or would be interested to 
receive treatment with a CT and also whether they had practised or would be 
interested in practising a CT. Results are presented in Figure 9. Overall, hospital 
doctors and pharmacists in this sample have little personal experience using CTs or 
practising CTs. Of note, only 12.7% of respondents had taken vitamins and/or 
minerals in the previous 12 months and 4.1% had taken herbal medicines. Massage 
was the most commonly received CT in the previous 12 months and the practice of 
vitamin/mineral therapy was of interest to the highest number of people. There was 
most interest in receiving acupuncture, massage, meditation and yoga amongst 
respondents and little interest in receiving or practising homeopathy, reflexology or 
spiritual healing.  
 
Respondents are interested in receiving treatment with the CTs they also consider 
useful – acupuncture, meditation, hypnosis, massage and yoga. Additionally, there is 
interest in receiving vitamin/mineral therapy even though this is not considered useful 
by as many respondents. Despite many respondents ranking chiropractic amongst the 
most potentially harmful CTs, 25.2% would consider receiving treatment with this 
modality in the future.  
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Figure 9. Respondents past behaviours regarding CTs and interest in receiving or practising CTs in the future 
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3.3.8 Doctors and pharmacists actively encouraging or 
discouraging patients about CTs  
 
Respondents would actively encourage the use of massage and meditation followed 
by yoga and acupuncture (Figure 10). These are the same CTs they considered 
potentially useful. Homeopathy and reflexology are the CTs most respondents would 
discourage patients use. This response does not appear to be due to their potential 
harmfulness but because of their perceived lack of usefulness. For most CTs, 
approximately one third of respondents did not feet confident to advise patients about 
use.  
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Figure 10. General responses to patients enquiry about whether they should use a CT 
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3.4 Cardiac surgery patients survey 
 
A total of 205 cardiac surgery patients met the inclusion criteria and 161 completed 
and returned the survey (78% response rate).  
 
3.4.1 Sample characteristics 
 
Participants had an average age of 69.6 years (+/- 13.1 years). Further demographic 
and baseline data is presented in Table 1.  Of note, 93% of respondents were taking at 
least 1 prescription medicine in the 2 weeks prior to admission.  
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Table 1. Characteristics of respondents               
        
 N(%)*   
Male 98(61%) 
Female 62(38.5%) 
Missing 1(0.5%) 
Gender 
Total number of respondents 161(100%) 
Did not complete high school 29(18%) 
Completed high school 45(28.5%) 
Completed technical 
studies/apprenticeship 
34(21.5%) 
Highest Level of 
Education 
attained 
Completed university studies 50(32%) 
Australia 109(68%) Place of birth 
Elsewhere 51(32%) 
Current smoker 1(0.5%) 
Past smoker 77(48%) 
Smoking status 
Non-smoker 82(51%) 
None 12(8%) 
Unsure 1(0.5%) 
One (1) 12(8%) 
Two (2) 15(10%) 
Three (3) 23(15%) 
Four (4) 25(16%) 
Number of 
prescription 
medicines taken 
in the 2 weeks 
prior to admission 
 
Five or more 23(15%) 
Less than $20,000 26(19%) 
$20,001-$60,000 73(52%) 
$60,001-$100,000 31(22%) 
Annual 
household 
income 
Over $100,000 10(7%) 
   % of total respondents 
3.4.2 Patterns of CMs use by cardiac surgery patients  
 
Overall, 50.6% of patients had used at least one CM product in the 2 weeks prior to 
admission. Of these patients, 35% had taken 1-2 products, 8% three products and 8% 
four or more products. The following factors were not significantly associated with 
CMs use: gender (χ2 (1) =1.24, p=.265), income (over $60K/yr compared with 
<$60K; χ2 (1) =.36, p=.551), education (F(3,151)=.139, p =.139) or age (r=.059, p 
=.466). Table 2 lists the distribution of CMs used.  
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Table 2. Complementary medicines used by cardiac surgery patients in the 2 weeks 
prior to admission 
 
List of CMs  
n(%) 
 
Fish oil supplements 
 
18 (25%) 
Multivitamins 18(25%) 
Glucosamine 16(22%) 
Vitamin C 15(21%) 
Vitamin B complex 12(17%) 
Calcium supplements 11(15%) 
Vitamin E 9(12.5%) 
Magnesium 8(11%) 
Coenzyme Q10 6(8%) 
Evening Primrose Oil 4(6%) 
Macuvision ® (by Blackmore’s 
Products Australia) 3(4%) 
Echinacea 2(3%) 
Ginkgo Biloba 2(3%) 
Chinese herbal medicines 2(3%) 
Ginger tablets 1(1%) 
Guarana 1(1%) 
Liquid herbs 1(1%) 
Garlic tablets or more than 1 clove 
daily 
1(1%) 
Celery (the herb) 1(1%) 
Licorice (the herb) 0(0%) 
Ginseng (Korean or Panax) 0(0%) 
Grapeseed extract 0(0%) 
Horseradish tablets 0(0%) 
Policosanol 0(0%) 
St John’s Wort (Hypericum 
perforatum) 0(0%) 
Feverfew 0(0%) 
Valerian 0(0%) 
Total patients responding 72(100%) 
% of total respondents 
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Of those patients taking CMs prior to admission, 42% intended to continue use whilst 
in hospital. In hospital, CMs were self-supplied by 71% of patients and 21% asked 
family and friends to deliver their supplements. Prior to admission, 75% of 
respondents spent less than $50 each month buying supplements with 5% spending 
more than $100. 
3.4.3 Reasons for use 
 
Patients reported using CMs to maximise health and wellbeing (71%), treat (30%) or 
prevent (20%) disease.  
3.4.4 Sources of recommendation to cardiac surgery patients 
 
Medical practitioners were the main source of recommendation as shown in Table 3.  
Females were significantly more likely to be taking medically prescribed CMs than 
males (58% compared to 52%;F(1,154)=3.93, p=.049). No significant differences 
were found for age (<=55yrs, 56-70yrs, 71-85yrs, 86+yrs;F(3, 154)=.904, 
p=.441).The CMs most often medically prescribed were fish oils and glucosamine 
supplements however most respondents reported using fish oil supplements without a 
medical recommendation.  
 
 
 
 
 
 
 
 
 
 
 
 260 
 
Prescriber of CM product 
 
Number (%) 
Medical practitioners ( general practitioners, physicians and surgeons) 52(56.5%) 
Self-prescribed 19(21%) 
CM practitioner 15(16%) 
Friend or family 14(15%) 
Pharmacist 6(6.5%) 
Health food store staff 3(3%) 
Total 92(100%) 
 
 
3.4.5 Communication with healthcare professionals pre- and 
post-admission  
 
In the two weeks prior to admission, 47.1% of cardiac surgery patients using CMs had 
discussed use with their GP, 29.4% a medical specialist, 17.6% a natural therapist, 
11.8% a surgeon, 2.9% a nurse, and no one had discussed use with a pharmacist.  
 
Whilst in hospital, 52% of CM users reported being asked about CMs by a nurse, 12% 
a surgeon, 12% a pharmacist and 8% an anaesthetist. Overall, 56% of CM users did 
not disclose use to any hospital staff member of which 67% reported that the main 
reason was not being asked, 54% thought it unimportant, 5% thought doctors 
‘wouldn’t understand’ and 5% didn’t want to be judged negatively. Only 12% of 
patients reported writing the information on a hospital form. Of those who did 
Table 3. List of people who had prescribed the CM products being taken by respondents 
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disclose use to hospital staff, 54.8% told a nurse, 22.6% medical specialist, 16.1% 
pharmacist, 16.1% surgeon, 12.9% a GP and 6.5% an anaesthetist.  
3.4.6 Sources of information about CMs and CTs 
 
The five most popular sources of general information reportedly used by cardiac 
surgery patients are pharmacists (43.8%), medical doctors (41.1%), health food stores 
(23.3%), natural therapists (21.9%) and books or magazines (21.9%). There was a 
non-significant trend for females to be more likely than males to have consulted 
natural therapists (29.4 % compared to 15.8%) or health food store staff (29.4% 
compared to 15.8%) for information. For safety information about CMs, pharmacists 
(50.0%) and medical doctors (44.7%) were most often consulted, followed by a 
natural therapist (17.1%), health food store staff (15.8%) and books or magazines 
(13.2%). Females were more likely than males to consult a natural therapist on safety 
issues (20.0% compared to 14.6%), ask staff at the health food store (25.7% compared 
to 7.3%) or pharmacy store staff (14.3% compared to 4.9%).  
 
3.4.7 Cardiac surgery patients perceptions about the safety of 
CMs  
 
Most respondents (48.5%) thought some CMs were safe whereas some (37.7%) were 
unsure about the safety of CMS and only 6.9% thought all CMs were safe with 6.2% 
stating they were safer than pharmaceutical medicines. Few (2.3%) thought no CMs 
were safe and 9.2% thought they were less safe than pharmaceutical medicines.  
3.4.8 Use of diet, lifestyle and CTs in hospitals 
 
85% of the total sample stated they would consider using at least one of the listed 
therapies if offered by hospitals with most interest shown in dietary advice and 
massage (Figure 1). Younger age and previous CM usage were predictive of a greater 
interest in the listed therapies (χ2(1)=7.82, p=.005; r=-.184, p=.041) whereas gender 
(χ2(1)=.48, p=.488), income (χ2 (3)=4.555, p=.207) or education (χ2 (3)=1.203, 
p=.752) were not significantly predictive.   
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Cardiac surgery patients interest in hospital based therapies
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Figure 1. Diet, lifestyle and CTs which respondents would consider using if offered by hospitals 
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3.5 Surgical patient survey 
The survey was offered to 602 patients, of whom 508 participated, giving a response 
rate of 84%.  
 
3.5.1 Sample characteristics 
 
The average age was 52.7 years (SD 17.6). Demographic and descriptive data is 
presented in Table 1. Of note, 68.6% were taking prescription medicines in the two 
weeks prior to admission.  
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Table 1. Participant demographic and descriptive data.  
 n 
% of total 
respondents   
Male 240 47.2% 
Female 266 52.4% 
Missing 2 .4% 
Gender 
Total number of respondents 508 100.0% 
Did not complete high school 110 21.9% 
Completed high school 145 28.9% 
Completed technical 
studies/apprenticeship 
86 17.1% 
Highest Level of 
Education 
attained 
Completed university studies 160 31.9% 
Australia 375 74.1% Place of birth 
Elsewhere 131 25.9% 
Current smoker 77 15.2% 
Past smoker 164 32.5% 
Smoking status 
Non-smoker 264 52.3% 
None 157 31.4% 
Unsure 4 .8% 
One (1) 110 22.0% 
Two (2) 80 16.0% 
Three (3) 50 10.0% 
Four (4) 42 8.4% 
Number of 
prescription 
medicines taken 
in the 2 weeks 
prior to admission 
 
Five or more 22 4.4% 
Less than $20,000 87 19.6% 
$20,001-$60,000 170 38.4% 
$60,001-$100,000 103 23.3% 
Annual 
household 
income 
Over $100,000 83 18.7% 
Less than $15 101 43.2% 
$16 to $30 84 35.9% 
$31 to $50 21 9.0% 
$51 to $75 10 4.3% 
$76 to $100 10 4.3% 
Average monthly 
spend on 
complementary 
medicines 
 
More than $100 8 3.4% 
 
 
 
 265 
3.5.2 Patterns of CMs use 
 
Overall, 46.4% of respondents had used CMs in the two weeks prior to admission of 
which 54% intended to continue use whilst in hospital with 39% bringing their own 
supplies to hospital and 9% would have friends and family bringing them in. Of those 
patients taking prescription medicines during this pre-admission period, 46% also 
used at least one complementary medicine product.  
 
Education was significantly associated with CMs use (F(3,483)=5.705, p=.001). 
People with a university education were significantly more likely to use CMs than 
people who did not complete high school (60% compared to 38%; t(480)=3.62, 
p<.001). Other significant predictors of use were female gender (χ2(1)=12.057, p= 
.001), current smoking status (2,486)=5.626, p=.004) and annual income 
(F(3,429)=4.5, p=.004). High income earners (>$Au 100,000/year) were significantly 
more likely to use CMs than low income earners (<$Au 20,000/year) (t(163)=3.622, 
p<.001). Age was not a significant predictor of use (χ2(4)=3.96, p=.412) nor was 
being Australian born (χ2(1)=.151, p=.697).  
 
Of those surgical patients taking CM products in the two weeks prior to admission, 
many used multiple products. More specifically, 41% of CM users had taken one CM 
product, 26% took two products, 13% took three, 5% took four, 2.5% took five and 
8% took more than five. Vitamins and/or minerals were most popular and used by 
53% whereas 21% used herbal medicines and 30% used other CMs. Table 2 lists the 
distribution of CMs used.  
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Table 2. CMs used by surgical patients in the 2 weeks prior to admission 
Responses  
CMs used in 2 weeks prior to admission n 
% of total 
respondents 
Multivitamins 91 42.1% 
Vitamin C 58 27.0% 
Fish oil capsules (omega 3 essential fatty acids) 55 25.5% 
Glucosamine 50 23.1% 
Vitamin B complex  40 18.5% 
Calcium 35 16.2% 
Iron supplements 22 10.2% 
Vitamin E 17 7.9% 
Magnesium 16 7.4% 
Echinacea 14 6.5% 
Garlic product or eating 1 clove daily 13 6.0% 
Evening primrose oil 12 5.6% 
Antioxidant formula 12 5.6% 
Zinc 8 3.7% 
Valerian 6 2.8% 
Coenzyme Q10 6 2.8% 
Liquid herbs 6 2.8% 
St John's wort (Hypericum perforatum) 4 1.9% 
Vitamin D 4 1.9% 
Ginkgo Biloba 4 1.9% 
Chinese herbal medicine (s) 3 1.4% 
Selenium 3 1.4% 
Cranberry supplements 3 1.4% 
Folic acid 3 1.4% 
Ginseng (Korean or Panax) 2 .9% 
Soy supplements 2 .9% 
Probiotics (e.g. acidophilus) 2 .9% 
Green barley 2 .9% 
Celery (the herb) 1 .5% 
Fibre supplements 1 .5% 
Ginger tablets/capsules/liquid 1 .5% 
Licorice (the herb) 1 .5% 
Policosanol 1 .5% 
Spirulina 1 .5% 
Vitamin A 1 .5% 
Total number of respondents 216 100.0% 
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3.5.3 Reasons for use 
 
Surgical patients reported using CMs because ‘it keeps me healthy/prevents disease’ 
(58%), ‘they were recommended by my doctor, pharmacist or friend’ (29%), ‘it gives 
me a sense of well-being’ (28%),  ‘to treat a specific disease (27%), ‘it fits into my 
way of life/philosophy (13%) ‘they have few side effects’ (12%) and ‘they work 
better or just as well as conventional medicines’ (9%).  
 
3.5.4 Sources of recommendation  
 
Of those patients using CM products, 38.2% of people had self-prescribed, 28.5% 
were taking CMs on the recommendation of friends or relatives, 26.8% due to 
recommendations by a GP, 14.0% by a medical specialist, 11.8% by a naturopath or 
herbalist, 11.8% a pharmacist and 11.0% by health food shop staff and 0.9% by a 
dietician.. 
 
3.5.5 Discussion with health care professionals pre- and post-
admission 
 
63% of patients using CMs in the 2 weeks prior to admission did not discuss their use 
with any community-based or hospital-based health professionals during this period. 
Of those that had,  31.6% discussed their CMs use with a general practitioner, 27.6% 
a surgeon, 19.7% a medical physician, 15.8% a naturopath or herbalist, 10.5% an 
anaesthetist, 7.9% a community pharmacist, 6.6% health food store staff whereas 
10.5% were unsure or couldn’t remember. 
 
After admission, 58% of CM-users did not discuss use of supplements with hospital 
staff and 56% reported not being asked. Of those patients who did discuss use, it was 
predominantly with nursing staff (83.5%) and fewer patients disclosed use to 
anaesthetists (24.7%) or surgeons (20.0%). When asked which hospital staff 
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member/s had asked them about use of CMs, it was reported that nursing staff were 
also most likely to ask (Table 3)  
 
Table 3. Hospital staff who asked patients about use of CMs 
Staff who asked about CMs use 
 
N(%) 
Nurse 150(73.2) 
Anaesthetist 49(23.9) 
Surgeon 39(19.0) 
Physician (medical specialist) 19(9.3) 
Unsure or can't remember 29(14.1) 
Total number of respondents 205(100.0) 
% of total respondents 
 
 
When patients were asked why they had not told hospital staff about CMs, few 
reported being concerned about being judged negatively (0.7%) whereas 80.1% stated 
it was simply because they were not asked. More information is presented in Table 4.  
 
 
Table 4. The reasons patients using CMs reported for not disclosing use to hospital 
staff  
Reasons for non-disclosure whilst in hospital 
 
N(%) 
Did not want to appear 'disloyal' 0(0.0) 
Didn't think it was important 55(40.4) 
Did not want to be negatively judged 1(0.7) 
It's none of their business 1(0.7) 
Not asked 109(80.1) 
Thought the hospital doctors wouldn't understand 4(2.9) 
Total number of respondents 136(100.0) 
% of total respondents 
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3.5.6 Sources of information  
 
Many (69.3%) of the surgical patients look for information about CMs and CTs 
however females are significantly more likely to look for information than males 
(81.5% vs 55.4%; χ2(1)=37.84, p<.001). Respondents most often gathered information 
from their health food store (36.8%), GP (34.8%), naturopath/herbalist (26.8%), 
parents, family or friends (24.8%), books or magazines (20.6%), 17.1% used the 
internet, 15.8% used pamphlets in store, 13.9% went to the community pharmacist, 
and 11.6% referred to the media.  Only 6.8% referred to their medical specialist and a 
total of 3.2% referred to the nurse, anaesthetist or surgeon for information. 
 
3.5.7 Perceptions and attitudes  
 
Of those patients using CMs, 25.5% thought their products were very effective, 30% 
thought they were effective enough and 9% thought they were slightly effective 
whereas 30% were unsure of their effectiveness. Nearly half (47%) thought some 
CMs were safe, 1.7% thought none were safe, 32.1% thought CMs were just as safe as 
conventional medicines while 42.1% of the respondents were not sure about the safety 
of CMs and 50.8% of respondents were not sure how safe they were compared to 
conventional medicines. 
Responses to the attitudinal statement are presented in Table 5. Of note, the statement 
about whether CMs are appropriate for use and should be made available in hospitals 
attracted the most responses and 55% agreeing with the statement whilst 39% were 
undecided and 6% disagreed.  
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Table 5. Surgical patient responses to attitudinal statements  
 
Responses  
 
Complementary medicines …. 
SA 
 
A NAD D  SD 
Are appropriate for use or should be 
made available in a hospital setting  
59 (13) 192(42) 180(39) 24(5) 13(5) 
Are generally a waste of time and 
money  
16(4) 35(8) 126(29) 202(46) 58(13) 
Can be dangerous and need to be 
supervised  
43(10) 159(37) 141(32) 80(18) 12(3) 
Are a cost effective way of looking 
after health  
13(5) 75(27) 130(46) 51(18) 13(5) 
Can cause dangerous interactions 
with conventional drugs  
26(9) 84(30) 138(49) 27(10) 8(3) 
Need more scientific research  
 
60(14) 199(45) 144(33) 26(6) 10(2) 
Are something most of my friends 
would consider using  
26(6) 192(44) 171(39) 43(10) 2(1) 
Regulations need to be tightened 
for complementary practitioners  
36(13) 107(38) 112(39) 23(8) 6(2) 
SA= strongly agree; A=agree; NAD=neither agree or disagree; D=disagree; SD=strongly disagree 
*%  of the total number of respondents for that statement 
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3.5.8 Use of CM, dietary and lifestyle therapies in hospitals 
 
Of the total sample, 85.0% were interested in hospitals offering at least one of the 
listed therapies, as depicted in Figure 1.  These patients were significantly more likely 
to be female (females 90.1% compared to males 79.7%; χ2(1)=9.80, p=.002),  have 
higher annual earnings (>$Au 100,000/yr 88.9% compared to 73.7% for <$Au 
20,000/yr; t(134.89)=-2.46, p=.015) and have previously used CMs ( χ2(1)=4.52, 
p=.034).  
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Patients interest in hospital based therapies
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Figure 1. Diet, lifestyle and CTs patients would consider using  
Chapter Four 
 
Interpretation of survey findings  
 
 
 
4.0 Introduction  
 
Five surveys were conducted, three of which were conducted with healthcare 
professionals working within Victorian hospitals and two with surgical patients 
attending two of the same hospital sites.  
 
This chapter is divided into six sections with the first five sections presenting a 
separate discussion of the results obtained for each survey and the final section 
providing a general discussion of the overall results and emerging themes. The final 
discussion also outlines the limitations of the surveys and how the information gained 
from this research project can be of value to hospital practice and the wider 
community. 
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4.1 Anaesthetists survey 
 
According to the Workforce Survey 2002 reported by the Australian and New 
Zealand College of Anaesthetists (ANZCA), our sample represents approximately 
15% of all active ANZCA Fellows in Victoria. The ratio of males to females in the 
sample is representative of the Australian anaesthesia workforce however our 
respondents are slightly younger (39.8 years vs 46.2 years). This is most likely 
because the survey was undertaken at teaching hospitals and some respondents were 
in the training program. Although non-response bias has influenced our results, the 
data available suggests that the characteristics of respondents and non respondents 
were comparable.  
 
4.1.1 Communication breakdown 
  
The documented reluctance of patients to disclose their use of CMs means 
anaesthetists must take an active role in initiating the discussion. This requires them to 
be familiar with CMs and have the confidence and knowledge to be able to conduct 
such a discussion in a meaningful manner.  
Although just over half the anaesthetists surveyed reported they forget to ask patients 
about CMs, this study has identified that lack knowledge about the evidence of CMs 
efficacy and safety, lack of confidence in dealing with issues relating to CMs and a 
perception of low patient usage are important underlying factors standing in the way 
of anaesthetists initiating the discussion. These same factors have been previously 
reported as communication barriers in studies involving physicians (16;121). As a 
result, anaesthetists are largely relying on indirect communication through admission 
forms or patients unprompted disclosure to learn about their use.  
 
An important finding from the present study is the challenge encountered by 
anaesthetists when presented with patients using CMs. Most anaesthetists feel 
inadequately prepared to counsel patients about CMs and have limited knowledge 
about the safety and efficacy of these medicines. As a result, they are less likely to ask 
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patients about use of CMs. Documentation of patient use is also inconsistent and the 
advice provided is inadequate and incomplete.  
 
Robinson and McGrail reported that the three main reasons patients did not disclose 
use of CM to physicians were because they were not asked, did not think it relevant 
because the physician could not provide useful information and fear of receiving a 
negative response  (359). The results from this study indicate that anaesthetists don’t 
routinely ask about CMs and if a patient was to tell their anaesthetist about use, they 
are unlikely to receive informed advice and may receive a negative opinion about 
their appropriateness for use within the hospital. As such, the reasons for patients non-
disclosure described in the review by Robinson and McGrail are also observed with 
this group of doctors.  
 
Important strategies towards closing the communication gap between patients and 
anaesthetists about CMs would be to increase their familiarisation with CMs through 
further education and providing ready access to appropriate resources. Furthermore, 
clear guidelines are required to encourage anaesthetists to ask patients about CMs and 
direct them towards the next steps required once use has been identified.  
 
4.1.2 Anaesthetists attitudes to CMs 
 
The attitudes of anaesthetists to CMs can be described as moderately negative, based 
on their responses to the attitudinal statements. It is apparent that anaesthetists are 
reluctant for CMs to be used alongside conventional medicine within the hospital 
setting and many think CMs are not cost effective and offer a false sense of hope.  
Considering nearly all agreed that more hospital based research is required, it is 
possible they think there is insufficient research at present to support their use. There 
is also a prevailing view that CMs are potentially dangerous and their use needs to be 
monitored. Of note, over 90% thought herbal medicines were potentially dangerous.   
 
It is not clear what influences have shaped these attitudes. Our sample had received 
little training about CM, had little knowledge of the evidence base of commonly used 
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CMs and little personal experience using CMs, so other influences must be at work. It 
is possible that perceived pressure from peers to confirm to a negative view is an 
influence, as suggested by their responses to the attitudinal questions, however 
knowledge and publication bias may also be influences.  
  
4.1.3 Anaesthetists perceptions and attitudes to CTs 
 
If acceptance of a CT can be considered when over 80% of respondents think it is 
useful then acupuncture, hypnosis, massage, meditation and yoga have become 
accepted by anaesthetists and are unlikely to be considered fringe therapies by this 
group. In particular, acupuncture stood out as being well accepted in terms of 
effectiveness and also attracted relatively higher interest in future personal use and 
practise than other CTs. Despite the high interest in this modality, less than 5% have 
practised acupuncture in comparison with 18% of Australian GPs, suggesting little 
integration (166). The ingested treatments (CMs) and chiropractic were perceived as 
potentially harmful by the most respondents which is a similar perception to 
Australian GPs and spiritual healing and reflexology were considered least useful 
(166).  
 
4.1.4 Little personal use and practice of CTs  
 
Anaesthetists have similar patterns of personal use of CTs to UK GPs but relatively 
less usage than Australian and German GPs (129;166). A comparison with the survey 
by Cohen et al of Australian GP practises indicates that there is little practise of any 
CT by anaesthetists and the integration of CTs into general practice is far more 
advanced than in the practise of anaesthesia in the hospital setting (166). This is not 
surprising as GPs have a broader scope of practise than the specialist practise of 
anaesthesia and therefore more opportunities where the use of CTs may be relevant.  
 
It was surprising to find very little practise of acupuncture despite it being regarded as 
useful by nearly all respondents and there being convincing evidence from 
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randomised controlled trials and systematic reviews for perioperative applications 
such as preoperative anxiety and for postoperative pain relief (360). Manual 
acupuncture requires specialist training and is labour-intensive and time-consuming, 
which may be limiting its applicability in many units.  
 
4.1.5 Training, knowledge and information seeking behaviour 
 
In the book Australasian Anaesthesia 2003 published by the ANZCA (Australian 
New Zealand College of Anaesthetists), Grauer states: “for the benefit of the patient 
and the physician, it is important for anaesthetists to inform themselves about the 
potential benefits, drug interactions and adverse effects of herbal medications and 
familiarity with the common 15-20 herbs .. is all that is really required” (361). This 
survey has identified that anaesthetists are not aware of the safety and efficacy 
evidence for 11 commonly used CMs identifying a a significant unmet need for 
further education about CMs. This also confirmed the findings of a smaller survey 
which demonstrated that anaesthetists have limited knowledge about herbal medicines 
(362). Particularly disturbing was the lack of awareness of common CMs which 
potentially increase bleeding.  
 
Unexpectedly, anaesthetist’s lack of confidence dealing with CMs, lack of 
knowledge, and belief that CMs are potentially dangerous, did not generally motivate 
them to seek information when patient use was identified. Time constraints, lack of 
opportunity and lack of ready access to appropriate information resources are some 
explanations however the real reasons remain unknown. Approximately two thirds of 
anaesthetists in this survey reported they were interested in future training about CMs 
and CTs indicating a willingness to devote some time and effort to changing the 
current situation. 
 
How anaesthetists should respond to patient’s use of CMs if identified remains 
uncertain. Currently the American Society of Anesthesiologists advises anaesthetists 
to ask patients to discontinue use of all herbal medicines two weeks prior to surgery, 
the time estimated for the compounds to be fully metabolized (246) however the 
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ANZCA has no formal policy or guidelines about CMs although Grauer advises that a 
more targeted approach be taken. Furthermore, he proposes that the question ‘Do you 
take any herbal medications or any other substances?’ should be a routine part of 
every anaesthetists pre-operative assessment.  
 
As the popularity of CMs continues, anaesthetists will no doubt come into 
increasingly frequent contact with patients who are using these medicines thereby 
making the issues of confidence, knowledge and strategies to improve patient safety 
more urgent.  
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4.2 Hospital pharmacists survey 
 
The three major functions of the pharmacist are: identifying potential and actual drug 
related problems, resolving actual drug-related problems and preventing potential 
drug-related problems (171). This requires knowledge of the available evidence 
regarding the drug, knowledge of the patient and their disease and communication 
with the patient and other health care professionals. 
 
As a reflection of the increased use of CMs by patients, the APAC (Australian 
Pharmaceutical Advisory Council) guidelines specify that CMs are to be included as 
part of a standard medication history and according to the National Strategy for the 
Quality Use of Medicine (QUM), the safe and appropriate use of CMs is also to be 
promoted. Professional associations in North America have also responded to the 
widespread use of CMs and between 2000 and 2004, the American Society of Health-
System Pharmacists (ASHP), the American College of Clinical Pharmacy (ACCP) 
and the Canadian Society of Hospital Pharmacists (CSHP) recommended that the 
pharmacy profession actively embrace CMs as part of a pharmacist’s scope of 
practice (363).  
 
Within the hospital setting, pharmacists play an essential role as medication 
counsellors within the healthcare team and promote medication safety and quality use 
of medicines. Many hospital pharmacists have direct input into patients’ clinical care, 
help determine whether self-medication is appropriate and conduct medication 
reviews to verify patients’ use and dosage.  
 
4.2.1 Pharmacists and communication failure 
 
Good communication between health professionals and patients is an essential part of 
providing safe and effective health. Whilst studies have been conducted to determine 
what communication barriers exist to prevent patients and physicians discussing CM 
use (359), relatively little is known about pharmacists in this regard. Studies with 
community pharmacists in the United States have produced inconsistent results with 
one study identifying that pharmacists rarely ask patients about CM use (364) 
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compared to another reporting 52% regularly ask patients about CMs (365).  The 
present survey has identified that 29% of pharmacists describe themselves as ‘always’ 
asking patients about CMs and 26% as ‘often’ asking patients with younger 
pharmacists more likely to ask patients about use. Surprisingly, having greater 
knowledge of CMs safety and efficacy was not associated with more frequent patient 
enquiry. The most common reason given for not asking all patients was forgetting to 
ask, whilst some pharmacists assumed patients would volunteer information 
unsolicited or that asking patients is too time consuming. This establishes that 
considering CMs is not part of the pharmacist’s usual routine and efforts are required 
to educate them to include CMs as part of a standard medication history and the 
practise of QUM.  
 
Lack of practitioner enquiry combined with lack of patient disclosure has previously 
been described as a ‘don’t ask, don’t tell’ culture in which communication barriers are 
continually reinforced (121). Not only is this situation potentially dangerous, it also 
means a missed opportunity to learn from patients about their reasons for using CMs 
which can reveal important details about their health and the effectiveness and 
limitations of their current treatments.   
 
4.2.2 Pharmacists training, knowledge and information sources 
 
As the use of CMs and CTs continues, hospital pharmacists are likely to come into 
contact with an increasing number of patients taking or enquiring about both. 
Although the majority of pharmacists have no formal training in CM, many believe it 
is their responsibility to have knowledge of CMs to be able to inform patients about 
their treatment options (178;366).  Overseas studies have reported that pharmacists 
are generally not satisfied with their level of knowledge about CMs (181) and are not 
comfortable with responding to CM inquiries (367). Respondents to this survey felt 
similarly which may account for the substantial number interested in further training. 
Overall, pharmacists actual knowledge of CMs is limited, a finding that has been 
reported elsewhere (178;368) and which confirms the urgent need for improved 
undergraduate training and further continuing professional education.   
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Identifying reliable information sources about CMs is difficult and the accuracy and 
currency of the information available varies considerably. Previously, books and 
magazines have been cited as major sources of CM information for pharmacists 
(369;370) however hospital pharmacists favour electronic information sources and the 
World Wide Web for information, with Medline reported as their most popular 
choice. Whilst many would consider Medline a credible and up-to-date information 
resource, its usefulness is limited by the information seeking skills of the user and the 
lack of availability of full-length research articles.  In regards to CMs and CTs, these 
issues are further complicated by the diverse nature of the area, the lack of consensus 
as to what CMs and CTs constitute and how they are best evaluated.  
 
4.2.3 Perceptions and attitudes to CMs and CTs 
 
Hospital pharmacists are concerned about safety, efficacy and cost issues associated 
with CMs and overall can be described as having a moderately negative attitude to 
CMs. It is difficult to make a detailed comparison with the only other Australian study 
of pharmacists however the overall impression is that there a discrepancy in attitudes 
between the two and hospital pharmacists are more cautious than community 
pharmacists regarding CMs (371).  
 
If acceptance of a CT can be considered when over 80% of respondents think it is 
useful, then acupuncture, massage, vitamin/mineral therapy and yoga have become 
accepted by hospital pharmacists and are unlikely to be considered fringe therapies by 
this group. Of these, relatively few pharmacists actively encourage the use of 
acupuncture and vitamin/mineral therapy, possibly because they are also perceived as 
potentially harmful by many respondents. In comparison with the anaesthetist’s 
survey, relatively few pharmacists think hypnosis is useful whereas fewer 
anaesthetists think vitamin/mineral therapy and herbal medicine is useful. It is likely 
that pharmacist’s greater focus on medicines and familiarity with commonly used 
CMs is responsible for this difference.  
 
Other CTs accepted as useful by over 70% of hospital pharmacists are Chinese herbal 
medicine, herbal medicine, chiropractic and meditation however less than 10% would 
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actively encourage their use, except for meditation which would be encouraged by 
30%. Once again, the variations in which CT would be encouraged appear to be a 
reflection of their perceived potential to cause harm.   
 
These results are similar to those reported in a study of predominantly Australian 
community pharmacists with the majority perceiving massage, acupuncture, 
meditation, herbal medicine and chiropractic as potentially useful (371). In 
comparison, a study of U.S. pharmacists by Welna et al reported that only 19% 
thought herbs and natural supplements were effective indicating a major difference in 
attitude between US and Australian pharmacists (372).  
 
In contrast, there is little acceptance of homeopathy by hospital pharmacists as few 
consider it potentially useful, there is little interest in personally receiving treatment 
and virtually no encouragement of its use. These results are similar to those obtained 
for anaesthetists and hospital doctors indicating overall little acceptance of this 
modality. According to Cohen et al, few Australian GPs consider homeopathy useful 
whereas Naidu et al reported nearly 40% of pharmacists ranked it amongst the top 10 
most useful CTs (166;373). It is likely that community pharmacists have greater 
exposure to homeopathy than hospital pharmacists and medical practitioners as many 
retail pharmacies stock these medicines and as a result, may have received 
information from manufacturers or patient feedback about their effects whereas 
hospital pharmacists and medical practitioners are unlikely to have received either.  
 
Hospital pharmacists also perceive some CTs as potentially harmful, particularly the 
ingested medicines which is a similar finding to that reported for Australian GPs 
(166). 
 
4.2.4 Pharmacists personal use and practice of CTs 
 
A cross-cultural comparison reveals 37-53% of U.S. pharmacists use CMs, 29% of 
Australian pharmacists according to Naidu et al and most (84%) pharmacists from 
Singapore and Malaysia use CTs (188;201;213;371). Australian hospital pharmacists 
also use CMs with 27% reporting use of vitamins/minerals in the previous 12 months, 
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10% Chinese medicine and 9% herbal medicine. Similarly to the finding by Naidu et 
al,, medicinal treatments were the most commonly used CTs by pharmacists (371). 
This survey further identified that massage was popular amongst hospital pharmacists 
and had been used by 26% in the previous 12 months whereas relatively few 
pharmacists in the other pharmacy survey reported use.  
 
Although medicinal CTs and massage were most frequently used by hospital 
pharmacists, many expressed an interest in receiving treatment with a range of other 
CTs such as meditation, acupuncture and yoga. Not surprisingly, these CTs were also 
considered useful by a majority of pharmacists.  When the results of this survey are 
compared with the anaesthetists and Frankston Hospital surveys, it is apparent that 
more pharmacists are interested in practicing the medicinal therapies than hospital 
doctors. Once again, this is somewhat expected as their training and professional 
practice has a focus on medicines.  
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4.3 Frankston Hospital – combined hospital doctors and 
pharmacists survey 
 
This survey of the medical and pharmacy population working at one hospital site 
provides information about the hospital staff responsible for taking medication 
histories, prescribing medication, and providing patients with drug information and 
counselling. The data collected enables comparisons to be made between sub-groups 
of health care professionals working within the same setting and when results from 
solely medical staff at Frankston Hospital are considered, it can be compared to 
surveys of Australian GPs to identify similarities and differences between hospital 
doctors and GPs.  
 
4.3.1 Don’t ask and don’t tell  
 
Clear and open communication is necessary for the practice of concordance and 
EBPC and is essential for the delivery of high quality, safe patient care (290). 
Previously, two studies in the international literature demonstrated that medical 
practitioners in Canada and Israel do not routinely ask patients about use of CM 
whereas there is no published information about Australian doctors in this regard 
(121;135). This survey has demonstrated that the problem of poor communication is 
widespread and hospital doctors and pharmacists do not routinely ask patients about 
CMs despite this being considered a standard part of taking a medication history and 
important for QUM. If patient use of CMs was recognised, this survey further 
identified that documentation of use is inconsistent making communication within the 
healthcare team ineffective and the identification and reporting of adverse reactions to 
CMs extremely difficult. 
 
Numerous studies demonstrate that Australians use CMs and use has increased in the 
last decade (14;15). This means hospital doctors and pharmacist are now coming into 
contact with patients who have been using or are still using CMs. This has been 
documented in studies conducted overseas and in Australia and now confirmed by the 
two surgical patients surveys conducted as part of this research project. In response to 
the widespread use of CMs and their potential to induce adverse effects and interact 
with conventional drugs, numerous articles have been published in the peer-reviewed 
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press of various professional disciplines describing the safety evidence. Nationally, 
CMs are incorporated within the practice of QUM and locally in Victoria, the 
Victorian Therapeutic and Advisory Group (VicTAG) and the Victorian Drug Usage 
Advisory Committee (VDUAC) has produced CM guidelines for all Victorian 
Hospitals which aim to promote open discussion about CMs and patient safety (374). 
Clearly, these avenues have had little impact on hospital practice and a change in 
medication history taking has not occurred.  
 
Grol and Grimshaw note that barriers to change can act at different levels – the 
individual, team and organisational levels (37).Within the context of this study, 
barriers have been identified within these levels and provide some explanation for the 
current behaviours. 
 
At an individual professional level, doctors and pharmacists have set routines that do 
not currently include considering patients use of CMs. This is seen in their responses 
to the questions regarding patient enquiry where forgetting to ask patients about CMs 
was commonly reported. Pharmacists fared better than hospital doctors and were more 
frequently asking patients about CMs however this was still not part of their standard 
routine. Attitudinal barriers were also detected as some respondents thought it 
irrelevant to ask patients about CMs. Cognitively, the individuals surveyed have 
limited knowledge of the safety and efficacy of commonly used CMs although many 
think they are potentially harmful and require monitoring. Emotionally, many do not 
feel sufficiently knowledgeable and confident when dealing with CM-related issues 
and are likely to be uncomfortable discussing CMs with patients.  
 
From a larger perspective, the prevailing opinions and behaviours of peers are other 
influences. The attitudinal section of the survey identified that 42% did not think CMs 
are appropriate for use within the hospital setting and nearly 50% thought CMs were a 
waste of time and money and presented false hope to patients. As such, the prevailing 
opinion does not encourage the use of CMs and can be described as somewhat 
dismissive of these treatments.   
 
From an organisational perspective, Frankston hospital does not have a designated 
CM policy or CM guidelines however it is expected that patient’s use of CMs is 
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considered during standard medication history taking procedures. Additionally, there 
have been no formal initiatives to increase awareness amongst patients or hospital 
doctors and staff about use of CMs and their potential benefits and hazards. As such, 
lack of communication with patients and inconsistent responses to patients use may 
also be attributed to a system failure.  
 
4.3.2 Lack of confidence is widespread 
 
In regards to communicating with patients about CMs, 27% were not confident to 
advice patients about CMs and only 2% were always confident they had sufficient 
knowledge to identify when CMs could adversely affect patient care. Within the four 
groups surveyed, both medical physicians and anaesthetists were more confident than 
surgeons and as a group, pharmacists were more confident than the complete medical 
group. This reflects the differences in their knowledge scores, information seeking 
behaviours and previous training about CMs compared with medical doctors.  
 
For example, surgeons achieved the lowest knowledge scores and were least likely to 
use resources to check for CM safety information or undertake post-graduate training 
or self-directed learning compared with the other groups. In contrast pharmacists 
achieved the highest knowledge scores, more frequently used resources for CM safety 
information and were most likely to have attended undergraduate lectures, specific 
seminars about CMs or undertaken self-directed learning. These results imply that 
surgeons may benefit from liaising with their pharmacist colleagues about CMs and 
undertaking formal training themselves.  
 
A study of UK GPs reported that although a minority were confident discussing CM 
with patients the CTs they were most confident discussing were: acupuncture and 
homeopathy (375). In contrast, this study found the CTs most hospital doctors and 
pharmacists were confident providing general advice about were chiropractic, 
massage, meditation and yoga with relatively less confident with acupuncture and 
homeopathy. 
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Of these four CTs, massage was the only one in which hospital doctors and 
pharmacists were most likely to encourage use whereas the general response to the 
other three would be neither encouragement nor discouragement. It is possible that 
more respondents felt confident providing general advice and encouragement for 
massage because it is widely perceived as useful, with low risk and 20% had 
personally received a treatment within the last 12 months. Whilst meditation and yoga 
were also perceived as useful and low risk by most respondents, only 6% reported 
personal use of meditation and 4% yoga which may explain why fewer respondents 
were confident in encouraging their use. Chiropractic was perceived as useful by most 
respondents’ but also potentially harmful and few (5%) had personally experienced a 
treatment which may explain respondent’s confidence in providing general advice but 
not displaying a distinct trend towards encouragement or discouragement.  
 
There was obvious interest in acupuncture and widespread agreement that it is a 
potentially useful therapy however only 4% had personally experienced a treatment 
within the last 12 months. It is possible that fewer people were confident encouraging 
its use because very few people were personally familiar with this treatment and the 
prevailing attitude is that it is also potentially harmful.  
 
4.3.3 Similar attitudes to CMs 
 
The results obtained in the attitudinal sections of all three practitioner surveys were 
remarkably similar and indicated a moderately negative attitude to CMs amongst all 
groups. At Frankston Hospital, few doctors and pharmacists agreed that CMs are 
appropriate for use in the hospital setting, there was more agreement that CMs are a 
waste of time and money than there was disagreement and over 80% thought CMs are 
potentially dangerous and need to be monitored.  Similar to the other surveys, there 
was widespread agreement that CMs require more hospital based research, regulations 
for CM practitioners need to be tightened and CMs do not offer patients cost effective 
treatment options. When combined with their responses to other parts of the survey, it 
is clear that doctors and pharmacists are cautious about CMs and many perceive them 
to be potentially useful but also associated with various risks such as patient harm, 
financial loss and false hope.  
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Surveys in the literature tend to report on physician or pharmacists attitudes to CTs as 
a complete entity rather than isolating CMs as a specific group making comparisons 
with other studies difficult.  
 
4.3.4 Perceptions about CTs 
 
The systematic review of physicians and CM in Chapter 1 Section B identified 
varying levels of interest and acceptance of CTs by physicians with results generally 
indicating a growing curiosity about specific CTs. According to Schmidt et al, the 
overall attitude of U.K. and German GPs toward CM was positive with a slightly 
more positive attitude expressed by the German GPs (376). The results of this survey 
indicate that numerous CTs are considered potentially useful by doctors and 
pharmacists and there are several which staff would be interested to personally 
receive treatment with and/or practise in the future, also demonstrating a level of 
acceptance and growing curiosity.  
 
Similar to the results obtained in the previous practitioner surveys, acupuncture, 
massage, meditation and yoga have become accepted by this group of hospital doctors 
and pharmacists as useful and are unlikely to be considered fringe therapies. When 
results for the medical participants at the site are grouped together and compared with 
pharmacists then it is apparent that hypnosis is also accepted by medical doctors but 
far less so by pharmacists. Pharmacists also differed in their perceptions and interest 
in medicinal CTs as they widely accept vitamin/mineral therapy as potentially useful, 
most would consider receiving treatment and half were interested in practising it in 
the future whereas less interest and acceptance was demonstrated by doctors. 
Although the sample of pharmacists in this survey was small, similar results were 
obtained in the larger pharmacist’s survey confirming this finding.  
 
When the results of all individual groups at this site are compared, it is apparent that 
anaesthetists in particular have a high level of acceptance of acupuncture with all 
anaesthetists in this sample considering it useful, and a relatively higher number 
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interested in receiving treatment and considering practise with this modality. These 
findings are consistent with the results obtained in the larger anaesthetist survey.  
 
There appears to be a cultural difference between the UK, US and Australia regarding 
practitioners perceptions of whether homeopathy, herbal medicine and chiropractic 
are useful and effective (120;166;377). Similar to a survey of US academic 
physicians, very few Frankston Hospital doctors and pharmacists perceived 
homeopathy as effective, whereas UK GPs were less sceptical. Herbal medicine was 
considered useful by over 60% of Australian hospital doctors and pharmacists and 
Australian GPs according to Cohen et al, whereas it received little support for being 
effective by UK GPs or academic physicians in the US. Results for chiropractic were 
also varied with many Australian hospital doctors and pharmacists and UK GPs 
perceiving it as useful however U.S academic physicians considered chiropractic 
amongst the least useful CT (120;166;378). 
In regards to perceptions of harmfulness, a study of primary care practitioners in 
Israel identified that 51% thought herbal medicines had no or only mild side effects, 
and 63% claimed that they had no or only mild interactions with conventional drugs 
(121). In contrast, over 80% of hospital doctors and pharmacists perceived herbal 
medicine as potentially harmful and in need of supervision.  
Overall, the perceptions of Australian hospital doctors and pharmacists are closely 
aligned with Australian GPs and indicate acupuncture, massage, yoga and meditation 
are widely regarded as useful whereas reflexology, homeopathy and spiritual healing 
attract little support (166). Similarly, there is the perception amongst community and 
hospital-based groups that chiropractic, Chinese medicine and herbal medicine are 
potentially harmful.  
 
 
4.3.5 Little personal use and practice of CTs 
 
Hospital doctors have similar patterns of personal use of CTs to UK GPs but 
relatively less usage than Australian and German GPs (129;166). A comparison with 
the survey by Cohen et al of Australian GP practises indicates that there is relatively 
 290 
little practise of any CT by Australian hospital doctors and the integration of CTs into 
general practice is far more advanced than in the hospital setting (see Table 1) (166). 
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Personal usage in 
the past 12 months 
Would consider 
receiving in future 
Have practised in 
the last 12 months 
Would consider 
practising in 
future 
 
 
Complementary 
therapy  
% 
hospital 
doctors  
% GPs 
 
 
% 
hospital 
doctors 
% GPs % 
hospital 
doctors 
% GPs % 
hospital 
doctors 
% GPs 
Acupuncture 4 12 52.5 56 0 18 15 31 
Aromatherapy 2 3 15 15 0 1 1 3 
Chinese herbal 
medicine 
1 4 17 23 0 1 2 7 
Chiropractic 8 7 22 27 0 1 2 5 
Herbal medicine 3 5 15 26 2 4 2 11 
Homeopathy 0 3 6 12 0 1 0 4 
Hypnosis 3 3 34 45 2 6 11 16 
Massage 20 26 51.5 55 1 11 13.5 29 
Meditation 6 11 51.5 56 1 18 16 22 
Naturopathy 1 3 13 16 0 2 3 4 
Osteopathy 1 3 16 20 0 1 1 3 
Reflexology 2 2 4 11 0 0 0 2 
Spiritual healing 3 3 10 15 0 1 2 2 
Vitamin/mineral 
therapy 
12 13 32 27 5 9 13 10 
Yoga  4 10 44 52 1 8 8 18 
 
 
 
Table 1. A comparison between hospital doctors at Frankston Hospital and Australian GPs as 
reported by Cohen et al (166). 
 292 
The therapies of most interest for personal use by both Australian hospital doctors and 
GPs are acupuncture, massage and meditation and not surprisingly, these are the same 
therapies they consider effective (166). Both groups have similar interests in regards 
to the CTs they would consider practising in future – notably meditation, acupuncture 
and massage with the exception of vitamin/mineral therapy where 13% of hospital 
doctors expressed an interest compared with 10% of GPs. Many more GPs were 
interested in practising yoga compared with hospital doctors, 18% and 8% 
respectively and no hospital doctors would consider practising homeopathy or 
reflexology compared with 4% and 2% respectively of GPs.  
 
A cross-cultural comparison of GPs in the UK and Germany has identified 
acupuncture had been personally used by 2% of UK GPs and 11% of German GPs 
whereas 4% of Australian hospital doctors reported use (379). A similar finding was 
obtained for use of chiropractic with 8% of Australian hospital doctors having 
received treatment compared with 6% and 7% respectively for UK and German GPs 
respectively. In regards to homeopathy, 2% of UK GPs and 5% of German GPs 
reported use compared with no respondents in the present survey.  Schmidt et al used 
the term phytotherapy to describe herbal medicine use and identified 1% of UK GPs 
and 4% of German GPs had previously used it. This survey divided phytotherapy into 
herbal medicine and Chinese herbal medicine for which 3% and 1% usage was 
identified respectively. Aromatherapy usage was also similar for all three groups and 
reported at 2%, 1% and 1% in the UK, Germany and Australia respectively. No other 
overseas studies reported specific information about the personal use of individual 
CTs such as massage, meditation, yoga, hypnotherapy or spiritual healing so no 
further comparisons can be made.   
 
Surveys of GPs in the UK, US, Germany and Australia and physicians in the UK 
demonstrate that acupuncture is practised in all countries by these groups however no 
hospital doctors n this study reported having practised acupuncture 
(117;131;166;380;381). Homeopathy is also practised by some GPs in the UK and 
Germany whereas only 1% of Australian GPs reported practise in the study by Cohen 
et al and no hospital doctors according to the present survey (129;166). Lewith et al 
identified that manipulative therapies were being practised by physicians in the UK, 
Schmidt et al reported that 11% of German GPs practised chiropractic and 3% 
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osteopathy whereas no hospital doctors reported having practised chiropractic or 
osteopathy (117;129). Similarly, Cohen et identified only 1% of Australian GPs as 
having practised chiropractic and osteopathy (166). 
 
4.3.6 Training, knowledge and information sources 
 
Despite the increasing number of research and review articles published about CMs 
and continuing education programs available, there is still substantial room for 
improvement in hospital doctors and pharmacists knowledge. The need to increase 
their familiarisation about the safety and efficacy of CMs and confidence in dealing 
with CM-related issues is urgent in order to safeguard patients from potentially 
harmful behaviours and avoid unnecessarily advising patients to cease use of safe and 
effective treatments. Additionally, lack of training and confidence breeds concerns 
about legal liabilities (382). 
 
Studies conducted with GPs in the U.S. have found that over 80% want more CM 
education (16;118). Similar results were obtained for anaesthetists and hospital 
pharmacists whereas approximately half the medical physicians and slightly less 
surgeons wanted further education. This indicates a general willingness to change the 
current situation and suggests an opportunity for further education would be 
welcomed by many practitioners.   
 
In Chapter 1 Section B, the systematic reviews of medical practitioners and CM 
identified a study of U.S. gastroenterologists which reported that 76% obtained 
information about CM from medical journals, 57% the media, 48.1% continuing 
medical education, 22.4%  the internet, or other sources (15.9%) (141). Similarly, 
hospital doctors in Australia use peer-reviewed journals, MEDLINE and the internet 
however they also reported using reference texts (40%) and pharmacists (31%) for 
information. It is imperative that hospital doctors and pharmacists have ready access 
to reliable information sources about CMs, particularly as they have received little 
formal education about these treatments and have limited knowledge about them. It is 
also essential that their information seeking skills are adequate so that relevant 
information can be retrieved when required.  
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4.3.7 Implications for patient safety and wellbeing 
 
The practise of EBM requires healthcare professionals to use current best evidence in 
making decisions (22). The shared decision making models such as concordance 
require a partnership to be formed between practitioner and patient, two-way 
communication, information giving and agreement. Based on the results of this 
survey, it is improbable that EBM or concordance is being achieved regarding CMs 
and patient safety and wellbeing is being compromised. Practitioners generally fail to 
ask patients about CMs and in turn, patients fail to disclose use. This prevents a 
therapeutic partnership from developing and is a clear breakdown in communication. 
If patients do provide information about their use of CMs, healthcare practitioners are 
unfamiliar with the evidence of CMs safety and efficacy and generally do not seek 
further information. As a result, the information they can provide is limited to their 
personal perceptions and biases and is of questionable value. A culmination of the 
previous factors means that an agreement about patient care cannot be achieved 
within this domain.  
 
This survey has further identified several barriers preventing the integration of 
evidence based CMs into hospital practice. These are lack of knowledge about the 
available evidence, due to limited training and irregular information seeking 
behaviours, little personal experience of using and practising CTs from which to gain 
familiarisation and understanding of their effects, the belief that CMs are not cost-
effective and that colleagues would not consider the use of CMs, thereby reaffirming 
their discomfort with it. Despite these observations, there is interest amongst hospital 
doctors and pharmacists in CTs and many are interested to learn more about them.  
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4.4 Cardiac surgery patients survey 
 
Cardiovascular disease (CVD) affects 3.2 million Australians with an expectation that 
this figure will substantially increase over the coming decades due to the growing 
number of older Australians (383). Of those people with CVD, 69% took 
pharmaceutical medication for heart or circulatory conditions in 2001 and in 2001-2, 
40 201 coronary angioplasties and coronary artery bypass grafts (CAGS) were 
preformed nationally in hospitals (260). Because of progressive ageing of the 
population and other factors, such as the increased use of pharmaceutical agents, the 
direct costs have been predicted to increase to approximately $11.5 billion by 2011 
(384).  
 
This is the first Australian survey to demonstrate that CMs are widely used by cardiac 
surgery patients and most are medically prescribed. Importantly, it identified that 
approximately 40% of patients using CMs preoperatively intended to continue use 
whilst in hospital and at least half of these patients did not tell hospital staff. Unlike 
general community usage patterns, CMs use was not associated with female gender, 
education, age or income (13;14;63). 
 
The survey demonstrated 51% of cardiac surgery patients take CMs in the 2 weeks 
prior to admission. This is consistent with international prevalence surveys which 
show that CMs use by surgical patients ranges from 51% (232) to 73% (234) in the 2 
weeks prior to surgery. Results from this survey contrast to a Melbourne survey of 
general surgical patients which found 20% used vitamin supplements in the 6 weeks 
prior to surgery and 14% used herbal medicines (242). 
 
It is also relevant to compare the results of this survey with Brownie and Rolfe as they 
investigated the patterns of CMs use amongst older Australians (> 65 years) and the 
average age of the cardiac surgery patient sample was 69.9years (108). Both surveys 
found fish oils, multivitamins and vitamin C were amongst the most popular 
supplements being used although glucosamine supplements were also highly favoured 
by cardiac surgery patients. The relatively higher use of fish oil supplements amongst 
cardiac surgery patients compared with participants in the Brownie and Rolfe survey 
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may be due to a higher prevalence of cardiovascular disease and the substantial 
evidence supporting the use of fish oils for this condition (385).  
 
In the international literature, only one study has been published which evaluated 
cardiac surgery patients use of CMs and CTs however it is difficult to compare 
prevalence findings as Liu et al enquired about use in the previous 12 months whereas 
this survey was limited to a shorter time frame, only 2 weeks (239). The U.S. survey 
did not report which specific CMs were being used by cardiac surgery patients or who 
had prescribed them so further comparisons cannot be made (386).  
 
In 2006, MacLennan et al reported that 70% of people use CMs to maintain general 
health, a result which was almost identical to the one obtained for cardiac surgery 
patients in this study and both studies found there was less emphasis on using CMs to 
treat disease (14). In comparison to the 2002 MacLennan et al study, nearly half the 
cardiac surgery patients thought some CMs were safe and by inference, some weren’t, 
compared with 65% who thought CMs could be potentially unsafe (13).  
 
4.4.1 Patient safety and CMs 
 
Some of the CMs used by the patients in this study are relatively innocuous, such as 
multivitamins and vitamin C, while others such as fish oils and coenzyme Q10 may 
be beneficial for the cardiovascular patient (387;388). The most concerning group are 
those patients taking CMs with the potential to induce adverse surgical events and 
drug interactions. A report by the Australasian Society of Cardiac and Thoracic 
Surgeons (ASCTS) together with the Department of Human Services states the most 
common adverse outcome after cardiac surgery is post-operative bleeding (389). 
Some of the CMs used by patients in this study, such as fish oils, vitamin E, evening 
primrose oil, garlic, ginger and ginkgo biloba, could potentially increase the risk of 
haemorrhage, either due to interactions or direct pharmacological activity (325).  
 
Previously, three surveys in the United States have been specifically conducted to 
determine whether surgical patients are taking CMs which could potentially increase 
the risk of haemorrhage (232-234). Using the same methodology employed by these 
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surveys, it was found that seven different CMs were being used which have potential 
antiplatelet or anticoagulation activity, notably 25% of cardiac surgery patients using 
CMs were taking fish oils and 12.5% were taking vitamin E supplements. 
 
In this survey, no cardiac surgery patient reported using St John’s wort, kava kava or 
garlic oil which are CMs which can induce pharmacokinetic interactions with 
numerous drugs used in cardiovascular disease management such as nifedipine, 
propranolol, simvastatin, verapamil and warfarin (390-392).  
 
It is important to note that the average age of participants was 69.9 years as older age 
is associated with an increased likelihood of adverse events (393). Furthermore, over 
90% of cardiac surgery patients were taking at least one prescription medicine in the 2 
weeks prior to admission, with 74% taking three or more. As such, there is the 
possibility of interactions with other drugs being used.  
  
Despite the potential for many OTC CMs to induce adverse events in hospital 
patients, there is still little information about actual occurrence rates for two main 
reasons. Firstly, there is little accurate information about the number of patients which 
use CMs and secondly, the number of perioperative complications and other adverse 
events definitively induced by CMs remains unknown. 
 
4.4.2 Cardiac surgery patients communication with others 
 
Communication between health care professionals and patients is an essential part of 
providing safe and effective health care. Consistent with findings from studies of 
general surgical patients (230;231;242) and patients visiting GPs in the community 
(13;14), there is little discussion about CMs between hospital staff and cardiac 
surgery patients. This survey further adds that patients don’t tell hospital doctors or 
pharmacists about their use of CMs because they are not asked and don’t think it is 
important and not because they fear a negative response. This is contrast to other 
studies which report fear of disapproval as a major reason for non-disclosure to 
medical doctors (359) and may be due to the considerable rate of medical prescribing. 
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In the hospital where the study was conducted, it is expected that admission nurses 
routinely enquire about CMs use however this method appears inadequate as 56% of 
CM users remained unidentified. Of concern, this method is not backed up by routine 
enquiry from surgeons, anaesthetists or pharmacists suggesting that better co-
ordination between staff is required to ensure that information about CMs is 
effectively collected, appropriately recorded and managed. Patient education is also 
necessary to increase their awareness that vitamin and mineral supplements and 
herbal medicines are medicines which should be discussed with hospital doctors and 
pharmacists to ensure they will not compromise patient safety.  
 
4.4.3 Medical acceptance? 
 
Medical practitioners were the chief source of recommendation of CMs to cardiac 
surgery patients which raises several questions. Firstly, on what basis do doctors make 
(or fail to make) recommendations about CMs? In Australia, the teaching of CM in 
medical schools remains highly variable between sites and there are few dedicated 
CM familiarisation courses in medical schools (394). Results from the anaesthetist’s 
survey and Frankston hospital survey suggest that few medical practitioners receive 
undergraduate training about CMs. Secondly, should hospital pharmacies supply 
medically prescribed supplements? According to these results, patients currently bring 
in their own supplies and rely on family and friends whilst in hospital. These means 
hospital staffs have limited control over the quality of supplements being used and 
monitoring patients use is more difficult. Thirdly, if a CM product is medically 
prescribed, does this signify it has been adopted as a conventional medicine? 
According to this study, fish oil and glucosamine supplements, which have been 
traditionally considered as complementary or alternative medicines, may have gained 
a level of acceptance.  
 
4.4.4 Health promotion and patient preferences 
 
In the context of CVD, health prevention relates to the promotion of healthy eating, 
regular physical exercise, quitting smoking, maintaining healthy weight and reducing 
blood pressure and cholesterol (260). Additionally, risk factors for CVD are strongly 
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influenced by wider circumstances such as access to social services. In the landmark 
INTERHEART study conducted in 52 countries, the risk of MI was associated with 
depression and psychosocial factors such as social isolation in the same order of 
magnitude as conventional risk factors such as hypertension, smoking and 
dyslipidemia (395;396). There are numerous pharmaceutical treatments available for 
hypertension, dyslipidemia and more recently, smoking cessation however many 
other health prevention strategies such as stress management, regular exercise and the 
consumption of fruits and vegetables can require patient education and motivation. As 
a result, it was of relevance to gauge patients interest in hospitals offering diet, 
lifestyle and complementary therapies, some of which would fit into the context of 
health promotion for CVD and prevention of MI.  
 
A large proportion of cardiac surgery patients would consider using at least one of the 
diet, lifestyle or complementary therapies if provided by hospitals regardless of 
gender, income or education. This interest was highest amongst younger cardiac 
surgery patients and those who reported using CMs prior to admission. Unexpectedly, 
only 45% were interested in receiving diet advice and 32% exercise consultations, 
despite good nutrition and physical activity being widely promoted as beneficial in 
CVD. It is possible cardiac surgery patients feel they have sufficient information 
already about diet and exercise, would prefer to use off site institutions and healthcare 
professionals for these services or lack interest in these areas however the reasons for 
this finding are unknown. It is notable that 41% of cardiac surgery patients were 
interested in massage and may reflect an unmet need for greater intimacy in the 
hospital setting. Of those therapies which could be described as providing 
psychosocial support, meditation and stress management were most popular. The 
introduction on these CTs into the hospital setting would provide patients with the 
opportunity to learn new skills that could be used after discharge and possibly have a 
beneficial impact on future disease.  
 
Currently, cardiac rehabilitation programs aim to maximize physical, psychological 
and social functioning of people with pre-existing cardiac disease and typically 
include health education, physical activity, counselling, behaviour modification and 
strategies for self management. According to these results, there is patient interest in a 
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variety of CTs such as massage, chiropractic, stress management and meditation 
which could also be considered.  
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4.5 Surgical patients survey  
 
This survey demonstrated that CMs are used by 46% of surgery patients at Cabrini 
and Frankston Hospitals in the 2 weeks prior to admission and unlike cardiac surgery 
patients in the previous survey; most are self-prescribed or recommended by family 
and friends. Importantly, it identified that the combined use of CMs and prescription 
medicines was not uncommon, many did not tell hospital doctors and pharmacists 
about use and approximately half of these patients intended to continue use whilst in 
hospital. Perioperative CMs usage raises practical issues such as communication and 
record keeping, safe storage and administration as well as safety, legal and ethical 
issues. 
 
The prevalence of CMs use identified for this sample was slightly less than reported 
in international prevalence surveys which ranges from 51% (232) to 73% (234) in the 
2 weeks prior to surgery but more consistent with findings from the cardiac surgery 
patients survey. This is the second survey to find the prevalence of CMs use amongst 
surgical patients was higher than previously reported for surgical patients at two 
Melbourne hospitals indicating the Grauer study has under-estimated use (242).  
 
Use of CMs by surgical patients was associated with female gender, higher income, 
higher education and being a non-smoker which is consistent with international 
studies of surgical patients and the Australian general public (14;231;233). This study 
provided the additional observation that age is not a significant predictor of use 
amongst surgical patients. This finding is important as older age is associated with an 
increased likelihood of adverse events (397).  
 
Similarly to the results obtained in the cardiac surgery patient survey and the survey 
of older Australians by Brownie and Rolfe, multivitamins, vitamin C and fish oils 
supplements were the most commonly used CMs (108) and the main reason for using 
CMs in general was for disease prevention and health maintenance. In accordance 
with the cardiac surgery survey, glucosamine was also found to be a popular 
supplement and used by nearly a quarter of patients and approximately half the 
patients using CMs thought they were effective or effective enough and thought some 
CMs were safe, and by inference, some were not.  
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4.5.1 You didn’t ask 
 
Consistent with findings from overseas studies (229-231), patient disclosure about 
their use of CMs is inconsistent. It is noteworthy that if surgical patients using CMs 
prior to admission did talk to a health care professional about use, it was most likely 
with a GP. Although the survey did not examine the reasons for this behaviour, it is 
possible patients feel more comfortable having this discussion with their GP than a 
hospital doctor or that GPs are more likely to ask patients about use however this 
remains to be further investigated.  
It appears that once patients are admitted to hospital, a ‘don’t ask, don’t tell’ scenario 
prevails. The practitioner surveys have established that hospital doctors and 
pharmacists don’t routinely ask patients about possible use of CMs and the patient 
surveys have established they don’t volunteer the information unsolicited and some 
think it is unimportant. Adusumilli et al identified a similar scenario in a New York 
study where few surgeons or anaesthetists enquired about CMs and patient disclosure 
was extremely low (229).  
 
4.5.2 Patient safety 
 
Although most over-the-counter CMs are considered safe, they can induce adverse 
effects, particularly when used by high risk patients or in high risk situations such as 
the perioperative period which is often characterised by polypharmacy and surgery or 
anaesthetic-induced physiological changes (398).  
 
Numerous interactions between CMs and prescription medicines have been 
documented, some of which have special significance for the surgical patient. 
Response to agents such as midazolam and fentanyl may be reduced with Hypericum 
perforatum (St John’s wort) due to pharmacokinetic interactions whereas a 
pharmacodynamic interaction may occur with tramadol (399). Data from human 
studies and case reports indicate that St John’s wort interacts with warfarin and 
cyclosporine by significantly reducing serum levels of both drugs due to cytochrome 
3A4 induction which has implications for the organ transplant patient or those 
requiring anticoagulation pre- and post-operatively (400). Coagulation disturbances 
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are also possible with numerous CMs due to direct anti-platelet activity or 
pharmacodynamic interactions with antiplatelet or anticoagulant drugs (248). 
 
Of the CMs being used preoperatively, fish oil supplements were most prevalent. 
Whilst there is strong evidence to support the use of fish oils, there is also evidence 
that it can increase the risk of haemorrhage when used in high doses and should 
therefore be used with caution (325). In addition, herbal licorice was being used 
which can induce hypokalaemia and elevated blood pressure (401). The herb St 
John’s wort was being used by four patients which is important because of its 
potential to interact with numerous drugs (402) and therefore influence other aspects 
of patient care beyond the perioperative period. 
 
It is interesting to observe that different information sources will report different CMs 
as potentially increasing the risk of haemorrhage. For example, using the same 
methodology employed by Norred in three published studies of surgical patients, 
(232-234), it could be concluded that besides fish oils, eight different CMs were being 
used by surgical patients which have the potential to increase bleeding risk, including 
licorice and celery (248). In contrast, using Braun and Cohen as an information 
source, there are seven CMs which may put patients at risk of bleeding besides fish 
oils, however these do not include licorice or celery but does include policosanol 
(325).This discrepancy highlights the problems practitioners face when trying to 
locate reliable information about CMs as inconsistencies in the literature are common. 
Until further investigation of the safety of CMs can be established using clinical 
studies and well documented case reports, variations in the literature will continue to 
prevail and patient safety and wellbeing may be jeopardised. 
 
4.5.3 Sources of information and recommendation  
 
Unlike the cardiac surgery survey, most patients in this sample self-prescribed their 
CMs which is similar to the finding by MacLennan et al for the general community 
(13). It is possible patients do not seek professional advice before using CMs in the 
belief that their potential benefits outweigh any potential harm and recommendation 
from a healthcare professional is not necessary. Self care is important and provides 
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patients with a sense of control, promotes an active interest in personal healthcare and 
can have economic and social benefits. However, in order for patients to make 
informed choices, they require access to easily understood, evidence based 
information. Surgical patients reported referring to a wide variety of information 
sources. The most popular are health food stores and GPs followed by naturopaths 
and herbalists, family and friends, books and magazines. Considering some of these 
sources may not provide up-to-date evidence based information, such as books and 
magazines, and some are unlikely to be familiar with the evidence, such as family and 
friends, it is imperative that medical practitioners, pharmacists and CM practitioners 
have adequate education to enable them to provide an informed, evidence based 
opinion.  
 
4.5.4 Health promotion with diet, lifestyle and CM therapies 
 
A major finding of this study is that a majority of surgical patients would consider 
using diet, lifestyle and CM therapies if offered by hospitals, suggesting there is an 
interest in seamless care and a desire to bridge the current divide between services 
offered in the community and hospitals. If future studies confirm this interest then 
practitioner and institution issues should be examined together with funding models to 
determine the feasibility of providing selected CTs to patients, as has already been 
done in numerous U.S. hospitals (8;403).    
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4.6 General Discussion 
 
Despite many strategically orientated initiatives developed in Australia to promote 
EBM, it appears that CMs have been largely ignored and overlooked in the practice of 
medicine and pharmacy within the hospital system. The anaesthetists, pharmacists and 
Frankston Hospital surveys have indicated that several barriers are preventing the 
integration of evidence based CMs into hospital practice as well as the detection of 
potentially harmful or non-evidence based CMs and these are present at the individual 
and group levels.  
 
A review of the literature reveals that barriers to the adoption of evidence into clinical 
practice are continuously being investigated in healthcare however CMs have not 
been investigated elsewhere. Some of the barriers identified in the literature are : lack 
of time and opportunity to become familiar with the evidence, lack of access to the 
evidence, organisational barriers, ineffectual continuing education programs, not 
being convinced of the evidence, not knowing how to apply it and also characteristics 
of the new evidence (37;38). This study has identified that many of the same barriers 
apply to the integration of evidence based CMs into hospital practice and several 
additional barriers specific to CMs.  
 
Importantly, there is a general lack of explicit knowledge about the available evidence 
of the efficacy and safety of commonly used CMs. This appears to be due to limited 
training and/or ineffective training and irregular information seeking behaviours. 
Whilst pharmacists performed better than medical practitioners in the knowledge 
section and were more likely to search for information about CMs, they still have 
limited knowledge about CMs and are ill-equipped to provide patients with evidence-
based opinions about their safe and appropriate use. Ultimately, individual 
professionals need to be informed, motivated and trained to incorporate the latest 
evidence into their daily work.  
 
Several surveys have identified that medical practitioners rely heavily on the opinion 
of colleagues when making clinical decisions (43;404-406). Furthermore, Mayer and 
Piterman identified that if medical practitioners found evidence conflicted with their 
own prior beliefs, they discuss the evidence with colleagues for psychological support 
 306 
and affirmation (407). The prevailing opinions of peers have been identified 
previously as an obstacle to adopting EBM in practice and appear to be a factor in the 
present study (37).  The present study identified that 37% of anaesthetists, 37% of 
pharmacists and 29% of staff surveyed at Frankston Hospital refer to colleagues for 
information about CMs and CTs. Based on results obtained in attitudinal section of 
the survey, it is highly possible that if a systematic review supporting the use of a CM 
product was identified and the individual was uncertain, they may want to discuss the 
evidence with a colleague. Within Frankston Hospital, it is likely that their medical or 
pharmacy colleague would have little knowledge of CMs thereby propagating 
uncertainty about the evidence at hand. Similarly, if an anaesthetist or pharmacist 
from one of the study sites were to ask an opinion of another anaesthetist or 
pharmacist, it is unlikely they will receive an informed opinion.  
 
Surveys have also demonstrated that practitioners place a great deal of importance on 
personal and professional experiences in the process of applying evidence with some 
considering previous experience of greater importance in clinical practice than 
external research evidence (39;406). 
 
All professional groups surveyed in this study reported little experience of personally 
using and practising CTs thereby failing to gain familiarisation and understanding of 
their potential benefits and harms via these avenues. In addition, not regularly asking 
patients about their use of CMs means a failed opportunity to learn about CMs from 
patients experiences. As a result, they have little tacit knowledge and few personal or 
patients experiences from which to draw when reading the literature or discussing 
CMs with colleagues and patients.  
 
In current health care practice, practitioner judgments often reflect clinician or societal 
values concerning whether intervention benefits are worth the cost (408). Over 60% of 
anaesthetists, pharmacists and Frankston staff did not think CMs offer patients a cost 
effective treatment option suggesting that this perception may be another barrier 
preventing their consideration.   
 
Ideally, education about CMs should be incorporated into under-graduate and post-
graduate training programs for doctors and pharmacists. In the United States, the 
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integration of complementary medicine education into the medical school curriculum 
has increased substantially over the past decade with  two-thirds of US and Canadian 
medical schools including either required CM instruction in their curriculum or CM 
electives (409). In Australia, the teaching of CM in medical schools remains highly 
variable between sites and there are few dedicated CM familiarisation courses in 
Australian medical schools (410).  
 
This study has identified that only 9% of anaesthetists have received undergraduate 
training about CM and 6.6% of hospital doctors at Frankston however the extent of 
training about CMs specifically is not known. Considering that most respondents are 
in their mid 40’s and have been in practise for 20 years, this reflects the lack of CM 
education in under-graduate training during that period. As this study shows, 
educational efforts regarding CMs to date have left doctors with little knowledge of 
the CMs that are potentially harmful or useful for their patients and little confidence 
dealing with CMs-related issues. 
 
Post-graduate lectures about CM have been attended by 27% of anaesthetists and 
13.2% of Frankston hospital doctors which suggests anaesthetists have been more 
active in learning about CM than surgeons and medical physicians. Not surprisingly, 
anaesthetists performed better on the knowledge section of the surveys than medical 
physicians and surgeons making them the most informed medical group in regards to 
CMs. The observation that knowledge scores were not significantly different for 
anaesthetists aged under 40 ears of age and over 40 years suggests any recent changes 
to undergraduate or specialty training in regards to CMs has had little impact on their 
knowledge base. In addition, relatively more anaesthetists are interested in future 
training about CMs and CTs compared with surgeons and medical physicians, further 
setting them apart from their other medical colleagues.  
 
Milden and Stokols suggest that medical practitioners receive little or no training 
about CTs due to the fundamental philosophical divide which has long separated 
Western medicine and CM (118). Many advances in Western medicine are largely 
due to the cultivation of objectivism, reductionism and the scientific method however 
these thinking styles have traditionally neglected the influence of the mind and spirit 
on health and disease, which are important features of many CTs. Wynia et al propose 
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that there is disinterest in including CM education because of practical issues which 
are considered more urgent and taken precedence (411). The results of the practitioner 
surveys provide some support for this view as most hospital doctors think it is 
somewhat important, approximately 10% think it is not important and approximately 
30% think it is very important for education about CM to be incorporated into the 
medical undergraduate curriculum. It is interesting to note that a higher percentage of 
pharmacists (48.6%) thought it was very important for CM education to be included 
within the medical undergraduate curriculum compared with hospital doctors.  This 
may relate to their greater familiarity with the evidence about commonly used CMs 
(as observed in the knowledge section) or their greater interest in CMs.  
 
Education about CMs has been introduced into the pharmacy undergraduate curricula 
in the U.S. and Australia (412).  In 1999, a survey of the Colleges of Pharmacy in the 
U.S. found that of the 58 colleges who responded, 19 had dedicated curricula in place 
with another 27 indicated that CM was being incorporated into existing courses. In 
Australia, most CMs training is incorporated into existing pharmacy undergraduate 
courses as part of pharmaceutics, pharmacognosy, therapeutic treatment of diseases 
and medication safety. The pharmacist survey identified that 45% had attended 
undergraduate lectures about CM, far more than reported for any medical group, and 
one factor likely to be responsible for their higher knowledge scores. Specific 
seminars had been attended by 16% and post-graduate lectures by 10% suggesting 
relatively little continuing education. Despite these efforts, current training about CMs 
is insufficient and many pharmacists are unconfident and ill-prepared to counsel 
patients about the safe and appropriate use of CMs.  
 
Of all the professional groups studied, pharmacists showed the most interest in future 
training about CM, particularly about vitamins, minerals and herbal medicines. If 
given the opportunity for further training, pharmacists are likely to maintain their 
position as the more knowledgeable group regarding CMs and could feasibly develop 
specialist expertise in herbal and nutritional supplement counselling within the 
hospital.  
 
In their review, Grol and Grimshaw suggest that the more successful educational 
strategies used to facilitate change in the workplace involve CME activities which are 
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conducted with small groups in an interactive style, computerised decision support 
systems and reminders such as posters and labels with messages (37). These 
approaches are relevant to this discussion and can be applied to improve awareness of 
safety and efficacy issues associated with CMs within hospitals.   
 
In today’s age, medical practitioners and pharmacists are no longer the main providers 
of healthcare information and advice. Previously, MacLennan et al reported that the 
main sources of advice people receive about CMs are from themselves, 
family/friends, medical doctors, the media, health food store, CM practitioners and for 
less than 10% of people it was the chemist (13). In both patient surveys, the sources of 
information about CMs and CTs were explored and slightly different results were 
obtained.  
 
For cardiac surgery patients, pharmacists and medical doctors were the chief sources 
of general and safety information regarding CMs and CTs and used by over 40% of 
respondents with approximately 1 in 5 patients referring to CM practitioners and 
health food stores. It is important to note that over 90% of cardiac surgery 
respondents were taking prescription medicines suggesting they have regular contact 
with medical practitioners and pharmacists and may more readily rely on them for 
healthcare information in general than people taking fewer prescription medicines. 
Patients in the other study reported that health food stores and GPs were their main 
source of information and approximately one quarter obtained information from 
naturopaths and herbalists, family and friends, 17% the internet and 14% from a 
pharmacy.  
 
As these results demonstrate, medical practitioners are relied upon as a source of 
information about CMs and CTs and pharmacists are also utilised, although less 
frequently. Considering people also use resources which may not provide evidence 
based information such as health food stores and the internet and those unlikely to be 
familiar with the evidence such as family and friends, it is imperative that medical 
practitioners, pharmacists and CM practitioners have adequate education to enable 
them to provide an informed, evidence based opinion.  
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4.6.1 EBPC, concordance and CMs within the hospital 
 
Originally, the skills necessary for evidence-based practice were described as : the 
ability to precisely define a patient problem, and what information is required to 
resolve the problem, conduct an efficient search of the literature, select the best of the 
relevant studies, apply rules of evidence to determine their validity, and to extract the 
clinical message and apply it to the patient problem (408). In 2000, a more patient-
centred approach was incorporated, specifically, an understanding of the patient’s 
values and how they affect the balance between advantages and disadvantages of the 
available management options and the ability to appropriately involve the patient in 
the clinical decision making process. The  pragmatic and humanistic basis of patient-
centred care is summed up by Hart who stated ‘health is the product of healthcare, and 
patients are one of the producers, not simply customers’ (413). Today, methods of 
eliciting information about patient values, understanding their beliefs and 
incorporating them in the clinical decision making process remains an important 
challenge in EBM (408). 
 
Systematic reviews show that patient-centred care results in increased adherence to 
management protocols, reduced morbidity and improved quality of life for patients 
(414). As a result, patient-centeredness has been promoted extensively in the literature 
and is now considered by many to be the standard for quality interpersonal care and 
both good clinical and moral practice (51). 
 
In parallel with these changes, the practice of pharmacy also began to evolve from a 
paternalistic approach to a more patient centred approach commonly known as 
concordance.  Concordance aims to achieve the best possible use of medicines and 
requires a frank exchange of information, negotiation and a spirit of co-operation 
between the health care prescriber and the patient (56). It requires health care 
prescribers to take into account patients beliefs, concerns and experiences of their 
illness and treatments and necessitates good communication and consultation skills. 
Australian pharmacists are supportive of the principles of concordance and believe 
that establishing a “therapeutic alliance” is a high priority in the consultation between 
pharmacists and their patients (57). 
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Both shared decision making models require a partnership to be formed between 
practitioner and patient, two-way communication, information giving and agreement. 
Based on the results of this study, it is unlikely that EBPC or concordance is being 
achieved regarding CMs.  
 
This study found that medical practitioners and pharmacists do not routinely ask 
patients about CMs and most patients fail to disclose use, chiefly because they are not 
asked and/or don’t think it is relevant and not because they fear a negative response. 
For a patient using CMs, this omission may hinder the development of an open 
therapeutic partnership and is a clear failure in effective communication. It is also an 
opportunity lost for practitioners to learn more about their patient’s values, beliefs and 
priorities, their experiences with CMs and reasons for use which may relate to their 
current treatments lack of efficacy or side effects. This study suggests that when 
patients do provide information about their use of CMs, healthcare practitioners are 
unfamiliar with the evidence of CMs safety and efficacy and do not necessarily seek 
further information so the information they can provide is likely to be limited to their 
personal experiences, perceptions, attitudes and feelings. Previously Rosenbaum et al 
had demonstrated that practitioners personal use of CM affects their attitudes and 
perceptions of CM and correspondingly, the advice given to patients (415). 
Considering that medical practitioners and pharmacists have limited personal 
experience with CMs, their attitudes and perceptions must be shaped by other 
influences such as peer-group values and possibly the opinions and experiences of 
family and friends. The cumulative effect of these factors means that the fourth and 
final step of achieving an agreement with the patient about their health care will not 
be satisfactorily achieved within this domain.  
 
The three practitioner surveys identified several barriers which prevent the first step 
towards achieving patient-centred care from being conducted i.e. open 
communication. It was consistently found that hospital doctors and pharmacists forget 
to ask patients about CMs suggesting this is not part of their standard routine. 
Furthermore, their attitudes suggest many are not aware of the relevance of asking, 
they lack confidence dealing with CM-related issues and have a perceived and actual 
lack of knowledge about CMs. The obvious remedies are to provide further education 
about the available evidence, ensure reliable resources are accessible and used when 
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in doubt and practical guidelines are developed and promoted which take into account 
patient’s possible use of CMs. The practitioner surveys also identified that databases 
such as MEDLINE were used by approximately half the hospital doctors and two-
thirds of pharmacists when looking for information about CMs and CTs. Evaluation 
of practitioner information seeking skills may also be required and training to improve 
them so evidence relevant to CMs can be more readily located.   
 
From the patient’s perspective, the main reason consistently reported for not telling 
hospital staff about use was not being asked and/or not thinking it is relevant. Patient 
education is required to encourage them to talk about their use of CMs, even without 
being directly asked, and to provide reasons why disclosure is important. It is possible 
that some patients may not consider their use of vitamins or food supplements as CMs 
so this should also be addressed.  
 
Besides communication serving the purpose of two-way information exchange, it is 
often a major component of the medical management in chronic and palliative care. 
Buckman states that compared with most medications, communication skills have 
undoubted symptom relieving effects, a wide therapeutic index and the most common 
problem in practise is sub-optimal dosing (416). At a more mercenary level, poor 
communication skills have been shown to be a predictor of medicolegal vulnerability. 
Whilst not every discussion about CMs will necessitate a change in medication or 
advice to actively alter current practice, it may improve patient wellbeing whilst 
fostering a more open relationship and also reduce the risk of medicolegal 
proceedings should an adverse outcome arise.   
 
Once a discussion about CMs commences, it will quickly become apparent that 
patients and the medical practitioners and pharmacists providing them with healthcare 
advice and treatment have different attitudes.  
 
A comparison between anaesthetists, pharmacists and Frankston hospital staff 
responses to attitudinal statements and the surgical patient’s responses reveals a major 
mismatch in beliefs about CMs and is an important finding of this study. In practice, 
this will present a major challenge for hospital doctors and pharmacists as they strive 
to practice EBPC whilst holding very different views. For example, 55% of patients 
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believe that CMs are appropriate for use and should be made available in a hospital 
setting whereas only 25% of pharmacists agree that CMs are appropriate for use in the 
hospital setting, 15% of anaesthetists and 16% of the Frankston staff. This raises 
issues of creating consensus in clinical practice as many hospital doctors and 
pharmacists are clearly are not supportive of CMs within the hospital setting yet their 
patients are interested and do use them. It also raises the concern that doctors and 
pharmacists may risk legal liability by ignoring patients use and preference for CM 
(417).  
 
Another disparity regards the perceived cost-effectiveness of CMs. Nearly half the 
anaesthetists and Frankston staff surveyed thought CMs are generally a waste of time 
and money compared with only 12% of patients. This is important to bear in mind 
when practitioners are considering whether CMs are worth the cost as their patients 
may believe that they are.  
 
Approximately 80% of anaesthetists and Frankston staff thought that CMs are 
potentially dangerous and require monitoring whereas only 47% of patients agreed 
and thought they need to be supervised. This presents a discrepant perception about 
the safety of CMs and provides a further explanation as to why patients don’t feel 
compelled to tell staff about CMs. It is interesting to find most doctors and 
pharmacists agree that CMs require monitoring yet they do not themselves routinely 
monitor use. It is possible that protocols have not been adequately developed and 
implemented so clinicians are unsure how to deal with issues surrounding the use of 
CMs or they think the responsibility of monitoring CMs lies with someone else.  
 
The statements about CMs requiring more research also attracted different responses 
with over 85% of hospital doctors and pharmacists agreeing they need more hospital 
based research and 59% of patients thinking they need more scientific research in 
general. This is somewhat expected as the practice of EBM emphasises the need to 
locate and use evidence when considering treatment options whereas the public 
appear to be less interested in the need to have scientific evidence supporting CMs 
products.  
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Whilst there is an obvious gap in beliefs between those in the hospital bed and the 
doctors and pharmacists standing next to it, this does not mean a meaningful 
conversation about CMs cannot ensue. Practitioners have an ethical obligation to 
respect patient values and an obligation to discuss treatment options whilst being 
frank about the level of understanding and experience with CMs (418). Sugarman and 
Burke suggest that a broad range of responses can arise when patient use and interest 
in CTs is identified (418). It can range from feeling a sense of obligation to stifle 
harmful practices, mere acceptance of non-harmful modalities to encouragement of 
beneficial CTs. In situations when conventional medicine is clearly ineffective, it may 
be somewhat easier to accept patient’s interest and use of CMs however it is more 
complex when conventional treatments have some evidence of efficacy yet are not 
entirely satisfactory. Additionally, it is more complex when a literature review reveals 
the available evidence does not correspond with ones personal views or is 
inconclusive or non-existent.  
 
In the latter two situations, practitioners could be described as operating within a grey 
zone in which clinical expertise and reasoning are the main tools available and these 
will always be influenced by personal bias (413). This is of particular relevance for 
CMs as some have not yet been subjected to investigation in RCTs. It is also relevant 
for other CTs where controlled clinical testing may not occur for many years, leaving 
clinicians to work within the grey zone.  
 
As discussed previously, when a clinician is faced with evidence which is discrepant 
with their personal bias, they may discuss the information with a colleague and seek 
reassurance however a range of other responses are also possible such as denial, 
disbelief, curiosity or acceptance depending on the practitioners level of awareness. It 
is possible that hospital doctors and pharmacists views that CMs are not cost 
effective, offer false hope and are potentially harmful have been major barriers 
preventing the integration of ‘proven’ CMs into their everyday practice. In the words 
of Anaïs Nin, "We don't see things as they are, we see things as we are." (419). 
 
It can be argued that following the steps in EBM can protect against bias, however 
there always remains the possibility that personal bias (whether consciously or 
unconsciously) influences interpretation of even the most rigorously conducted 
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research study and painstakingly developed guidelines. In the article ‘Mindful 
practice’, Epstein proposes that. mindful critical self reflection can help to uncover 
and manage personal bias (419). Furthermore, mindfulness can link evidence-based 
and relationship-centered care and help to overcome the limitations of both 
approaches. It is likely that the integration of evidence based CMs into hospital 
practice will require practitioners to become more self-reflective and aware of their 
personal biases in addition to the attainment of greater knowledge and familiarisation 
with CMs and development of guidelines to provide a practical direction.  
 
4.6.2 Integration of CTs into hospital practice  
 
For decades the concept of integration has transformed innovation and change in 
healthcare and consisted of forging links between providers, caregivers and patients 
(420). Integration reduces fragmentation and aims to improve efficiency and 
effectiveness in healthcare.  
 
A national survey of 5,810 hospitals in the United States identified that 15% offered 
CM services with nearly half of these centres reporting that patient demand was the 
primary motivating factor (420). The CTs offered include: acupuncture, massage, 
mind-body techniques (e.g. meditation), nutritional counselling and herbal medicine 
counselling. Most started as outpatient clinics either employing CM practitioners or 
providing consultative and referral services and nearly 80% have research ties. 
Interviews with centre directors indicated that deciding which CTs to provide was 
reliant on identifying what the patients want, what doctors thought was credible and 
practitioner availability. In some instances, suitably qualified doctors and nurses 
provide CM services however this is mainly undertaken by licensed CM practitioners. 
Another national survey found that most hospitals offering CM services also offer 
external CM education programs to the community and internal education for staff 
(421).  
 
Based on the practitioner survey findings, there is little practise of any CT by 
Victorian hospital doctors and the integration of CTs into general practice is far more 
advanced than in the hospital setting (166). Similarly, community pharmacists see 
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CM as an integral part of their practise however the same cannot be said of hospital 
pharmacy practice in Victoria (373).Whilst this is the current situation, these surveys 
identified several CTs which are widely accepted as potentially useful by hospital 
doctors and pharmacists and some specific CTs which are of special interest. In 
particular, approximately one quarter of anaesthetists would consider practising 
acupuncture, 35% of pharmacists would consider practising vitamin/mineral therapy 
and 27% herbal medicine. There is also broad acceptance of massage, meditation, 
hypnosis and yoga as useful modalities of little harm, and chiropractic as potentially 
useful but also potentially harmful.  
 
Results from the larger surgical patient survey indicate that nearly 60% would 
consider hospital based massage, approximately half would consider clinical 
nutrition/diet advisory services and exercise consultations, over a third would 
consider stress management and approximately 1 in 4 would consider meditation, 
yoga and naturopathy. There was also patient interest in chiropractic with 
approximately 20% reporting they would consider use of this modality. 
 
If a comparison is made between what patients want (arbitrarily considered as being 
at least 20% of patients) and what hospital doctors and pharmacists think is 
potentially effective (arbitrarily considered as being over 70% agreeing they are 
useful) then the list of CTs remaining is : massage, meditation, yoga, chiropractic and 
possibly acupuncture (19% surgical patients interested and 22% cardiac surgery 
patient) (see Figure 1). Whilst acupuncture was considered useful by nearly all 
hospital doctors and pharmacists, the larger patient study reported 19% would 
consider using it however the cardiac surgery patient survey identified 22% as 
showing interest, thereby placing this on the borderline. Whilst over 20% of patients 
also expressed an interest in clinical nutrition/dietary advice, exercise consultations 
and stress management, these have not been included in this analysis because the 
perceptions of doctors and pharmacists were not evaluated for these lifestyle 
approaches. If further investigation revealed they were also considered useful by a 
majority of practitioners, then the overlap list would be longer.  
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Figure 1. The overlap between what CTs patients would consider using and which CTs 
most hospital doctors and pharmacists think are effective.  
 
 
 
 
Whilst CM services have been integrated into some hospitals in the United States, 
several barriers have been identified which are relevant to this discussion. Santa Ana 
suggests three main barriers exist : a perceived lack of research and data about CM, 
reimbursement complexity and conflict between medical practitioners and CM 
practitioners (422). Ruggie and Cohen confirm that maintaining financial self-
sufficiency is difficult for many centres and ‘belief’ barriers exist whereby medical 
practitioners do not believe CTs are worthwhile offering (8).  
 
The practitioner surveys identified that many hospital doctors and pharmacists have 
limited education about CM and knowledge of the evidence of CMs. This study did 
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not evaluate practitioner’s awareness of the evidence for other CTs although it did 
detect that many CTs are considered potentially useful. As such, the first barrier of 
perceived lack of research data appears to be relevant to the integration of CMs but 
may not be as relevant to acupuncture, massage, meditation, chiropractic and yoga. 
The second barrier regarding reimbursement complexity and financial sustainability 
was not investigated in this research project and in depth investigation of potential 
funding models, health insurance coverage and patients willingness to pay for services 
is required to establish whether this too may be a barrier.  
 
Conflict between medical practitioners and CM practitioners is likely to be based on 
their philosophical differences in their understanding of health, disease, treatment and 
management. By focussing on the common goal of improving patient’s quality of life, 
these viewpoints may align more closely and conflicts avoided. U.S. surveys further 
indicate that CM practitioners must also be committed to teamwork and the idea of 
integrated care if the provision of integrated CM services is to be successful (420). 
 
Based on experiences from Integrative Medicine (IM) centres in the United States, six 
factors must be taken into account when considering the integration of CTs into 
hospitals (8;403;423;424). These are: mission consistency, patients interests, 
organisational interest, scope of service, staffing and financial viability. The 
practitioner and patient surveys have provided baseline information for four of these 
factors. They have identified which CTs are of interest to surgical patients and which 
CTs are accepted as useful by doctors and pharmacists, although their attitudes 
towards hospitals offering these services was not evaluated. By cross-referencing CTs 
accepted by doctors and pharmacists and those of interest to patients, suggestions 
have been made as to which CTs could be considered within the scope of service. 
Identifying that most doctors and pharmacists do not consider regulation of CM 
practitioners as sufficiently stringent has emphasized the need to ensure staff is well 
trained and appropriately credentialed.  
 
Currently Victoria is the only Australian jurisdiction to formally regulate CM 
therapists, requiring practitioners using the title ‘acupuncturist’, ‘Chinese herbal 
medicine practitioner’ or ‘Chinese medicine practitioner’ to register with the Chinese 
Medicine Registration board (425). All state jurisdictions have legislation for 
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registration of chiropractors and osteopaths however the regulation of naturopaths, 
Western herbalists and massage therapists remains subject to various forms of self-
regulation.  
 
As such, if CM practitioners are to be considered for the provision of CTs, training 
and credentialing will need to be rigorous and is extremely important. In regards to 
patient safety, this will be of particular importance in the provision of chiropractic and 
acupuncture as many respondents perceived them as potentially harmful. Meanwhile, 
it is feasible that hospital doctors and pharmacists could more readily accept other 
health care professionals providing CTs, such as anaesthetists providing acupuncture 
and pharmacists providing advice about herbal medicine and vitamin/mineral therapy, 
as they already have registration and are integrated into the hospital system. If 
excellence of care is to be achieved, then it is important that clinicians don’t 
underestimate the depth and breadth of knowledge involved in practising CTs. 
Appropriate training and adequate experience is essential before providing these 
services.  
 
Further investigation is required to confirm these results and evaluate the level of 
acceptance and interest of other patient and practitioner groups at the same and other 
hospital sites, hospital administrators and hospital board’s level of interest and 
importantly, an evaluation of potential funding models.  
 
The containment of rising healthcare costs and patient morbidity are major goals of 
clinicians, hospital administrators and government. CTs may offer the potential for 
substantial public health gains and cost savings from a number of perspectives such as 
in the areas of preventative medicine, optimisation of health and management of 
chronic diseases which are not adequately treated by conventional medical 
approaches. There is also the possibility of long-term cost savings such as reduced 
length of hospital stays and re-admission rates, reduced drug requirements and 
incidence of adverse events, such as admission for gastrointestinal haemorrhage due 
to the use of non-steroidal anti-inflammatory drugs(426).  Currently there are too few 
studies to make firm conclusions about cost-savings for all CTs however, there is 
already evidence that several may be beneficial, notably spinal manipulation therapy 
(such as chiropractic)(426), acupuncture (426), (427) and herbal medicine (427).  
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Investigation of some lifestyle approaches such as meditation and yoga has also 
started and provided some encouraging results. For example, a 5 year study 
undertaken by a U.S, insurance company found that people who practise meditation 
had a 63% reduction in healthcare expenditure, 11.4 times fewer hospital admissions 
for CVD, 3.3 times fewer admissions for cancer and 6.7 times fewer admissions for 
mental disorders and substance abuse compared with those who did not practise 
meditation (428). Another example is provided by the randomised controlled study 
conducted by Dean Ornish which demonstrated that a comprehensive lifestyle 
program which included meditation, yoga and a vegetarian diet in conjunction with 
standard care was associated with improved quality of life, a reversal of coronary 
heart disease angiographically and a cost savings of $58,000 (US) per person when 
compared with a  control group who solely received standard care (429). Since then, 
one of the largest health insurers in the U.S, has started offering the plan to its 
subscribers on site in Pittsburgh and of more than 350 participants who have 
participated since the programs inception, none have suffered a heart attack or stroke, 
none have required bypass surgery and only one has required a surgical procedure 
(430). Based on these impressive results, Highmark Blue Cross Blue Shield has 
created a new company to expand the program around the country.  
 
4.6.3 Patient safety and CMs 
 
CMs manufactured in Australia according to the code of Good Manufacturing 
Practice (GMP) and available over-the-counter (OTC) are regulated as low risk 
products by the Therapeutic Goods Administration however data from in vitro, in 
vivo and human studies and case reports indicate that adverse events and interactions 
with pharmaceutical medicines are possible (284). Safety is of particular concern 
when used without professional supervision by patients at higher risk of adverse 
events such as the elderly, those using multiple medicines or high alert medicines (e.g. 
narrow therapeutic index medicines), with reduced renal or hepatic function, with 
acute or serious disease or who are confused. Safety is also of concern when used by 
patients in situations which can put them at higher risk of adverse events such as 
hospitalisation (431) and the perioperative period which is often characterised by 
polypharmacy and surgery-induced physiological changes (398;432) . 
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There is a culture of continual improvement in patient safety within the hospital 
setting. One important aspect of this relates to medication safety. Part of the strategic 
plan for medication safety in hospitals includes communication, error detection and 
reporting and the use of information to improve medication safety. Hospital doctors 
and pharmacists play an important role in promoting medication safety when taking 
medication histories and recording patient use, prescribing medicines and providing 
information about medicines to patients and other health care professionals.  
 
The medical practitioner and pharmacist surveys indicate there are important 
omissions in the current systems which have allowed surgical patients to take 
potentially harmful CMs during the preoperative period without being identified or 
supervised by an informed practitioner. The likelihood that hospital doctors and 
pharmacists will be able to detect and prevent drug-CM interactions or adverse events 
induced by CMs is slim. The current situation makes it extremely difficult to 
safeguard patients from harmful outcomes associated with the use of CMs and 
strategies are required on multiple levels to remedy the situation.  
 
The use of CMs in the perioperative period has important implications for 
anaesthetists, surgeons and their patients. Morbidity and mortality associated with 
CMs may be more likely in the perioperative period due to the physiological 
alterations that occur during this period and the frequent use of multiple 
pharmaceutical agents. Complications may include excessive bleeding, cardiovascular 
instability, prolonged or inadequate anaesthesia, adverse immunological effects and 
drug interactions with serious outcomes such as organ transplant rejection (398;433). 
 
It has been reported that the most common adverse outcome after cardiac surgery is 
post-operative bleeding (389). As demonstrated in the cardiac patient survey, CMs 
with the potential to induce bleeding are being taking preoperatively by these patients 
however it is not known how many or to what extent complications can be attributed 
to their use. Well-documented usage information and case reports are valuable when 
considering whether bleeding may be a significant risk with CMs and provide grounds 
for hypothesis-testing experiments in the future. Importantly, further research is 
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required to determine the clinical significance of existing evidence which is often 
obtained from in vitro and animal studies. 
 
Research is also required to establish whether the use of CMs together with other 
agents affecting coagulation (e.g. heparin and anti-platelet drugs) will further increase 
the risk of bleeding, as is already seen with some pharmaceutical antiplatelet 
medicines (434). Norred and Brinker report that potentiation of anticoagulant effects 
is suspected when vitamin E is used together with warfarin and documented 
interactions resulting in excessive bleeding have occurred when ginkgo biloba, garlic, 
devil’s claw, dan shen or dong quai were used with warfarin (248). Currently, much 
of this information is based on case reports and remains speculative as most lack 
laboratory analysis of the alleged substances.   
 
Besides having the potential to increase bleeding risk or other unwanted effects in 
surgery, CMs have the potential to interact with drugs used in standard care. Both 
patient surveys identified that the combined use of prescription medicines with CMs 
is not uncommon, presenting the possibility of interactions. Of note, many patients in 
the larger surgical patient study had self-prescribed their CMs, over 40% were also 
taking prescription medicines and several were taking the herbal medicine St Johns 
wort which has demonstrated numerous drug interactions in clinical studies. Results 
from the practitioner surveys indicate that few hospital doctors are aware of 
interactions with commonly used CMs and checking for safety information about 
CMs does not regularly occur. Pharmacists were better in these regards and appear to 
be more likely to detect and prevent interactions if given the opportunity to screen 
patients.  
 
Current knowledge of the pharmacodynamic and pharmacokinetic properties of many 
CMs is incomplete making it difficult to predict when patients should be advised to 
cease use of CMs known or suspected to affect coagulation or cause other unwanted 
effects. The American Society of Anesthesiologists advises anaesthetists to ask 
patients to discontinue use of all herbal medicines two weeks prior to surgery, the 
time estimated for the compounds to be fully metabolized however this time frame is 
largely speculative (246). Grauer proposes a more targeted approach (361) as does 
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Ang-Lee et al who suggest the use of various herbal medicines should be discontinued 
24 hours to 7 days prior to surgery based on the available pharmacokinetic data (398). 
In clinical practice, following these recommendations is problematic. The patient 
surveys found that many do not discuss use of CMs with a health care professional 
within the 2 week period before admission and not all discuss use with hospital 
doctors and pharmacists prior to surgery. It has also yet to be established whether GPs 
and other healthcare professionals in the community are sufficiently informed of the 
potential risks associated with preoperative use of CMs and are able to provide an 
informed opinion to surgical patients.  
 
This discussion of CMs safety has primarily focussed on surgical patients however 
CMs also have the potential to induce adverse effects in other hospital patients and 
patients after discharge. According to Reidle and Casillas, factors which increase the 
likelihood of a general adverse drug reaction include serious illness, renal 
insufficiency, liver disease, polypharmacy and alcoholism (435). Immune reactions 
also occur and are more likely in female patients, adults, those with HIV infection, 
concomitant viral infection, and previous hypersensitivity to a chemically related 
drug, asthma, specific gender polymorphisms, SLE and dependant on the route of 
administration (436). Although CMs have not been specifically investigated in this 
regard, it is likely that similar factors apply and healthcare practitioners should be 
particularly vigilant with these higher-risk groups.  
 
The prevention, recognition and treatment of complications due to CMs begin with 
explicitly eliciting and documenting a history of CMs use and familiarisation with the 
scientific literature. There is an urgent need to provide hospital doctors and 
pharmacists with education about CMs so they are more aware of the possible risks 
associated with use, more confident discussing CMs with patients and more likely to 
document use when taking a medication history. Whilst many patients already 
perceive CMs as potentially unsafe, some are uncertain and many will not tell hospital 
staff about their use because they are not asked or don’t think it’s important. This 
indicates a need for patient education so they will understand the importance of 
discussing their use of CMs with doctors and pharmacists, regardless of whether they 
have been asked or not.  
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Whilst this research has identified the potential for ADRs induced by CMs to go 
undetected and unsupervised, the actual rate and extent of ADRs remains unknown. 
Further research is urgently required for specific CMs and their potential to induce 
ADRs to determine the clinical relevance of these safety issues.  
 
4.6.4 Limitations of the surveys 
 
The practitioner surveys have several limitations which must be acknowledged. 
Firstly, results and care must be taken when results are generalized to hospital 
anaesthetists, pharmacists and doctors nationally since the surveys were conducted in 
metropolitan Melbourne, Victoria. Secondly, whilst the survey instrument was pre-
tested before distribution, it was newly developed and could benefit from a more 
rigorous validation process. Thirdly, it is possible that respondents misunderstood 
survey questions although it was assumed that individuals interpreted questions in the 
intended manner. Fourthly, AltMedDex database was used to provide answers to the 
knowledge section because it is widely available in Victorian hospitals through the 
Clinicians Health Channel however because of variations in the published literature, 
the use of another database or resource may have produced a different set of correct 
answers thereby influencing the results. Finally, this was a voluntary, self-
administered survey, so incomplete data collection may have resulted in response 
bias.  
 
The patient surveys also have several limitations which must be acknowledged. The 
results obtained provide baseline data about a select group of surgical patients 
attending either Cabrini or Frankston Hospitals in Victoria and care must be taken 
when results are generalized to surgical patients nationally. It was a voluntary survey, 
distributed by nurses and self-administered by patients therefore response bias due to 
incomplete survey distribution and data collection is possible. Additionally, whilst the 
survey instrument was pre-tested before distribution, it was newly developed and 
could benefit from a more rigorous validation process. Several other caveats are also 
acknowledged such as exclusion of non-English speakers and participants 
misunderstanding some questions and the term ‘complementary medicines’, even 
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though an explanation was provided. Some patients may not have been aware of the 
ingredients within their CMs or forgotten what was being used and have incorrectly 
indicated which ones they use or omitted the information entirely. Whilst the 
inclusion of medically prescribed CMs may be questioned as they may be considered 
part of standard care and not ‘complementary’, the primary aim of the study was to be 
exploratory in nature, and therefore it was decided to be over-inclusive. 
 
Overall, for both the practitioner and patient surveys, survey items had been carefully 
constructed after extensive consultation and interviews with relevant heads of hospital 
departments, peers, mentors and a statistician which ensured the survey questions had 
face validity however a further formal validation process would have been valuable.   
 
Whilst collecting information by a second method such as additional face-to-face 
interviews and then cross-referencing the results to identify emerging themes would 
have been beneficial, the very good response rates achieved in all surveys, amongst 
all groups at all sites provides confidence in the findings.   
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Chapter Five 
 
Conclusion  
 
 
 
 
5.0 Final Conclusion 
 
Despite many strategically orientated initiatives developed in Australia to promote 
EBM, it appears that CMs have been largely ignored and overlooked in the practice of 
Medicine and Pharmacy within the hospital system. Furthermore, it appears that in 
regards to CMs a ‘don’t ask, don’t tell, don’t know’ culture exists within hospitals and 
that evidence based patient-centred care and concordance is not being achieved and 
thus patient safety and wellbeing is being compromised. Further research is required 
however to ascertain the extent of any possible adverse outcomes. 
 
Surgical patients have a high usage of CMs such as fish oil supplements, 
multivitamins, vitamin C and glucosamine supplements as well as other CMs 
considered as potentially increasing the risk of bleeding or inducing drug interactions. 
Although many CMs taken by surgical patients are medically prescribed, their usage 
is not routinely documented or monitored within the hospital system and it is 
uncommon for patients using CMs to tell hospital staff about this use, mainly because 
they are not asked. Thus many surgical patients are currently taking potentially 
harmful CMs during the preoperative period without being identified or supervised by 
an informed medical practitioner or pharmacist. Further research is required to 
ascertain whether the use of CMs is common amongst other inpatients and so enable 
educational and policy development to be targeted to the relevant healthcare 
professionals 
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The unidentified and unsupervised use of CMs by surgical patients highlights some 
important omissions in current hospital practice. Currently, hospital doctors and 
pharmacists do not routinely ask patients about CMs and do not consistently 
document patient use despite this being considered a standard part of taking a 
medication history and important for QUM. Hospital staff also appear unfamiliar with 
the evidence around CMs and there is likely to be under-reporting of adverse events 
and interactions both internally (within the hospital) and externally (to spontaneous 
reporting schemes). There also needs to be better identification of which CMs should 
be ceased before surgery, when this should happen and when they can be safely 
reintroduced. Further clinical research is also required to evaluate the extent of 
adverse reactions to CMs and their clinical significance along with identifying the 
CMs that may help produce positive health outcomes for surgical patients.  
 
In line with the principles of QUM, drug committees should consider the addition of 
safe and clinically proven CMs to hospital drug formularies, especially when they 
may be more cost effective than pharmaceutical treatments. The inclusion of CMs 
into hospital drug formularies will further promote the integration of evidence based 
CMs into hospital practice and allow patients improved access. It will also allow 
closer supervision of patient use and provide some quality assurance that products 
manufactured under GMP are being used.  
 
While there is the need to further document the use of CMs by hospital patients and to 
establish the clinical significance of both the adverse and positive effects of these 
medicines, it seems that at present the data is not being collected. It is of paramount 
importance that all patients are asked about their use of CMs and this information is 
recorded in the history and medication chart. It should also be communicated to GPs 
via the discharge summary. The two steps of enquiry and documentation are essential 
first steps towards preventing, detecting and managing adverse reactions and 
interactions. Formal CM policy which is based on the best available evidence will 
ensure greater awareness amongst hospital doctors and pharmacists to elicit 
information from patients and document CMs use and thereby optimise patient care. 
 
Several barriers currently prevent the inclusion of evidence based CMs into Medical 
and Pharmacy practice within hospitals. These barriers include a lack of confidence 
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amongst hospital staff in dealing with CMs-related issues which appears to stem from 
the perception of having insufficient knowledge, actual limited knowledge and little 
personal experience with CM along with irregular information seeking behaviours and 
little discussion with patients. Furthermore while hospital medical staff and 
pharmacists support further hospital-based research on CMs, they appear to maintain 
a sense of wariness about CMs expressing concerns about their safety, efficacy and 
cost effectiveness. Barriers also exist at the organisation level as many hospitals do 
not have a designated CM policy or CM guidelines.  
 
While hospital staff currently have little training in or knowledge of, CMs many 
practitioners are interested in further education in this area. Education is urgently 
required at a post-graduate and under-graduate level to ensure current and future 
medical practitioners and pharmacists can provide patients with informed, evidence 
based advice about CMs. In this way patients will not only be safeguarded against the 
use of potentially harmful treatments but also be prescribed safe and effective CMs.  
 
More reliable internet-based and electronic CM databases and reference texts are 
required within various hospital settings including libraries, pharmacy departments 
and wards. Staff continuing education sessions are necessary to ensure that 
practitioners are aware of these resources and able to retrieve the information. 
Communication with CM practitioners may also be useful when patients are unable to 
provide adequate details of the CMs they are taking. The appointment of dedicated 
staff in the hospital, ideally with both mainstream and CM qualifications, would 
provide a further resource as well as providing leadership in regards to maintaining 
and disseminating information about CMs in the hospital.  
 
There is substantial interest in hospital-based diet, lifestyle and CTs by surgical 
patients with 85% of surgical patients stating that they would consider using CTs if 
offered by hospitals. Furthermore, a majority of hospital based practitioners perceive 
CTs as potentially useful and express personal interest in receiving and practising 
some CTs. This was most notable amongst anaesthetists and pharmacists. Several CTs 
are accepted by doctors and pharmacists as potentially useful, especially acupuncture, 
massage and meditation, whereas chiropractic and the medicinal CTs were considered 
potentially harmful. Medical practitioners further consider hypnosis as a useful 
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modality whereas fewer pharmacists are of the same opinion and are more likely to 
consider Chinese medicine, herbal medicine and vitamin/mineral therapy as 
potentially useful. Despite this interest and the growing evidence base to suggest that 
some CTs have proven health benefits, there is currently little practise of CTs by 
Victorian hospital doctors and the integration of CTs into general practice is far more 
advanced than in the hospital setting (166). Similarly, community pharmacists see 
CM as an integral part of their practise however hospital pharmacy do not appear to 
have actively embraced CMs as part of their scope of practice (373).  
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About this Survey 
 
The following survey has been designed to assess hospital patient’s understanding of herbal products and 
supplements and their influence on health. The study hopes to identify areas where practices can be 
improved. The results from this survey are to be used as part of a PhD project conducted by Lesley Braun 
under the supervision of Prof Marc Cohen in the School of Health Sciences at RMIT University. No 
identifying personal information will be recorded and all information will be treated as confidential and 
anonymous. No information from the survey will be given to any health care professional involved in your 
care and answering this survey is voluntary and will not influence the care that you receive in hospital. The 
pooled results will be written up for publication in a medical journal and information may be released 
through the media. Data will be kept for a period of 5 years. For further information about this project please 
contact Lesley Braun or Prof Marc Cohen on 9925 7440. 
 
It is estimated this survey will take you approximately 10-15 minutes to complete. Participation is voluntary 
and your consent is implied by you completing the survey. If you do not wish to fill in the survey, just put 
back it into the envelope and return it - your decision will not affect the care you receive. 
 
This survey has been approved by the Human Research Ethics Committee at RMIT University and the Cabrini Hospital 
Ethics Committee. Any complaints about your participation in this project may be directed to the Secretary, RMIT 
Human Research Ethics Committee, University Secretariat, RMIT, GPO Box 2476V, Melbourne, 3001. Telephone (03) 
9925 1745. Details of the complaints procedure are available from the above address. 
 
Survey on complementary medicine use in hospital patients  
 
In this survey, the phrase ‘complementary medicines’ refers to herbal medicines, vitamin and mineral 
supplements and food supplements which are products that can be bought in a supermarket, pharmacy, 
health-food store, on the internet, from a mail order company or from a practitioner. It does not refer to 
therapies such as massage, acupuncture or chiropractic unless specified. 
1) What is your age?  (please specify) ________years 
2) What is your gender?   Male  Female 
3) What is your highest level of education? 
 Did not complete high school      Completed high school 
 Completed technical studies/apprenticeship   Completed university studies  
4) What is your country of birth? 
 Australia      Other –(please specify)__________________________________ 
5) What is your smoking status?  
 Current Smoker   Past Smoker    Non-Smoker 
6) What is your level of household income per year ? 
 Less than $20,000   $20,001 - $60,000    $60,001 - $100,000    over $100,000 
7) Why are you in hospital?  
 Unsure  
 Surgery (please specify what type)_________________________________________________ 
 Health problem (please specify)__________________________________________________ 
 Injury (please specify)___________________________________________________________ 
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8) How long do you expect to be in hospital? 
 Less than a day   Overnight stay   More than one night stay  
9) How many different prescription medicines have you taken in the 2 weeks before being 
coming to hospital? 
 None    Unsure   One  (1)   Two  (2)  
 Three (3)    Four (4)   Five (5)   More than five 
10) How many different complementary medicine products have you taken in the 2 weeks 
before coming to hospital? 
 None (go directly to question 20 on the last page) 
 Unsure    One  (1)   Two (2)   Three (3)  
 Four (4)    Five (5)    More than five 
11) Please indicate which complementary medicines products you took in the 2 weeks 
before coming to hospital. 
(Please tick as many as appropriate) 
 Multivitamins   Ginger tablets 
 Vitamin C  Licorice (the herb) 
 Vitamin E  Glucosamine 
 Vitamin B complex  Echinacea 
 Fish Oil    Ginseng (Korean or Panax) 
 Evening primrose oil  Horseradish tablets 
 Calcium supplements  St John’s Wort (hypericum)  
 Coenzyme Q10  Feverfew  
 Valerian    Grapeseed extract 
 Policosanol    Guarana 
 Ginkgo Biloba   Liquid herbs 
 Garlic tablets or more than 1 clove/day   Chinese herbal medicine   
 Other (please specify below) 
________________________________________________________________________ 
________________________________________________________________________ 
12) Who recommended or prescribed the complementary medicine products you are taking? 
 GP      Specialist     Pharmacist  
 Health food shop staff    Friend/Relative    Myself 
 Complementary medicine practitioner (eg naturopath/herbalist)  
13) Are you taking a complementary medicine product for the problem that brought you to 
hospital? 
 No   Yes (please specify which complementary medicines_______________________ 
_________________________________________________________________________
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14) With whom did you discuss your use of complementary medicine products during 
the 2 weeks prior to coming to hospital?  
(Please tick as many as appropriate) 
 I did not discuss this with anyone (Go to Question 18)    
 Can’t remember or unsure    General Practitioner  
 Anaesthetist      Physician (medical specialist)   
 Surgeon       Hospital Pharmacist 
 Community Pharmacist     Nurse 
 Hospital information form      Natural Therapist 
 Other (please specify)_____________________________________________________ 
15) If you did not tell anyone in the hospital about your use of complementary medicine 
products was it because: 
(Please tick as many as appropriate) 
 I was not asked 
 I didn’t think it was important 
 The hospital doctors would not understand 
 It’s none of their business 
 I did not want to be judged negatively 
 I did not want to appear ‘disloyal’ 
 Other reasons (please specify)______________________________________________ 
16) Do you intend to continue taking your complementary medicine products while in 
hospital? 
 Yes   No    Don’t know 
17) How will you obtain your complementary medicine products while in hospital?  
 I brought them to hospital myself  
 Family or friends will bring them in 
 They will be delivered by a pharmacist  
 They will be delivered by a naturopath or herbalist 
 Other way of receiving them (please specify) ___________________________________ 
18) Why do you take complementary medicine products?  
(Please tick as many as appropriate) 
 To maximise my health and well-being 
 To prevent disease(s)  
 To treat disease(s) (please state which disease(s))________________________________ 
Other (please specify)________________________________________________________ 
19) On average how much do you spend on complementary medicine products per month? 
  Less than $25     $26 to $50    $51 to $75 
 $75 to $100      $100 -$150   More than $150 
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20) Which of the following people directly asked you about your use of complementary 
medicine products?  (Please tick as many as appropriate) 
 General Practitioner    Anaesthetist  
 Surgeon      Physician ( medical specialist)   
 Hospital pharmacist   Community pharmacist 
 Nurse     None of the above people asked  
 Can’t remember or unsure 
20) Which of the following statements about complementary medicine products do you think 
is correct? 
 All are safe   Some are safe  None are safe   Don’t know 
21) Where do you go to for general information about complementary medicine products?   
(Please tick as many as appropriate) 
 I don’t ask or look for general information about natural and complementary medicines 
 Parents, family or friends 
 Media 
 Internet 
 Books or magazines 
 Pharmacist 
 Surgeon 
 Anaesthetist 
 Doctor  
 Natural Therapist 
 Pharmacy shop staff 
 Pamphlets in stores 
 Product labels 
 Nurse 
 Unsure 
 Health food store staff
 Other (please specify)_____________________________________________________ 
22) Where do you go to for safety information about complementary medicine products?    
(Please tick as many as appropriate) 
 I don’t ask or look for safety information about natural and complementary medicines 
 Parents, family or friends 
 Media 
 Internet 
 Books or magazines 
 Pharmacist 
 Surgeon 
 Anaesthetist 
 Doctor  
 Natural Therapist 
 Pharmacy shop staff 
 Pamphlets in stores 
 Product labels 
 Nurse 
 Unsure 
 Health food store staff
 Other (please 
specify)______________________________________________________ 
23) Which of the following complementary therapies, would you consider using if they were 
made available in hospitals? 
(Please tick as many as appropriate) 
 Stress Management   Dietary Advice  Exercise Consultation 
 Massage  Chiropractic  Osteopathy  
 Chinese Herbal Medicine   Homeopathy  Hypnosis  
 Naturopathy   Meditation  Acupuncture  
 Herbal medicine   Aromatherapy   Ayurvedic Medicine  
 Yoga  Unsure   None of the above  
 Other (please specify)_____________________________________________________ 
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About this Survey 
 
The following survey has been designed to assess hospital patients use and 
understanding of herbal products and supplements and their influence on health. The 
study hopes to identify areas where hospital practices can be improved. The results from 
this survey are to be used as part of a PhD project conducted by Lesley Braun under the 
supervision of Prof Marc Cohen in the School of Health Sciences at RMIT University. No 
identifying personal information will be recorded and all information will be treated as 
confidential and anonymous. No information from the survey will be given to any health 
care professional involved in your care and answering this survey is voluntary and will not 
influence the care that you receive in hospital. The pooled results will be written up for 
publication in a medical journal and information may be released through the media. Data 
will be kept for a period of 5 years. For further information about this project please 
contact Lesley Braun or Prof Marc Cohen on 9925 7440. 
 
It is estimated this survey will take you approximately 10-15 minutes to complete and 
consists of 6 pages. Participation is voluntary and your consent is implied by your 
completing the survey. If you do not wish to fill in the survey, just put back it into the 
envelope and return it - your decision will not affect the care you receive. 
 
This survey has been approved by the Human Research Ethics Committee at RMIT 
University and Peninsula Health. Any ethical complaints about your participation in this 
project may be directed to the Convenor, Peninsula Health Research and Ethics 
Committee on 9784 7695. 
 
Survey on complementary medicine use in hospital patients  
 
In this survey, the phrase ‘complementary medicines’ refers to herbal medicines, 
vitamin and mineral supplements and food supplements which are products that 
can be bought in a supermarket, pharmacy, health-food store, on the internet, from 
a mail order company or from a practitioner. It does not refer to therapies such as 
massage, acupuncture or chiropractic unless specified.  
 
1) What is your age?  (please specify) ________ years 
2) What is your gender?   Male  Female 
3) What is your highest level of education? 
 Did not complete high school      Completed high school 
 Completed technical studies/apprenticeship   Completed university studies  
4) What is your country of birth? 
 Australia     
 Other (please specify)__________________________________ 
5) What is your smoking status?  
 Current Smoker   Past Smoker    Non-Smoker 
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6) Why are you in hospital?  
 Surgery - please specify what type 
_________________________________________________________________ 
_________________________________________________________________ 
 Medical condition/s – please list them  
 
__________________________________________________________________ 
 Injury – please specify  
 
 Unsure  
7) How long do you expect to be in hospital? 
 Less than a day    Overnight stay   More than one night stay 
 
8) Please indicate which of the following people in the hospital directly asked if you 
were taking any nutritional supplements, herbal products or complementary 
medicines?          Tick as many as appropriate 
 Surgeon        Nurse 
 Anaesthetist        Hospital pharmacist 
 Physician (medical specialist)     None of the above people asked  
 Can’t remember or unsure 
  
9) How many different prescription medicines have you taken in the 2 weeks before 
coming to hospital? 
 None     Unsure   One (1)   Two  (2)  
 Three (3)    Four (4)   Five (5)             More than 5 
 
10) How many different vitamin, mineral or herbal products or complementary 
medicines have you taken in the 2 weeks before coming to hospital? 
 Unsure    One (1)   Two (2)   Three (3)  
 Four (4)    Five (5)    More than five 
 None (please go directly to question *21 on page 5 to continue the survey) 
 
11) On average, how much do you spend on nutritional supplements, herbal 
products or complementary medicines each month? 
  Less than $15     $16 to $30   $31 to $50 
 $51 to $75      $76 to $100   More than $100 
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• If the product or complementary medicine(s) you have been taking or are still taking 
is not in the list, or are you are not sure, please write down the name(s) on the 
following line  
 
------------------------------------------------------------------------------------------------------------------- 
12) Here is a list of popular supplements and  
complementary medicines   Please tick the boxes to  
indicate which ones you have taken or are taking now    
I was taking in the  
2 weeks before 
coming to hospital 
I am taking while 
in hospital 
Multivitamins   
Vitamin C   
Calcium supplements   
Magnesium supplements    
Iron supplements   
Coenzyme Q10   
Antioxidants (e.g. Macuvision ®)   
Vitamin B complex (e.g. Berocca ®)    
Vitamin E   
Fish oil capsules (omega 3 essential fatty acids)   
Glucosamine    
Echinacea   
Ginkgo biloba   
Ginger tablets / capsules / liquid   
Garlic product or eating 1 clove daily   
Evening primrose oil   
St John’s wort (Hypericum)    
Liquorice (the herb)    
Policosanol   
Ginseng (Korean or panax)   
Valerian   
Celery (the herb)   
Liquid herbs   
Chinese herbal medicine (s)   
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13) Why do you take nutritional supplements, herbal products or complementary 
medicine/s ? Tick all the answers that apply to you 
 keeps me healthy / prevents disease  gives me a sense of control 
 gives me a sense of wellbeing  because they have few side effects 
 fits into my way of life / philosophy   they are less expensive  
 problem not serious enough to see a doctor   
 they work better or just as well as conventional medicines 
 they were recommended by my doctor, pharmacist or friend 
 to treat a specific disease(s) or condition  
 Other reason for taking them – please specify  
__________________________________________________________________ 
14) Who recommended or prescribed your nutritional supplement, herbal product or 
complementary medicine/s? Tick all the answers that apply to you 
 GP      Medical specialist   Pharmacist  
 Health food shop staff   Friend / Relative    Myself 
 Naturopath / herbalist  Other – please specify 
 
15) How effective is the nutritional supplement, herbal product or complementary 
medicine/s you have been taking or are taking now ?    
 ineffective / useless                 very effective 
 slightly effective         extremely effective    
 effective enough    don’t know, unsure  
16) How will you obtain your nutritional supplements, herbal products or 
complementary medicines while in hospital?  
 I brought them to hospital myself  
 Family or friends will bring them in 
 They will be delivered by a pharmacist  
 They will be delivered by a naturopath or herbalist 
 Other way of receiving them (please specify)  
__________________________________________________________________ 
18) With whom did you discuss your use of nutritional supplements, herbal products 
or complementary medicines during the 2 weeks before coming to hospital? Tick all 
answers that apply to you  
 I did not discuss this with anyone  General practitioner (GP)   
 Surgeon      Community pharmacist 
 Physician (medical specialist)     Health food store staff 
 Anaesthetist      Naturopath / herbalist   
 Can’t remember or unsure    Other person – please specify below  
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19) Who have you told in the hospital about your use of nutritional supplements, 
herbal products or complementary medicines ? Tick all answers that apply to you 
 I did not discuss this with anyone  General practitioner (GP)   
 Surgeon      Nurse 
 Physician (medical specialist)     Naturopath / herbalist 
 Anaesthetist      Wrote it on hospital form 
 Can’t remember /’ unsure     Other person – please specify    
  
 
20) If you did not tell anyone in the hospital about your use of these products, was it 
because:  Tick all answers that apply to you 
 I was not asked                                        I didn’t think it was important 
 hospital doctors would not understand    It’s none of their business 
 I did not want to be judged negatively      I did not want to appear ‘disloyal’ 
 Other reasons - please specify       not applicable   
     
 
 
*21) Which of the following statements about complementary medicines do you think   
is correct?      Tick one box from each list 
  All are safe          They are safer than conventional medicines 
 None are safe         They are just as safe as conventional medicines 
 Some are safe                             They are not as safe as conventional medicines 
 Don’t know 
 
22) Where do you go for information about vitamin, mineral and herbal products, 
complementary medicines or therapies ?  Tick all the answers that apply to you 
 I don’t ask or look for information about these medicines 
 Parents, family or friends 
 Media  (e.g. TV, newspaper) 
 Internet 
 Books or magazines 
 Pamphlets in stores  
 Product labels 
  G.P. 
 Medical specialist 
 Surgeon 
 Anaesthetist 
 Community pharmacist 
 Pharmacy shop staff 
 Nurse 
 Naturopath / 
herbalist 
 Health food store 
 Other – please 
specify on line below
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23) Do you agree or disagree with the following statements ? 
(Please tick one box in each column)  
24) Which of the following complementary and alternative therapies have you used in the last month or 
are still using now ?   Tick all the answers that apply to you 
 Stress Management   Dietary Advice (Clinical nutrition)  
 Exercise Consultation  Massage 
 Chiropractic  Osteopathy  
 Acupuncture  Homeopathy  
 Hypnosis   Ayurvedic (Indian) medicine   
 Meditation  Traditional Chinese medicine (herbs and acupuncture)  
 Naturopathy   Western herbal medicine  
 Aromatherapy  Yoga 
 Unsure   None of the above  
 Other – please explain _______________________________________ 
25/ Which of the following complementary and alternative therapies would you consider using if they 
were made available by hospitals?             Tick all the answers that apply to you 
 Stress Management   Dietary Advice (Clinical nutrition)  
 Exercise Consultation  Massage 
 Chiropractic  Osteopathy  
 Acupuncture  Homeopathy  
 Hypnosis   Ayurvedic (Indian) medicine   
 Meditation  Traditional Chinese medicine (herbs and acupuncture)  
 Naturopathy   Western herbal medicine  
 Aromatherapy  Yoga 
 Unsure   None of the above  
 Other - please suggest a therapy_________________________________________ 
26) What is your level of household income per year ? 
 Less than $20,000        $20,001 - $45,000       $45,001 - $60,000    
 $60,001 – $100,000       over $100,000 
THANKYOU FOR TAKING THE TIME TO FILL IN THIS SURVEY 
Co     Complementary, alternative medicines and therapies 
Strongly 
Agree 
Agree Neither 
agree or 
disagree 
Disagree Strongly 
Disagree 
▫ should be made available in hospitals      
▫ are generally a waste of time and money      
▫ can be dangerous and need to be supervised      
▫ offer people a false sense of hope       
▫ need more scientific research      
▫ are something most of my friends would 
consider  
     
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About this Survey 
 
The following survey has been designed to assess hospital staff’s attitudes and understanding of 
complementary medicines and therapies and their influence on patient health and safety. The 
study hopes to identify areas where current practice can be improved. The results from this 
survey are to be used as part of a PhD project conducted by Lesley Braun under the supervision 
of Prof Marc Cohen in the School of Health Sciences at RMIT University. No identifying personal 
information will be recorded and all information will be treated as confidential and anonymous. 
The pooled results will be written up for publication in a medical journal and information may be 
released through the media. Data will be kept for a period of 5 years. For further information about 
this project please contact Dr Michael Ben Meir on 0413089529 or at the Emergency Department 
on 95081500 or  Lesley Braun on 0417 362 900 or Prof Marc Cohen on 9925 7440 
It is estimated this survey will take you approximately 15 - 20 minutes to complete.  
Participation is voluntary and your consent is implied by you completing this survey. 
This survey has been approved by the Human Research Ethics Committee at RMIT University. Any complaints about your participation in 
this project may be directed to the Secretary, RMIT Human Research Ethics Committee, University Secretariat, RMIT, GPO Box 2476V, 
Melbourne, 3001. Telephone (03) 9925 1745. Details of the complaints procedure are available from the above address. 
Survey on complementary medicine use in hospitals  
In this survey, the phrase ‘complementary medicines’ refers to herbal medicines, vitamin and mineral 
supplements and food supplements which are products that can be bought in a supermarket, pharmacy, 
health-food store, on the internet, from a mail order company or from a practitioner. It does not refer to 
therapies such as massage, acupuncture or chiropractic unless specified.  
1) What is your position in the hospital? 
 Obstetrician / gynecologist  Emergency Medicine Doctor  Paediatrician  
 Hospital pharmacist Anaesthetist 
 Physician/Specialist –(please specify specialty)________________________________ 
 Surgeon (please specify specialty) ___________________________________________ 
 Other (please specify)_________________________ 
2) What is your age?  (please specify) ________years 
3) What is your gender?   Male  Female 
4) How many years have you been in practice? (please specify) ________years 
5) Are you directly involved in patient care?   Yes    No (go to question 14) 
6) What is the average number of patients you see each week? ________________ 
7) Do you ask patients about use of complementary medicines? 
 Always       Often – more than 60% of the time 
 Sometimes – (30% – 59%)   Occasionally  -(5% –29%) 
 Rarely – less than 5%   Never (go to question 9) 
Comment_______________________________________________________________ 
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8) If you do ask patients about use, what do you do with this information?  
(Please tick as many as appropriate) 
 Verbally inform relevant surgeon, anaesthetist or physician about CM use 
 Verbally inform other health professionals about CM use (eg. pharmacist, dietician) 
 Don’t record patient use  
 Record use in the patient history  
 Record use on inpatient medication chart 
 Other (please specify below) 
___________________________________________________________________ 
9) Reasons for not asking patients about complementary medicines use include: 
(Please tick as many as appropriate)  
 It’s too time consuming     I forget to ask 
 I don’t have the opportunity to ask   I don’t have sufficient knowledge about it  
 I don’t think it is relevant     I assume patients will tell me  
 Other (please specify below) 
________________________________________________________________________ 
10).Do you feel confident that you have sufficient knowledge to identify when 
complementary medicines could adversely affect patient care? 
 Always       Often – more than 60 % of the time 
 Sometimes – (30% – 59%)   Occasionally  -(5% –29%) 
 Rarely – less than 5%   Never  
Comments - 
 
11) How often do you check for side effects and drug interactions if complementary 
medicines are being used? 
 Always       Often – more than 60% of the time 
 Sometimes – (30% – 59%)   Occasionally  -(5% –29%) 
 Rarely – less than 5%   Never  
12) What advice do you generally give to patients who are taking complementary 
medicines? (Please tick as many as appropriate)  
 I don’t feel confident to advise on complementary medicines use 
 Advise them to consult another health care practitioner about complementary medicines 
 Advise them to keep taking all their complementary medicines  
 Advise them to cease taking all their complementary medicines  
 Advise them to cease taking specific complementary medicines (Please specify which ones 
below) 
________________________________________________________________________ 
 
________________________________________________________________________ 
 
Comments_______________________________________________________________ 
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13) What percentage of your patients do you think take complementary medicines 
products in the 2 weeks prior to coming to hospital? 
 None    Less than 10%  
 10%-25%   26%-40%  
 41%-50%   51%-60% 
 61%-70%   above 70% 
14) What percentage of your patients do you think take complementary medicines 
products during their hospital stay? 
 None    Less than 10%  
 10%-25%   26%-40%  
 41%-50%   51%-60% 
 61%-70%   above 70% 
15) To what extent do you agree with the following statements: 
(Please tick one box in each column)  
 
Complementary medicines  
Strongly 
Agree 
Agree Neither 
agree or 
disagree 
Disagree Strongly 
Disagree 
are appropriate for use in a hospital setting      
are generally a waste of time and money      
are potentially dangerous and need to be monitored      
offer a false sense of hope and exploit vulnerable 
individuals 
     
offer patients cost effective treatment options      
need more hospital based research       
are something that most of my colleagues would 
consider 
     
regulations for complementary medicine 
practitioners need to be tightened 
     
16) Where do you source information about complementary medicines and therapies? 
(Please tick as many as appropriate)  
 I don’t refer to any sources  Reference texts such as MIMs  
 Databases such as Pubmed/medline   Internet – world wide web eg. google  
 Peer-reviewed medical journals    Medical media/non peer reviewed journals 
 Seminars / conferences/ lectures    Community or hospital pharmacist  
 Friends and/or family     Colleagues  
 Complementary medicine practitioners  Health food shop staff 
 Company literature     Other (please specify)__________________ 
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17) What level of training have you had about complementary medicine and therapies 
 No formal training      Lectures during my postgraduate training 
 Lectures in my undergraduate course  Self directed study 
 Attended specific lectures / seminars  Formal study (cert/diploma/degree) 
 Other (please specify)_______________________ ____________________________ 
18) Are you interested in receiving further training about complementary 
medicines/therapies? 
 Not interested   Interested 
19) How important do you think it is for education on complementary medicine to be 
included in the medical undergraduate curriculum?  
 Not Important   Somewhat Important   Very important 
20) Below is a list of commonly used complementary medicines. Which ones (if any) 
do you consider to have the following properties. (Please tick as many as appropriate)  
 May 
increase 
the risk 
of 
bleeding 
Has 
CNS 
sedative 
activity 
Has 
proven 
clinical 
use 
Interacts 
with 
warfarin 
Interacts 
with 
digoxin 
Interacts 
with 
SSRIs 
Interacts 
with 
cyclosporin 
1) Unsure        
2) Chamomile        
3) Co Q10        
4) Echinacea        
5) Ginger        
6) Garlic        
7) Ginkgo Biloba        
8) Glucosamine        
9) Fish oils        
10) St John’s Wort        
11) Valerian          
12) Vitamin E        
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21) Indicate your opinion of the potential usefulness AND potential harmfulness in general, 
of the following complementary therapies by ticking the appropriate boxes  
(Please tick “No opinion” or one box in each category) 
 
USEFULNESS HARMFULNESS 
  
NO 
OPINION 
NOT 
USEFUL 
MODERATELY 
USEFUL  
HIGHLY 
USEFUL 
NOT 
HARMFUL  
OCCASIONALLY 
HARMFUL  
FREQUENTLY 
HARMFUL  
 1 2 3 4 5 6 7 
a) Acupuncture 
              
  
              
b) Aromatherapy 
              
  
              
c) Chinese Herbal Medicine 
              
  
              
d) Chiropractic 
              
  
              
e) Herbal Medicine 
              
  
              
f) Homeopathy 
              
  
              
g) Hypnosis 
              
  
              
h) Massage 
              
  
              
i) Meditation 
              
  
              
j) Naturopathy 
              
  
              
k) Osteopathy 
              
  
              
l) Reflexology 
              
  
              
m) Spiritual Healing eg. Reiki 
              
  
              
n) Vitamin / Mineral Therapy 
              
  
              
o) Yoga 
              
  
              
p) Other ________________ 
              
 (please specify) 
 
Comments: 
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22a) Have you received, or considered receiving, treatment yourself with any of the 
following therapies? 
22b) Have you practiced or considered practicing any of the following therapies? 
(Please tick as many as appropriate) 
RECEIVED 
 
PRACTICED  
  WOULD NOT 
CONSIDER 
receiving 
treatment 
WOULD 
CONSIDER  
receiving 
treatment  
HAVE 
RECEIVED 
treatment 
in the  past 
12 months 
 WOULD 
NOT 
CONSIDER 
practicing 
WOULD 
CONSIDER  
practicing  
HAVE 
PRACTICED 
in the past 12 
months 
  
1 2 3  4 5 6 
a) Acupuncture 
            
  
            
b) Aromatherapy 
            
  
            
c) Chinese Herbal Medicine 
            
  
            
d) Chiropractic 
            
  
            
e) Herbal Medicine 
            
  
            
f) Homeopathy 
            
  
            
g) Hypnosis 
            
  
            
h) Massage 
            
  
            
i) Meditation 
            
  
            
j) Naturopathy 
            
  
            
k) Osteopathy 
            
  
            
l) Reflexology 
            
  
            
m) Spiritual Healing eg Reiki 
            
  
            
n) Vitamin / Mineral Therapy 
            
  
            
o) Yoga 
            
  
            
p) Other ____________ 
            
  (please specify) 
Have you personally used any vitamin, mineral, herbal or other supplement in the past 4 weeks?  
If so please list them below. 
______________________________________________                    ________________________________________________________ 
______________________________________________                    ________________________________________________________ 
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23)  If a patient asked you whether they should use, or consult a practitioner of one 
of the following therapies how would you generally respond?  
 
  NOT CONFIDENT TO 
DISCUSS THE 
ADVANTAGES AND 
DISADVANTAGES 
WITH PATIENTS 
ACTIVELY 
DISCOURAGE 
NEITHER 
ENCOURAGE NOR 
DISCOURAGE 
ACTIVELY 
ENCOURAGE  
  1 2 3 4 
a) Acupuncture 
 
      
  
 
      
b) Aromatherapy 
 
      
  
 
      
c) Chinese Herbal Medicine 
 
      
  
 
      
d) Chiropractic 
 
      
  
 
      
e) Herbal Medicine 
 
      
  
 
      
f) Homeopathy 
 
      
  
 
      
g) Hypnosis 
 
      
  
 
      
h) Massage 
 
      
  
 
      
i) Meditation 
 
      
  
 
      
j) Naturopathy 
 
      
  
 
      
k) Osteopathy 
 
      
  
 
      
l) Reflexology 
 
      
  
 
      
m) Spiritual Healing e.g. Reiki 
 
      
  
 
      
n) Vitamin / Mineral Therapy 
 
      
  
 
      
o) Yoga 
 
      
  
 
      
p) Other ________________ 
 
      
  (please specify) 
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24)   In the past 4 weeks can you estimate how many patients have you seen who you 
consider to have experienced the following:  
  DON’T KNOW  
or  
UNABLE TO 
ESTIMATE 
ADVERSE EVENT 
from a 
complementary 
therapy  
INTERACTION  
between 
complementary 
therapy and 
medical therapy  
INAPPROPRIATE 
WITHDRAWAL 
 from medical 
therapy by a 
complementary 
therapist 
DELAY IN DIAGNOSIS 
or effective treatment 
due to inappropriate 
use of complementary 
therapies  
Please write the number of corresponding patients in each box or place a zero or line through boxes that do not apply to your patients. 
No of patients No of patients No of patients No of patients 
 
a) Acupuncture      
 
   
  
     
 
   
b) Aromatherapy      
 
   
  
     
 
   
c) Chinese Herbal Medicine      
 
   
  
     
 
   
d) Chiropractic      
 
   
  
     
 
   
e) Herbal Medicine      
 
   
  
     
 
   
f) Homeopathy      
 
   
  
     
 
   
g) Hypnosis      
 
   
  
     
 
   
h) Massage      
 
   
  
     
 
   
i) Meditation      
 
   
  
     
 
   
j) Naturopathy      
 
   
  
     
 
   
k) Osteopathy      
 
   
  
     
 
   
l) Reflexology      
 
   
  
     
 
   
m) Spiritual Healing eg. Reiki      
 
   
  
     
 
   
n) Vitamin / Mineral Therapy      
 
   
  
     
 
   
o) Yoga      
 
   
  
     
 
   
p) Other ________________      
 
   
 (please specify) 
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Preamble 
This resource document has been developed by VicTAG as a model that can be adapted to the 
needs of individual health care facilities in accordance with hospital policy and the approval of 
the hospital’s Drug and Therapeutics Committee. The model aims to encourage open disclosure 
and discussion about the use of CAMs by patients and their health care providers in order to 
promote patient safety and minimise adverse events. 
 
• Currently 50 to 60% of the adult population use CAMs on at least an annual basis. 
Australian data suggest that 39% of people taking CAMs will also consume 
conventional medicines. CAMs are also commonly administered by parents or 
guardians to paediatric or dependant patients. 
• Information about CAMs is variable. Some CAMs have good quality evidence about 
their benefits and risks, whereas others have very limited information about their effects. 
For this reason, interactions with other medicines, conditions and procedures can be 
unpredictable. Use of CAMs can lead to adverse drug interactions and increase the risk 
of bleeding during or after surgery. 
• It is important to be open-minded and non-judgmental about CAMs and encourage 
patients/carers to inform healthcare professionals if they have been using them, and if 
they wish to continue their use while in hospital. 
• Taking a positive, pro-active approach to CAM usage is important in order to maintain a 
positive professional relationship with the patient/carer and apply an evidence-based 
approach to minimizing patient harm. 
 
Definitions 
The primary body that regulates drug registration in Australia is the Therapeutics Goods 
Administration (TGA). It is a requirement under the Therapeutic Goods Act 1989 (the Act) that 
medical products to be imported into, supplied in, or exported from Australia be included in the 
Australian Register of Therapeutic Goods (ARTG) as either a registered medicine or a listed 
medicine. In order for a product to be included in the ARTG, a sponsoring company is required 
to make an application, which usually consists of a form accompanied by data to support the 
quality, safety and efficacy of the product. Individually compounded medicines prepared for an 
individual do not have to be registered or listed. 
 
Registered medicines 
Prescription medicines 
Medicines assessed as having a higher level of risk must be registered (not listed). The degree 
of assessment and regulation they undergo is rigorous and detailed, with sponsors being 
required to provide comprehensive safety, quality and efficacy data. 
Prescription medicines fit into the sub-category of registered medicines as high-risk registered 
products. This group includes all prescription medicines (ie. medicines with ingredients which 
are included in Schedule 4 or Schedule 8 of the Standard for the Uniform Scheduling of Drugs 
and Poisons) and some specified products such as sterile injectables. 
These medicines are identified by an ‘Aust R’ number on their packaging e.g. for Lipitor®, the 
Aust R number is 59603. 
 
Non-prescription (OTC) medicines 
Low-risk Registered products are non-prescription medicines. They usually contain ingredients 
which are described in Schedule 2, Schedule 3, and sometimes Schedule 5 or 6 of the 
Standard for the Uniform Scheduling of Drugs and Poisons. Products in this category are 
considered to be lower risk than prescription medicines. However, they still require a high level 
of scrutiny, for example to ensure adequate labelling for appropriate use. 
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Listed medicines 
Listed medicines are usually considered to be relatively benign, so the regulations allow for 
sponsors to 'self assess' their products in some situations. The majority of listed medicines are 
self-selected by consumers and used for self-treatment. 
They are all unscheduled medicines (ie. not described in the Standard for the Uniform 
Scheduling of Drugs and Poisons) with well-known established ingredients, usually with a long 
history of use, such as vitamin and mineral products or sunscreens. These are assessed by the 
TGA for quality and safety but not efficacy. 
This does not mean that they do not work. It simply means that the TGA has not evaluated them 
individually to see if they work. It is a requirement under the Act that sponsors hold information 
to substantiate all of their product's claims. For example, sunscreens can be a listed product 
yet, they must have complied with testing under the Australian standard for sunscreens. 
These medicines are identified by an ‘Aust L’ number on their packaging e.g. for CoEnzyme 
Q®, the Aust L number is 69050. 
 
Complementary and alternative medicines (CAMs) 
CAMs describe a group of products that are not presently considered to be part of 
‘conventional medicine’. People use CAMs in a variety of ways. CAMs used alone are often 
referred to as ‘alternative therapies’. CAMs used in addition to ‘conventional medicine’ are 
referred to as ‘complementary’ or ‘integrative’. CAMs include vitamin, and mineral supplements, 
herbal medicines, other nutritional supplements, traditional medicines such as ayurvedic 
medicines and traditional Chinese medicine (TCM), homeopathic medicines and aromatherapy 
oils. 
CAMs may be either registered or listed, depending on their ingredients and the claims made. 
Most CAMs included in the ARTG are listed and some are registered. Individually compounded 
CAMs prepared for an individual and some other CAMs (particularly those imported from 
overseas) are usually not registered or listed. The quality of such products may vary or not be 
known. 
 
Special Access Scheme (SAS) 
The SAS refers to arrangements that provide for the import and/or supply of an unapproved 
therapeutic good for a single patient, on a case by case basis. It requires approval from the 
TGA or from a delegate appointed to act on TGA's behalf. 
 
 
Hospital Formulary 
Within the hospital, medications can be: 
(a) Available on the formulary. This means that doctors in the hospital are authorised to 
prescribe them and the hospital is able to supply them. There can be some restrictions on who 
can prescribe formulary medications and these restrictions usually relate to cost and safety. 
Some formulary items may also be prescribed by nursing staff e.g., paracetamol. To be 
available on the formulary, medications must be assessed by the Drug and Therapeutics 
Committee or equivalent body that is responsible for drug therapy within the hospital. This 
committee has the authority to add any medicinal compound to the formulary. Some CAMs may 
be available on the hospital formulary for example calcium supplements, folic acid, vitamin and 
mineral supplements etc. 
 
(b) Non formulary items. Many medications that are registered or listed for use by the 
TGA are not on the formulary. This may be because they are new products and an application 
for inclusion on the formulary has not been made, there may be no perceived need for that 
medication to be available on the formulary e.g., a similar medication of the same class may 
already be available, or a decision may have been made not to include the medication on the 
formulary because of concerns about cost, safety or efficacy. If a patient is already using a non 
formulary medication when admitted to hospital they may be asked to provide their own supply 
in circumstances when the medication is not readily available within the hospital. 
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When non formulary items, including CAMs, are being prescribed frequently a submission 
should be made to the hospital’s Drug and Therapeutics Committee or equivalent body for 
formulary inclusion. The hospital Drug and Therapeutics Committee or equivalent body will then 
evaluate the safety and efficacy of the medications. 
 
Other Definitions 
Guardian – the term guardian, as used in these guidelines, refers to those who have the legal 
right to make decisions on behalf of a patient, this may include parents. 
Carer – the term carer as used in these guidelines refers to any person who may assist in the 
care of a patient and includes parents, guardians, other family members and friends. A carer is 
not able to make decisions on behalf of a patient unless they have been legally appointed as a 
guardian. 
 
Guideline statement 
This guideline is not an endorsement for or against general use of CAMs, rather, it is an 
acknowledgement by the hospital that CAMs are widely used by the public. This guideline aims 
to provide procedures within the hospital for the handling of CAMs and can be modified in 
accordance with local hospital policy as approved by the hospital’s Drug and Therapeutics 
Committee. 
 
The hospital has a duty of care to all patients to ensure that any materials, drugs, substances or 
equipment supplied to or used by inpatients including any CAMs used within the hospital, 
whether patient/carer administered or not, are used as safely as possible taking into account 
quality, safe dosage and storage, and usage. 
 
This guideline applies to CAMs where use is initiated by in-patients or by their guardians, and 
the CAM(s) is/are brought into the hospital to be administered during their stay in hospital. It 
does NOT apply where use of the CAMs is initiated and prescribed by hospital clinicians. 
These fall within general hospital policies about the supply, administration, and safe storage of 
medicines. 
 
The fundamental requirements within the guidelines are: 
• It is the patient’s or their guardian’s prerogative if they wish to continue using CAMs, 
however, they must discuss this with their treating doctor(s), particularly if the CAMs will 
be taken during their inpatient stay. 
• The treating doctor(s) must decide whether to approve usage or advise the patient or 
their guardian against use. The doctor should also advise the patient and their carers of 
any changes to their primary treatment which are necessary because of the patient’s use 
of CAMs and document this in the medical record. 
• When the use of CAMs is approved by the doctor they must be prescribed on the 
Medication Chart and be administered by the nursing staff. 
• When the doctor advises the patient or their guardian that use of CAMs is not 
recommended but the patient or their guardian wishes to continue using these CAMs, the 
patient or their guardian is required to sign a usage statement listing products used 
without their doctor’s approval and self medicate with documentation on the CAM Self 
Medication Chart. The doctor should also sign the usage statement to indicate that they 
have advised against the use of the listed CAMs during the hospital stay and note why 
they have recommended against the use of the listed CAMs. 
• The CAM Self Medication Chart must be kept with the Medication Chart. A note should 
be made on the Medication Chart to indicate that the CAM Self Medication Chart is being 
used. 
• When CAMs are prescribed on the Medication Chart or recorded on the CAM Self 
Medication Chart a full description of the product including active ingredient(s), brand 
name, strength and the dosage must be recorded. 
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• Patients and their carers are responsible for the procurement of their own supply of 
CAMs (unless they are available on the hospital formulary and prescribed by a medical 
officer). 
• The hospital and the treating doctor(s) do have a duty to advise a patient or their 
guardian of any risks which may arise given the patient’s or their guardian’s wish to 
continue with any CAMs. The hospital and the treating doctor(s) may determine, in the 
patient’s best interest, that they should not provide any treatment or service which will 
increase any risk to a patient’s health, given the patient’s or their guardian’s wish to 
continue use of any CAMs. In all circumstances the doctor(s) should ensure that the 
advice given and the decision of the patient is clearly documented in the medical record. 
• Suspected adverse drug reactions or interactions involving CAMs should be reported to 
the Adverse Drug Reaction Advisory Committee (ADRAC) in the same manner as for 
‘conventional medications’. The same hospital procedures for handling suspected 
adverse drug reactions or interactions should be applied to both CAMs and ‘conventional’ 
medicines. 
 
Responsibilities 
Responsibilities of patient or guardian 
• To notify clinical staff of any CAMs they are using and/or wish to use during their inpatient 
stay. 
• To obtain approval from their treating doctor if they wish to use CAMs during the inpatient 
stay. 
• If the patient or their guardian is advised by their treating doctor that use of any CAMs is 
not recommended and the patient or their guardian wishes to use the CAMs against 
medical advice, the patient or their guardian is required to: 
1. Sign a usage statement listing the products. 
2. Self medicate with documentation on the CAM Self Medication Chart. 
3. Notify nursing staff when doses are required. 
4. Inform nursing staff when doses are administered. 
• To supply any CAMs not available on the hospital formulary. 
• To give the CAMs, in their original packaging clearly labelled with the patient’s name, to 
nursing staff to safely store in the locked ward cupboard, locked bedside locker, drug 
trolley or other medication storage facility. 
 
Responsibilities of hospital clinical staff 
• Hospital clinical staff should not administer CAMs or permit the administration of CAMs by 
patients or carers except according to the hospital policy. 
• On admission, medical, nursing and pharmacy staff should specifically ask patients and 
carers about use of CAMs when taking the medication history. 
• On admission patients and their carers should be provided with the CAM patient 
information brochure. 
• Discuss with the patient and their carers the use of CAMs with the aim of ensuring that: 
− the patient and their carers can distinguish between CAMs that may be helpful and 
those that are potentially harmful. 
− the patient and their carers are advised: 
− of the importance of disclosing information about use of CAMs to health care 
professionals because interactions with other prescribed and over the 
counter medications can be unpredictable. In certain cases there is strong 
evidence to say that these interactions are harmful. 
− that quality control is not guaranteed with all CAMs in the same way as 
conventional medicines. 
− the possibility of any risk of interaction with their primary treatment. 
− the possibility of any risks associated with a procedure. 
− of any potential adverse effects. 
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− how to report any adverse effects or withdrawal effects associated with using 
CAMs. 
• Communicate with other health professionals involved in the care of the patient regarding 
the use of CAMs as required with the patient’s or guardian’s permission. 
 
Responsibility of the treating doctor(s) 
• To seek information about the potential effects and quality of the patient’s CAMs 
• Provide information about the potential effects and quality of the patient’s CAMs to the 
patient and their carers. 
• To ensure that the patient and their carers have been provided with the CAM patient 
information brochure. 
• Decide whether to approve the use of CAMs or advise against use of CAMs during the 
hospital stay. 
• If the decision is to approve use of CAMs during the inpatient stay then to prescribe the 
CAMs on the Medication Chart as with other pre-admission medication. A full description 
of the product including active ingredient(s), brand, strength and dosage must be 
recorded. 
• If the decision is to advise against use then to advise the patient and their carers that the 
use of the specified CAMs is not recommended and explain why they are not 
recommended and document this in the patient’s medical record. 
• Advise the patient and their carers of any changes to their primary treatment which are 
necessary because of the patient’s use of CAMs and document this in the patient’s 
medical record. 
• If the patient or their guardian wish to continue the use of CAMs against medical advice 
then to: 
1. Document this decision and the CAMs being used in the patient’s medical record. 
2. Ask the patient or their guardian to sign the usage statement listing the products 
being used against medical advice. 
3. Sign the usage statement and document the reasons why the products are not 
recommended. 
4. Ask the patient or their guardian to complete the CAM Self Medication Chart. 
• Ensure that any use of CAMs is recorded in the patient’s medical record and on the 
discharge summary (including if they are not used during inpatient stay). The information 
recorded should include: 
− discussions regarding the approval process; 
− the name of the CAMs being used; 
− when and how administered; 
− in what dosage; and  
− who is responsible for administration. 
• Record and report any adverse reactions as per hospital guidelines. 
 
Responsibility of nursing staff 
• Monitor use and safe storage of CAMs. 
• Safely store CAMs in the locked ward cupboard, locked bedside locker, drug trolley or 
other medication storage facility. 
• Provide CAMs to patients and their carers when they are to ‘self administer’ a dose. 
• Only administer CAMs when prescribed on the medication chart. 
 
Resources 
 
Useful resources for information about CAMs 
• Hospital Drug Information Centre 
• Altmedex (from Clinician’s Health Channel) 
• Review of Natural Products (Facts & Comparisons) 
• AusDI – herbal monographs 
   
 
Complementary and Alternative Medicines 
 
Date of approval by Drug and Therapeutics Committee  Page   
Date of review: 
7 
• Herbal Medicines (Pharmaceutical Press, UK) 
• Natural Medicines Comprehensive Database (http://www.naturaldatabase.com/) 
• Braun L and Cohen M. Complementary medicine interactions Part 1. The Journal of 
Complementary Medicine 2004; 8 : 78-85 
• Braun L and Cohen M. Complementary medicine interactions Part 2. The Journal of 
Complementary Medicine 2004; 10 : 88-91 
• Braun L and Cohen M. Complementary medicine interactions Part 3. The Journal of 
Complementary Medicine 2004; 11 : 70-82 
• Braun L and Cohen M. Herbs and natural supplements – an evidenced based guide. 
Elsevier Australia. 2004 
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Appendix 1. Name: 
CAM self medication chart  
 
UR number: 
 
 
 or affix patient label 
This chart is to be filled out by the patient or guardian and must be kept with the Medication Chart 
at all times. 
 
√ = medication taken     x = not taken  
 
CAMs 
Include full details of 
active ingredient(s), 
brand, strength and 
dosage. 
Dose 
times 
    
  
Date Date Date Date 
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Appendix 2. 
Complementary & Alternative Medicines (CAM) Usage 
Statement for Inpatients 
       
 
 
 
 
 
 
 
Background 
CAMs describe a group of products that are not presently considered to be part of 
‘conventional medicine’. People use CAMs in a variety of ways. CAMs used alone are often 
referred to as ‘alternative therapies’. CAMs used in addition to ‘conventional medicine’ are 
referred to as ‘complementary’ or ‘integrative’. CAMs include vitamin, and mineral supplements, 
herbal medicines, other nutritional supplements, traditional medicines such as ayurvedic 
medicines and traditional Chinese medicine (TCM), homeopathic medicines and aromatherapy 
oils. 
This hospital has a duty of care to all patients to ensure that CAMs used within the hospital, 
whether self-administered by the patient or guardian or not, are used as safely as possible, 
taking into account quality, safe dosage and storage and appropriate use. If inpatients wish to 
use CAMs within this hospital, they may use them only within the guidelines. 
For the full guideline refer to the pharmacy department. 
If a patient or their guardian wishes to use CAMs while he/she is an inpatient, he/she 
must first discuss it with his/her treating doctor. If the doctor recommends against use 
but the patient or guardian still wishes to use the CAMs they must sign the CAM use 
against medical advice statement. 
 
 
 
 
Patient/guardian section 
 
I…………………………………….(patient/guardian) of……………………………………………... 
 
………………………………………………………………………………………………….…(address) 
 
wish to continue use of the following Complementary or Alternative Medicines (CAMs) during 
this admission, commencing on ……/……/……(admission date) (list CAM(s)) …………………… 
 
………………..……………………………………………………………………………………...……… 
 
………………………………………………………………………………………………………………. 
 
………………………………………………………………………………………………………………. 
 
AGAINST THE ADVICE OF THE TREATING DOCTOR Dr ………………………………………… 
 
I have been advised that continuing use of these CAMs is not, in the opinion of the above 
named doctor, in my/the above named patient’s best medical interests. Despite receiving this 
advice, I wish to continue use of the CAM(s) listed above. 
 
AFFIX IDENTIFICATION LABEL 
 
 
Or print name and UR Number 
1. Read the hospital’s CAM guideline and discuss with the patient or guardian 
2. Provide patient or guardian with a Complementary & Alternative Medicines Brochure 
3. Obtain the signature of the patient or guardian for CAMs usage against medical advice 
4. Document the reasons for the recommendation and sign the CAM usage statement 
COMPLEMENTARY AND ALTERNATIVE MEDICINE USE AGAINST MEDICAL ADVICE 
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I have been given the opportunity to obtain information on the effects and interactions between 
these CAMs and other medicines and procedures. I understand that there may be limited 
information available and therefore I have been advised that some adverse effects and 
interactions that may present a risk to me/the patient named above may occur and cannot be 
predicted. 
 
I have been given a copy of the CAM brochure and I agree to: 
1. Supply the CAM(s) for myself/the patient named above. 
2. Take/give the dose recommended by the supplier of the CAM(s). 
3. Notify nursing staff when I take/give each dose of CAM(s). 
4. Label the CAM(s) with my/the patient’s name and give the CAM(s) to nursing staff to 
store. 
5. Record on the CAM Self Medication Chart when each dose has been taken. 
I agree to take/give the CAMs according to the above conditions and the guideline as outlined. 
 
………………………………….  …………………………………. ………………………… 
Patient or guardian name    Signature    Date 
 
Medical practitioner section 
 
I…………………………………………………..medical practitioner of ……………………………….. 
 
…………………………………………………………………………………………………….(address) 
 
have advised ………………………………………………………(name of patient or their guardian) 
 
that in my opinion continuing treatment with the CAM(s) listed above is not in the best medical 
interest of this patient because of the following reasons……………………………………………… 
 
………………………………………………………………………………………………………………. 
 
………………………………………………………………………………………………………………. 
 
……………………………….…..  ………………………………… ………………………… 
Medical practitioner name    Signature    Date 
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Appendix 3 Patient information brochure 
Using Complementary and Alternative Medicines (CAMs) 
 
What are complementary and alternative medicines (CAMs)? 
CAMs describe a group of products that are not presently considered to be part of conventional 
medicine. People use CAMs in a variety of ways. CAMs used alone are often referred to as 
‘alternative’ therapies. CAMs used in addition to ‘conventional’ medicine are referred to as 
‘complementary’ or ‘integrative’. CAMs in Australia include herbal medicine, vitamin and mineral 
supplements, other nutritional supplements, traditional medicines such as ayurvedic medicines 
and traditional Chinese medicine (TCM), homeopathic medicines and aromatherapy oils. An 
herbal practitioner or naturopath or your general practitioner may have prescribed these. You 
may have purchased them from a pharmacy, supermarket, health food store, on-line or you may 
have prepared them at home using ingredients passed on by generations of family members. 
 
How can I be sure that CAMs are safe and effective? 
A common misconception with CAMs is that many people think that because they are “natural” 
they are safe. However harmful effects have occurred and can be quite serious, such as liver 
poisoning. It is therefore important to discuss all medicines including CAMs with your doctor. 
In Australia, registered medicines are required to meet strict standards. Most medicines 
prescribed by your doctor are TGA registered. This means that there are scientific studies to 
prove that they are safe and effective. An ‘Aust R’ number on their packaging identifies these 
medicines. Medicines can also be TGA listed. Listed medicines are considered to be safe, but 
there may be limited information to say that they are effective. These medicines have an ‘Aust 
L’ number on the label.  
If a medicine or CAM does not have an Aust R or L number there is limited information to say 
that it is safe and effective and the quality of the product may vary or not be known. 
 
Use of CAMs in hospital 
Information about CAMs is variable. Some CAMs have good quality evidence about their 
benefits and risks, whereas others have very limited information about their effects. For this 
reason their interactions with other medicines, conditions and procedures can be unpredictable. 
We want to provide you with the best care we can. By telling medical staff, nursing staff or the 
pharmacist about ALL your medicines including CAMs, we can discuss with you the risks or 
benefits about continuing them while you are in hospital. 
 
You need to tell your doctor, nurse and pharmacist about: 
♦ All medicines prescribed by your GP and any specialists. 
♦ Patches, HRT (hormone replacement therapy), eye drops, inhalers. 
♦ Creams, ointments or lotions used for medical conditions. 
♦ CAMs, eg Naturopathy, homeopathy, health shop products. 
♦ Pharmacy medicines available without a prescription. 
♦ Vitamins, mineral, supplements and herbs. 
♦ Preparations prescribed by your naturopath or herbalist. 
♦ Traditional herbal preparations used by your family. 
If in doubt, ask your doctor, nurse or pharmacist. 
 
CAMS and interactions with other medicines 
Over half of the Australian population use CAMs each year. Many will take conventional 
medicines at the same time. Information about interactions is increasing, but some effects are 
still unpredictable. For your safety, your doctor may recommend that you cease your CAMs 
when new medication is started.  
For example the following CAMs may increase the risk of bleeding in patients who are taking 
warfarin, though the effect can depend on the amount you are taking: 
Carnitine, Celery, Dong Quai, Evening Primrose Oil, Fish Oils, Garlic, Ginger, Ginkgo, Korean 
Ginseng, Policosanol, Vitamin E. 
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These are only examples and it is important that you speak to your doctor or pharmacist to see 
if there is any risk of interactions between your CAMs and conventional medicines. 
 
CAMs and surgery 
If you are booked or admitted for surgery you should always tell your doctor or pharmacist about 
all your medicines, including CAMs. Some CAMs can lead to complications during or after 
surgery. 
For example the following CAMs may increase your risk of bleeding during or after surgery, 
though the effect can depend on the amount you are taking: 
Celery, Devil’s Claw, Dong Quai, Feverfew, Vitamin E, Garlic, Ginkgo, Korean Ginseng, Green 
Tea, Policosanol. 
Other CAMs can affect blood pressure and blood sugar which may cause problems when you 
have an anaesthetic. 
Your doctor may advise stopping your CAMs for about a week before surgery to minimise the 
risk of complications. However, if you have any concerns about stopping your CAMs you should 
discuss this with your doctor. The products listed are only examples and it is important to 
provide your doctor with a full list of all the medicines you are taking, including CAMs. 
 
What if I wish to keep taking CAMS in hospital? 
If you wish to continue taking CAMs during your hospital stay discuss this with your treating 
doctor. Occasionally we may advise you to stop taking CAMs, because of concerns about 
possible interactions with conventional medicines, risks associated with a procedure or with 
your medical condition. If your doctor recommends that you stop your CAMs during your 
hospital stay but you wish to continue using them we will ask you to sign a usage statement. 
Your doctor will explain the reasons why you should stop taking any CAMs 
 
If I get side effects from starting or stopping CAMs should I report this? 
It is important that you tell medical staff, nursing staff or the pharmacist about any side effects 
that you think may be caused by starting or stopping CAMS so that they can be reported. This 
information may help healthcare professionals to assess the benefits and risks both for you and 
for other patients in the future. 
 
Will the hospital supply CAMs? 
If you are continuing the use of CAMs during your admission, you may use your own supply of 
CAMs during your hospital stay. These will be locked safely in the hospital’s medicine cupboard, 
in accordance with our medicines policy. You can ask the nursing staff for them when you need 
them. The hospital will not be responsible for supplying or administering CAMs unless 
prescribed by your doctor. 
 
Our responsibilities 
• To ask you about all of your medicines. 
• To advise you about the safety of all medicines. 
 
Your responsibilities 
• To tell us about all of your medicines. 
• To tell us if you wish to continue taking a complementary medicine while you are in 
hospital. 
• To supply your own complementary medicines while you are in hospital. 
• To give all your medicines to the nurses for safe storage. 
 
Where can I obtain more information about CAMs? 
You should always discuss your CAMs with your doctor or pharmacist. 
The NPS Medicines Line is a consumer medication information service that is available on 
weekdays during normal business hours on 1300 888 763 
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Interpreter Services 
Patients and carers who experience English language difficulties may ask to have a 
professional interpreter to assist with any queries about the information provided. Please ask 
the staff to make arrangements for an interpreter to visit whilst in hospital. Telephone interpreter 
service 131450 
 
This brochure is available in translation. 
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Appendix 4 
Flowchart for use of CAMs 
 
Patient wishes to use 
CAM(s) whilst in hospital. 
 
No Yes 
Treating doctor approves of 
CAM(s) use. 
Patient signs usage statement. 
Treating doctor documents reasons for 
recommendation and signs usage statement. 
Patient or carer records non-approved CAM(s) on the 
CAM Self Medication Chart including a full description 
of the product and dosage. 
Record the use of the CAM Self Medication Chart on 
the Medication Chart and keep the two charts together. 
Patient or carers to supply all CAMs in original 
containers and labelled with the patient’s name. 
All CAMs kept in locked medication storage facility. 
Prescribe CAM(s) on 
the medication chart 
- include full 
description of 
product and dosage. 
- if the product is a 
non-formulary item 
ask patient to 
provide own supply. 
- all CAM(s) to be 
labelled with the 
patient’s name and 
kept in locked 
medication storage 
facility. 
 
 
Treating doctor to 
counsel patient or 
guardian regarding 
risks associated with 
continued use of 
CAM(s). 
Patient wishes to 
continue use of 
CAMs. 
Discontinue use 
and document in 
the patient’s 
medical record. 
Yes 
No 
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9th December 2004 
(SET) Science Engineering &  
Technology  
Portfolio Office  
 
        Bundoora campus  
        Building 201  
        Level.2, Room.06 
     PO Box 71  
     Bundoora 3083 
      Victoria Australia 
 
      Tel +61 3 9925 7096 
Fax +61 3 99257098 
Dear Lesley,  
 
FLSAPP 14 – 04 BRAUN “Reducing clinical risk in patients taking complementary 
medicine products” 
 
Thank you for your letter regarding an amendment / extension to your research 
project. The committee reviewed your request at meeting 11 – 04 on Wednesday 
December 1st 2004  
 
It was noted under G2 on you original application that the following Hospitals would 
be used for data collection purposes. Monash Medical Centre, (Clayton Campus), 
Frankston Hospital, Cabrini Hospital and Alfred Hospital. The committee further 
noted that it has only sighted an Ethics approval / Hospital approval letter from the 
Cabrini Hospital. The committee must sight these documents prior to the 
commencement of data collection. The committee requests that these documents be 
forwarded to Julie Barnett at your earliest convenience.  
 
I am pleased to inform you that the committee has recommended that your request to 
extend your study sample to include Pharmacy staff at the Austin Hospital and Royal 
Melbourne Hospital be approved subject to receiving the relevant approval from 
both these organisations  
 
If you require any further clarification please contact me on 9925 7714 or via email 
Barbara.polus@rmit.edu.au  
 
Once you have met these requirements you will receive confirmation that you can 
commence your research. 
 
Yours faithfully, 
 
Barbara Polus, 
Chair, Science Engineering & Technology   
Portfolio HREC Sub-committee (Life)  
 
cc:  Marc Cohen 
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12 August 2004  
 
 
 
Ms Lesley Braun 
C/- Prof Marc Cohen 
RMIT University 
Swanston Street 
MELBOURNE   VIC   3000 
 
Dear Lesley 
 
01-09-08-04 
Complementary medicines use in surgical patients. 
 
The Cabrini Human Research Committee discussed your project at its 
meeting on 9 August 2004.  The questionnaire was approved for use 
after the following amendments are incorporated: 
 
• increasing the font size to at least 12 pitch; and 
• including the Cabrini complaints person. 
 
The questionnaire would be enhanced by the incorporation of a 
definition of complementary medicine. 
 
Please advise whether input from nurses has been considered .  It is 
noted that nurses are expected to administer the study.  It is 
acknowledged that prescribers are surveyed. 
 
The focus groups are not yet approved, due to lack of information. 
Please clarify who will be recruited to the focus groups, what their role 
will be, how focus groups will be conducted and their expected 
outcomes. 
 
Prof Legg and A/Prof Lording have been delegated by the CHREC to 
review your amendments and give final approval. 
 
We look forward to hearing from you. 
 
Yours sincerely 
 
 
 
 
Val Johnson 
Manager 
Cabrini Human Research Ethics Committee 
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Friday 19 November 2004 
 
To HRE-SC 
 
RE Amendment/ extension of our research project 
 
 
Dear Dr Polus and members of the HRE-SC,   
 
I am very pleased to report that the Complementary Medicines in Hospitals study is 
progressing well and generating a lot of interest. Last week I was invited to speak at the 
Victorian Therapeutic Advisory Group meeting about this research project and have 
since been asked to formally advise on their Complementary Medicine in hospital 
guidelines. This meeting was attended by Directors of pharmacy departments at 
numerous Victorian hospitals and has generated further support for the project.  
 
As a result, I would like to extend the sample to include hospital staff at two other 
Victorian hospitals in addition to the ones listed in the original ethics application. 
Specifically, I would like to include pharmacy staff at the Austin hospital and Royal 
Melbourne Hospital as these hospitals have large departments and their involvement 
will greatly aid the study.  
 
The purpose of this letter is to ask permission for the sample to be extended to include 
these two additional groups. The same survey tool will be used and provided with 
envelopes to preserve anonymity and data collection will be undertaken in the same 
way. Directors of each department have been notified and are aware of the project.  
 
  
I look forward to hearing from you soon. 
  
Kind regards,  
 
 
 
Lesley Braun 
 
 
 
Marc Cohen 
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9th December 2004 
(SET) Science 
Engineering &  
Technology  
Portfolio Office  
         Bundoora Campus 
         Building 201 
         Level.2, Room.06 
      PO Box 71  
      Bundoora 3083 
       Victoria Australia 
        Tel +61 3 9925 7096 
Fax +61 3 99257098 
Dear Lesley,  
 
FLSAPP 14 – 04 BRAUN “Reducing clinical risk in patients taking complementary 
medicine products” 
 
Thank you for your letter regarding an amendment / extension to your research 
project. The committee reviewed your request at meeting 11 – 04 on Wednesday 
December 1st 2004  
 
It was noted under G2 on you original application that the following Hospitals would 
be used for data collection purposes. Monash Medical Centre, (Clayton Campus), 
Frankston Hospital, Cabrini Hospital and Alfred Hospital. The committee further 
noted that it has only sighted an Ethics approval / Hospital approval letter from the 
Cabrini Hospital. The committee must sight these documents prior to the 
commencement of data collection. The committee requests that these documents be 
forwarded to Julie Barnett at your earliest convenience.  
 
I am pleased to inform you that the committee has recommended that your request to 
extend your study sample to include Pharmacy staff at the Austin Hospital and Royal 
Melbourne Hospital be approved subject to receiving the relevant approval from 
both these organisations  
 
If you require any further clarification please contact me on 9925 7714 or via email 
Barbara.polus@rmit.edu.au  
 
Once you have met these requirements you will receive confirmation that you can 
commence your research. 
 
Yours faithfully, 
 
 
Barbara Polus, 
Chair, Science Engineering & Technology   
Portfolio HREC Sub-committee (Life)  
cc:  Marc Cohen 
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         23/12/04 
Hi Lesley 
  
Project Title       Reducing clinical risk in patients taking complementary medicine 
products 
Project No         H2003/02130 
  
 I am pleased to be able to advise you that you study has been approved under the 
Expedited Ethical Review Process pending advise from Kent Garrett that he is 
happy for his staff to participate .  The study may commence once we receive this 
advise. 
  
This approval will be tabled at the next HREC meeting on 20.01.2005 for 
ratification. 
  
regards 
  
Pauline  
  
Pauline Jacklin  
Administrative Secretary  
Research Support Unit  
Tel 9496 4090  
-----Original Message----- 
From: Lesley Braun [mailto:lgbraun@bigpond.net.au] 
Sent: Monday, 20 December 2004 11:57 
To: JACKLIN, Pauline 
Subject: expedited HREC forms attached 
Hello Pauline, here is the information regarding the complementary 
medicine survey. 
If you need more, please dont hesitate to ask, kind regards, Lesley Braun 
 
************************************************** 
This email contains confidential information intended only for the person named above and may 
be subject to legal privilege and confidentiality obligations imposed by legislation or be subject 
to intellectual property protection or copyright. If you are not the intended recipient, any use, 
disclosure, copying or distribution of this transmission is prohibited. If you have received this 
message in error, please notify us immediately by return email and delete the original email and 
any attachments. Austin Health provides no guarantee that this transmission is free of virus or 
that it has not been intercepted or altered.  
************************************************** 
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        2/2/05 
Hello Lesley  
Just a quick note to let you know that your extension was approved at Monday night's meeting.  
You will receive written notification as soon as we get the chance to type the letter!  
Best wishes  
Val Johnson  
Manager, Cabrini Clinical Education and Research Institute  
183 Wattletree Rd  
Malvern 3144  
ph 9508 1376  
fax 9508 1993  
email vjohnson@cabrini.com.au  
 
---------------------------------------------------------------------------- 
This email and any attachments may be confidential, and are intended solely 
for the use of the individual(s) or entity to whom they are addressed. 
If you are not the intended recipient of this communication, please notify 
the sender immediately and delete the email and any attachments. 
Cabrini does not guarantee that this email is virus or error free. 
----------------------------------------------------------------------------  
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        28/04/05 
 
 
Dear Lesley, 
 
 I have been given authority by the HRE-SC to recommend approval for this extension 
of your study (Frankston cohort) subject to the condition that, as you outlined below, 
the methods for distributing and collecting surveys is the same as has been previously 
approved at Cabrini, that the survey is essentially the same as those previously 
approved by the HRE-SC except that minor changes that need to be made so that 
relevant questions are asked for each survey group and that copies of the final survey 
are delivered to Julie Barnett so they can be filed along with your application. 
Frankston HREC approval also needs to by sighted and filed by us. 
 
A copy of the extract of the minutes which determined this method of handling 
extensions to your project will be forwarded to you as quickly as possible. 
 
I wish you well in your research endeavours. 
 
Regards, 
 
Dr. Barbara Polus 
Chair, HRE-SC (Biomedical) 
SET Portfolio 
RMIT University 
 
>>> "Lesley Braun" <lgbraun@bigpond.net.au> 04/26/05 4:26 pm >>> 
Hi Barb, 
The study is progressing very well and data is pouring in at the moment from austin and 
alfred hospitals.  
 
The Frankston staff survey has achieved over a 70% response rate with all medical and 
pharmacy staff. Needless to say, they are now interested to have their patients included 
in the study  to determine actual patient use and attitudes at their site.  
A research assistant from the Dept of Thoracic medicine is available and has agreed to 
undertake data collection of 2 key groups at the hospital - 
a/ surgical inpatients 
b/ oncology outpatients 
 
Together, with Dr Gary Braun (Thoracic physician at frankston hospital - also my 
husband), we will fill in the ethics papers for that site so i would like to apply to extend 
the study to include these patients. The surgical inpatient population will be given their 
survey in a blank envelope on the ward by the research nurse who will also collect them 
which is essentially the same methodology as before. The same patient survey as has 
been used at Cabrini will be used for this group.  
 
The oncology outpatient group will be given their survey whilst waiting to be seen by 
their Dr in the outpatient waiting area. Once again, the survey is an anonymous one and 
will be delivered in a blank envelope. This patient survey will have minor 
modifications from the cabrini patient survey and a sample of the finalised survey will 
be forwarded to you when complete. 
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Thanking you in advance, 
Lesley Braun  
 
 
 
 
 
 
 
 
 
Dear Lesley      10/3/05 
  
Thanks for your enquiry. You have ethics approval to conduct this survey in Anaesthesia. 
  
Best wishes. 
  
-----------------------------------------------------  
Rowan Frew  
Ethics Manager, Research & Ethics Unit  
Alfred Hospital  
Commercial Road  
Melbourne VIC 3004  
Ph  +613 9276 3848  
Fax +613 9276 2222  
Email r.frew@alfred.org.au  
------------------------------------------------  
-----Original Message----- 
From: Lesley Braun [mailto:lgbraun@bigpond.net.au]  
Sent: Wednesday, 9 March 2005 10:47 
To: r.frew@alfred.org.au 
Subject: CM study at the Alfred 
Good morning Rowan,  
The complementary medicine study has started with the Alfred's 
Pharmacy department and I am now contacting you in regards to 
extending the study to include staff anaesthetists.  
I have contacted Paul Myles who has agreed for his department to be 
involved and now would like to apply for ethics approval so we can 
move ahead.  
The same survey will be used as the one already approved for the 
pharmacists which is an anonymous, self administered survey.  
  
Thanks, Lesley Braun 
  
 
Cabrini hospital surgical patients – phase 2 
Modification to cardiac patient surveys for general surgical patient survey.  
 
Having completed the pilot study amongst inpatients on wards 1 north and 1 south, it is now clear that 
some modifications would be desirable to the original survey.  
 
These modifications are in blue on the attached sample survey and in summary, are the following – 
a. deletion of 2 questions 
b. changed positioning of several questions 
c. condensing 2 questions into one question with new question/answer format for easier patient use 
d. addition of 2 new questions (1 from the approved staff survey) for more information about patient 
attitudes 
e. addition of extra answer options for some questions to provide more specific information 
f. clarification of the term ‘complementary medicines’ throughout the survey 
 
In detail, these changes are the following -  
 
1. Although the phrase complementary medicine was defined on the first page, it appears that further 
clarification is required within the actual survey. As such, the phrase has been expanded and is 
now ‘vitamin, mineral, herbal products or complementary medicines’ or ‘nutritional supplements, 
herbal products or complementary medicines’ where appropriate.  
2. Nursing staff suggested that some respondents were not interested in filling out the survey because 
it asked them to divulge their income. In order to encourage more participants, this question has 
now been placed at the end of the survey. 
3. The list of complementary medicines has been expanded to include additional answers that have 
been received from respondents in the pilot study. E.g. magnesium and zinc supplements 
4. The position of previous question 20 has been shifted to appear earlier in the survey and is now 
after question 12. This means people are asked why they take complementary medicines after 
recording which ones they take. This should provide more accurate information. Answers to this 
question have also been expanded to allow more details to be recorded.  
5. The position of previous question 22 has been shifted to appear earlier in the survey and is now 
after question 7.  
6. The position of previous question 19 has been shifted to appear earlier in the survey and is now 
after question 10.  
7. Question 15 is a new question and asks people about their perception of how effective their 
complementary medicines are. This will help to determine why they are taking them and may be 
an influence on disclosure rates.    
8. In questions 18 and 19, the term ‘natural therapist’ has been replaced with  ‘ naturopath / herbalist’ 
which is more specific. 
9. Previous questions 13 and 25 have been removed.  
10. Previous questions 11 and 14 have been condensed into new question 12. Now people are asked 
which complementary medicines they were taking 2 weeks prior to admission and which ones 
they are still taking in hospital within the same question. The format is also different to make this 
question easier to answer.  
11. Question 21 – a new answer option has been added 
12. Question 23 is a new question. This is adapted from question 14 in the approved staff survey. It 
provides all respondents with an opportunity to express negative or positive attitudes to 
complementary medicine.   
 
